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Evidence of neuroanatomical abnormalities in subjects with a recent first episode of psychosis 
(FEP) has been heterogeneous, possibly due to the increased risk of false positives and 
heterogeneous findings associated with small samples that dominate the literature. In addition, 
the clinical impact of such findings has been limited. Machine learning promises to overcome this 
limitation, however, initial attempts to identify FEP have yielded inconsistent results. Within this 
movement, deep learning has recently emerged as a promising approach in areas such as visual 
and speech recognition, as well as other areas of medicine. Its ability to capture highly abstract 
and complex interactions may be useful to capture the characteristic subtle and widespread 
neuroanatomical changes of FEP. 
 
The overarching aim of this doctoral thesis was to investigate neuroanatomical abnormalities in 
FEP at the individual level in a mega-analytic approach. Structural Magnetic Resonance Imaging 
(sMRI) data was collated from five independent studies, totalling 1074 participants. FEP and 
healthy controls (HC) were first compared using voxel-based morphometry in a large-scale mega-
analysis. This was followed by a thorough review of the current evidence for deep learning in 
psychiatric and neurologic neuroimaging. A deep neural network, along with other well-
established methods for comparison, were then used to classify FEP and HC at each site 
separately to test for the reproducibility of findings. Finally, a deep neural network was used to 
classify the two groups in a large-scale mega-analysis. 
 
Collectively, results revealed a pattern of fronto-temporal-insular changes identified both at group 
and individual level. Deep neural networks performed better than traditional machine learning 
approaches, albeit by a small margin. However, performances were lower than expected overall, 
ranging between 50 and 70%. Upon interpreting these results, I was able to show evidence for 
publication bias, suggesting that initial studies may have been over-optimistic. Consist with this, 
the large-scale deep learning analysis suggested that the reliable classification of FEP based on 
neuroanatomical data may be around 60%. In light of these results, future studies should continue 
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1.1. Introduction to psychotic disorders  
Psychotic disorders are amongst the most debilitating mental disorders (C. J. L. Murray et al., 
2012; Walker, McGee, & Druss, 2015). With a lifetime prevalence of approximately 3% (Perälä et 
al., 2007), psychotic disorders constitute one of the costliest disorders, representing about 9% of 
all economic costs of brain disorders in Europe (Olesen et al., 2012). The experience of a 
psychotic episode can involve a constellation of symptoms, typically categorized in positive (or 
‘reality distortion’) symptoms such delusions, hallucinations and formal thought disorder, and 
negative (or ‘psychomotor poverty’) symptoms such as problems with emotion experience (e.g. 
anhedonia, avolition, apathy) and emotion expression (e.g. blunted/restricted affect) (van Os & 
Kapur, 2009).  
 
Current diagnostic systems such as the International Statistical Classification of Diseases and 
Related Health Problems (ICD-10) (World Health Organization, 2004) and the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-5) (American Psychiatric Association, 2013) classify 
the psychotic illness into a myriad of categories that describe how symptoms can be clustered to 
allow grouping of patients. These categories are often further grouped into non-affective 
psychosis, which includes schizophrenia, schizophreniform disorder, schizoaffective disorder, 
delusional disorder, brief psychotic disorder, substance induced psychotic disorder; and affective 
psychosis which includes depression/bipolar disorder with psychotic features. The classification 
of the observed symptoms into one of these psychotic disorders mainly depends on the number 
and duration of symptoms, presence or absence of affective symptoms and substance use.  
 
Within psychotic disorders, schizophrenia emerges as one of the most disabling mental illnesses 
with a devastating impact on the individual (J. F. Hayes, Marston, Walters, King, & Osborn, 2017; 
Olfson, Gerhard, Huang, Crystal, & Stroup, 2015; Simon et al., 2018), their carers (L. Hayes, 
Hawthorne, Farhall, O’Hanlon, & Harvey, 2015) as well as wider society (Jin & Mosweu, 2017). 
With an estimated global annual incidence of 15.2 per 100,000 people (McGrath, Saha, Chant, & 
Welham, 2008), and lifetime prevalence of 0.40% (Saha, Chant, Welham, & McGrath, 2005), 
schizophrenia affects approximately 1% of the population worldwide (World Health Organization, 




background (der Werf et al., 2014). Considerable efforts have been made over the past half a 
century to investigate a range of neurobiological (Howes, McCutcheon, & Stone, 2015), genetic 
(Consortium et al., 2014), cognitive (Fett et al., 2011) and environmental (van Os, Kenis, & Rutten, 
2010) factors that may lead to a better understanding of the disorder. Nevertheless, despite these 
efforts, the pathophysiology of schizophrenia is not yet fully understood and there is no evidence 
that the individual and social burden associated with the illness has subsided (J. F. Hayes et al., 
2017; Hjorthøj, Stürup, McGrath, & Nordentoft, 2017).  
 
The search for markers of schizophrenia has been mostly focused on patients suffering from this 
disorder for several years, i.e. chronic schizophrenia (ChSz). This it has made it difficult to 
disentangle which alterations observed in these patients are an intrinsic feature of the disorder or 
if they represent a secondary effect of factors associated with long duration of illness such as 
pharmacological treatment (Huhtaniska et al., 2017; Nielsen et al., 2015; A Vita, De Peri, Deste, 
Barlati, & Sacchetti, 2015) or chronicity (Olabi et al., 2011; A Vita, De Peri, Deste, & Sacchetti, 
2012). Therefore, many researchers have recently begun focusing their efforts on those thought 
to be in the illness’ earliest stages (McGorry, Killackey, & Yung, 2007). Within this relatively new 
line of research, many have focused primarily on those who have experienced a recent first 
episode of psychosis (FEP). This typically involves investigating individuals experiencing their first 
episode of schizophrenia, although it is also common to include other psychotic disorder, as 
defined by the ICD or DSM. 
 
This shift has been mostly driven by the assumption that the effects associated with long duration 
of a psychotic illness will be reduced, if not at all absent, in individuals at this stage of illness, thus 
enabling a better access to the primary mechanisms underlying the illness. It is therefore 
ultimately hoped that this effort in investigating the onset of the illness will lead to early detection 
and treatment options that minimise and/or prevent the onset of established recurrent psychotic 
episodes. 
 
1.2. Neuroanatomical abnormalities in first episode psychosis  




when Johnstone et al. (1976) reported an increased ventricular volume in ChSz using computed 
axial tomography. Since then, a vast number of studies quickly followed in the quest to find an 
anatomical marker of schizophrenia. This surge was further propelled by the development of 
magnetic resonance imaging (MRI) which later became one of the most commonly used 
neuroimaging techniques, mostly due to its non-invasive nature and lack of radiation. Using this 
approach, most studies investigating neuroanatomical abnormalities in psychotic disorders have 
focused on the measurement of grey matter (GM) volume or density of cortical and subcortical 
brain regions between patients and controls, although a growing number of studies have also 
investigated cortical thickness.  
 
Forty years since the first study, the presence of structural brain abnormalities in ChSz has been 
well established (Glahn et al., 2008; Haijma et al., 2013; Honea, Crow, Passingham, & Mackay, 
2005; Shepherd, Matheson, Laurens, Carr, & Green, 2012; Wright et al., 2000). Reductions in 
GM volume, primarily in the frontal and temporal lobes, and enlargement of the lateral ventricles 
are among the most replicated findings (Glahn et al., 2008; Haijma et al., 2013; Wright et al., 
2000). Changes in cortical thickness are less consistence, however there is evidence supporting 
a widespread cortical thinning across the brain, mostly in fronto-temporal regions including the 
fusiform, parahippocampal, inferior temporal gyri, and insula; as well as an increased thickness 
in mostly parietal regions (van Erp et al., 2018). Critically, these changes have been shown to be 
associated with chronicity (Olabi et al., 2011; van Erp et al., 2018; Vita, De Peri, Deste, & 
Sacchetti, 2012) and anti-psychotic medication (Radua et al., 2012; Shah et al., 2017; Antonio 
Vita et al., 2015). This suggests that the evidence from ChSz, although useful to describe the 
extent of neuroanatomical alterations observed in chronic patients, they may not reflect the 
changes associated with the emergence of the illness itself. Based on this premise, several 
studies have focused on the investigation of neuroanatomical alterations in individuals 
experiencing their first episode of a psychotic disorder. The following sections provide an overview 
of the investigation of grey matter volume and cortical thickness in FEP. 
 
1.2.1. Grey matter volume 




voxel-based morphometry (VBM), an automated computerised technique that allows voxel-wise 
analysis of anatomical brain images (Ashburner & Friston, 2000). In one of first the VBM studies 
in FEP, Job et al. (2002) found a GM reduction in the anterior cingulate, medial frontal lobe, middle 
temporal gyrus, postcentral gyrus, as well as in the limbic lobe in patients relative to controls. 
Since then, several studies have quickly followed, and the number of neuroanatomical studies is 
now far greater than any other imaging modality. In the first attempt to summarise this evidence, 
Ellison-Wright et al. (2008) conducted the first meta-analysis of VBM studies in FEP. It was 
reported that, relative to controls, patients exhibited a significant reduction in GM volume in the 
thalamus, left uncus/amygdala region, bilateral insula and anterior cingulate. In addition, FEP 
patients also had a widespread pattern of GM volume increases including the putamen, insula, 
cerebellum and the superior frontal, middle frontal, superior temporal, precentral, lingual and 
fusiform gyri. Several other meta-analyses have been conducted in an effort to summarize the 
large number of VBM studies that followed (Table 1.1). In the largest meta-analysis yet, Radua et 
al. (Radua et al., 2012) analysed the findings from 25 studies and found GM reductions in the 
insula, middle temporal, superior temporal, precentral, medial frontal and cingulate gyri. In the 
latest meta-analysis, Gao et al. (2018) investigated 16 studies of anti-psychotic naïve FEP 
patients and found a widespread pattern of deficits including the superior and middle temporal, 





Table 1.1. Main findings from the last meta-analyses of VBM studies in FEP.   
 FEP<HC FEP>HC 
Ellison-
Wright et al. 
(2008) 
Bilateral: uncus/ amygdala, insula, caudate, inf 
frontal g; Left: postcentral g, cerebellum; Right: 
cingulate g, precentral g, thalamus 
Bilateral: sup frontal g, 
precentral g; Left: putamen, 
mid frontal g, lingual g, 
cerebellum, sup temporal g; 
Right: fusiform g, insula 





Bilateral: insula, sup temporal g, inf frontal g, 
med frontal g, postcentral g; Left: amygdala, 
mid frontal g, uncus, transverse temporal g; 




Bora et al. 
(2011) 




et al. (2012) 
Right:  sup temporal g; Left: insula, cerebellum - 
 
Radua et al. 
(2012) 
Bilateral: insula, mid temporal g, sup temporal 
g, precentral g, med frontal g, cingulate g 
Right: lingual g; Left: 
precentral g 
Fusar-Poli 
et al. (2014) 
Right:  sup temporal g; Left: insula, cerebellum, 
cingulate 
- 
Shah et al. 
(2017) 
(AN) 
Bilateral: insula, sup temporal g, rolandic 
operculum, heschl g, putamen; Right: mid 
temporal g, cingulate; Left: inf frontal g, 
postcentral g, inf frontal g, supramarginal g, 
fusiform g, cerebellum, parahippocampal g 
Left: inf parietal g, 
paracentral g, precentral g, 
supplementary motor area 
Shah et al. 
(2017) 
(AT) 
Bilateral: cingulate, insula, precentral g, sup 
temporal g, postcentral g, inf frontal g, 
supramarginal g, sup frontal g; Right: ronaldic 
operculum; Left: mid temporal g, inf temporal g 
Right: inf occipital g, mid 
occipital g, sup occipital g, 
sup frontal g, precentral g,  
Gao et al. 
(2018) 
Bilateral: insula, sup temporal g; Right: rolandic 
operculum, mid temporal g, supramarginal g; 
Left: fusiform g, cerebellum, parahippocampal 
g, hippocampus, inf frontal g, inf parietal g 
Right: lingual g, cerebellum, 
sup frontal g 


























































Poli et al 
(2014)
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Taken collectively, these meta-analyses show that grey matter reductions in the early stages of psychosis 



























Figure 1.1. Brain regions identified in the meta-analyses in Table 1.1. The plot shows all the unique regions 




decreases of GMV are shown with and without a black circle, respectively. Note: there is substantial overlap 
in the studies included between meta-analyses and some of them are limited to a specific topic, for example 
anti-psychotic naïve (Fusar-Poli et al., 2012; Shah et al., 2017) or multimodal imaging (Radua et al., 2012). 
AT: anti-psychotic treatment; AN: anti-psychotic naïve. 
 
Reductions in the superior frontal and temporal gyri, insula and cingulate are amongst the most 
consistent findings across meta-analyses, albeit the exact location of these reductions varies 
considerably. Volume reductions in several other brain regions, such as middle temporal gyrus, 
inferior and medial frontal gyri, pre and postcentral gyri and cerebellum have also been implicated, 
although less consistently. Findings of GM increases are far less consistent with some evidence 
towards parietal and frontal regions. 
 
In conclusion, although fewer in number, neuroanatomical studies in FEP conducted to date 
suggest that the widespread alterations in GM observed in the ChSz appear to be already present 
in early psychosis, albeit to an less severe degree (Ellison-Wright et al., 2008; Torres et al., 2016). 
Notability however, there seems to be a significant heterogeneity in findings between individual 
studies. This is particularly salient with respect to GM deficits in the insula and fusiform gyrus (X. 
Gao et al., 2018; Shah et al., 2017), as well as in the middle and inferior frontal, precentral, 
superior and middle temporal gyri (Shah et al., 2017). Such heterogeneity may stem from 
methodological issues, such as the use different imaging methods, the use of small sample sizes 
or different recruitment criteria (Bora et al., 2011; Fusar-Poli et al., 2014), or from the 
neuroanatomical heterogeneity between patients (Brugger & Howes, 2017).  
 
1.2.2. Cortical thickness 
In addition to alterations in GM volume, the investigation of neuroanatomical abnormalities in 
psychosis can also be expressed in terms of changes in cortical thickness. While the analysis of 
GM volume provides a mixed measure of GM, including cortical surface area or cortical folding 
and cortical thickness, the analysis cortical thickness specifically targets the presence of cortical 
atrophy (Hutton, De Vita, Ashburner, Deichmann, & Turner, 2008; Hutton, Draganski, Ashburner, 




recommended to use in combination to provide a more complete representation of 
neuroanatomical changes (Hutton et al., 2009).  
 
Studies in FEP patients have shown consistent evidence of a widespread thinning of the cortex. 
Within the frontal lobe for example, Asmal et al. (2018) revealed a reduction in cortical thickness 
in several areas of the orbitofrontal, superior, middle frontal regions of the brain in a sample of 92 
FEP and 92 controls. Similar findings were also reported by Xiao et al. (2015) and 
Venkatasubramanian et al. (2008) who found significant thinning of the orbitofrontal cortex and 
inferior frontal gyrus. Further cortical thinning has also been observed in across the temporal lobe, 
including in the superior, inferior and middle temporal gyri (Benetti et al., 2013; Qiu, Gan, Wang, 
& Sim, 2013; Scanlon et al., 2014; Song et al., 2015). Within the occipital lobe, reductions in 
cortical thickness have also been observed in the cuneos (Asmal et al., 2018; Qiu et al., 2013; 
Xiao et al., 2015) of FEP patients relative to controls, as well as in occipitotemporal regions, 
including the lingual (Asmal et al., 2018) and fusiform gyri (Asmal et al., 2018; Haring et al., 2016; 
Qiu et al., 2013). Finally, further cortical thinning has also been found in the parietal lobe in the 
precentral and postcentral gyri (Xiao et al., 2015) and precuneos (Asmal et al., 2018). In addition 
to cortical GM regions, thickness deficits have also been identified in a range of subcortical 
structures including the parahippocampal gyrus (Asmal et al., 2018; Qiu et al., 2013; Schultz et 
al., 2010), insula (Haring et al., 2016; Song et al., 2015) and anterior cingulate (Fornito et al., 
2008; Haring et al., 2016). Taken together, the evidence currently available suggests the presence 
of multiple regions of altered thickness within both cortical and subcortical structures that could 
potentially be used as identifiable markers of FEP patients. 
 
1.3. Mega-analysis of neuroanatomical data in psychiatric neuroimaging 
Despite the impressive advances in the understanding of the neurobiological basis of psychiatric 
disorders in the last decades, there are growing concerns about the reliability and reproducibility 
of most findings (Anonymus, 2013). Perhaps the most noteworthy source of concern are the small 
sample sizes that dominate most of the neuroscientific literature (Button et al., 2013). It has been 
argued that such lower powered studies are more prone to false positives (Button et al., 2013) 




compared to larger and more powerful studies. These concerns have led the neuroimaging 
community to acknowledge the pressing need for larger samples. However, this comes with 
several challenges including the limited time for recruitment impose by funding grants, financial 
costs, training and availability of patients in a given geographic location. 
 
In light of such difficulties, the neuroimaging community is embracing the Big Data movement as 
a way to achieve sample sizes that would not be feasible within a single research site (Iniesta, 
Stahl, & McGuffin, 2016; Mahmoodi, Leckelt, van Zalk, Geukes, & Back, 2017; Poldrack & 
Gorgolewski, 2014; Van Horn & Toga, 2014). The last decade has seen a growing number of 
neuroimaging consortia. Notable examples include the ENIGMA (Bearden & Thompson, 2017), 
ADNI (Mueller et al., 2005b) and UK Biobank (Sudlow et al., 2015) which have resulted in 
unprecedented sample sizes in schizophrenia (van Erp et al., 2018), bipolar disorder (Hibar et al., 
2018), major depressive disorder (Schmaal et al., 2017; Shen et al., 2017), autism (Postema et 
al., 2019) and Alzheimer’s disease (Weiner et al., 2017). In what is perhaps the most prominent 
example in psychotic disorders, the ENIGMA consortium has led to unprecedented sample sizes 
in ChSz research, with two recent studies of neuroanatomical cortical abnormalities in 4474 
patients and 5098 controls (van Erp et al., 2018), and subcortical changes in a smaller, albeit still 
impressive, sample of 2028 patients and 2540 controls (van Erp et al., 2016). These sample sizes 
steam for an organized effort to combine the results from several single-site studies, where each 
site uses the same pipeline for data preprocessing and analysis; once analysed, single-site results 
are pooled and summarized in a meta-analysis. Data-sharing initiatives are also increasing 
rapidly, with over 40 online repositories for neuroscientific data in 2015 (Eickhoff, Nichols, Van 
Horn, & Turner, 2016; Ferguson, Nielson, Cragin, Bandrowski, & Martone, 2014). In the first effort 
to combine several publicly available datasets of ChSz, Gupta et al. (C. N. Gupta et al., 2015) 
analysed 784 patients and 936 healthy controls collected from 23 sites. More recently, Rozycki 
(2018) analysed data from 5 sites totalling 448 healthy controls and 387 ChSz patients.  
 
Taken collectively, these studies represent the initial steps of a movement that will hopefully pave 
way for more reliable and reproducible findings in psychiatric neuroimaging in general, and 




integration of data from different scanners or greater heterogeneity amongst participants, larger 
samples are more likely to be more representative of the illness and thus carry more translational 
potential. Critically, similar mega-analytic efforts focussed on the initial stages of psychosis, when 
the effects of confounders are minimal, are still non-existent and, as described in the previous 
section, evidence is still reliant on small to modest sized studies. 
 
1.4. Machine learning 
The emergence of neuroimaging in the 1990s has led to impressive advances in the 
understanding of brain disorders including both psychiatric and neurological disease. However, 
the traditional case-study design that has dominated most of the neuroimaging literature for the 
past three decades, rooted on lesion studies (Scoville & Milner, 1957) and theories of modularity 
(Fodor, 1983), was designed to test hypotheses about neural mechanisms and without 
translational goals in mind. Therefore, while much progress has been made, very few results have 
been incorporated into clinical practice (Dazzan, 2014; Prata, Mechelli, & Kapur, 2014; Woo, 
Chang, Lindquist, & Wager, 2017). In an attempt to bridge this gap between research and clinical 
practice, the neuroimaging community has developed a growing interest in machine learning in 
the hope that this approach will circumvent some of the limitations of classical statistics that are 
hindering the translational application of findings. There are at least four ways in which machine 
learning breaks with classical statistics that may help achieve this: 1) it allows individual rather 
than group-level inferences, 2) it is inherently a multivariate, as opposed to univariate, approach, 
3) it focuses on prediction and generalizability, instead on explained variability, and finally 4) it is 
more sensitive to heterogeneity in the data, rather than creating a ‘typical’ average participant. 




Machine learning is an area of artificial intelligence that has emerged as part of the ongoing quest 
for building intelligent machines that are capable of learning. Although the term ‘machine learning’ 
was coined in 1959 (Samuel, 1959), machine learning only emerged as an area of artificial 




several disciplines including computer science, engineering, mathematics, statistics, psychology, 
and neuroscience. Perhaps as a result of its short history and interdisciplinary nature there has 
been much debate about the definition of machine learning. Nevertheless, machine learning is 
usually referred to as an area of artificial intelligence that is concerned with identifying patterns 
from data and use the same patterns to make predictions about unseen data (Mitchell, 1997). 
From here it follows that the main outcome of machine learning is a measure (proxy) of 
generalizability: the extent to which a model is capable of outputting correct predictions when 
presented with new data, based on learned rules from previous exposure to similar (but not the 
same) data (Domingos, 2012).  
 
1.4.2. Machine learning versus classical statistics 
1.4.2.1. Individual-level versus group-level inferences  
One of the main reasons for the existing gap between research and clinical practice is that the 
former has been dominated by methods that only allow inferences at group-level (e.g. a group of 
psychosis patients have larger ventricles than a group of controls); whilst a clinician has to make 
diagnostic or treatment decisions at the level of the individual. A key reason why machine learning 
is gaining considerable attention amongst the research and medical communities is that it 
promises to bridge this gap. By learning patterns in the data that best distinguish between patients 
with a certain disease of interest and healthy individuals, for example, it is possible to estimate 
the likelihood that a new set of data acquired from an individual belongs to a patient or a healthy 
individual. Similarly, by learning patterns in the data that best distinguish between patients who 
benefit from a certain treatment and patients who do not benefit from it, it is possible to estimate 
the likelihood that a new set of data acquired from an individual belongs to a “responder” or a 
“non-responder”. Therefore, machine learning opens new possibilities in personalized medicine, 
by allowing the development of novel tools that could be used to inform diagnostic and treatment 
decision-making in everyday clinical practice. 
 
1.4.2.2. Multivariate versus univariate analysis 
The vast majority of clinical neuroimaging studies are based on mass-univariate methods, i.e. a 




statistical parametric mapping is typically used to perform a large number of voxel-wise 
comparisons between groups, without considering possible interaction between voxels. However, 
this approach is not in line with the current understanding of brain anatomy and function (Biswal 
et al., 2010; Fox et al., 2005). Indeed, as explained in the previous section, neuroanatomical 
abnormalities in psychosis are characterized by subtle and widespread changes, rather than 
isolated focal alternations. Machine learning, on the other hand, is inherently a multivariate 
approach; it is capable of taking the relationship between multiple variables inputted into the same 
model into account, thereby allowing greater sensitivity to subtle and widespread changes in brain 
anatomy.  
 
1.4.2.3. Prediction and generalizability versus explained variability 
Classical inferential statistics is mainly concerned with elucidating the relationship between 
observed phenomena of interest, for example to what extent changes in the brain anatomy explain 
severity of symptoms (Yarkoni & Westfall, 2017). In neuroimaging, for instance, studies typically 
involve the use of the general linear model, which estimates the strength of the association 
between independent and dependent variables, and returns a measure of explained variability or 
goodness of fit, i.e. the extent to which a statistical model accounts for the variation in the data 
(Friston et al., 1994). It is often assumed that models with high explanatory power or goodness 
of fit have high predictive power when applied to real-world cases. However, from a statistical 
perspective, the model that best describes a set of observations at group-level will not necessarily 
be the most successful at predicting real-world outcomes (Arbabshirani, Plis, Sui, & Calhoun, 
2017; Shmueli, 2010). This is because, whilst a statistical model may achieve a high explanatory 
power or goodness of fit when fitted to a particular dataset, it will likely incorporate the unique 
characteristics of the dataset (Yarkoni & Westfall, 2017). When a dataset is large enough to 
ensure representativeness of the population from which it was drawn, this is less likely to be an 
issue. However, in the vast majority of clinical neuroimaging research which involves studies with 
small samples, representativeness is not guaranteed, and models will likely capture fluctuations 
in the data that are unique to a particular sample; this is known as ‘overfitting’. The extent to which 
findings from a single study are generalizable to other samples is not usually addressed in studies 




necessarily solve the issue of generalizability. However, it does at least attempt to measure it. In 
fact, building models capable of accurate predictions in unseen data is the fundamental goal of 
machine learning.  
 
1.4.2.4. Heterogeneity versus ‘typical patient’ 
It is well known that psychiatric and neurological disorders tend to be heterogenous in terms of 
underlying neuroanatomical and neurofunctional alterations, clinical presentation and progression 
over time (Holmes & Patrick, 2018; Insel et al., 2010; Wardenaar & de Jonge, 2013). However, 
most advances in brain disorders research, including rigorous clinical trials for example, are based 
on the idea of a ‘typical patient’, which masks individual variability. In contrast, by looking for a 
multivariate pattern across a group of individuals during training, machine learning is sensitive to 
heterogeneity in the data. However, integrating heterogeneity in individual-level modelling can be 
challenging, as it becomes more difficult to find patterns that are relevant to the task at hand 
above and beyond individual heterogeneity (Schnack, 2017). In light of the current trend to recruit 
larger and larger sample sizes, data is likely to become more heterogeneous. This is in sharp 
contrast with the traditional case-control approach where, ideally, the patient group and the control 
group are expected to be as homogeneous as possible. On the other hand, larger samples are 
likely to be more representative of the illness and thus carry more translational potential in real-
word clinical practice. 
  
1.4.2.5. Data-driven versus hypotheses-driven models 
Historically, research into brain disorders has been heavily based on deductive (top-down) or 
theory-driven approaches, where carefully thought-out and well-defined hypotheses are tested 
and ultimately confirmed or rejected. Having a priori hypothesis is considered paramount as it 
minimises the risk of false positive findings and post-hoc explanations (Kitchin, 2014). More 
recently, increasing access to large datasets combined with technological advances have 
propelled the emergence of data-driven approaches, such as machine learning, where insights 
are generated purely from data in a bottom-up fashion. Contrary to classical statistics, where the 
aim is to test a priori hypotheses whilst making significant assumptions about the data (e.g. 




itself, whilst making as few assumptions as possible about the data  (Bzdok, 2017; Jordan & 
Mitchell, 2015; Mahmoodi et al., 2017).  
 
1.4.3. Bias-variance trade-off, model assumptions and regularisation 
There are multiple ways in which a model can learn patterns from the data, resulting in a multitude 
of machine learning algorithms. A common taxonomy organizes the different approaches 
according to the style of learning. Based on this categorization, machine learning methods can 
be grouped into four different types of learning: supervised, unsupervised, semi-supervised, and 
reinforcement learning. Supervised learning is by far the most commonly used approach in 
general and in psychiatric neuroimaging, and also the type of learning used in this thesis. The 
main aim of any supervised machine learning model is to build a function that maps the observed 
data (i.e. features) and a target variable capable of generalizing beyond the set of data used to 
develop this function. Essential to the implementation and interpretation of any supervised 
machine learning model are the concepts of bias-variance trade-off, regularisation and model 
assumptions. This section briefly introduces these concepts. 
 
Building a successful machine learning model is often a continuous process, where increasingly 
more complex models (e.g., models with large number of parameters to estimate) are developed 
to achieve better performances. As complexity increases, however, there are two main sources 
of error - bias and variance - that need to be balanced (Figure 1.2). Bias arises when the model 
learns a faulty assumption in the data. In the presence of high bias, the algorithm will not be able 
to model the relationship between features and target correctly; this is known as underfitting. As 
shown in Figure 1.2A, although data tends to plateau, the model assumes there is a linear 
association between the variables. A model that uses inefficient or uninformative features, a very 
small number of observations, or a too simple algorithm, for example, is likely to be too simple to 
capture any meaningful patterns and result in a highly biased model. On the other hand, variance 
results from modelling detailed fluctuations in the data. An algorithm with high variance will 
capture specific aspects of the training data that do not generalize well in the test set; this is 
known as overfitting. This happens when, for example, there are too many features relative to the 








Figure 1.2. Bias-variance trade-off. (A) Three models with different levels of bias and variance. The model 
in the left has low variance but high bias, while the one on the right has high variance but low bias. An optimal 
solution would be a model with a good balance between bias and variance. (B) Bias-variance trade-off. As 
model complexity increases, variance increases and bias decreases. Ideally, bias and variance can be 
balanced, and the algorithm will achieve convergence (when additional training will not improve the model). 
(C) Diagnosing underfitting and overfitting. By assessing the error in the training and validation sets, it is 
possible to establish whether a model is under- or overfitting the data.  
 
When an algorithm performs poorly, this will most likely be due to either a high bias or high 
variance issue. Therefore, to improve the model’s performance, it is necessary first to identify 
whether a model is underfitting or overfitting the data (Figure 1.2C). When the model is too simple, 
error in both training (data used to develop the model) and validation (data used to test the model) 
sets is high, indicating that the model is not a good fit, i.e., the model is underfitting the data. On 
the other hand, when the model is too complex, it fits the training data very well, i.e., the error is 
close to zero; however, the error in the validation set is high, indicating overfitting and poor 
generalizability. Several reasons may help explain poor performance, either due to under- or 
overfitting. One important reason may be that the data does not meet the assumptions that 
underly the inner workings of the model. A simple example here is the common assumption 
among several traditional supervised machine learning algorithms that the target variable can be 
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predicted with a linear combination of the features. This means that if this assumption is wrong, 
the model will underestimate the strength of the relationship between the two. Different machine 
learning models have their own specific assumptions and if the data does not meet these 
assumptions, this will likely lead to poor performance. Overfitting is another common reason for 
poor performance. Since the chances of overfitting increase with model complexity, a common 
approach to help minimize (or even prevent) overfitting involves penalizing model complexity. This 
is referred to as regularization; a group of strategies that force a model to favour simpler (i.e. less 
complex) solutions. The use of regularization is common in psychiatric neuroimaging research. 
The dimensionality of the image data is often much larger than the number of observations. In a 
typical neuroimaging study, there are potentially hundreds of thousands, or even millions, of 
dimensions (e.g. voxels), whereas the number of observations is typically of the order of dozens 
to hundreds, implying that machine learning built with neuroimaging data are extremely ill-posed 
(i.e., have more than one solution) (Lautrup et al., 1995). Common examples of regularization 
techniques include ridge regression or L2, lasso or L1 and elastic net. Briefly, these strategies 
involve the use of weight decays to penalize models with very high weights. By forcing weights to 
remain low, the model becomes less dependent on the training data (i.e., performance does not 
rely heavily on a particular set of weights) and can better generalize to unseen data (Nowlan & 
Hinton, 1992). Other types of strategies also exist. For example, dropout consists of temporarily 
removing a random number of neurons and their respective incoming and outgoing connections 
from the network during training of deep learning models (Srivastava, Hinton, Krizhevsky, 
Sutskever, & Salakhutdinov, 2014); early stopping involves stopping training when the error in the 
training set stops decreasing, especially if this is accompanied by an increase in the error in the 
validation set, a strong indicator of overfitting (Prechelt, 1998). 
 
1.4.4. Machine learning studies of first episode psychosis  
Over the last decade several different machine learning approaches have been applied in brain 
disorders (Woo et al., 2017). Amongst the most popular ones are logistic regression and support 
vector machine, for example. The simplicity, interpretability and ease of use of these the 
approaches have resulted in a wealth of evidence across psychiatric neuroimaging in search of 




Sartori, & Mechelli, 2012; Wolfers, Buitelaar, Beckmann, Franke, & Marquand, 2015; Woo et al., 
2017). In psychosis, several studies have been able to successfully distinguish between ChSz 
patients and healthy individuals based on neuroanatomical data (Kambeitz et al., 2015; 
Zarogianni, Moorhead, & Lawrie, 2013). However, it is unclear to what extent the distinction 
between two groups could be influenced by structural abnormalities associated with typical 
confounding variables in ChSz, such as long duration of illness and antipsychotic medication. 
Pattern classification applied to FEP could thus allow a clearer insight into the underlying 
mechanisms of the illness. The assumption here is that, whilst separating FEP from controls may 
be more difficult due to the subtler changes, the neuroanatomical differences driving the 
distinction between the two are likely to be more reflective of the underlying mechanisms of 
psychosis. Consistent with this, both disease-stage and antipsychotic medication were identified 
as significant moderators in a recent meta-analysis of machine learning studies in psychosis 
(Kambeitz et al., 2015).  
 
Compared to ChSz, evidence from FEP studies conducted so far has been less consistent. In 
one of the first studies, Sun et al (2009) was able to distinguish between patients and controls 
with an accuracy of 86% in a sample of 36 FEP and 36 controls. To mitigate the effect of sex as 
a possible confounder, Takayanagi et al. (Takayanagi et al., 2010, 2011) ran separate classifiers 
for males and females with accuracies between 76% and 87% for males and between 81% and 
83% for females. Later, Borgwardt et al. (2013) were able to classify patients and controls with an 
impressive accuracy of 87%. Shortly after however, Petterson-Yeo et al. (2013) reported a much 
lower result of 63%. More recently, Xiao et al. (2017) successfully distinguished FEP and controls 
in one of the largest studies yet, with 163 anti-psychotic naïve patients and 163 controls, based 
on measures of thickness and surface area of several cortical brain regions with 82% and 85% 
accuracy, respectively. Meanwhile, Winterburn et al. (2017) tested several different classifiers on 
three popular neuroanatomical features – two measures of voxel-wise GM volume and cortical 
thickness – in a sample of 50 FEP and 50 controls. Most accuracies fell between 55% and 70%, 
and the best performance was achieved with cortical thickness with 74% accuracy. In conclusion, 
the evidence from machine learning studies applied to neuroanatomical data to identify the initial 




inconclusive so far.   
 
1.5. Deep Learning 
The ease of use of several machine learning methods such as SVM have propelled a vast amount 
of evidence during the last decade across the field of clinical neuroimaging (Woo et al., 2017). 
Common to all these conventional methods, however, is their limitation in processing data in its 
raw form. Therefore, since the performance of any machine learning method is heavily reliant on 
the choice of features, much of the effort that goes into developing a successful conventional 
machine learning pipeline is spent on carefully creating useful features from the raw data, i.e. 
feature engineering (Domingos, 2012). Representation learning is a class of machine learning 
methods that addresses this limitation by discovering the optimal set of features, i.e. 
representation, from the data automatically. Deep learning is a family of representation learning 
methods loosely inspired on biological neurons that learn increasingly abstract levels of 
representations obtained from combining multiple layers of interconnected nonlinear processing 
units known as ‘artificial neurons’ (Bengio, Goodfellow, & Courville, 2015). This structure results 
in a great flexibility that can be leveraged to create a vast number of different architectures, many 
of which tailored for specific purposes. Perhaps the simplest model is the general-purpose deep 
neural network (also known as multilayer perceptron, fully-connected neural network, or similar 
variations). Other popular architectures include for example, autoencoders (Vincent, Larochelle, 
Lajoie, Bengio, & Manzagol, 2010) which are typically used for dimensionality reduction, 
convolutional neural networks (LeCun, Bottou, Bengio, & Haffner, 1998) which are mainly used 
to process images and recurrent neural networks which are used to process sequential data such 
as speech, video or even functional imaging data. 
 
Deep learning has seen a dramatic surge in interest during past decade in the wider research 
community and industry (LeCun, Bengio, & Hinton, 2015). This has been largely driven by 
increases in computational power and the availability of massive new datasets, which ultimately 
led to record-breaking performances in visual and speech recognition tasks (Graves, Mohamed, 
& Hinton, 2013; Krizhevsky, Sutskever, & Hinton, 2012; Le, 2013). In medicine, deep learning is 
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& Khullar, 2019), including the detection of diabetic retinopathy (Gulshan et al., 2016) and skin 
cancer (Esteva et al., 2017) from retinal fundus and skin images, respectively. Despite the recent 
outpouring of interest however, the origins of deep learning can be traced back to 1940s with the 
‘perceptron’, one the first attempts to model the biological neuron (McCulloch & Pitts, 1943). After 
a long and controversial history (Schmidhuber, 2015), including the inability to solve nonlinear 
problems (i.e. ‘XOR-problem’) and the ‘vanishing or exploring gradients’ problem, the perceptron 
evolved to become a network comprised of sever ‘hidden layers’ connected by weights which 
were optimized via backpropagation, known as artificial neural networks (Durstewitz, Koppe, & 
Meyer-Lindenberg, 2019). However, such networks were able to handle only a limited number of 
layers. It was only in the 2000s that researchers developed a new approach for training artificial 
neural networks that allowed the inclusion of several hidden layers by first pre-training the network 
layer by layer followed by the finetuning of the entire network, resulting greater levels of 
complexity (Hinton, Osindero, & Teh, 2006). This breakthrough led to the development of a new 
family of machine learning methods known as deep learning. 
 
In light of its ability to learn latent and abstract patterns, it has been suggested that deep learning 
may be of particular value to uncover complex effects within a certain modality, for example subtle, 
widespread and heterogenous reductions in grey matter volume; or even capture cross-modality 
relations, such as the interaction between genetics and neuroimaging (Calhoun & Sui, 2016; Plis 
et al., 2014; Schnack, 2017). In addition, given that studies have traditionally relied on mass-
univariate techniques, we often lack strong hypothesis about how GM volume across the brain 
relate to each other or how different modalities may be related, and therefore data driven methods 
such as deep learning may be particularly useful (Durstewitz et al., 2019). Plis et al. (2014) is 
often referred to as the first study to apply deep learning in the context of clinical neuroimaging. 
By applying a deep belief network to structural data, authors were able to successfully distinguish 
controls from schizophrenia patients as well as predict the severity of symptoms in patients 
diagnosed with Huntington disease. This study was quickly followed by several others using a 
variety of different modalities and types of networks that aimed to distinguish controls from 
Alzheimer’s disease or mild cognitive impairment (Hu, Ju, Shen, Zhou, & Li, 2016; Liu et al., 2015; 




Craddock, Buchweitz, & Meneguzzi, 2018) and ADHD (Kuang & He, 2014; Zou, Zheng, & 
McKeown, 2017); or to identify individuals suffering from mild cognitive impairment would go on 
to develop Alzheimer’s disease (Liu, Liu, Cai, Che, et al., 2015; Suk & Shen, 2013). 
 
A limited number of studies have also been conducted in ChSz. In addition to Plis et al (2014), 
Kim et al. (2016) applied a deep neural network to functional MRI data in a sample of 50 ChSz 
and 50 controls and was able to classify the two groups with 86% accuracy. A similar result was 
also found by Yan et al. (2017), in which a variation of a deep neural network was also used to 
distinguish between patients and controls based on functional imaging, albeit in a much larger 
sample of 1100 participants. In an attempt to combine structural and functional imaging data, 
Ulloa et al. (Ulloa, Plis, & Calhoun, 2018) built a model also based in a deep learning network 
capable of classifying patients and controls with an accuracy of 85% in a sample of 304 
participants. In a large multi-centre study, Zeng et al. (2018) applied an autoencoder-based model 
to functional imaging in a sample of 734 participants. Accuracies of 85% and 81% were obtained 
in the multi-site pooling classification and leave-site-out classification, respectively.  
 
In conclusion, deep learning is a promising approach capable of capturing intricate relations from 
the data that may be useful to detect biomarkers for psychosis. Its application to clinical 
neuroimaging in ChSz is still at the very early stages and there have been no studies applying 
deep learning to the early stages of the illness.  
 
1.6. Aim and hypothesis 
In summary, although there is already a considerable amount of studies investigating focal 
neuroanatomical abnormalities in FEP, the vast majority of findings come from small local studies, 
which may help explaining the current heterogenous evidence in the literature. This is in line with 
growing concerns across the wider neuroscientific community regarding the failure of replication 
and reproducibility of findings and subsequent calls for greater collaboration to build larger and 
more robust studies. Coinciding with this furthermore, are the increasing calls for translatable 
findings into clinical practice. As a result, there has been a growing number of studies applying 




can be used to assist with decision-making in the clinical practice. Despite the recent advances 
in the last few years however, evidence from the yet small number of studies in FEP has been 
inconclusive. Finally, within this movement, deep learning has recently emerged as a promising 
avenue for the search of biomarkers in psychiatric neuroimaging. Although initial evidence is 
encouraging, more research is needed, especially in the early stages of psychotic disorders, when 
diagnosis may be uncertain, and treatment is yet to be decided. 
 
In the context outlined above, the primary research questions of the current thesis and respective 
hypotheses were as follows: 
 
1.6.1. Are there neuroanatomical brain differences between FEP and controls consistent across 
several independent sites? 
My first objective was to use standard univariate analyse to examine GM volume changes in FEP 
relative to controls that are expressed consistently across several independent samples using a 
multi-centre mega-analytic approach. The following hypothesis were considered: 
H1. The FEP group would show GM volume reductions in a distributed 
bilateral network including fronto-temporal, insular and cingulate areas compared 
to the control group. 
H2. GM volume in the FEP group would be negatively correlated with 
severity of symptoms. 
H3. GM volume in the FEP group would be negatively correlated with 
duration of illness. 
H4. GM volume in the FEP group would not be correlated with anti-
psychotic medication. 
 
1.6.2. What is the evidence for deep learning applications in psychiatric and neurologic 
neuroimaging?  
My second aim was to review the literature with respect to the applications of deep learning to 
neuroimaging data in psychiatric and neurologic disorders. Machine learning is relatively new to 




standing artificial neural networks, is particularly novel to the community. Therefore, in addition to 
providing an overview of the main deep learning architectures, I aimed to carry out a systematic 
survey of the current literature in terms of diagnostic and longitudinal outcome studies that used 
some form of deep learning, as well as highlighting its limitations and main future directions. 
 
1.6.3. Can brain neuroanatomy be used to classify FEP and controls consistently across several 
independent datasets? 
My third aim was to elucidate the extent to which the application of popular traditional machine 
learning techniques to neuroanatomical data allows distinction between FEP and controls at the 
individual level by putting place a series of precautions to minimise the risk of overfitting. To 
assess the reproducibility of the findings, the same pipelines were applied to five independent 
datasets. It was hypothesized that: 
H5. FEP and HC would be classified with statistically significant performances ranging 
between 70% and 80%. 
H6. Performances would remain stable across the five datasets. 
 
1.6.4. Can deep learning be used to classify FEP and controls based on brain neuroanatomical 
information? 
My fourth aim was to examine whether deep neural networks could classify FEP and controls 
based on neuroanatomical data. It was hypothesized that: 
H7. Deep neural networks would be able to classify FEP and controls with statistically 
significant performances ranging between 70% and 80%. 
H8. Deep neural networks would show a superior performance compared to traditional 
shallow approaches. 
 
1.6.5. Can deep learning be used to classify FEP and controls based on brain neuroanatomical 
information in a large-scale analysis? 
The final aim of this doctoral work was to investigate whether it would be possible to classify FEP 
and controls using deep neural networks in a multi-centre mega-analytic approach.  




significant performances around 70%. 
H10. Deep neural networks would show a superior performance compared to traditional 
shallow approaches. 
H11. The main regions driving classification would include fronto-temporal 
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2.1.1. Study sample 
A total of 1249 participants were collected from five previously published independent studies: 
- Site 1: Chengdu, China (Gong et al., 2015) 
- Site 2: London, England (GAP1 study; Di Forti et al., 2009)  
- Sites 3 and 4: Santander A and B, Spain (PAFIP2 study; Pelayo-Terán et al., 2008) 
- Site 5: Utrecht, The Netherlands (GROUP3 study; Korver, Quee, Boos, Simons, & de Haan, 
2012) 
 
These datasets are also part of a larger pool of legacy data for the project PSYSCAN - Translating 
Neuroimaging Findings from Research into Clinical Practice, an EU-funded multi-centre study 
that aims to develop neuroimaging-based tool to help physicians in the management of patients 
with psychotic disorders4. Permission to use this data was obtain from the PSYSCAN committee. 
The final sample sizes for each study included this thesis are shown in Figure 2.1. The 
demographic and clinical characteristics are provided in the respective chapters.  
 
2.1.2. Participants 
Site 1: Chengdu University, China 
A total of 167 patients aged 18-44 years were recruited from the West China Hospital of Sichuan 
University in Chengdu between 2009 and 2012. Diagnosis for first episode of schizophrenia within 
the previous 24 months was determined by the consensus of two clinical psychiatrists using the 
Structured Interview for the DSM-IV Axis I Disorder (SCID-I) (First & Gibbon, 2004). At the time 
of scanning, all patients were medication-naïve. A total of 163 healthy controls were recruited by 
poster advertisement and screened using the SCID-I to confirm the lifetime absence of psychiatric 
disorders, as well as interviewed and subsequently excluded if they had any known history of 
psychiatric illness in first-degree relatives. Participants were excluded if they met any of the 
following criteria: i) history of drug or alcohol abuse, ii) pregnancy, and iii) any physical illness 
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such as hepatitis, cardiovascular disease, or neurological disorder, as assessed by interview and 
review of medical records.  The study was approved by the local research ethics committee and 
all participants provided written informed consent. 
 
Site 2: King’s College London, England 
Ninety-four patients aged 18-65 years were recruited from the South London and Maudsley 
Foundation Trust and scanned at the Institute of Psychiatry, Psychology and Neuroscience in 
London between December 2005 and October 2008. All patients meeting ICD–10 criteria for a 
diagnosis of psychosis (codes F20–F29 and F30–F33) (World Health Organization, 2004) were 
invited to participate in the study; patients with a diagnosis of organic psychosis (i.e. psychosis 
caused by a known physical illness such as toxic-metabolic encephalopathies and stroke) were 
later excluded. Clinical diagnosis was established by administering the Schedules for Clinical 
Assessment in Neuropsychiatry (SCAN) (Wing et al., 1990). A total of 110 healthy controls were 
recruited through local advertisement from the same geographical areas as patients. The 
Psychosis Screening Questionnaire (Bebbington & Nayani, 1995) was used to exclude the 
presence of psychotic symptomatology or a history of psychotic illness. Participants were 
excluded if they met any of the following criteria: i) learning disabilities (IQ < 70 derived from the 
Wechsler Adult Intelligence Scale–Third Edition (WAIS III); Wechsler (1997), ii) current or past 
neurological illness, iii) brain injury with loss of consciousness for more than 1 hour and iv) 
suspected or confirmed pregnancy. Ethical permission was obtained from the Trust and the 
Institute of Psychiatry, Psychology and Neuroscience research ethics committee and all 
participants provided written informed consent. 
 
Site 3 and 4: Santander University, Spain 
Data from two Spanish sites - Santander A (N patients = 144, N healthy controls = 113) and 
Santander B (N patients = 145, N healthy controls = 78) - was acquired as part of the same large 
prospective longitudinal study on first episode psychosis in the region of Cantabria, although with 
two different scanners. Patients aged 15-55 years were recruited from both inpatient units and 
community services throughout the entire region between February 2001 and February 2005. 




schizoaffective disorder, brief reactive psychosis, or not otherwise specified psychosis) according 
to DSM-IV criteria was confirmed by administering the structured interview SCID–I (First & 
Gibbon, 2004). Patients were recruited if there was no evidence of prior treatment with 
antipsychotic medication or, if previously treated, a total lifetime of adequate antipsychotic 
treatment of less than 6 weeks. Patients with DSM-IV based diagnoses of a psychotic disorder 
directly caused by a general medical condition or use of substances, mental retardation or 
substance dependence (except nicotine dependence) were excluded. Age and sex matched 
healthy controls were recruited from the community through advertisements and were screened 
for current or past history of psychiatric, mental retardation, neurological or general medical 
illness, including substance dependence and significant loss of consciousness, as determined by 
using an abbreviated version of the Comprehensive Assessment of Symptoms and History 
(CASH) (Andreasen, Flaum, & Arndt, 1992). Clinical records and family interview also confirmed 
the absence of psychosis in first-degree relatives. Ethical permission was obtained from the local 
institutional review board and all participants provided written informed consent. 
 
Site 5: Utrecht University, The Netherlands 
A total of 105 patients aged 16-50 years were recruited from inpatient and outpatient regional 
psychosis departments or academic centres in Utrecht. Diagnosis of a first episode of non-
affective psychosis (schizophrenia, schizophreniform disorder, schizoaffective disorder, brief 
reactive psychosis, or not otherwise specified psychosis) according to DSM-IV criteria was 
established by administering the Comprehensive Assessment of Symptoms and History 
(Andreasen et al., 1992). A total of 120 healthy controls were recruited through a system of 
random mailings to addresses in the catchment areas of the cases and were screened for current 
or past psychotic disorder and first-degree family member with a lifetime psychotic disorder. The 
study protocol was approved centrally by the Ethical Review Board of the University Medical 







Figure 2.1. Diagram showing initial and final sample size for the univariate and machine learning analysis.  
 
2.2. Structural magnetic resonance imaging 
Magnetic resonance imaging (MRI) is a non-invasive technique that can be used to visualise 













175 images excluded due to:
- Poor quality or presence of artifacts upon visual inspection 
- Outside the age range (18-55)











Chapter 3: Univariate 
analysis
Age and sex added as covariates 
in the statistical model.
Site 1 N = 240
Site 2 N = 168
Site 3 N = 257
Site 4 N = 223
Site 5 N = 186
Chapter 5 and 6: Machine 
learning analysis
HC and FEP were matched 1:1 for 
sex and age (+/- 5yrs) for sites 1-3 
and 5. Site 4 was matched 1:2.
Site 1 N = 224
Site 2 N = 142
Site 3 N = 220
Site 4 N = 210




within the nuclei of hydrogen atoms to produce images.  
 
Every cell of the body contains hydrogen particles. The atom of each hydrogen particle comprises 
of a single charged proton which rotates, or ‘spins’, on its own axis with a specific direction and 
intensity referred to as angular momentum (Figure 2.2A). In the absence of an externally applied 
magnetic field, the collective magnetic moment of all spins has random orientations (Figure 2.2B). 
As a result, there is no overall magnetic field, i.e. the net magnetisation is equal to zero. However, 
when subjected to an external magnetic field (B0) – the primary magnetic field – the spins’ 
magnetic moments will align with this external field in one of two orientations with respect to B0, 
parallel or anti-parallel (Figure 2.2C). Protons with a parallel alignment are more stable and thus 
possess low energy; conversely, the protons with an anti-parallel alignment are less stable and 
carry more energy. In this magnetisation state, there are more spins in the low-energy parallel 
state compared to high-energy anti-parallel state. Summing the contributions of all the spins’ 
magnetic vectors will therefore result in a net magnetic vector (M) aligned with the longitudinal z-
axis of B0, referred to as longitudinal magnetisation (Figure 2.2D). In addition, protons will also 
spin along the longitudinal (z) axis of B0 at a frequency known as the Larmor frequency; this is 
known as precession (Figure 2.2E). When protons precess together, this is known as in-phase, 
whereas when protons precess separately, this is known as out of phase. 
 
By applying a radio frequency (RF) pulse with the same frequency at which the protons are 
precessing (process called resonance), a second external magnetic field (B1) perpendicular to the 
z-axis is generated, in the x-y plane. This disturbs the proton alignment by forcing the protons in 
parallel alignment to ‘flip’ to the higher energy anti-parallel state, decreasing longitudinal 
magnetisation. In addition, it will also force all protons to precess in-phase within the x-y plane. 
As a result, the net magnetisation M tilts from the z-axis direction into the transverse x-y plane; 
this is known as transverse magnetisation (Figure 2.2F). The resulting magnetic vector Mx-y 
induces an electrical current detected by a receiver coil forming the magnetic resonance (MR) 
signal. The time taken between the RF pulse being applied and an MR signal being received is 
known as the echo time (TE) whereas the time between the application of each RF pulse is known 


















Figure 2.2. MRI physics. A. Charged, spinning hydrogen proton creates a magnetic moment. B. In the 
absence of an externally applied magnetic field, protons have random orientations. C. When an external 
magnetic field B0 is applied the protons align themselves parallel or anti-parallel with respect to B0. D. The 
net alignment M is oriented along B0 and the z-axis. E. Proton spinning: E1. The atom spins in its own axis, 
E2. Precession. F. RF pulse produces a second magnetic field Mx-y and M is tilted from its original longitudinal 
z-axis orientation, along the direction of the external magnetic field B0, into the transverse x-y plane. [Adapted 
from Puddephat (2010)]  
 
Once the RF pulse is removed, the protons release the absorbed energy and gradually return to 
their original lower energy state; this is known as relaxation. Relaxation can be measured in two 
directions: longitudinal relaxation (T1) and transverse relaxation (T2). Longitudinal relaxation (T1) 
refers to the process in which protons flip back to their original low-energy state parallel to the 
primary magnetic field B0 (z-axis), which results in an increase in the longitudinal magnetisation. 
Plotting the recovery of longitudinal magnetisation over time produces an exponential curve, 
called the T1 curve. It is difficult to exactly pinpoint the end of longitudinal relaxation. Therefore, 


















T1 refers to the time taken for longitudinal magnetisation to regrow approximately 63% of its final 
value. Critically, not all protons return to their original energy state at the same time; different 
tissues have different rates of T1 relaxation. This allows to create images at a time when the 
distance between the different tissues T1 relaxation curves is maximal. The result is known as a 
T1-weighted image, where tissues with a long T1, such as the cerebral spinal fluid (CSF), have 
low signal intensity and therefore appear dark on the image, whilst those with a short T1 such as 
white matter (WM) have a high signal intensity and therefore appear bright on the image (Figure 
2.3A). Transverse relaxation (T2), on the other hand, occurs when the protons that were in-phase 
begin to de-phase in the transversal plane (x-y plane), which results in a reduction in transverse 
magnetisation. Similarly to T1 relaxation, it is possible to plot T2 relaxation over time. This time, 
T2 is defined as the time that it takes the transverse magnetization to decrease to 37% of its 
starting value.  Contrary to T1, in T2-weighted images, tissues with a long T2 such as CSF, appear 





Figure 2.3. T1 and T2 relaxation curves and respective images. A. T1-weighted image. B. T2-weighted 
image. [Adapted from (Puddephat (2010)] 
 
2.2.1. Image formation 
In order to build a 3-dimensional image (3D), it is necessary to identify the location within the brain 
from which the RF signal was emitted. This is done by superimposing magnetic field gradients on 
the otherwise homogeneous external magnetic field B0. This is achieved using three separate 
magnetic field gradients, one for each phase of image formation: 1) slice-selection, 2) phase-
encoding and 3) frequency-encoding.  
 
2.2.1.1. Slice-selection  








that different cross sections of the brain will experience a magnetic field of different strength. 
Accordingly, protons will precess at different frequencies depending on their position along the 
gradient. Therefore, when the RF pulse is applied, only the protons precessing at the same 
frequency as the RF pulse will ‘flip’ into the transverse plane. As a result, only the signal from the 
protons in this location will be picked up by the receiver coil. This allows a given slice to be 
selected along the z-axis, with its thickness determined by the strength of the superimposed 
magnetic field gradient. Once a given slice is selectively excited, the signals arising from each 
slice element – pixel – within that section need to be spatially encoded. This is achieved using 
phase- and frequency-encoding gradients. 
 
2.2.1.2. Frequency encoding 
During frequency encoding, a different magnetic field gradient is superimposed upon B0 such that 
the precessional frequency of protons in the already selected slice is graded along the x-axis. 
Application of an RF pulse and subsequent recording of the MR signal results in spatial encoding 
along the x-axis, reflecting the interference pattern formed by the different frequencies along the 
x-axis. 
 
2.2.1.3. Phase encoding  
Phase encoding requires the application of a magnetic field gradient superimposed upon B0 and 
is used to account for the alterations in phases that differ along the gradient applied in frequency 
encoding. Here, the gradient is applied along the y-plane orthogonal to those used in slice 
selection and frequency encoding. A pulse sequence is then repeatedly applied with only the 
phase encoding gradient changing, with field strength declining to zero and then increasing back 
to its original amplitude. The number of times the pulse sequence is repeated is equal to the 
number of pixels in the subsequent image matrix generated.  
 
Repeating phase and frequency encoding for each slice along the z-axis, corresponding 
information is collected for each volume-element, or voxel, the size of which is governed by the 
slice selection gradient. A Fourier transformation can then be used to generate a signal intensity 




can be converted into intensities on a grey scale forming a 3D volumetric image, the resolution of 
which depends on the voxel size. 
 
2.2.2. MRI acquisition parameters 
Site 1: Chengdu University, China 
High-resolution 3D T1-weighted images were acquired on a 3 T General Electric MRI scanner 
(Milwaukee, WI, USA) at the Huaxi MR Research Centre in Chengdu. Images were acquired 
using a spoiled gradient-recalled acquisition (SPGR) sequence with the following parameters: 
time TR=8.5ms, TE=3.4ms, flip angle=12°, voxel size=0.47x0.47x1mm, matrix=512x512x156. 
 
Site 2: King’s College London, England 
High-resolution 3D T1-weighted images were acquired on a 3 T General Electric MRI scanner 
(Milwaukee, WI, USA) at the Maudsley Hospital, London. Images were acquired using a SPGR 
sequence with the following parameters: TR=6.9ms, TE=2.8ms, flip angle=18°, voxel 
size=1.02x1.02x1.2mm, matrix=256x256x166.  
 
Site 3: Santander University A, Spain 
High-resolution 3D T1-weighted images were acquired on a 3T Philips Medical Systems MRI 
scanner (Achieva, Best, The Netherlands) at the Hospital Marques of Valdecilla, Santander, 
Spain. Images were acquired using a spoiled gradient-recalled acquisition (SPGR) sequence with 
the following parameters: TR=8.2ms, TE=3.7ms, flip angle=8°, voxel size=0.94x0.94x1mm, 
matrix=256x256x160. 
 
Site 4: Santander University B, Spain 
High-resolution 3D T1-weighted images were acquired on a 1.5T General Electric MRI scanner 
(Milwaukee, WI, USA) at the University Hospital Marques of Valdecilla, Santander, Spain. Images 
were acquired using a SPGR sequence with the following parameters: TR=24ms, TE=5ms, flip 






Site 5: Utrecht University, The Netherlands 
High-resolution 3D T1-weighted images were acquired on a Philips 1.5T Achieva MRI scanner 
(Philips Medical Systems, Best, The Netherlands) at the University Medical Center Utrecht. 
Images were acquired using a SPGR sequence with the following parameters: TR=30 ms, 
TE=4.6ms; flip angle=30°, voxel size=1x1x1.2mm, matrix=256x150x150. 
 
2.2.3. Preprocessing 
Three approaches were used to preprocess the structural MRI (sMRI) images: voxel-based 
morphometry (VBM), voxel-based cortical thickness (VBCT) and surface-based morphometry 
(SBM). All three approaches allow the extraction of neuroanatomical information from T1-
weighted images. However, while the first two share some of the main assumptions and data 
preprocessing, the latter rests on an entirely different approach. 
 
VBM uses deformation fields to identify focal differences in cerebral tissue, either white or grey 
matter, by comparing different brains on a voxel-by-voxel basis while discounting large scale 
differences in gross anatomy and position (Ashburner & Friston, 2000). The original purpose of 
this preprocessing was to generate brain images that would allow comparing at least two groups 
of brains on a voxel-by-voxel fashion. However, more recent studies are also using the same 
preprocessed images for machine learning analysis (Nieuwenhuis et al., 2012; Pettersson-Yeo et 
al., 2013). This section describes the main steps involved in VBM preprocessing as implemented 
by the Statistical Parametric Mapping (SPM) software (http://www.fil.ion.ucl.ac.uk/spm). More 
recently, this approach has been extended to VBCT, a voxel-based method to measure cortical 
thickness, as described in Hutton (2008). The main motivation for this method is that while VBM 
provides a mixed measure of cortical grey matter including cortical surface area or cortical folding 
as well as cortical thickness, VBCT selectively investigates cortical atrophy. Consequently, both 
can be used in combination to build a more complete description of the extent of neuroanatomical 
alterations (Hutton et al., 2009). Surface-based methods on the other hand, rely on geometrical 
models that reconstruct the cortical surface from T1-weighted MRI images to quantify different 
aspects of brain anatomy, including the volume of cortical and subcortical structures as well as 




(e.g. Brain Visa, CARET, Brain Voyager). In this thesis, SBM was implemented with FreeSurfer 
(surfer.nmr.mgh.harvard.edu).  
 
Studies using a combination of the different three methods – VBM, VBCT and SBM – have 
reported different results, which has been attributed to differences in the methods themselves 
and/or the underling biology being measured with each method (Blankstein, Chen, Mincic, 
McGrath, & Davis, 2009; Voets et al., 2008). Importantly for machine learning analysis, these 
different approaches can also result in data with different dimensionalities. While whole-brain 
voxel-based data contains thousands of voxels, surface-based volumes and thickness are 
typically used in a region of interest (ROI) approach and therefore have much lower 
dimensionality. Based on the described above, three sets of data were extracted from each 
structural image: two voxel-based anatomical measures – 1) voxel-wise grey matter volume 
(VWGMV) extracted using VBM, 2) voxel-wise cortical thickness (VWCT) extracted using VBCT 
as well as 3) surface-based regional subcortical and cortical GM volume and cortical thickness 
extracted using SBM (SB-ROIs). In what follows, a description of the preprocessing for each type 
of neuroanatomical measure is provided.  
 
2.2.3.1. Voxel-based anatomical measures 
Both VWGMV and VWCT are voxel-based measures and therefore share some of the 
preprocessing steps. Common to both measures, structural images were first reoriented along 
the anterior-posterior commissure line and set the anterior commissure as the origin of the spatial 
coordinates to assist with the normalization algorithm. The unified segmentation procedure 
(Ashburner & Friston, 2005) was then used in combination with the Diffeomorphic Anatomical 
Registration through the Exponentiated Lie algebra (DARTEL) algorithm (Ashburner, 2007) to 
segment and subsequently normalise the reoriented structural images. This process consists in 
first segmenting each image into GM, WM and CSF. This is achieved by assigning each voxel a 
probability of it being GM, WM and CSF, such that the sum of the tissue probabilities at each voxel 
adds up to one. The output is a set of three new images for each subject, each one a probability 
map for a type of tissue in the space of the input data (i.e. native space). The GM and WM 




all subjects, thus allowing a voxel-for-voxel correspondence across the subjects’ images. The aim 
of this procedure is to reshape each brain to a more appropriate and study-specific template, as 
opposed to a more generic one (e.g. MNI-305) (Ashburner, 2007). This is achieved through a 
nonlinear registration which allows local areas to stretch and compress with respect to each other. 
The transformations necessary to match each voxel in the input image to match the template are 
mapped in a deformation field. Once the images are segmented and the DARTEL template 
created, the rest of the preprocessing is done using two separate approaches - VBM and VBCT 
- to extract VWGM and VWCT, respectively. 
 
2.2.3.1.1. Voxel-based morphometry  
To create the VWGM maps, the segmented GM partitions were warped to the new study-specific 
reference space, using each subject-specific deformation field. This creates an image that is in 
voxel-for-voxel registration with the template. The warped GM partitions were then affine-
transformed into MNI space. A further processing step referred to as “modulation” was also used 
to compensate for the expansions and/or contractions each voxel was subjected to when the 
deformation field was applied, thus ensuring that the total amount of signal in each voxel was 
conserved (C. D. Good et al., 2001). Finally, the GM probability maps are smoothed in a process 
that involves convolving an isotropic kernel across each image such that the intensity in each 
voxel is a locally weighted average of the signal intensity from a region of surrounding voxels as 
defined by the size of the kernel (Ashburner & Friston, 2000). There are several reasons for using 
smoothing. First, it compensates for residual anatomical variability after spatial normalization and 
renders the data more normally distributed increasing the validity of any statistical parametric test. 
Second, it is required to comply with the assumptions underlying Gaussian Field theory. 
Additionally, smoothing also reduces the effective number of statistical comparisons, thus making 
the correction for multiple comparisons less severe. The value at a voxel in the final modulated 
smoothed image is interpreted as the volume of GM at that location. 
 
2.2.3.1.2. Voxel-based cortical thickness 
The first step of VBCT is to create a cortical thickness map for each subject. This consisted in 




first automatically extract the inner and outer cortical GM boundaries followed by the 
measurement of the distance between the two. This process can be challenging since the cortical 
sheet is highly folded and with variable thickness. In the method proposed by Hutton et al. (2008) 
this is addressed by dividing the cortex into sub-layers and consider the thickness of each 
sublayer separately. This approach has two motivations. First, it has an analogous association to 
the known layer-wise structure of the cortex. Second, the calculations necessary to estimate the 
thickness of adjacent layers is similar to that of other mathematical problems and can be solved 
using Laplace’s equation (Jones, Buchbinder, & Aharon, 2000). The resulting VBCT maps contain 
the cortical thickness values within voxels identified as GM and are saved in the native space of 
the input images. Once created, each VBCT map was warped to the new study-specific reference 
space by applying the corresponding subject specific deformation field. The warped images were 
then modulated and smoothed with Gaussian kernel. The same warps, modulation and smoothing 
were also applied to a binary mask created from each original VBCT map. The smoothed VBCT 
maps were divided by the corresponding smoothed mask. The effect of this procedure was to 
project the Gaussian smoothing kernel applied to the warped images, into the native space of the 
subject while preserving the cortical thickness value over a region the size of the smoothing 
kernel. As a final step, the warped and smoothed VBCT maps were affine transformed into MNI 
space. 
 
2.2.3.2. Surface-based morphometry  
FreeSurfer is a widely used method for processing anatomical MRI images (Fischl, 2012). Its 
‘recon-all’ processing stream is a fully automated procedure that takes a T1-weighted image as 
the input and outputs the segmented image as well as cortical measures such as volumes and 
surface. The technical details of each stage have been extensively described elsewhere (Dale, 
Fischl, & Sereno, 1999b; Fischl & Dale, 2000; Fischl, Sereno, & Dale, 1999; X. Han et al., 2006). 
Briefly, each raw T1-weighted image is first corrected for intensity bias to address the intensity 
variations due to magnetic field inhomogeneities. Any extra-cerebral voxels are then removed 
from the resulting normalized intensity images, using a ‘skull-striping’ procedure. This is followed 
by the automatic segmentation of the subcortical WM and deep GM volumetric structures (e.g. 




volume is then used to derive a tessellated surface representing the grey/white matter boundary 
(inner surface, also referred to as WM surface), which is automatically corrected for topology 
defects and expanded to model the pial–grey boundary (outer surface, also referred to as pial 
surface). Each surface can be described as a mesh of vertexes, connected by edges, that form a 
mesh of tessellated triangles along the cortical mantle. Once the cortical models are completed, 
a number of deformable procedures are performed for further data processing including surface 
inflation to allow the measurement of hidden sulci and registration to a spherical atlas which is 
based on the individual cortical folding patterns to match cortical geometry across subjects. 
Finally, each spherical model is parcellated based on a spherical in-built atlas [Desikan-Killiany 
atlas (Desikan et al., 2006)] to extract morphometric measurements (e.g. cortical thickness and 
surface area) for specific cortical regions (e.g. fusiform gyrus, middle temporal cortex, superior 
frontal gyrus) (Fischl et al., 1999). Based on this procedure, several cortical metrics can be 
estimated by the use of different overlays that assign a value for each metric (e.g. thickness, 
volume, curvature) for each vertex. For example, for each vertex, cortical thickness is calculated 
as the average of the distance from the WM surface to the closest point on the pial surface and 
from that vertex back to the closest point on the WM surface (Fischl & Dale, 2000). 
 
Within this thesis, three SB-ROIs measures were used: 1) volumes of subcortical regions, 2) 
thickness and 3) volume of cortical regions from each hemisphere. Most ROIs were measures in 
both hemispheres separately, totalling 169 ROIs. A complete list of all the regions included in the 












Table 2.1. List of cortical and subcortical brain regions extracted with FreeSurfer. 
Cortical structures Subcortical structures 
Banks of superior temporal sulcus  Third ventricle 
Caudal anterior cingulate Fourth ventricle 
Caudal middle frontal gyrus  Brainstem 
Cuneus cortex Corpus callosum anterior  
Entorhinal cortex Corpus callosum central  
Fusiform gyrus Corpus callosum midanterior  
Inferior parietal cortex  Corpus callosum midposterior  
Inferior temporal gyrus  Corpus callosum posterior  
Isthmus of cingulate cortex  CSF 
Lateral occipital cortex  Accumbens 
Lateral orbitofrontal cortex  Amygdala 
Lingual gyrus Caudate 
Medial orbitofrontal cortex  Cerebellum cortex  
Middle temporal gyrus  Cerebellum white matter  
Parahippocampal gyrus  Hippocampus 
Paracentral sulcus Inferior lateral ventricle  
Frontal operculum Putamen 
Orbital operculum Lateral ventricle  
Triangular part of inferior frontal gyrus  Pallidum 
Pericalcarine cortex Thalamus proper  
Postcentral gyrus Ventral DC 
Posterior cingulate cortex  
Precentral gyrus  
Precuneus cortex  
Rostral anterior cingulate cortex   
Rostral middle frontal gyrus  
Superior frontal gyrus  
Superior parietal gyrus  
Superior temporal gyrus   
Supramarginal gyrus  
Frontal pole  
Temporal pole  
Transverse temporal cortex  
Insula  
 
2.3. Data Analysis 
2.3.1. Univariate analysis 
2.3.1.1. Voxel-based morphometry 
Group-level differences between FEP and HC on VWGMV and VWCT were estimated using the 
general linear model (Frackowiak, 2004). According to this framework, the data can be described 
in terms of effects of interest, confounds of no interest, and residual error. Statistical analysis is 
performed by fitting a pre-defined model to the data to estimate the contribution, i.e. parameter 




F-test) can then be applied to the estimated parameters to identify differences between effects of 
interest at each voxel. The results are then used to generate a statistical parametric map (SPM), 
where each voxel is assigned a t-statistic. Given the mass-univariate nature of the approach, a 
correction for multiple comparisons based on Gaussian random field (GRF) theory is also to 
minimise the risk of false positives (Worsley et al., 1996). 
 
2.3.1.2. Surface-based morphometry 
Differences in mean for each SB-ROI between FEP and HC were analysed with an independent-
sample t-test as implemented in SPSS 24.0 using a statistical threshold of p<0.05 and additional 
Bonferroni correction for multiple comparisons. 
 
2.3.2. Machine learning 
The supervised machine learning pipeline for a binary task can be divided into two main stages: 
training and testing. During the training stage, a machine learning algorithm identifies the features 
that best distinguish the two groups. In the testing phase, a previously unseen subject is assigned 
to one of the groups based on the decision function the algorithm learned during training. Within 
this general framework, there are a multitude of machine learning algorithms that can be applied. 
This thesis focuses on the application of a deep learning algorithm known as deep neural network. 
However, it is considered to good practice to test different approaches for the same task. 
Therefore, three additional and well-established approaches were also used: 1) K-nearest 
neighbours (KNN), 3) logistic regression (LR) and 3) support vector machine (SVM). These 
machine learning algorithms were chosen based on their increasing order of complexity: KNN is 
a straightforward algorithm often used as a benchmark, whilst deep learning can be more powerful 
at the expense of transparency; and popularity: SVM and LR and among the most commonly 
used techniques used in previous studies. The implementation of each one if these algorithms 
followed the same pipeline: 1) dealing with confounding variables, 2) feature extraction and 
dimensionality reduction 3) scaling, 4) model training and finally 5) model evaluation (Figure 2.4). 
The following subsections provide the details of the strategies and techniques used to build this 






Figure 2.4. Summary of the machine learning pipeline implemented in this thesis. 
 
2.3.2.1. Confounding variables 
Given the well-established effect of sex and age on brain neuroanatomy (Luders et al., 2004; 
Pina-Camacho et al., 2016), these two demographic variables were treated as possible 
confounders. In order to mitigate their effect, FEP and HC groups from each site were matched 
for sex and age. To maximize the use of the data made available, matching was carried out by 
taking the group with smallest sample size and randomly selecting participants from the other 
group according to age (+/- 5 years) and sex. For all sites, the FEP:HC matching ratio was 1:1, 
except for site 4 where the ratio was 2:1. Due to this imbalance in site 4, balanced accuracy was 
used as the performance metric of choice and all machine learning algorithms were trained using 

































sizes for each site are shown in Table 2.1. and Chapter 5. 
 
2.3.2.2. Feature extraction and dimensionality reduction 
The VWGMV, VWCT and SB-ROIs data extracted using the procedures explained in section 
2.2.3. were used as input features for the diagnostic classification of FEP and HC. The 
preprocessed VWGMV and VWCT maps contain several thousands of voxels, i.e. they are very 
high-dimensional. The deep learning architecture used in this work is not designed to handle 
whole-brain voxel-level data as this would result in an unfeasible number of parameters to 
estimate during training (see section 2.3.2.4.2. Deep neural networks). A possible solution to this 
issue is to extract a new set of features that compress the information in the original data into a 
substantially smaller number of features. This procedure is known as dimensionality reduction. 
Therefore, to mitigate the likelihood of overfitting and alleviate computational requirements, the 
dimensionality of VWGMV and VWCT maps was reduced via principal components analysis. Two 
of the alternative methods used in this work – LR and SVM – are regularized methods and 
therefore do not need this step. However, PCA was also used in combination with these methods 
to facilitate comparison between all approaches as well as to alleviate computational 
requirements during training. 
 
Principal component analysis (PCA) is a well-established unsupervised method for dimensionality 
reduction that has been widely used in neuroimaging (Mwangi, Tian, & Soares, 2014) and which 
technical details have been extensively reported (Lever, Krzywinski, & Altman, 2017). Using this 
approach, the original and likely correlated features are transformed into a set of values of linearly 
uncorrelated variables called principal components. Briefly, this is achieved by projecting the 
original data into a new coordinate system where the first axis, called the first principal axis, 
corresponds to the direction along which the data varies the most; the second axis, called the 
second principal axis, corresponds to the direction along which the data varies the most after the 
first direction; and so on. The first principal component is the projection of the original data onto 
first principal axis and captures the greatest amount of the variance in the data. The second 
principal component is the projection of the original data onto second principal axis and explains 




component. Data is thus decomposed such that each subsequent principal component explains 
the greatest amount of variance possible under the constraint that it is orthogonal to the preceding 
principal components. Dimensionality reduction can therefore be attained by selecting only the 
principal components that capture the most variability of the original data. In this thesis, PCA was 
implemented with the function PCA from the module decomposition from the Scikit-Learn library 
(sklearn, version 0.20) for python 3.5.  
 
2.3.2.3. Scaling 
To model the data correctly and effectively, most machine learning algorithms require the data to 
be on the same scale. This is because if a feature’s variance is orders of magnitude greater than 
the variance of other features, that particular feature might dominate the others in the dataset. 
There are several possible solutions to avoid this issue, collectively known as feature scaling. In 
this thesis, data was transformed such that the distribution of each feature resembles a standard 
normal distribution with mean=0 and variance=1; this is known as standardization or z-score 
normalization. Each normalized value !!! is calculated by taking each data point "", subtracting 
the mean # and then dividing by the standard deviation (SD) of the same feature: 
  
                !!! =	
($"#$%&'#(%	!!)
()"#$%&'#	(
                                                         (2.1) 
 
In this work, scaling was implemented using the function StandardScaler from sklearn (version 
0.20, Pedregosa et al. (2011)) for python 3.5. 
 
2.3.2.4. Model training 
2.3.2.4.1. Cross-validation 
The training and testing of each machine learning algorithm was implemented via nested stratified 
10-fold cross-validation (CV). This involves dividing the total data into 10 groups, training the 
model in 9 groups and use the left-out group for testing. This is done iteratively, using a different 
group for testing each turn, until all groups have been used for testing. Given the 2:1 ratio of FEP 
and HC in site 4, the ratio FEP:HC was kept consistent across iterations of the CV to avoid a 




of the machine learning algorithms used in this work relies on the specification of different 
hyperparameters. This choice of values for these hyperparameters was done via nested CV. This 
creates a second, inner, CV inside the already defined primary, outer, CV. At each iteration of the 
outer CV, the training set is further divided into training and validation sets, where different 
possible values for the hyperparameters are fitted to the training set and tested in the validation 
set. The hyperparameters with the best performance in the validation set are then used to fit the 
model to the training set as defined by the outer CV. The final performance is subsequently 
estimated by averaging the performance in the test set across all outer CV iterations. 
 
In order to ensure the independence between training and test sets necessary for an accurate 
measure of generalizability of the trained model, PCA and normalization were implemented as 
part of the CV scheme. For PCA, this was done first extracting the minimum number of principal 
components whilst retaining cumulative 90% of the variance from the data in the training set only. 
The VWGMV/VWCT maps were then projected onto the resulting principal components and the 
resulting values were used for training the classifier. The VWGMV/VWCT maps from the test set 
were projected onto the same components derived from the training set and the resulting values 
were used for testing the classifier. Likewise, the scaling procedure was implemented by first 
estimating the mean and standard-deviation separately for each feature in the training set only. 
These were subsequentially used to scale both the training and test sets. Both PCA and scaling 
procedures were done iteratively for each fold of the CV. 
 
2.3.2.4.2. Deep neural networks 
The flexibility inherent to deep learning models has propelled a vast family of possible 
architectures, each one built for a specific purpose. Amongst all the possible architectures, deep 
neural networks (DNN) (or multilayer perceptrons) emerges as the simplest and most 
straightforward application of deep learning. This section provides an overview of the main 
elements of DNN: structure, training, regularization ang hyperparameter tuning. 
 
2.3.2.4.2.1. Structure 




as units or artificial neurons), loosely inspired by the biological neuron (Figure 2.5). Each neuron 
is connected to the neurons in adjacent layers to create a network, akin to a network of biological 
neurons. Connections are represented by weights & that reflect the strength and direction 
(excitatory or inhibitory) between two neurons.  
 
 
Figure 2.5. A. Biological neuron B. Artificial neuron. 
 
Each neuron transforms the incoming data " by calculating the weighted sum of the output of the 
neurons in the previous layer; then passing it through a nonlinear function ' to derive the output 
for that neuron. There are several nonlinear functions, also known as activation functions, that 
can be used; some of the most common ones include the rectified linear unit (ReLU), hyperbolic 




Figure 2.6. Example of commonly used activation functions: sigmoid (left), tanh (centre) and 
ReLU (right). 
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The first layer of the network corresponds to the input layer where data is entered into the model 
(Figure 2.6). The last layer is the output layer. In a classification task, the number of neurons in 
the output layer corresponds to the number of classes. Here, a special nonlinear function is 
typically used to yield the probability of a given subject belonging to each class; this nonlinear 
function is called softmax function. The layers between the input layer and the output layer are 
referred to as hidden layers, and their number represents the depth of the model (hence the term 
‘deep’ learning). In a typical network, all neurons in one layer are connected to all neurons in 
adjacent layers; this is known as a fully-connected network. The consecutive nonlinear 
transformations and propagation of information form the input through the hidden layers until it 
reaches the output layer, is known as forward propagation. 
 
 
Figure 2.7. Exemplar application of a DNN to neuroimaging data. SM-ROIs are transformed into a 1D vector 
and used as input data for the first layer of a fully-connected DNN. 
 
In order to fully-describe the network before training, the number of layers and neurons as well 
other hyperparameters need to be specified. In this thesis, this was done via automatic 
hyperparameter tuning, discussed in section 2.3.2.4.3.4. 
 
2.3.2.4.2.2. Training 
In a typical DNN, training consists of an iterative process of adjustment of the weights between 
the neurons within the network, much like a human brain learns through the fine-tuning of 
connections between neurons (Bengio, 2009). These weights can be thought of as ‘knobs’ that 
determine the relationship between the input data and the network’s output (LeCun et al., 2015). 




the relationship between input and output. Weights can be learned by framing training as an 
optimization problem: find the network’s weights that minimize the difference between prediction 
and true target (i.e. error). There are several ways in which this optimization can be implemented. 
The most commonly used are Gradient Descendent (GD) based optimizers (such as vanilla GD 
or Adam (Kingma & Ba, 2014)). This section provides an intuitive description of GD (a detailed 
technical explanation can be found in Goodfellow (2016)). 
 
An intuitive way to describing GD is to think of the optimization task as the search for the lowest 
point in a chain of mountains. In this analogy, the loss function can be thought of as a chain of 
mountains and valleys, in which every point along the chain is associated with a possible set of 
values of the network’s weights, and where the deeper the valley, the smaller the error; this is 
usually referred to as the loss landscape (Figure 2.7). In turn, optimization through GD can be 
thought of as a way to navigate through this landscape to the bottom of the deepest valley, also 
known as global minima. At the beginning of training, the weights of the DNN are initialized at 
random. A training observation (e.g. data from one participant) is then entered into the input layer 
and the information forward propagated through the network until it reaches the output layer, 
where the network outputs a prediction value and the error is calculated using a loss function. In 
the analogy described above, the value of this error can be thought of as a random location in the 
loss landscape, from which the optimizer will navigate in search for the global minima (point A in 
Figure 2.7).  
 
 
Figure 2.8. Loss landscape. The random initiation of the DNN results in an error of magnitude equivalent to 
a random point in the landscape (point A). The lower the ‘valley’, the smaller the error of the loss function. 




very small error. 
 
From here, the GD algorithm checks which direction, out of all possible options, results in the 
steepest decline, i.e., a larger decrease in the value of the loss function; this is formally known as 
the gradient: its direction reflects the direction with the steepest descent, and its magnitude 
indicates how steep the descent is. Once the direction of the steepest descend has been 
established, the size of the step towards that direction needs to be determined; this is known as 
learning rate. Once the gradient and learning rate are determined, the optimizer takes its first 
step. Formally, this is translated in a set of updated weights. Once a further data observation is 
passed thought the network, and a new value for the loss function – in principle of smaller amount 
– is generated. This corresponds to a new position in the loss landscape. At this new position, the 
gradient is recomputed, and the optimizer takes another step towards the minima. This is done 
iteratively and, as the optimizer approaches the minima, the contour of the function, i.e. the ridges 
of the valley, become almost flat. This will result in a very small gradient, i.e. there is no more 
‘downwards’ to go from here, and a minima has been reached. Critically, the size of the step – 
learning rate – is typically adjusted as the optimizer gets closer to the minima. This is because, 
while it may be useful to take larger steps at the beginning, this might result in overshooting the 
minima once the optimizer gets closer to it. Therefore, the size of the learning rate is typically 
reduced along the iterations. This is specified by another hyperparameter of GD, known as 
learning rate decay. Importantly, it is not trivial to calculate the gradient of the weights of the 
network’s hidden layers at each iteration of the GD. It was only in the 1980s that an efficient 
method of computing gradients was developed, known as “backward propagation of errors” or 
backpropagation (LeCun et al., 2015; Schmidhuber, 2015; Werbos, 1982).  
 
The type of GD can vary depending on the number of training samples used to calculate the error. 
There are three main variations of the GD: stochastic, batch and mini-batch. In stochastic gradient 
descent, the error and respective updates are computed for each observation in the training 
dataset. Perhaps the most intuitive of the GD variations, it can result in a noisy gradient signal, 
making it hard for the algorithm to settle on a minimum value. Batch gradient descent on the other 




stable gradient signal may converge prematurely, thus resulting in a less optimal network’s 
weights. Finally, mini-batch gradient descent splits the training data into small batches – mini-
batches – that are used to calculate the error and update the model coefficients. This approach 
represents a reasonable trade-off between the two other methods, and as such is the most 
common form of GD and the one used in this thesis. Similarly to the other hyperparameters, batch 
size also needs to be determined a priori or tuned as part of the machine learning pipeline. 
 
2.3.2.4.2.3. Regularization 
Due to the large number of connections between neurons, the training of DNNs involves the 
estimation of a considerable number of parameters, i.e. weights. This can lead to the model 
learning particular fluctuations in the training data that only work in the training set, i.e. overfitting. 
Therefore, modern DNNs try to minimize this risk by applying different strategies, collectively 
known as regularization. In this thesis two forms of regularization were used: L2 norm and drop-
out. L2 norm involves penalizing models with very high weights. By forcing weights to remain low, 
the network becomes less dependent on the training data (i.e. performance does not rely heavily 
on a particular set of weights) and can better generalize to unseen data (Nowlan & Hinton, 1992). 
Dropout, on the other hand, consists of temporarily removing a random number of neurons and 
their respective incoming and outgoing connections from the network during training. This results 
in the extraction of different sets of features that can independently produce a useful output, which 
in turn has the effect of enhancing generalizability (Srivastava, Hinton, Krizhevsky, Sutskever, & 
Salakhutdinov, 2014).  
 
2.3.2.4.3.4. Model specification and hyperparameter optimization 
DNN models rely on the specification of several architectural and learning hyperparameters. A 
detailed description of how each hyperparameter was specified is provided in Chapter 5 and 6. 
In brief, each layer was initialized via Glorot initialization (normal distribution) (Glorot & Bengio, 
2010). In the output layer, classification was performed by a softmax function. A mini-batch of 8 
training samples was used for the VWGMV and VWCT feature sets, while a mini-batch of 128 
was used for SM-ROIs. The number of layers and neurons at each layer, optimizer, learning rate, 




a nested CV from a range of possible values defined a priori. A more detailed description of 
hyperparameter tuning is given in Chapter 5 and 6. 
 
2.3.2.4.3. Traditional machine learning algorithms 
2.3.2.4.3.1. K-nearest neighbours 
KNN is a straightforward algorithm often used for its ease of implementation and interpretation. 
Due its simplicity it is often used in the literature as a benchmark for more complex algorithms 
(Jain, Duin, & Jianchang Mao, 2000). KNN belongs to a special type of learning known as ‘lazy 
learning’. Whilst most algorithms learn an optimal function that map features and target variable 
during a training phase, which is then tested in the test set, KNN does not rely on an explicit 
training phase; instead, it simply stores the entire training data in memory, which is subsequently 
used as “knowledge” to make predictions of unseen data. Once the training data has been stored, 
the distance between the new observation in the test set and each observation in the training set 
is estimated. This distance works as a proxy for similarity and is typically calculated using the 
Euclidean distance, which estimates the distance between two points by calculating the length of 
the straight-line between them, such that the larger the distance, the farther and less similar they 
are to each other. Formally, the Euclidean distance between two data points ( = ((*, (+, … , (,) 
and - = (-*, -+, … , -,) is given by: 
 
.((, -) = 	/((* −	-*)+ +	((+ −	-+)+ +⋯+	((, −	-,)+ 
                                            =	/∑ ((" − -")+,"-*                                                                        (2.2) 
 
Once all distances have been estimated, the algorithm identifies a set of training observations 
that are closest, i.e. neighbours, to the new unseen observation. The size of this set, i.e. 
neighbourhood, is given by the hyperparameter 4. In case of classification, the unseen 
observation will be assigned to the majority class among the 4 observations. The appropriate 
choice of k has significant impact on the performance of KNN algorithm. A small k forces the 
algorithm to ignore the overall distribution of the training data. As a result, it provides a flexible fit, 




considers more observations and hence is more resilient to outliers. This results in a smoother 
decision boundary, with lower variance but increased bias.  
 
2.3.2.4.3.2. Logistic regression 
Logistic regression is one the simplest yet more powerful machine learning algorithms. Either in 
its simplest form or in more complex variations, logistic regression has been extensively used in 
the literature. Contrary to linear regression where the outcome is a real number in a continues 
scale, logistic regression models the probability of belonging to a certain class. Formally, for a 
binary classification problem with labels A and B, logistic regression models the log odds of 
belonging to class A as opposed to class B, given the observed predictor variables:  
 
                                       log	(.(/!-0	|!!*,!!+,…,!!,)
.(/!-4	|!!*,!!+,…,!!,)
) = 	85 +	8*""* +	8+""+ +⋯+	8,"",                               (2.3) 
 
Since 9(:" = ;	|""*, ""+, … , "",) = 1 − 	9(:" = >	|""*, ""+, … , "",), the probability of belonging to 
class A is given by: 
                                    9(:" = >	|""*, ""+, … , "",) = 	
6-./	-*0!*/	-+0!+/⋯/	-,0!,
*7	6-./	-*0!*/	-+0!+/⋯/	-,0!,
                                  (2.4) 
 
As a linear method, logistic regression finds the optimal linear combination of the input features 
and predicts an output value by assigning each feature a coefficient or weight learned from the 
training data. Once learned, these weights are used to output the probability of the input data 
belonging to a default class (e.g. HC), which can then be converted to a binary prediction, i.e. if 
the probability of belonging to class A is higher than 0.5, the input data is assigned to this class, 
otherwise it is assigned to class B. There are different approaches to learn the optimal weights 
during training (e.g. maximum likelihood estimation, stochastic gradient descent). In this thesis, 
weight optimization was implemented via stochastic gradient descent (GD), as described in 
section 2.3.2.4.2.2. 
 
Logistic regression can be combined with regularization strategies to mitigate the likelihood of 
overfitting. Elastic net is a commonly used method that consists in the combination of two 




Operator) and L2 norm from ridge regression. Both penalize non-zero coefficients. However, this 
is done differently for each technique. Briefly, the L1 penalty discards features that contribute 
most to the error by shrinking their weights to zero, effectively working as a feature selector. The 
reduced number of features reduces model complexity and thus help prevent overfitting. 
Conversely, the L2 penalty retains all variables, whilst forcing their weights to be low. This will 
result in a model less reliant on a specific group of features from the training set, and therefore 
more likely to generalize to new data. From here it follows that, while both methods allow to use 
correlated predictors, they solve the issue of multicollinearity differently. From the same group of 
highly correlated features, L1 norm selects one while the rest are removed, whereas L2 norm 
assigns all features similar weights. Therefore, in the context of neuroimaging data, where high-
dimensional data tends to be highly correlated and the effect of each feature is thought to be 
subtle, the former may result in unwanted loss of information, while the latter will only mitigate 
model complexity as the number of features is kept the same. Elastic net can therefore be used 
to combine both penalties and overcome each technique’s shortcomings.  
 
2.3.2.4.3.3. Support vector machine 
Support vector machine (SVM) is one of the most widely used classifiers in the machine learning, 
including in psychiatric neuroimaging (Orrù et al., 2012). The technical details of SVM have been 
extensively reported (Vapnik, 1995). Briefly, SVM try to separate observations into classes using 
a decision boundary in a high-dimensional space. The separation boundary can then be used to 
classify unknown observations. In a high-dimensional space, the separation between the two 
classes can be visualized as a hyperplane as defined by:  
 w. x + b = 0                                               (2.5) 
 
where x represents the input features, w the weight vector and b the bias. However, there are 
many possible hyperplanes that can separate the two classes. The assumption here is that finding 
a hyperplane that has the maximum distance, or margin d, between the most difficult data points 
of either class to classify will maximise generalisability. Formally, the margin can be defined as 
distance between the points closest to the hyperplane: 





These data points are the nearest observations of either class to the hyperplane and are 
collectively known as the support vectors (Figure 2.9).  
 
 
     Figure 2.9. Hyperplane and support vectors. 
 
The optimal hyperplane can therefore be obtained through an optimization problem where the 
aim is to maximize " (which is equivalent to minimizing ||&||). Once obtained, the classification 
problem can be solved intuitively by assigning an observation to one of two classes (1 or -1), 
according to the sign of the equation 2.7 as follows: 
 
                                                             f(x) = sign(w. x + b)	                                                   (2.7) 
 
such that, if f(x) ≥ 0 the participant is classified as class +1 (e.g. patients) otherwise it is classified 
as class -1 (e.g. controls). 
                                                            
Since real-world data might not be perfectly separated with a hyperplane, SVM includes a 
hyperparameter that allows some data points in the training data to violate the separating 
hyperplane whilst still trying to maximize the margin between data points of different classes. This 
trade-off is regulated by the soft-margin or C hyperparameter. For C=0 no violation is allowed; 
this is known as a hard margin classifier. For large values of C, a smaller-margin hyperplane is 
chosen if it results in all the training points being classified correctly. Conversely, a very small 
value of C will cause the algorithm to look for a larger-margin separating hyperplane, even if that 




allows for an additional regularization penalty. This is typically either the L1 or L2 discussed in the 
previous section. While L1 aims to reduce the number of features by assigning a weight of zero 
to a subset of less important features, L2 keeps all features but forces their weight to remain low. 
In this thesis, the default L2 regularization strategy was used as implemented in the SVM module 
in scikit learn library (Pedregosa et al., 2011). 
 
When groups cannot be separated with a linear decision boundary (even with the aid of a soft 
margin), SVM allows the use of kernels - a similarity function over pairs of data points in their raw 
representation - that transform the initial features space into a new higher-dimensional space 
which may allow the distinction of initially nonlinearity separable classes. In this thesis, a linear 
kernel was used to contrast with the characteristic nonlinear approach of deep learning. This 
consists of transforming the initial feature space by computing the dot product between each pair 
of observations.  
 
2.3.2.5. Model evaluation 
2.3.2.5.1. Performance metrics 
Balanced accuracy was used as the main outcome of interest, along with sensitivity and 
specificity. Below is a summary of the definition of each metric and how they were calculated. 
 
Balanced accuracy: average between the accuracies for each class or the average between the 
sensitivity and the specificity. 






                          (2.8) 
 
Sensitivity: proportion of FEP patients correctly identified. 
                                               Sensitivity = 89:6	;<=">"?6
89:6	;<=">"?67@AB=6	,6CA>"?6
                                           (2.9) 
 
Specificity: proportion of HC correctly identified. 
                                                 Specificity = 89:6	,6CA>"?6
89:6	,6CA>"?67@AB=6	;<=">"?6




2.3.2.5.2. Significance testing 
Testing for statistical significance is considered an important step, especially when dealing with 
small sample sizes, to minimize the risk of over-optimistic conclusions. Significance testing is 
usually carried out using permutation testing. In essence, this method measures the likelihood 
that the model’s performance would be observed by chance. For a supervised algorithm, this is 
estimated by first randomly shuffling the target variables for all subjects. This is was done 1000 
times such that any statistical relationship between the target variable and the input features was 
lost. At each permutation, the same previously trained model was applied to the input features 
and the corresponding randomly assigned labels. Critically, the same stratified cross-validation 
scheme used during the training of the model was also used here, to ensure a balanced ratio 
between the two labels in each fold. The balanced accuracy was then calculated for each 
permutation, resulting in a statistical distribution of balanced accuracy which reflects the null 
hypothesis that the model behaves by chance. The number of times the performance was greater 
than or equal to the original performance was then divided by the number of permutations (i.e. 
1000) to estimate a p-value (P. Good, 1994). In this thesis, each models’ final balanced accuracy 
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Neuroanatomical abnormalities in schizophrenia have been well documented for the past three 
decades (Glahn et al. 2008; Bora et al. 2011). While the initial research was performed in patients 
with long-term schizophrenia (Ellison-Wright et al. 2008), more recent studies have focussed on 
individuals in the early stages of the illness, when the effects of chronicity (Olabi et al. 2011; Vita 
et al. 2012) and antipsychotic medication (Radua et al. 2012; Vita et al. 2015; Shah et al. 2017) 
are minimal. The results of these studies, however, tend to be inconsistent from one investigation 
to another (Radua et al. 2012; Gao et al. 2017; Shah et al. 2017). For example, reports of insular 
abnormalities have been heterogeneous, with some studies reporting increased (Salgado-Pineda 
et al. 2003; Ren et al. 2013) and others decreased (Jayakumar et al. 2005; Chua et al. 2007; 
Venkatasubramanian, 2010) GM volume in this region. A possible explanation for these 
inconsistencies, is that most studies have used small sample sizes and therefore may have been 
under-powered. For example, in the most recent meta-analyses (Radua et al. 2012; Gao et al. 
2017; Shah et al. 2017), out of a total of 37 studies included (after accounting for overlapping 
studies across meta-analyses), 20 had a total sample size of 60 or less. Studies with small sample 
sizes are likely to result in overestimates of effect size and low reproducibility due to low statistical 
power (Button et al. 2013); which suggests that several of these individual small studies may have 
had an increased risk of reporting false positives. In addition to being under-powered, different 
studies have also varied significantly in terms of their methods such as recruitment criteria, 
imaging acquisition parameters, preprocessing and statistical analysis (Radua et al. 2012). 
Furthermore, the vast majority of studies have examined participants from a single research site, 
raising the possibility that the results might be specific to the characteristics of the local sample 
investigated. 
 
To overcome some of these limitations, the ENIGMA consortium developed a standardized 
pipeline detailing data preprocessing and analysis procedures; once data is analysed, single-site 
results are pooled and summarized in a meta-analysis. This approach has led to unprecedented 
sample sizes in schizophrenia research, with two recent studies of cortical abnormalities in 4474 
patients and 5098 controls (van Erp et al. 2018), and subcortical changes in a smaller, albeit still 




this approach mitigates some of the main limitations of traditional meta-analysis by reducing the 
heterogeneity of the pooled single-studies, findings still rely on reported results from individual 
studies, which may result in limited accuracy (Shah et al. 2017). Multi-centre mega-analyses, 
involving the preprocessing and integration of data from independent studies in one single 
statistical analysis, provide an opportunity to overcome this limitation. Gupta et al. (2015) 
analysed neuroanatomical abnormalities in the first mega-analysis in schizophrenia in a sample 
comprised of 784 individuals with established schizophrenia and 936 healthy controls collected 
from 23 sites. Similar mega-analytic efforts focused on the initial stages of the illness, when the 
effects of confounders are minimal, are still non-existent and evidence is still reliant on small to 
modest sized studies (X. Gao et al., 2018; Shah et al., 2017). 
 
In light of the limitations of the existing literature, the aim of this study was to use a multi-centre 
mega-analytic approach to test for neuroanatomical changes in FEP that are consistent across 
independent samples. Based on the findings of the recent meta-analyses (Radua et al. 2012; Gao 
et al. 2017; Shah et al. 2017), we hypothesize that i) patients would show grey matter volume 
reductions in a distributed bilateral network including fronto-temporal regions and well as the 
insula and cingulate; ii) grey matter volume in the FEP group would be negatively correlated with 
severity of symptoms; and iii) given previous reports of progressive neuroanatomical changes in 
psychosis (Olabi et al. 2011; Vita et al. 2012), grey matter volume in the FEP group would also 




A total of 1074 participants recruited as part as five Independent studies (Chengdu, China (Gong 
et al. 2015), London, England (Di Forti et al. 2009) Santander, Spain (Pelayo-Terán et al. 2008) 
and Utrecht, The Netherlands (Korver et al. 2012)) were included in the analysis. All patients were 
experiencing their first psychotic episode, defined as the first manifestation of psychotic 
symptoms meeting criteria for a psychotic disorder, as specified by the DSM-IV (APA, 2000) or 
ICD-10 (Organization World Health, 1992). Recruitment details are reported in Chapter 2, 




summarized in Table 3.1. 
 
3.2.2. MRI data acquisition  
At all 5 sites, volumetric MRIs were acquired using a T1-weighted protocol. At four sites, the 
scanner field strength was 3T, and at 2 sites it was 1.5T. The details of the image acquisition 
sequence are reported in Chapter 2, section 2.2.2. 
 
3.2.3. Data analysis  
3.2.3.1. Socio-demographic and clinical parameters 
Differences between FEP and HC in sex, age and TIV were assessed with a chi-square and 
independent-sample t-test for categorical and continuous data respectively, using SPSS v24. 
 
3.2.3.2. Preprocessing 
Differences in GM volume between HC and FEP were examined using VBM, as implemented in 
SPM12 software (http://wwwfilionuclacuk/spm) running under MATLAB 92 (The MathWorks, Inc, 
Natick, Massachusetts) (Ashburner & Friston, 2005). The following steps were followed for the 
preprocessing of each site: (1) checking for scanner artefacts and gross anatomical abnormalities 
for each subject, (2) setting the image origin to the anterior commissure and reorienting the image 
along the AC-PC line and (3) segmenting the image into grey matter, white matter and CSF maps. 
Next, all available images were used to create a study-specific template as implemented by the 
DARTEL toolbox (Ashburner, 2007). This procedure warps the GM and WM partitions into a new 
study-specific reference space representing an average of all the subjects included in the 
analysis, thus maximizing accuracy and sensitivity (Yassa & Stark, 2009). Finally, GM volume 
maps were normalized to the Montreal Neurological Institute (MNI) template and subsequently 
smoothed with an 8mm Gaussian filter. A “modulation step” was also included in the normalization 
step to preserve the information about the absolute GM values (Mechelli et al. 2005). The final 
smoothed, modulated, normalized data were used for the statistical analysis. 
 
3.2.3.3. Statistical analysis 




and scanning site as factors, resulting in 10 experimental groups. Age and gender were included 
as covariates of no interest. The option of proportional scaling was selected to remove 
confounding driven by global differences. Neuroanatomical alterations in patients with FEP 
relative to HC consistent across the five datasets were identified using the “inclusive masking” 
option as implemented in SPM software. This option allowed us to test for voxels which showed 
(i) an overall statistically significant difference between patients and healthy controls across all 
sites (p<0.05 FWE corrected) and (ii) at least a strong trend at each site (p<0.05 uncorrected). 
Specifically, this consisted on the following steps in SPM: i) comparing all FEP against all HC at 
p<0.05 FWE corrected using an overall main contrast - FEPall sites vs HCall sites (e.g.  FEPall sites < 
HCall sites), ii) overlaying this contrast with a second set of five FEP vs HC contrasts, one for each 
site (e.g.  FEPsite 1 < HCsite 1) at p<0.05 uncorrected each, and finally iii) identifying voxels of 
increased/decreased GMV in FEP relative to HC that survived both the overall and the site-level 
contrasts (Figure 1). This procedure ensured that any overall statistically significant difference 
across the five sites would also be present at each site, at least at trend level. Statistical inferences 
were made using a minimum extent threshold of 50 voxels.  
 
 
Figure 3.1. Inclusive masking procedure used to identify neuroanatomical abnormalities in FEP relative to 
HC consistent across all five sites. Left: an overall contrast with all FEP against all HC (p<0.05 FWE 
corrected) was combined with five site-level contrasts (p<0.05 uncorrected); this allowed us to identify only 





The total intracranial volume (TIV) for each image was estimated by first calculating the volume 
of gray matter, white matter and CSF separately at each voxel from the segmented images; the 
total volume for each type of tissue was then calculated by summing the respective voxel-level 
volumes; finally, TIV was obtained by adding the volume of all three tissue types. The effects of 
symptom severity, illness duration and anti-psychotic medication on the identified clusters were 
estimated using Pearson’s correlation between the values of GMV for the peak coordinate of each 
statistically significant cluster and each one of the clinical variables of interest. The raw psychotic 
symptom severity scores (acquired with either PANSS or SANS/SAPS) were first normalized to 
ensure comparability across sites. This normalisation was achieved using the following formula:   
 
                                          New	score = 	 DEFGHGFIJK	LJM	NOPLQ%RGEGSIS
RJTGSIS	%RGEGSIS
                                          (3.1) 
 
where Minimum and Maximum refer to the lowest and highest score allowed for either PANSS or 
SAPS/SANS. The resulting disease severity scores were scaled between 0 and 1. Across all sites 
(except site 1, where all patients were AP-naïve), AP medication dose was estimated by 
calculating the chlorpromazine equivalent (mg/day) for each individual according to Gardner et 
al. (2010). Both chlorpromazine equivalent and duration of illness were log transformed. The 
statistical significance of Pearson’s correlation was assessed using a p-value<0.05 with 
Bonferroni correction for multiple comparisons.   
 
3.3. Results 
3.3.1. Socio-demographic and clinical parameters 
There were no significant differences between FEP and HC in sex, age and TIV, both when 
considering all sites together and within each single site. Patients reported comparable median 
duration of illness across sites (Table 3.1).  
 
3.3.2.1. Decreased GM volume in FEP compared to HC 
Relative to HC, FEP showed a widespread pattern of GM volume reduction in fronto-temporal, 




in the left gyrus rectus, located in the inferior frontal lobe (Figure 3.1).   
 
Figure 3.2. GM volume decreases in FEP relative to HC. A. Regions showing statistically significant 
decreases in FEP relative to HC across the whole brain. B. Location of the gyrus rectus (straight gyrus) 
where the largest GM volume decrease was found and mean and standard deviation of the GM volume in 
this region for each site. 
 
Negative correlations were found between GM volume in this region and severity of both positive 
and negative symptoms as well as duration of illness (Table 3.4). The left lingual and inferior 
temporal gyri also showed statistically significant negative correlations with both positive and 





Table 3.1. Demographic and clinical characteristics for FEP and HC for each site and total sample. 
TIV: total intra-cranial volume; L: liters; M: male; F: female; FEP: first episode psychosis, HC: healthy controls; aPANSS: Positive and Negative Symptoms Scale; bSAPS: 








Santander A, Spain 
(N=257) 
  









  HC FEP HC FEP HC FEP HC FEP HC FEP HC FEP 
N 118 122 92 76 113 144 78 145 101 85 502 572 
Sex (%) 
M  56 (48) 55 (45) 37 (40) 41(54) 70 (62) 81 (61) 48 (61) 89 (61) 69 (68) 68(80) 280 (56) 341 (60) 
F 62 (52) 67 (55) 55 (60) 35 (46) 43 (38) 56 (39) 30 (39) 56 (39) 32 (32) 17 (20) 222 (44) 231 (40) 
 χ2= ns χ2= ns χ2= ns χ2= ns χ2= ns χ2= ns 
Age M(SD) 
25.8 (8.0) 27.0 (7.3) 26.5 (6.5) 27.0 (6.8) 29.7 (7.7) 29.3 (8.1) 28.0 (7.4) 29.5 (8.7) 26.8 (8.2) 25.4 (5.9) 27.8 (7.5) 27.7 (8.0) 
t= ns t= ns t= ns t= ns t= ns t= ns 
TIV (L) M(SD) 
1.5 (0.1) 1.5 (0.2) 1.5 (0.1) 1.5 (0.2) 1.5 (0.1) 1.4 (0.2) 1.5 (0.1) 1.5 (0.2) 1.5 (0.1) 1.5 (0.2) 1.5 (0.1) 
        t= ns 
1.5 (0.2) 
 t= ns t= ns t= ns t= ns t= ns 
Positive symptoms 
M(SD) 
- 24.5 (6.9)a - 13.7 (5.5)a - 14.3 (4.4)b - 13.5 (4.3)b - 15.8 (6.3)a - - 
Negative symptoms 
M(SD) 






- 16.2 (6.9)a - - 
Duration of illness 
(years) Med (IQR) 









Cluster Size  
(No of voxels) 
z p 




L medial orbital gyrus -9,54,-15 8.4 




L fusiform gyrus -20,2,-42 8.8 




R middle temporal gyrus 62,-32,-12 8.7 




R fusiform gyrus -46,-58,-22 8.6 
L middle temporal gyrus -58,-21,-14 161 8.8 .002 
R lingual gyrus 2,-80,-10 106 8.7 .004 
L middle temporal gyrus -52,-42,-18 63 8.5 .009 
L superior temporal gyrus -48, 18,-16 86 8.4 .006 
R insula 45,18,-8 88 8.3 .006 
L: left; R: right. 
 
3.3.2.2. Increased GM volume in FEP compared to HC 
A significant increase in GM volume in FEP relative to control was found in the right superior 
temporal gyrus (MNI coordinates: 38,16,-38; cluster size: 338; z=81; p<001) (Figure 3.2). The 
volume of this region was not significantly associated with severity of positive (r=.05, p=.785) or 
negative (r=.07, p=.801) symptoms, duration of illness (r=.02, p=.967) and anti-psychotic 





Table 3.3. Pearson’s correlations between regions showing GM volume changes in FEP relative 










Decreased GVM in FEP relative to HC   
    L gyrus rectus  -.31 -.20 -.10 -.08 
    L med. orbital gyrus -.17 -.17 -.03 -.06 
    L sup. temporal pole -.06 -.07 -.09 -.04 
    L fusiform gyrus -.05 -.05 -.11 .02 
    R inf. temporal gyrus -.11 -.04 -.08 -.04 
    R mid. temporal gyrus .04 .07 -.01 -.02 
    L inf. temporal gyrus -.17 -.13 -.10 -.11 
    R fusiform gyrus -.15 -.12 -.08 -.09 
    L mid. temporal gyrus .09 .08 .06 .02 
    R lingual gyrus -.20 -.16 -.18 -.13 
    L mid. temporal gyrus -.07 -.06 -.11 -.08 
    L sup. temporal gyrus .02 -.04 -.06 -.03 
    R insula .03 -.02 -.15 -.08 
Increased GVM in FEP relative to HC    
    R sup. temporal gyrus .05 .07 .02 -.08 
L: left; R: right; med: median; sup: superior; inf: inferior; mid: middle. Statistical inferences were made at 
p<0.05 after Bonferroni correction for multiple comparisons based on the number of regions; this resulted in 













where the GM volume increase in FEP relative to HC was found. B. Mean and standard deviation of the GM 
volume in this region for each site. 
 
3.4. Discussion 
Most previous studies on the neuroanatomical basis of FEP have used small samples recruited 
within a single site, and have yielded heterogeneous findings (Radua et al. 2012; Gao et al. 2017; 
Shah et al. 2017). The aim of this study was to use a multi-centre mega-analytic approach to 
identify neuroanatomical changes in FEP that are expressed consistently across several 
independent studies. As hypothesized, we found a widespread bilateral pattern of GM volume 
reductions in fronto-temporal, insular and occipital regions. Some of these effects, particularly in 
the gyrus rectus and the lingual gyrus, were correlated with symptom severity and duration of 
illness. In addition, an increase in GM volume was found in the right superior temporal lobe. 
Critically, all patients were experiencing their first episode of psychosis, one of the five samples 
was medication-naïve and an additional two were medication-naïve or with limited (up to 6 weeks) 
lifetime exposure to antipsychotics; this means the current results are unlikely to be explained by 
illness chronicity and medication effects. In what follows, we discuss the brain structures that 




A significant GM volume reduction was found in two sub-regions of the orbifrontal cortex (OFC), 
namely the gyrus rectus (straight gyrus) and the orbital gyrus (Buchanan et al., 2004; Nakamura 
et al., 2007). Grey matter deficits in the OFC have been reported in established psychosis (e.g. 
Kim et al. 2017; Kong et al. 2015; Rimol et al. 2012; Xu et al. 2017) and, to a lesser extent, in 
FEP (e.g. Huang et al. 2015; Keymer-Gausset et al. 2018; Liao et al. 2015), in keeping with the 
“hypofrontality” hypothesis of psychosis; although increases in this region have also been 
observed (Gao et al. 2017). The OFC has been implicated in multiple functions, including 
cognitive flexibility, reward learning and decision making (see Kringelbach 2005 and Schoenbaum 
et al. 2009 for a review), most of which are impaired in people with psychosis (Murray et al. 2008; 




with the most pronounced GM volume reduction within the OFC and the whole brain. Consistent 
with our finding, this region has been reported to be decreased in FEP regardless of antipsychotic 
medication status in a recent meta-analysis (Shah et al. 2017). GM volume  reduction in this 
region was also found in the largest single-site VBM study of first-episode patients to date which 
included 93 FEP participants and 175 controls (Meisenzahl et al. 2008); although evidence for 
normal volume has also been reported (Roiz-Santiáñez et al. 2011; Takayanagi et al. 2011). As 
hypothesized, GM volume in the gyrus rectus was inversely related to positive and negative 
symptoms – consistent with previous studies (Szendi et al. 2006; Sans-Sansa et al. 2013; Kim et 
al. 2017) – and negatively correlated with duration of illness, once again consistent with previous 
studies (Sapara et al., 2007). 
 
Insula 
Despite inconsistences across individual studies, most of the existing literature indicates deficits 
in the insular cortex of people with FEP, albeit with some inconsistencies in the exact location of 
the effect (Nekovarova et al. 2014; Gao et al. 2017; Shah et al. 2017; ONeill et al. 2018). Here it 
was the anterior part of the insula that showed reduced GM volume. This region plays an important 
role in salience processing (Menon & Uddin, 2010), emotional appraisal and social cognition 
(Eckert et al. 2009), all of which are affected in psychosis (Wylie & Tregellas, 2010). Notably, grey 
matter deficits in the insula, as well as in the gyrus rectus and superior temporal gyrus, have also 
been found in individuals at ultra-high risk for psychosis who later transition to psychosis 
(Smieskova et al. 2010); this suggests this region may represent a neuroanatomical signature of 
vulnerability to psychosis. Furthermore, GM volume reductions in this region have been shown to 
be above and beyond ethnic variations in incidence and clinical expression (Gong et al. 2015).  
 
Temporal cortex 
Reductions in temporal regions are amongst the most replicated findings in psychosis, including 
in FEP (Chan et al., 2011; Radua et al., 2012; Shah et al., 2017). In this study, several temporal 
regions showed GM volume deficits, namely the superior, middle and inferior gyri as well as the 
temporal portion of the fusiform gyrus bilaterally. GM volume  deficits in the left superior temporal 




et al., 2015; Modinos et al., 2013), possibly due the role of this region in language perception and 
processing; it has been suggested that impairment to this region may lead to a misattribution of 
internal speech (Frith & Done 1988; Mechelli et al. 2007). The fusiform gyrus is also thought to 
play an important role in the psychopathology of psychosis, mainly due to its contribution to facial 
recognition (Haxby, Hoffman, & Gobbini, 2002; Haxby et al., 2000), which is impaired in psychosis 
(see Green et al. 2015 and Barkl et al. 2014 for a review) and is often seen as a proxy for the 
social cognition deficits characteristic of the illness (Green et al., 2015). Perhaps more challenging 
to interpret is the significant increase in GM volume in right superior temporal gyrus. Nevertheless, 
increases in patients relative to controls across the brain, including the temporal cortex, have 
been reported before (J.-J. Kim et al., 2003; J. S. Lee et al., 2011; Radewicz, Garey, Gentleman, 
& Reynolds, 2000; Taylor et al., 2005), and are typically interpreted in terms of a “compensatory 
mechanism” (Guo, Palaniyappan, Liddle, & Feng, 2016) or a transient inflammation resulting from 
increased apoptotic activity, i.e. removal of cells that have been programmed to die (Berger et al. 
2003; Adler et al. 2005).  
 
Lingual gyrus 
Evidence supporting structural abnormalities in the lingual gyrus in FEP has not been as 
consistent, with some studies reporting decreased (Ellison-Wright et al. 2008) and others 
increased (Gao et al. 2017) GM volume. Such inconsistency may be explained by medication 
status, as shown by Shah et al. (2017), where GM volume of the lingual gyrus was decreased in 
antipsychotic naive FEP patients but increased in FEP patients under-going antipsychotic 
treatment. However, in our study, which included both samples with and without exposure to 
antipsychotics, there was a consistent reduction in the lingual gyrus in the five sites, suggesting 
that reductions in this region may be present above and beyond medication status. The lingual 
gyrus is involved mainly in visual processing (Lee et al. 2000; Hahn et al. 2006) which are well 
documented in psychosis (see Butler et al. 2008 and Silverstein & Keane 2011 for a review) and 
are also thought to underlie some of the cognitive impairments characteristic of the illness (Surti 
et al. 2011; Surti & Wexler, 2012; Contreras et al. 2018). The lingual gyrus also contributes to the 
evaluation of emotional faces (Fusar-Poli et al. 2009) which, together with the deficits found in the 





A first limitation of this study was that clinical data was acquired using different instruments 
(positive symptoms were assessed with either the PANSS or SAPS and negative symptoms with 
the PANSS or SANS). We overcame this limitation by normalizing individual scores within each 
scale as in previously studies (Gong et al., 2018). The resulting scores were highly correlated 
(r=.87) with automated methods to convert scores between these two widely used scales (van 
Erp et al. 2014). A further limitation is that, while most FEP participants had limited or no exposure 
to antipsychotics, participants from sites 4 and 5 were medicated.  
 
3.5. Conclusion 
This study aimed to overcome the limitations of small and single-site studies by conducting a 
multi-centre mega-analysis of neuroanatomical abnormalities in FEP. To the best of our 
knowledge this is the largest VBM study in FEP to date. We found a widespread pattern of fronto-
temporal, insular and occipital GM volume reductions in FEP that were expressed consistently 
across five independent studies; this provides evidence for reliable neuroanatomical alterations 
in FEP, expressed above and beyond site-related differences in recruitment criteria and scanning 
parameters. With the increasingly availability of larger datasets, future multi-centre mega-
analyses could investigate the diagnostic specificity of these findings by integrating data collected 







Using deep learning to 
investigate the 
neuroimaging correlates 
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In the last two decades, neuroimaging studies of psychiatric and neurological patients have relied 
on mass-univariate analytical techniques (e.g. statistical parametric mapping). These studies 
typically compared patients with a diagnosis of interest against disease-free individuals and 
reported neuroanatomical or neurofunctional differences at group-level. The simplicity and 
interpretability of this approach have led to significant advances in our understanding of the 
neurobiology of psychiatric and neurological disorders. Mass-univariate analytical techniques, 
however, suffer from at least two significant limitations. First, statistical inferences are drawn from 
multiple independent comparisons (i.e. one for each voxel) based on the assumption that different 
brain regions act independently. This assumption, however, is not in line with our current 
understanding of brain function in health and disease (Biswal et al., 2010; Fox et al., 2005); for 
example, several psychiatric and neurological symptoms are best explained by network-level 
changes in structure and function rather than focal alternations (Kennedy & Courchesne, 2008; 
Mulders, van Eijndhoven, Schene, Beckmann, & Tendolkar, 2015). Second, mass-univariate 
techniques can be used to detect differences between groups but do not allow statistical 
inferences at the level of the individual. In contrast, a clinician has to make diagnostic and 
treatment decisions about the person in front of them. These two limitations may have contributed 
to the limited translational impact of neuroimaging findings in everyday clinical practice so far.  
 
In an attempt to overcome these limitations, the neuroimaging community has developed a 
growing interest in machine learning, an area of artificial intelligence that aims to develop 
algorithms that discover trends and patterns in existing data and use this information to make 
predictions on new data. This is achieved through the use of computational statistics and 
mathematical optimization (Hastie, 2009). Machine learning methods are multivariate and 
therefore take the inter-correlation between voxels into account, thereby overcoming the first 
limitation of mass-univariate analytical techniques. In addition, machine learning methods allow 
statistical inferences at single subject level and therefore could be used to inform diagnostic and 
prognostic decisions of individual patients, thereby overcoming the second limitation of mass-
univariate analytical techniques (Arbabshirani et al., 2017). Machine learning methods can be 




learning, one seeks to develop a function which maps two or more sets of observations to 
predefined categories or values. In contrast, unsupervised methods seek to determine how the 
data is organised without using any a priori information supplied by the operator; here the main 
objective is to discover unknown structure in the data (Hastie, 2009). 
 
Over the past decade, several machine learning methods have been applied to neuroimaging 
data from psychiatric and neurological patients with varying degrees of success (Arbabshirani et 
al., 2017; Wolfers et al., 2015). The most popular amongst these methods is Support Vector 
Machine (SVM), a supervised technique that works by estimating an optimal hyperplane that best 
separates two classes. When these classes are not linearly separable, SVM uses external 
functions (kernels) that map the original data into a new feature space where the data become 
linearly separable (Pereira & Mitchell, 2008; Vapnik, 1995). The application of SVM (and most 
traditional machine learning algorithms in general) typically involves two steps prior to 
classification: “feature extraction” and “feature selection”. Feature extraction involves the 
transformation of the original data into a set of “features” that can be used as input. This may 
consist of transforming each three-dimensional image into a column vector of features where 
each value corresponds to the intensity (e.g., brain activity or grey matter volume) of a single 
voxel. Feature selection, on the other hand, involves the selection of a subset of the original 
features. The aim is to discard any features considered to be either of minimal importance or 
redundant for the task at hand. In neuroimaging, this may consist of manually selecting regions 
of interest or, alternatively, use data-driven approaches such as recursive feature elimination. 
Whilst feature selection represents an optional step, the use of feature extraction is typically a 
prerequisite of SVM. Indeed, despite its popularity, SVM has been criticised for not performing 
well on raw data and thus requiring the significant expertise to extract informative features from 
the data, which are then used for classification. While SVM remains a very popular technique 
within the neuroimaging community, an alternative family of machine learning methods known as 
deep learning (Bengio, 2009) is gaining considerable attention in the wider scientific community 
(Arbabshirani et al., 2017; Calhoun & Sui, 2016; LeCun et al., 2015). Deep learning methods are 
a type of representation-learning methods, which means that they can automatically identify the 




2015). This is achieved through the use of a hierarchical structure with different levels of 
complexity, which involves the application of consecutive nonlinear transformations to the raw 
data. These transformations result in increasingly higher levels of abstraction, where higher-level 
features are more invariant to the noise present in the input data than lower level ones (LeCun et 
al., 2015). Inspired by how the human brain processes information, the building blocks of deep 
learning neural networks – known as “artificial neurons” – are loosely modelled after biological 
neurons. Artificial neurons are organized in layers. A deep neural network consists of an input 
layer, two or more hidden layers and an output layer. The input layer comprises the data inputted 
into the model (e.g. voxel intensity); the hidden layers learn and store increasingly more abstract 
features of the data; these features are then fed to the output layer that assigns the observations 
to classes (e.g. controls vs. patients). Learning is achieved through an iterative process of 
adjustment of the interconnections between the artificial neurons within the network, much like in 
the human brain (Bengio, 2009). An essential aspect of deep learning that differentiates it from 
other machine learning methods is that the features are not manually engineered; instead, they 
are learned from the data, resulting in a more objective and less bias-prone process. Besides, the 
ability to achieve higher orders of abstraction and complexity relative to other machine learning 
methods such as SVM makes deep learning better suited for detecting complex, scattered and 
subtle patterns in the data (Plis et al., 2014).   
 
From a historical perspective, the use of deep learning in scientific research can be traced back 
to the perceptron (i.e. the original version of the artificial neuron), which many researchers refer 
to as the first machine learning algorithm (McCulloch & Pitts, 1943). After several setbacks, the 
pioneering work of Warren McCulloch and Walter Pitts resulted in the development of what is now 
known as artificial neural networks. However, such networks were able to handle a limited number 
of hidden layers. It was only in the 2000s that researchers developed a new approach for training 
artificial neural networks that allowed the inclusion of several hidden layers resulting in greater 
levels of complexity (Hinton et al., 2006). This breakthrough led to the development of a new 
family of machine learning methods - known as deep learning - which has been shown to 
outperform previous state-of-the-art classification methods in areas such as speech recognition, 





The use of deep learning could be particularly useful in the investigation of psychiatric and 
neurological disorders, which tend to be associated with subtle and diffuse neuroanatomical and 
neurofunctional abnormalities. Since high-level features can be more robust against noise in the 
input data, deep architectures may be more suitable to identify diagnostic and prognostic 
biomarkers than conventional machine learning methods. Deep learning techniques might also 
provide an ideal tool to investigate the multi-faceted nature of psychiatric and neurological 
disorders since cross-modality relationships (e.g. neuroimaging and genetics) are likely to occur 
at an even deeper level (Plis et al., 2014). In addition to these conceptual differences, the use of 
deep learning to investigate psychiatric and neurological disorders has the practical advantage of 
not requiring manual feature extraction (LeCun et al., 2015). Therefore, it is unsurprising that an 
increasing number of neuroimaging studies are using deep learning to elucidate the neural 
correlates of these disorders (J. Kim et al., 2016; Payan & Montana, 2015; Plis et al., 2014). 
 
Given the insurgence of interest in deep learning within the field of neuroimaging, this review aims 
to give a brief overview of deep learning and potential applications to the investigation of brain-
based disorders. In the first part of the review, we outline the underlying concepts of deep learning. 
To achieve this, we will use one of the simplest deep learning structures, i.e. the multilayer 
perceptron, to illustrate the steps of training and testing. This will be followed by a brief description 
of the most common deep learning architectures used in the field of neuroimaging, including 
stacked autoencoders, deep belief networks and convolutional neural networks. The second part 
of this article aims to summarise the studies that have applied deep learning to neuroimaging 
data to investigate psychiatric and neurological disorders. Finally, in the third part of the review, 
we discuss the main themes that have emerged from our review of the existing literature, and 
make a number of suggestions for future research directions.  
 
4.2. Overview 
Deep learning refers to the training and testing of multi-layered neural networks that are capable 
of learning complex structures and achieve high levels of abstraction. There are two main types 




the network. In feedforward networks, the information is propagated through the network in just 
one direction, from the input to the output layer. Recurrent networks, in contrast, contain feedback 
connections that allow the information from past inputs to affect the current output. These 
connections enable the information to persist within the neural network, akin to a form of memory, 
and this allows the models to process sequential data, such as speech and language, in a natural 
way. 
 
The implementation of deep learning in the context of supervised classification problems involves 
two main steps. In the first step, the so-called training phase, a subset of the available data known 
as the training set is used to optimize the network’s parameters to perform the desired task 
(classification). In the second step, the so-called testing phase, the remainder subset which is 
known as the test set is used to assess whether the trained model can blind-predict the class of 
new observations. When the amount of available data is limited, it is also possible to run the 
training and testing phases several times on different training and test splits of the original data 
and then estimate the average performance of the model – an approach known as cross-
validation. The two phases of training and testing are not a specific feature of deep learning but 
are used in conventional machine learning methods. 
 
In this section, we will discuss the use of feedforward deep learning for classification problems. 
We will start with the multilayer perceptron (MLP), the simplest deep learning architecture, to 
illustrate three important aspects of deep learning – network structure, training and testing. We 
will then describe more complex networks, including stacked autoencoders and deep belief 
networks. Finally, we will describe the increasingly popular convolutional neural networks (CNN), 
an important adaptation of the MLP that has come to be considered the state-of-the-art for 
computer vision. 
 
4.2.1. Multilayer perceptron 
4.2.1.1. Network structure  
MLPs are organized in a layer-wise structure where each layer stores increasingly more abstract 




into the model. In neuroimaging, the data can be represented as a one-dimensional vector with 
each value corresponding to the intensity of one voxel. The last layer is the output layer which, in 
the context of classification, yields the probability of a given subject belonging to one group or the 
other. The layers between the input and output layers are called hidden layers, with the number 
of hidden layers representing the depth of the network. Each layer comprises a set of artificial 
neurons or “nodes” (Figure 4.1A) in which each neuron is fully connected to all neurons in the 
previous layer (Figure 4.1B). Each connection is associated with a weight value, which reflects 
the strength and direction (excitatory or inhibitory) of each neuron input, much like a synapse 
between two biological neurons. Compared to other networks, the multilayer perceptron has a 
generic structure and therefore is a general-purpose network, i.e. they are not built to process a 
specific type of data. However, due to its fully connected layers and respective high number of 











Figure 4.1. Artificial neuron and deep neural network. A. The building block of deep neural networks – 
artificial neuron or node. Each input !! has an associated weight "!. The sum of all weighted inputs, Σ!!"!, is 
then passed through a nonlinear activation function #, to transform the pre-activation level of the neuron to 
an output $". For simplicity, the bias terms have been omitted. The output $" then serves as input to a node 






activation level to an output value. The most commonly activation functions used are the rectifier function 
(where neurons that use it are called rectified linear unit (ReLU)), the hyperbolic tangent function, the sigmoid 
function and the softmax function. The latter is commonly used in the output layer as it can compute the 
probability of multiclass labels. B. Example of a feedforward multilayer neural network (also referred to as 
multilayer perceptron) with two classes, in which the nodes in one layer are connected to all neurons in the 
next layer (fully connected network). For each neuron j in the first hidden layer, a nonlinear function is applied 
to the weighted sum of the inputs. The result of this transformation ($") serves as input for the second hidden 
layer. The information is propagated through the network up to the output layer, where the softmax function 
yields the probability of a given observation belonging to each class.  
 
Unlike SVM, which relies on expert designed transformations to handle nonlinearly separable 
classes, the structure of neural networks itself allows the transformation of the input space. The 
consecutive layers perform a cascade of nonlinear transformations that distort the input space 
allowing the data to become more easily separable (Figure 4.2). The optimal number of layers 
and nodes within each layer are not estimated as part of the learning process itself but are defined 
a priori and are called hyperparameters. It should be noted that the development of algorithms to 
find optimum values of these hyperparameters is an active area of research, and that at present 
there are no fixed rules (Bergstra, Bardenet, Bengio, & Kégl, 2011; Gelbart, Snoek, & Adams, 
2014). 
 
Figure 4.2. Effect of the depth of the model plotted using a neighbourhood-based embedding. With more 
hidden layers, the data becomes more easily separable due to nonlinear transformations along the network 





4.2.1.2. Training  
Traditionally, neural networks can learn through a gradient descent-based algorithm. The gradient 
descent algorithm aims to find the values of the network weights that best minimize the error 
(difference) between the estimated and true outputs. Since MLPs can have several layers, in 
order to adjust all the weights along the hidden layers, it is necessary to propagate this error 
backward (from the output to the input layer). This propagation procedure is called 
backpropagation, and allows the network to estimate how much the weights from the lowers layer 
need to be changed by the gradient descent algorithm. Initially, when a neural network is trained, 
the weights are set at random. When the training set is presented to the network, this forward 
propagates the data through the nonlinear transformation along the layers. The estimated output 
is then compared to the true output, and the error is propagated from the output towards the input, 
allowing the gradient descent algorithm to adjust the weights as required. The process continues 
iteratively until the error has reached its minimum value. The backpropagation algorithm does not 
work well with the original models of DNNs that were based on sigmoid and hyperbolic tangent 
nonlinearities. In these models, the information of the error becomes increasingly smaller as it 
propagates backward from the output to the input layer, to a point where initial layers do not get 
useful feedback on how to adjust their weights – an issue known as the vanishing gradient 
problem. Therefore, initially, the use of backpropagation yielded poor solutions for networks with 
three or more hidden layers (Schmidhuber, 2015). In 2006, however, Hinton and colleagues put 
forward the idea of “greedy layerwise training”, which consists of two steps: 1) an unsupervised 
step, where each layer is trained individually and 2) a supervised step, where the previously 
trained layers are stacked, one additional layer is added to perform the classification (the output 
layer), and the whole network parameters are fine-tuned (Hinton et al., 2006). This breakthrough 
led to the fast-growing interest in deep learning and enabled the development of at least two types 
of pre-trained networks that have shown promising results: stacked autoencoders and deep belief 
networks. It should be noted that these methods are not actual classifiers themselves; instead, 
they are networks that are pre-trained to learn useful patterns in the data and then fed to a real 
classifier at the final layer. These two types of networks and their unique characteristics are 





4.2.1.3. Testing  
As with traditional machine leanrning models, the performance of a deep neural network can be 
evaluated by several performance measures, such as sensitivity, specificity, accuracy and F-
score. Sensitivity refers to the proportion of true positives correctly identified (e.g. the proportion 
of subjects that were predicted as patient and are true patients), and specificity refers to true 
negatives correctly identified (e.g. the proportion of subjects that were predicted as healthy 
controls and are true healthy controls). The accuracy of a classifier represents the overall 
proportion of correct classifications. The statistical significance of this overall accuracy can be 
tested using parametric tests such as permutation testing, which measures how likely the 
observed accuracy would be obtained by chance. Metrics such as F-score and balanced 
accuracy, which take into account each group’s sample size, are particularly useful in cases where 
classes are unbalanced. The F-score is the weighted harmonic mean of the test’s precision and 
recall5. Balanced accuracy, on the other hand, corresponds to the average accuracy obtained on 
either class (Brodersen, Ong, Stephan, & Buhmann, 2010). 
 
4.2.1.4. Parameters, hyperparameters, and hyperparameters tuning 
Similarly to the coefficients in a linear or logistic regression, the weights and bias are the 
parameters of a deep learning network. As mentioned in section 4.2.1.2. these are estimated form 
the data during training via the optimization of a loss function, usually through the use of a 
gradient-descent based algorithm in combination with backpropagation. Hyperparameters on the 
other hand, are, broadly speaking, a configuration that is external to the model and whose value 
cannot be estimated from data. However, some model’s aspects (e.g. the step-size in the 
recursive feature elimination (RFE) procedure) can be considered hyperparameters and it might 
be possible to estimate them from the data (e.g. using nested cross-validation); however this is 
not always possible to do, for example due to computational reasons. The number of layers, the 
number of neurons within each layer, the activation function, the optimizer, the learning rate, and 
the regularization strategy are only a few examples of a long list of hyperparameters one has to 
consider when building a multilayer perception (and deep learning models in general, although 
specific network architectures may have additional ones). This long list results in an endless 
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number of possible combinations of hyperparameters. Although automated tuning (e.g. grid 
search, random search or Bayesian optimization), in which the algorithm is instructed to test 
alternative values and select those that provide the best result, is possible, it can be 
computationally expensive. However, with the fast-growing availability of graphical processing 
units, the application of DL is likely to become less expensive and more feasible in the future. 
Manual optimization, i.e., trial and error, is arguably the most common type of hyperparameter 
tuning in brain disorders research. Although guidelines are available (Bengio, 2012), manual 
adjustment is mostly based on the intuition of how the network behaves with different 
hyperparameters. This approach has the advantage of being much less computationally 
expensive than automatic tuning; however, it requires a great deal of technical expertise and is 
potentially prone to subjective bias. Importantly, regardless of the tuning method, any study that 
aims to be replicable should ideally report both the explored set of hyperparameters and the 
hyperparameters adopted in the final solution. Without the information on the architecture of the 
DNN and the explored and adopted hyperparameters, any result would be challenging to replicate 
and as such should be taken with caution.  
 
4.2.1.5. Risk of overfitting and possible strategies  
Due to the use of multiple nonlinear transformations, deep networks are highly complex models 
that involve the estimation of a very large number of parameters. This can lead to the model 
learning particular fluctuations in the training data that are irrelevant for the purpose of 
classification – an issue known as “overfitting”. When this happens, the model will perform very 
well on the training data but will not be able to replicate its performance on unseen data 
(Srivastava et al., 2014). The risk of overfitting is particularly high in the context of neuroimaging, 
where the number of data points (e.g. number of voxels) for a subject is much larger than the total 
number of subjects, resulting in high-dimensional data (Arbabshirani et al., 2017). However, there 
are a number of strategies that can be used to minimise the risk of overfitting, collectively known 
as “regularization”. A first strategy involves the use of weight decays (e.g., L1 and L2 norms) to 
penalise models with very high weights. It has been observed that extreme (very low or very high) 
weight values in a machine learning model are symptomatic of the model trying to learn the 




network becomes less dependent on the training data and is able to better generalize to unseen 
data (Nowlan & Hinton, 1992). A second strategy, known as dropout, consists of temporarily 
removing a random number of nodes and their respective incoming and outgoing connections 
from the network during training. This means that the contribution of dropped-out neurons to the 
activation of downstream neurons is temporally removed on the forward pass and that any weight 
updates are not applied to these neurons on the backward pass. The aim of dropout is to extract 
different sets of features that can independently produce a useful output, thereby allowing higher 
levels of generalizability (Srivastava et al., 2014).  
 
4.2.2. Autoencoders  
Autoencoders are a special case of feedforward networks which comprise of two main 
components. The first component, i.e. the “encoder”, learns to generate a latent representation of 
the input data, whereas the second component, i.e. the “decoder”, learns to use these learned 
latent representations to reconstruct the input data as close as possible to the original (Figure 
4.3A) (Vincent et al., 2010).  
 
 
Figure 4.3. Autoencoder. A. Shallow or simple autoencoder. In its shallow structure, an autoencoder is 
comprised of an input layer, that represents the original data (e.g., pixels in an image), one hidden layer that 
represents the transformed data, and an output layer that reconstructs the original input data. B. Stacked 
autoencoder. Two simple autoencoders are stacked with a 2- class softmax classifier as the final layer. From 
each simple autoencoder, the output layer is discarded, and the hidden layer is used as the input layer for 






Since an autoencoder does not make use of labels, its training is an unsupervised learning 
process. In its shallow structure, an autoencoder is comprised of three layers: an input layer, one 
hidden layer and an output layer. The training to perform the input-copying task can be useful to 
extract meaningful features of the input data. This automatic feature extraction can be performed 
using an error function (or loss function) that encourages the model encoder to have specific 
characteristics, such as sparsity of the representation (sparse autoencoders) and robustness to 
noise (denoising autoencoders). Since autoencoders are automatic features extractors, they can 
also be stacked to create a deep structure to increase the level of abstraction of learned features. 
In this case, the network is pre-trained, i.e. each layer is treated as a shallow autoencoder, 
generating latent representations of the input data. These latent representations are then used 
as input for the subsequent layers before the full network is fine-tuned using standard supervised 
learning (Figure 4.3B) (Larochelle, Erhan, Courville, Bergstra, & Bengio, 2007). In neuroimaging, 
the most common application of autoencoders has been for pre-training networks (Heinsfeld, 
Franco, Craddock, Buchweitz, & Meneguzzi, 2018; Kim, Calhoun, Shim, & Lee, 2016), although 
they can also be used for other purposes such as dimensionality reduction, akin to principal 
components analysis (Hazlett et al., 2017) or, more recently, to building normative models 
(Pinaya, Mechelli, & Sato, 2018). 
 
4.2.3. Deep belief networks 
Deep belief networks (DBNs), proposed by Hinton et al. (2006), are technically the first deep 
learning models. Similar to stacked autoencoders, DBNs are comprised of stacked shallow 
feature extractors, known as restricted Boltzmann machines (RBMs). An RBM is composed by 
only two layers: a visible layer and a hidden layer. Just like autoencoders, RBMs also aim to learn 
and extract useful features from the data. However, RBMs differ from autoencoders with regards 
to their training processes. RBMs can be interpreted as a stochastic neural network. Therefore, 
instead of using deterministic functions and the reconstruction error (like the autoencoders), the 
RBM uses the maximum-likelihood estimation to find a stochastic representation of the input in 
its hidden layer (latent features). To do this, RBMs are usually trained using a gradient descent 




contrastive divergence (Hinton et al., 2006). Here the input data, stored in the visible layer, are 
propagated to the hidden layer as in a feedforward network, and the resulting sum of the weighted 
inputs provides a measure of the neuron activation probability. The activation of hidden neurons 
can be thought of as the network’s internal representation of the data, which is then propagated 
back to the visible layer in an attempt to reconstruct the input data from the network’s internal 
representation. The network, therefore, learns by adjusting the weights based on the discrepancy 
between the true and reconstructed data. Similarly to autoencoders, RBMs can be stacked to 
create a deep network, where the hidden layer representation of one RBM serves as input layer 
for the following RBM, and the network can learn higher-level features from lower-level ones to 
arrive at an abstract representation of the data. Furthermore, the neural network corresponding 
to a trained DBN can be augmented by adding an output layer, where units represent the labels 
corresponding to the input sample. This results in a standard neural network for classification that 
can be further trained using supervised learning algorithms. 
 
4.2.4. Convolutional neural networks 
Convolutional neural networks (CNNs) are a special type of feedforward neural networks that 
were initially designed to process images, and as such are biologically-inspired by the visual 
cortex (LeCun et al., 1998). In addition to the input and output layers, CNN can comprise of three 
types of layers: a convolutional layer, a pooling layer, and a fully-connected layer (Figure 4.4). 
The convolutional layer is organized in several feature maps. Every neuron in a feature map is 
connected to a fixed set of neurons in a local region of the previous layer – the receptive field – 
in such a way that the whole image is covered (“local connectivity”). Within the same feature map, 
the connections between each neuron and the corresponding receptive field share the same 
weights, whereas different feature maps use different sets of weights (“weight sharing”).  
 
As a result of this architecture, a feature map can be thought of as a “feature detector” that scans 
the whole image for the same pattern. This pattern is usually known as the kernel. Kernels in a 
CNN are learned during the training process, as opposed to in SVM, where they are defined a 
priori. In a network with several convolutional layers, each layer codes for increasingly more 




number of neurons of the previous convolutional layer. The fully-connected layers are similar to 
the hidden layers from the conventional MLP where the neurons are connected to all neurons 
from the previous layer. All combined, the properties of CNN (local connectivity, weight sharing 
and pooling) result in a significant reduction in the number of parameters, which in turn decreases 
the likelihood of overfitting, and alleviates computational processing. Historically, CNNs have 
been specifically designed to process images and to this day this is the most commonly type of 
data used. In principle however, CNNs can be useful when one wants to make the most out of 
dependencies among features based on spatial distances, i.e. grid-like data. In psychiatric and 
neurologic neuroimaging, this is applicable to voxel-level MRI data (Payan & Montana, 2015) 
including functional MRI (Sarraf & Tofighi, 2016) but also electroencephalograms (Acharya, Oh, 










Figure 4.4. Generic structure of a CNN. For illustrative purpose, this example only has one layer of each 
type; a real-world CNN, however, would have several convolutional and pooling layers (usually interpolated) 
and one fully-connected layer. A. Input layer. In its simplest way, the data is inputted into the network in such 
a way that each voxel corresponds to one node in the networks. B. Convolutional layer. A 3x3 filter or kernel 
(in green) is used to multiply the spatially corresponding 3x3 nodes in the image. The resulting weighted 
sum is then passed through a nonlinear function to derive the output value of one node in the feature map. 
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feature map. The same procedure with different kernels (in orange and blue) will result in separate complete 
feature maps. C. Pooling layer. The size of each feature map can be reduced by taking the maximum value 
(or average) from a receptive field. 
 
4.3. Review of deep learning studies of psychiatric or neurological disorders 
In order to identify previous applications of deep learning in neuroimaging studies of psychiatric 
or neurological disorders, a search was conducted on 1st August 2016 across several databases 
(PubMed, IEEE Xplore, Scopus and ArXiv) using the following search terms: ("deep learning" OR 
"deep architecture" OR "artificial neural network" OR "autoencoder" OR "convolutional neural 
network" OR "deep belief network") AND (neurology OR neurological OR psychiatry OR 
psychiatric OR diagnosis OR prediction OR prognosis OR outcome) AND (neuroimaging OR MRI 
OR “Magnetic Resonance Imaging” OR "fMRI" OR “functional Magnetic Resonance Imaging” OR 
PET OR "Positron emission tomography"). This review did not include EEG studies, although 
there is some evidence that deep learning can also be used with this type of data, particularly in 
epilepsy (Page, Turner, Mohsenin, & Oates, 2014).  The initial search yielded a total of 172 
articles. As the next step, we screened and cross-referenced these articles for studies that had 
applied a deep learning model to neuroimaging data to investigate a psychiatric or neurologic 
condition; this identified a total of 25 articles which were relevant to our review. We organized 
these articles as follows: i) diagnostic studies, which aimed to classify patients from healthy 
controls, ii) studies on conversion to illness, which used baseline scans from individuals identified 
as being at high risk of developing a psychiatric or neurologic disorder to predict subsequent 
transition to the illness, and finally iii) studies predicting treatment response, which used baseline 
scans from individuals with a neurological or psychiatric diagnosis to predict subsequent 
treatment response. These studies are summarised in Tables 1, 2 and 3 which provide the 
following information: sample size; type of data used as input; whether a whole brain (WB) or 
region of interest (ROI) approach was used; whether the information inputted into the model 
comprised of voxel or region-level features; whether feature selection or dimensionality reduction 
was used before inputting the data into the model; general type of deep learning architecture; 
diagnostic groups being investigated; and accuracy. Whenever performed, we also report the 




two classes (e.g. healthy controls vs. mild cognitive impairment vs. Alzheimer’s disease). 
 
 
4.3.1. Diagnostic studies 
Studies using deep learning to classify psychiatric or neurological patients from healthy 
individuals have used a range of neuroimaging modalities including structural MRI (sMRI), 
resting-state fMRI (rsfMRI), positron emission tomography (PET) and a combination of different 
modalities (multimodal studies) (see Table 4.1). From Table 1 it can be seen that the vast majority 
of these studies were carried out in Alzheimer’s disease (AD) and its prodromal stage, mild 
cognitive impairment (MCI). In addition, a smaller number of studies examined psychosis, 
attention deficit/hyperactivity disorder (ADHD), cerebellar ataxia and temporal lobe epilepsy 
(TLE). Within each diagnostic category, we first give an overview of the studies that have used a 
single neuroimaging modality, followed by studies that employed a multimodal approach and, 
finally, studies that have combined neuroimaging and clinical data within a single classifier.  
 
Mild Cognitive Impairment and Alzheimer Dementia. In one of the first studies using deep learning 
in AD and MCI, Gupta et al. (2013) argued that, since (i) natural images and brain imaging have 
similar, and therefore interchangeable, low-level features (e.g. lines and corners) and (ii) natural 
images, contrary to neuroimaging, are abundant, then natural images could be used to learn low 
level features which could then be used to identify lesions along the surface and ventricles of the 
brain. This process, whereby the features learned in one set of data are used to solve a problem 
in another set of data, is known as “transfer learning”. Based on this premise, the authors pre-
trained a sparse autoencoder to learn features from natural images, which were then applied to 
structural MRI data via a CNN, achieving a classification accuracy of 94.7% for AD versus 
controls, 86.4% for MCI versus controls and 88.1% for AD versus MCI. Consistent with the 
authors’ hypothesis, the method where features were extracted from natural images outperformed 
the one where the learned features were extracted from the neuroimaging data (93.8%, 83.3% 
and 86.3% for the same comparisons, respectively). However, a few years later and using a 
similar approach, Payan and Montana (2015) found comparable classification accuracies using a 




potentially be explained by the fact that Payan and Montana (2015) used a much larger sample, 
as well as by the fact that authors used 3D brain images, as opposed to 2D, which possibly 
contain more useful patterns for classification. Indeed, Payan and Montana (2015) reported that, 
in general, the models based on 3D outperformed those based on 2D brain images (AD vs. HC 
(2D/3D)=95.4%/95.4%; AD vs. MCI (2D/3D)=82.2%/86.8%; MCI vs. HC (2D/3D)=90.1%/92.1%). 
The best accuracy (97.6%) from single modality studies came from Hosseini-Asl et al. (2016), 
who also used transfer learning. Instead of extracting features from natural images and then fine-
tuning the model on Alzheimer’s patients and controls, as seen in Gupta et al. (2013), Hosseini-
Asl et al. (2016) used one Alzheimer’s dataset for pre-training and another independent 
Alzheimer’s dataset to fine-tune the model. By performing the pre-training on an Alzheimer’s 
dataset, this approach allowed for the network to extract generic features related to AD 
biomarkers, such as the ventricular size, hippocampus shape, and cortical thickness as opposed 
to more generic low-level features as in Gupta et al. (2013). By using two independent samples 
during the complete learning process, the final learned features for classification are much less 
dataset-specific, and should therefore be more generalizable. The final model’s architecture was 
also deeper than in previous studies, which probably also contributed to the high accuracy. Taken 
collectively, these studies suggest that the application of deep learning to structural MRI data 
allows the classification of individuals with AD and MCI with high levels of accuracy. Consistent 
with the increasing popularity of CNN models, studies that have applied either CNN or a 
combination of AE and CNN have shown better performances compared to those using only AE, 
although it should be noted that the former group of studies tended to have larger samples than 
the latter group. In addition, and similar to the trend reported in computer vision competitions and 
research, the best performances were obtained by the deepest CNN models.   
 
Studies of AD and MCI using resting-state imaging have also achieved promising results. For 
example, Han et al. (2015) designed a hierarchical convolutional sparse autoencoder (HCSAE), 
which essentially extracts the most discriminating features from the resting-state data and 
encodes them in a convolutional manner. This particular arrangement allows for the extraction of 
the most useful information while conserving abundant detail. The final model classified AD and 




accuracy of 50% (Figure 4.4). While this is a promising result, the model assumed that functional 
networks were statistic over time – an assumption which underlies the vast majority of machine 
learning applications to resting-state neuroimaging data. However, recent studies have shown 
that the network-level functional organization of the brain is dynamic rather than static (Hutchison 
et al., 2013). Suk et al. (2016) have addressed this issue by developing an approach which 
classifies people with MCI and healthy controls using a deep autoencoder to extract hierarchical 
nonlinear relations among 116 brain regions (each region represented the average intensity of 
the voxels within that region), whilst modelling the inherent functional dynamics of resting-state 
data. This was also one of the few studies in which the same deep learning model was tested 
against and surpassed other competing models in two independent datasets (72.6% for dataset 
1 and 80.0% for dataset 2), thus providing evidence of replicability, a crucial feature for diagnostic 
tools. In line with the studies using structural imaging, the best performance for the classification 
of AD patients with resting-state data was also obtained by a CNN model applied to minimally 
pre-processed voxel-level data with an accuracy of 96.9% (Sarraf & Tofighi, 2016). These studies 
provide initial evidence that brain activity at resting state can be useful in identifying MCI and AD 
patients. We note that, compared to the performances obtained from structural data, deep 
learning models applied to functional data seem to perform worse. This discrepancy could be 
explained by the substantial difference in sample size between the two types of studies – while 
the smallest study using structural data included 140 subjects (Hosseini-Asl et al., 2016) the 
largest study using functional data included 62 subjects (H.-I. Suk, Wee, et al., 2016). 
 
With regards to multimodal studies, Liu et al. (2014) applied a stacked autoencoder (SAE) to 
structural and PET data and successfully distinguished AD and MCI from controls with an 
accuracy of 87.8% and 76.9%, respectively. Using a very similar dataset, the same team (Liu, Liu, 
Cai, Che, et al., 2015) achieved a better performance by designing a model where the hidden 
layers were able to infer the correlations between sMRI and PET, thus better capturing the 
synergy between the two modalities. This model classified AD and MCI against controls with an 
accuracy of 91.4% and 82.1%, respectively. Interestingly, the application of the same model to a 
structural data alone resulted in less impressive accuracies of 82.6% and 72% for AD and MCI, 




improve classification accuracy. However, this conclusion should be drawn with great caution 
since that the authors did not report classification accuracy for PET data alone. 
 
Finally, four studies have tried combining neuroimaging data with clinical information to build a 
more robust classification model. For example, Suk and Shen (2013) used a SAE to extract latent 
features from neuroimaging data (sMRI, PET and CSF), which were then used to predict clinical 
data (measured using the Mini-Mental State Examination - MMSE - and Alzheimer's Disease 
Assessment Scale's cognitive subscale - ADAS-cog) and class labels. As the final step, the 
resulting learned features were used to classify AD and MCI from healthy individuals with an 
accuracy of 95.9% and 85.0%, respectively. Notably, two more studies (Li et al., 2014; H.-I. Suk, 
Lee, & Shen, 2015) that have used the same exact sample (taken from the publicly available 
dataset ADNI; Alzheimer's Disease Neuroimaging Initiative) and the same types of data (sMRI, 
PET, CSF, MMSE and ADAS-cog) have also reported high accuracies for both AD and MCI 
despite using different implementations of deep learning. In general, studies combining clinical 
with neuroimaging data have, in general, reported higher accuracies than studies using single 
modality or multiple neuroimaging modalities. This is in line with previous studies using 
conventional machine learning methods (Moradi et al., 2015; Willette et al., 2014) and highlights 
the usefulness of adding clinical information in the classification of AD and its prodromal phase. 
It should be noted however, that adding clinical information as predictors may add unwanted 
circularity to the model. This is because labels are established based on clinical measures and 
therefore the two are likely to be highly correlated. Thus, it is recommended that the association 
between these features and the labels is first investigated, and the features with a significant 
association removed; otherwise the performance is likely to be inflated (Donini et al., 2019). 
 
Table 4.1. Diagnostic studies. 









Gupta et al. 
(2013)1 
AD=200 sMRI WB 
voxel-
level 
No Sparse AE 
& CNN 
HC vs. AD  94.7 
MCI=411 HC vs. MCI 86.4 
HC=232 AD vs. MCI  88.1 
 
HC vs. AD vs. MCI 85.0 











HC vs. MCI 92.1 
MCI = 755 AD vs. MCI 86.8 
 
HC vs. AD vs. MCI 89.5 
Hosseini-Asl et 
al. (2016)1,2 
HC = 70* sMRI WB 
voxel-
level 
No AE & CNN HC vs. AD  97.6 
AD = 70*    HC vs. MCI 90.8 
MCI = 70*    AD vs. MCI 95.0 
    HC vs. AD vs. MCI 89.1 
Chen et al. 
(2015)1 
HC = 123 sMRI WB 
voxel-
level 
Yes SAE  HC vs. AD  89.0 
AD = 94 HC vs. MCI 81.7 
MCI = 121 
  
Liu et al. 
(2015a)1 
HC = 204 sMRI WB 
region-
level  
Yes SAE HC vs. AD  82.6 
AD = 180 HC vs. MCI 72.0 
MCI = 374 
  
Gao and Hui 
(2016) 
HC =117 CT WB 
voxel-
level 
No CNN HC vs. AD vs. Lesion 87.7 






HC =15 rsfMRI WB 
voxel-
level 
No CNN HC vs. AD  96.9 
AD = 28 
  
Suk et al. 
(2016)1 
HC = 31 rsfMRI WB 
region-
level  
Yes DAE HC vs. MCI 72.6 
MCI =31 
  
HC = 25 rsfMRI WB 
region-
level  
Yes DAE HC vs. MCI 81.1 
MCI = 12 
  
Hu et al. (2016)1 HC = 52 rsfMRI WB 
region-
level 
No SAE HC vs. MCI 87.5 
MCI = 48     
Han et al. 
(2015)1 
HC = nr rsfMRI WB 
voxel-
level 
No AE & CNN HC vs. AD  80.0 
AD = nr 
  
Liu et al. 
(2015a)1 
HC = 77 sMRI & PET WB 
region-
level  
Yes SAE HC vs. AD  91.4 
AD = 85 HC vs. MCI 82.1 
MCI = 169 
  
Suk et al. 
(2014)1 
HC = 101 sMRI & PET WB 
region-
level  
Yes DBM HC vs. AD  94.9 
AD = 93 HC vs. MCI 80.6 
MCI = 204  
  
Liu et al. (2014)1 HC =77 sMRI & PET WB 
region-
level  
Yes SAE HC vs. AD  87.8 
AD = 65 HC vs. MCI 76.9 
MCI = 169 
  
Suk et al. 
(2015b)1 







HC vs. AD  95.1 
AD = 51 HC vs. MCI 80.1 
MCI = 99 HC vs. AD vs. MCI 62.9 







HC vs. AD  90.3 
AD = 198 HC vs. MCI 70.9 
MCI = 403 HC vs. AD vs. MCI 57.7 
Liu et al. 
(2015b)1 





Yes SAE HC vs. AD  90.1 
AD = 85 HC vs. AD vs. MCI 59.2 
MCI = 169 
  
Suk et al. 
(2015a)1 
HC = 52 sMRI & PET & 





Yes SAE HC vs. AD  98.8 
AD = 51 HC vs. MCI 90.7 
MCI = 99 AD vs. MCI 83.7 
Li et al. (2014)1 HC = 52 sMRI & PET & 





Yes MLP HC vs. AD  91.4 
AD = 51 HC vs. MCI 77.4 
MCI = 99 
  
Suk and Shen 
(2013)1 
HC = 52 sMRI & PET & 





No SAE HC vs. AD  95.9 




MCI = 99 
  
Han et al. 
(2015)3 
HC =  nr rsfMRI WB 
voxel-
level 
No AE & CNN HC vs. ADHD 65.0 
ADHD = nr   
Deshpande et al. 
(2015)3 
HC =744 rsfMRI WB 
region-
level  
Yes FCC HC vs. ADHD-C ~90.0 
ADHD-C = 
260 
HC vs. ADHD-I ~90.0 
ADHD-I = 
173 
ADHD-C vs. ADHD-I 95.0 
Kuang et al. 
(2014)3 






Yes DBN HC vs. ADHD-C vs. 






16 to 95 
HC vs. ADHD-C vs. 





ADHD-I = 2 
to 5 
HC vs. ADHD-C vs. 






1 to 50 
  
Kuang and He 
(2014)3 




Yes DBN HC vs. ADHD-C vs. 






0 to 77 
  




0 to 6 
  
Hao et al. 
(2015)3 








Yes DBaN HC vs. ADHD-C vs. 






16 to 95 
  




1 to 50 
  
Plis et al. (2014) HC = 191 sMRI WB 
voxel-
level 
No DBN HC vs. SZ 91** 
SZ and FEP 
= 198 
  
Kim et al. 
(2016)4 
HC =50 rsfMRI WB 
region-
level  
Yes SAE HC vs. SZ 85.8 
SZ =50   
Munsell et al. 
(2015) 
HC = 48  DTI WB 
region-
level  
No SAE HC vs. TLE 69.0 
TLE = 70   
Yang et at. 
(2014) 
HC =31 sMRI ROI 
(Cerebell
um) 
No SAE HC vs. SCA2 vs. SCA6 
vs. AT 
86.3 
SCA2 = 4   
SCA6 = 27   
AT = 18   
1 ADNI dataset; 2 CADDementia dataset, 3ADHD-200 dataset; 4COBRE dataset; *Sample sizes for the fine-tuning stage 
only (pre-training included an additional 386 samples); **F-score; ***Range of accuracies obtain from the different datasets 
used; HC, healthy controls; SZ, schizophrenia, FEP, first episode psychosis; ADHD, attention deficit/hyperactive disorder; 
ADHD-C, attention-deficit/hyperactive disorder combine subtype; ADHD-I, attention-deficit/hyperactive disorder 
inattentive subtype; ADHD-H, attention-deficit/hyperactive disorder hyperactive subtype; SCA2, spinocerebellar ataxia 
type 2; SCA6, spinocerebellar ataxia type 6; AT, ataxia-telangiectasia; TLE, temporal lobe epilepsy; AD, Alzheimer’s 
disease; MCI, mild cognitive impairment; CC, cingulate cortex; VC, visual cortex, PFC, pre-frontal cortex; SSC, 
somatosensory cortex; sMRI, structural MRI; rsfMRI, resting-state functional MRI; CT, computed tomography; PET, 
Positron emission tomography; DTI, diffusion tensor imaging; CSF, cerebrospinal fluid; MMSE, mini mental state 
examination; ADASCog, Alzheimer's Disease Assessment Scale's cognitive subscale; AE, autoencoder, SAE, stacked 




convolutional neural network; DAE, deep autoencoder; DBM, deep Boltzman machine; DW-S2 MTL, deep weighted 
subclass-based sparse multi-task learning; MLP, multilayer perceptron; nr, not reported. 
 
Attention-deficit/hyperactive disorder. With regards to attention-deficit/hyperactivity disorder 
(ADHD), all five studies included here have used resting-state neuroimaging data. For example, 
Deshpande et al. (2015) applied a fully connected cascade artificial neural network - a variation 
of the multilayer perceptron – to functional connectivity from ADHD and healthy controls. The 
model successfully distinguished between the inattentive and combined subtypes from healthy 
controls with an accuracy of 90% for both comparisons, while the two subtypes were discriminated 
with an accuracy of 95%. Connections between frontal areas and the cerebellum were identified 
as the most discriminating features. There is also evidence that healthy children and children 
diagnosed with three different ADHD subtypes (inattentive, hyperactive and combined) can be 
distinguished in one single model using a multiclass approach, without the need to perform binary 
classifications between healthy controls and each ADHD subtypes. This evidence comes from 
three studies that have used data from different sites taken from the ADHD-200 consortium, a 
data-sharing platform aimed at understanding the neural basis of ADHD (Milham, Fair, Mennes, 
& Mostofsky, 2012). Kuang et al. (2014) attempted to discriminate between healthy controls and 
ADHD subtypes (inattentive, hyperactive and combined) using data acquired from three different 
sites. Rather than looking at the whole brain, the authors first parcellated the brain and trained 
different DBNs for each brain area using the voxel-level intensities within a given region as 
features, to examine which part of the brain best discriminated ADHD (regardless of subtypes) 
from healthy controls. A 4-way DBN was then performed for the each best discriminating area – 
prefrontal (PFC), cingulate (CC) and visual (VC) cortex – in each one of the three datasets 
separately (dataset 1: PFC=37.4%, CC=37.1%, VC=34.4%; dataset 2: PFC=54.0%, CC=54.0%, 
VC=51.2%; dataset 3: PFC=71.8%, CC=72.7%, VC=68.8%). Kuang and He (2014) partially 
replicated these findings by applying the same deep learning approach to functional measures of 
the prefrontal cortex; this allowed a 4-way classification accuracy of 44.4%, 55.6% and 80.9% in 
three independent samples from the ADHD-200 consortium. Finally, Hao et al. (2015) used the 
same type of features to first identify the most discriminating areas – prefrontal, cingulate, 




input data were put through a deep Bayesian network (DBaN), where a DBN was used to reduce 
the dimensionality of the data and a Bayesian network was used to extract the relationships 
between the data. The resulting model achieved a 4-way classification accuracy of 48.8%, 54.0% 
and 72.7% for three independent samples also taken from the ADHD-200 consortium. These 
three studies suggest that deep learning can be used to solve multiclass classifications problems, 
as all performances were well above chance level (25% for a classification with 4 classes). In 
addition, these studies suggest that deep learning can extract meaningful information from 
patterns of brain functioning to classify ADHD from controls and, more notably, to differentiate 
between ADHD subtypes.  Nevertheless, we note that all four studies conducted in ADHD had 
unbalanced sample sizes between classes. For example, in Kuang et al. (2014), there were just 
between 2 and 5 children in the Inattentive subtype within each site, while the number of healthy 
children ranged from 69 to 110 per site. Similarly, each site in Kuang and He (2014) did not include 
any participants on at least one ADHD subtype which may have introduced a bias in the 4-way 
classification performed across all sites. With the exception of Hao et al. (2015) which reported 
sensitivity and specificity, all studies assessed model performance by estimating the overall 
accuracy. This metric is simply the proportion of participants correctly identified, and therefore 
does not take the unbalance between classes into account; this means that it is possible to have 
a good overall accuracy even if several participants from a class are misclassified (or even if all 
participants from a class are misclassified if the sample size for that class is very small compared 
to the total sample size). Therefore, given the highly imbalanced sample sizes, the possibility that 
the performances reported in these studies are inflated cannot be ruled out. This possibility is 
supported by the observation of much lower sensitivities (43.9%, 22.9% and 55.6% for each site) 
than specificities (68.8%, 87.7% and 83.0%), in Hao et al. (2015). In addition, by running several 
models (i.e. one for each region), authors may have increased the risk of finding a positive result 
by chance. Perhaps a more appropriate strategy for investigating multiple regions could have 
been using the whole set of regions, include a nested procedure to select the most informative 
ones within the training set, and only then test the model; alternatively, they could have also 
corrected their final results for the multiple regions/models. 
  




Using structural MRI data from four independent studies, Plis et al. (2014) applied a DBN to the 
original preprocessed images obtaining an impressive F-score of 91%. While this was a highly 
promising result, the patients group included both first episode and chronic schizophrenia 
patients, which could have diluted the models’ performance. More recently, Kim et al. (2016) 
extracted functional connectivity patterns obtained from resting-state functional MRI of individuals 
diagnosed with schizophrenia and healthy controls and performed a series of experiments with 
an SAE-based model, in which different hyperparameters were tested. The proposed model 
consisted of an SAE with weight sparsity control, i.e. only a random selection of neurons in a 
given layer was activated, that classified schizophrenia patients and controls with an accuracy of 
85.5%, outperforming SVM by a margin of 8.1%. Consistent with the literature on brain functional 
abnormalities in schizophrenia (Minzenberg, Laird, Thelen, Carter, & Glahn, 2009), the most 
relevant features for the classification were the functional connectivity between the thalamus and 
the cerebellum, the frontal and temporal areas and between the precuneus/posterior cingulate 
cortex and the striatum. Despite this encouraging result, the sample sizes for each class were 
modest (50 for each group) and, therefore, it is not clear how well these findings will generalise 
to a different sample. Nevertheless, both studies suggest that deep learning can effectively 
classify psychosis patients on the basis of neuroanatomical and neurofunctional information. 
Despite the evidence that structural and functional data provide complementary information on 
the neural basis of psychosis (Cabral et al., 2016; Radua et al., 2012; Schultz et al., 2012), to 
date there have been no deep learning studies using a multimodal approach in psychosis. In 
addition, despite the evidence that psychosis, similar to AD, is preceded by a prodromal stage 
(Yung et al., 2005), there have been no studies applying deep learning to neuroimaging data to 
classify individuals at high risk of developing psychosis from healthy controls or distinguishing 
between high risk individuals who will and will not develop the illness.  
 
Temporal lobe epilepsy. One study examined the potential of deep learning to classify healthy 
individuals and patients diagnosed with temporal lobe epilepsy (TLE) from diffusion-weighted 
images (DWI) (Munsell et al., 2015). A stacked autoencoder was used to extract meaningful 
features from patients’ connectome while SVM was chosen as the classifier. Deep learning was 




nonlinear relationships in high dimension data. This combination yielded a relatively modest 
accuracy of 69%. In addition, this model was outperformed by another approach where features 
were extracted using a well-known linear automated method (ElasticNet) instead, which achieved 
an accuracy of 80%. This discrepancy in favour of the second model could potentially be 
explained by the absence of any form of regularizers in the first model. Given the high complexity 
resulting from the numerous parameters to be estimated, deep learning models are more prone 
to overfitting (high performance on the training data while performing poorly on unseen data) than 
conventional machine learning approaches. One standard solution, that the authors did not use, 
is to address this issue by tuning the level of model complexity and penalizing highly intricate 
ones in order to have better generalizing models.  
 
Cerebellar ataxia. One study was conducted in cerebellar ataxia (CA), a neurodegenerative 
disorder that affects mainly the cerebellum, with multiple genetics variations each with its 
characteristic pattern of anatomical degeneration. Yang et al. (2014) applied a stacked AE to T1-
weighted images of the cerebellum taken from healthy controls and individuals suffering from 
three CA subtypes: spinocerebellar ataxia type 2 (SCA2), spinocerebellar ataxia type 6 (SCA6) 
or ataxia-telangiectasia (AT). The proposed method classified the four groups with an accuracy 
of 86.3%, an impressive result for a 4-way classification. However, the confusion matrix reported 
by the authors indicates that no case with the SCA2 subtype was correctly classified. Because 
the sample size of this group (only four participants) contributed very little for the total sample size 
(80), it is still possible to misclassify all its cases and achieve a low error rate. In such cases, a 
high accuracy can be misleading, as it may reflect an overestimation of the algorithm’s 
performance (Arbabshirani et al., 2017). Balanced accuracy, for example, is a potentially useful 
alternative as it calculates the average of correct predictions of each class individually (Alberg, 
Park, Hager, Brock, & Diener-West, 2004).  
 
In short, since the first study published in 2013, there is already preliminary evidence that deep 
learning allows the accurate classification of a range of neurologic and psychiatric disorders, by 
extracting discriminating features from either single or multimodal imaging as well as other types 





4.3.2. Conversion to illness  
From Mild Cognitive Impairment to Alzheimer Dementia. A total of 8 studies have attempted to 
predict transition to illness using neuroimaging data, and all of them have focussed on the 
transition from MCI to AD (Table 4.2). Most studies used a multimodality approach, with three of 
them also including clinical measures in the prognostic model. The highest accuracy (83.3%), 
was achieved by a model which included sMRI, PET, CSF and two clinical measures: the MMSE 
and the ADAS-cog (H.-I. Suk et al., 2015). Interestingly, the lowest performance (57.4%) resulted 
from a model which used the same input data (sMRI, PET, CSF, MMSE and ADASCog) and a 
similar sample size (Li et al., 2014). However, the two studies differed on the deep learning 
approach, with the former employing a semi-supervised approach with a multilayer perceptron 
pretrained using a stacked sparse autoencoder, and the latter using a pure supervised approach. 
These findings highlight the potential impact of the deep learning architecture on performance, 
although we cannot exclude the contribution of other sample-specific factors to the results (e.g. 
recruitment criteria). Overall, this initial sample of studies suggests that individuals diagnosed with 
MCI who later convert to dementia can be identified using cutting-edge deep learning methods. 
Although, in general, accuracies are not as high as when classifying AD or MCI from healthy 
controls, this is not surprising since brain differences as well as clinical and cognitive symptoms 
between those identified as being at risk who do and do not develop a disorder are likely to be 
subtle. In addition to these encouraging results, the suitability of deep learning to multiclass 
classification means this analytical approach can easily be employed to examine the biomarkers 
of different stages of the illness. Four studies have taken advantage of this by conducting 4-way 
classifications to discriminate between no eminent risk of AD (healthy controls), individuals in the 
prodromal stage who did not (MCI-C) and did develop dementia (MCI-C) and established 
Alzheimer’s (AD). Accuracies ranged from 46.3% to 53.8%. By using a deep Boltzmann machine 
to extract features from structural MRI and PET images, Liu et al. (2015) classified the four groups 
with an overall accuracy of 53.8%. Suk et al. (2016) examined the replicability of a deep learning 
approach known as deep weighted subclass-based sparse multi-task learning (DW-S2 MTL) in 
two different datasets, considering both binary and multi-way comparisons. The proposed model, 




comparable performance for both binary (74.2% vs. 73.9%) and 4-way (53.7% vs. 47.8%) 
classifications, thus suggesting good replicability. Taken collectively, these studies provide initial 
evidence that deep learning methods could be used to discriminate amongst different stages of 
illness – a common challenge in standard clinical settings. 
 
Table 4.2. Conversion to illness. 
1 ADNI dataset; DL: deep learning; HC, healthy controls; AD, Alzheimer’s disease; MCI-NC, mild cognitive impairment 
non-converters; MCI-C, mild cognitive impairment converters; sMRI, structural MRI; PET, Positron Emission Tomography; 
CSF, cerebrospinal fluid; MMSE, mini mental state examination; ADASCog, Alzheimer's Disease Assessment Scale's 
cognitive subscale; SAE, stacked autoencoder; DBM, deep Boltzmann machine; DW-S2 MTL, deep weighted subclass-
based sparse multi-task learning; MLP, multilayer perceptron. 
 









Liu et al. 
(2015a)1 
HC = 204 sMRI WB region-level  Yes SAE AD vs MCI-C vs 
MCI-NC vs HC 
46.3 
AD = 180 
    
MCI-C=160 
    
MCI-NC=214 
    
Suk et al. 
(2014)1 




    
Liu et al. 
(2015a)1 
HC = 77 sMRI & PET WB region-level  Yes SAE AD vs MCI-C vs 
MCI-NC vs HC 
53.8 
AD = 85 
    
MCI-C=67 
    
MCI-NC=102 
    
Liu et al. 
(2014)1 
HC =77 sMRI & PET WB region-level  Yes SAE AD vs MCI-C vs 
MCI-NC vs HC 
47.4 
AD = 65 
    
MCI-C= 67 
    
MCI-NC = 
102 
    
Suk et al. 
(2015b)1 
MCI-C = 43 sMRI & PET & 
CSF 





AD vs MCI-C vs 
MCI-NC vs HC 
53.7 
AD =51 
    
HC =52 
    
MCI-C = 167 sMRI & PET & 
CSF 





AD vs MCI-C vs 
MCI-NC vs HC 
47.8 
HC= 52 
    
AD = 198 
    
Li et al. 
(2014)1 
MCI-C = 43 sMRI & PET & 
CSF & MMSE & 
ADASCog 




    
Suk and 
Shen (2013)1 
MCI-C = 43 sMRI & PET & 
CSF & MMSE & 
ADASCog 




    
Suk et al. 
(2015a)1 
MCI-C=43 sMRI & PET & 
CSF & MMSE & 
ADASCog 








4.3.3. Treatment outcome 
Prediction of response to treatment is a research area of high clinical interest. In several 
psychiatric and neurological disorders, a better understanding of why some patients benefit from 
a certain treatment whereas others do not, could help clinicians make more-effective treatment 
decisions and improve long-term clinical outcomes (Mechelli, Prata, Kefford, & Kapur, 2015). 
However, so far, only one study has used deep learning to predict clinical response to treatment 
(Table 4.3).  
 
Table 4.3. Treatment outcome. 









Munsell et al. (2016) TLEns = 41 DTI WB region-level  No SAE TLEns vs 
TLEs 
57.0 
TLEs = 29 
     
DL: deep learning; HC, healthy controls; TLE-ns, temporal lobe epilepsy without seizures; TLE-ns, temporal lobe epilepsy 
with seizures; DTI, diffusion tensor imaging. 
 
Munsell et al. (2015) attempted to develop an algorithm that distinguished between patients with 
TLE who did and did not benefit from surgical treatment. This was implemented using a stacked 
autoencoder to extract meaningful features from the connectome of patients who were then 
classified using SVM. This model, however, yielded a low accuracy of 57%. For comparison, the 
author investigated another option where features were extracted with an alternative linear 
approach instead of an autoencoder. This second model resulted in a higher accuracy of 70%. 
Again, this discrepancy in favour of the second model could potentially be explained by the 
absence of any form of regularizers in the first model. This model comprised 4 layers, resulting in 
a high number of weights to be estimated which, together with a modest sample size (41 patients 
without seizures and 29 with seizures after treatment), might have resulted in overfitting. 
 
4.3.4. How does deep learning compare to a traditional machine learning approach? 
A total of twenty-five studies included in this review compared a deep learning model against a 
kernel-based model (SVM or MKL) in order to elucidate how deep learning compares to a more 
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4.5. It can be seen that, for the majority of studies, deep learning showed improved performance 
compared to SVM. Given the small sample of studies, it is difficult to identify specific 
characteristics of the studies associated with greater or smaller improvement in performance 








Figure 4.5. Results of studies comparing deep learning and kernel-based models. The graph shows the 
accuracies (F-score for Plis et al. (2014)) for deep learning models (blue), kernel-based models (red) and 
the difference between the two (green). HC, healthy controls; ADHD, attention deficit and hyperactive 
disorder; AD, Alzheimer’s disease; MCI, mild cognitive impairment; MCI-NC, mild cognitive impairment non-
converters; MCI-C, mild cognitive impairment converters; SZ, schizophrenia; TLE, temporal lobe epilepsy; 
TLEs, temporal lobe epilepsy with seizures after treatment; TLEns, temporal lobe epilepsy without seizures 
after treatment. 
 
However, a margin favouring deep learning studies appears to be more evident in studies that 
have integrated different modalities with cognitive and/or clinical data (Figure 4.6). This anecdotal 
observation is consistent with the notion that deep learning is a powerful tool for detecting abstract 
relations within the data, especially between different types of data that are likely to be associated 
in complex ways, such as neuroimaging and clinical/cognitive information (Plis et al., 2014). Since 
deep learning requires a large number of observations to learn increasingly complex patterns 
compared to conventional machine learning methods, one would expect to find a greater 
difference between the two methods as sample size increases. However, the effect of sample 
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currently available. There is a minority of studies where SVM/MKL matched or even outperformed 
the proposed deep learning model. Amongst these, Munsell et al. (2015) reported the largest 
margin favouring SVM. However, this article had one of the smallest sample sizes (118 for the 
diagnostic comparison and 70 for the treatment outcome comparison) while employing one of the 









Figure 4.6. Difference in performance of deep learning against kernel-based methods for single modality, 
multimodal as well as for multimodal with cognitive/clinical data studies, according to sample size. 
 
Notably, out of all the studies comparing the two approaches, Munsell et al. (2015) was the only 
one that did not make any formal attempt to prevent overfitting of the deep learning model, for 
example through the use of regularization. We note that susceptibility to overfitting becomes more 
pronounced when deeper and thus more complex networks are used, as in the study by Munsell 
et al. (2015), due to the higher number of weights to be estimated (Srivastava et al., 2014). 
Therefore, we speculate that the use of small sample sizes, coupled with the high-dimensionality 
of the data (i.e. when the number of variables highly exceeds the number of participants), may 
have increased the risk of overfitting in this study.  
 
4.4. Discussion  




its advantages over traditional analytical methods based on mass-univariate statistics. In 
particular, machine learning methods take the inter-correlation between regions into account, 
while mass-univariate methods operate under the assumption that different regions act 
independently. In addition, machine learning methods can be used to make inferences at the 
single-subject level – a critical difference with mass-univariate analytical methods that are only 
sensitive to differences at group-level. Deep learning is a type of machine learning which is 
increasingly used in neuroimaging after leading to major scientific advances in the areas of 
speech recognition, computer vision and natural language processing by significantly 
outperforming other state-of-the-art classification methods (Krizhevsky et al., 2012; Le, 2013). 
There are two main characteristics that distinguish deep learning from conventional machine 
learning methods: first, deep learning is capable of learning features from the raw data without 
the requirement for a priori sophisticated feature extraction, resulting in a more objective or less 
bias-prone process; second, deep learning uses a hierarchy of nonlinear transformations, which 
make this approach ideally suited for detecting complex, scattered and subtle patterns in the data. 
Given its ability to detect abstract patterns from the data, deep learning can be considered a 
promising tool in neuroimaging, as most brain-based disorders are characterized by a scattered 
and diffused pattern of neuroanatomical and neurofunctional alterations (Plis et al., 2014). In 
previous sections of this review, we have described the most common deep learning architectures 
and have provided an overview of the studies that have applied deep learning to neuroimaging 
data to investigate psychiatric and neurological disorders. In this final section, we discuss the 
main themes that have emerged from the review of these studies. These will include (i) 
consistencies and inconsistencies in the existing literature (ii) the promise of CNNs, (iii) the issue 
of multiclass classification, (iv) how deep learning performs compared with conventional machine 
learning methods, (v) interpretability of deep learning in neuroimaging, (vi) the challenge of 
overfitting and (vii) technical expertise and computational requirements. We conclude by 
discussing possible directions for future research. 
 
4.4.1. Main conclusions from the existing literature 
The majority of published studies have been conducted in patients with MCI and/or AD; this may 




patients, to the neuroimaging community (Mueller et al., 2005a, 2005b). However, studies have 
also been conducted in other disorders including ADHD, psychosis, TLE and cerebellar ataxia. 
Taken collectively, the findings published so far suggest that deep learning can be applied to 
neuroimaging data, including both structural and functional modalities, to classify diagnostic 
groups from healthy individuals. Indeed, the performance of the classifiers has been consistently 
high, with several studies reporting accuracies above 95% for binary classifications between 
patients and controls (Deshpande et al., 2015; Hosseini-Asl et al., 2016; Payan & Montana, 2015; 
Sarraf & Tofighi, 2016; H.-I. Suk et al., 2015; H.-I. Suk, Lee, et al., 2016; H. Il Suk & Shen, 2013). 
Nevertheless, the application of a supervised model for diagnostic classification is arguably 
circular: since diagnostic labels in the training and testing datasets are predetermined through 
clinical examination, logic dictates that a perfect performance from a machine learning algorithm 
will simply mimic clinical assessment. Being able to predict a future diagnosis, or anticipate who 
will and will not benefit from a certain treatment, are questions of greater translational value in 
clinical practice. A total of 8 studies have applied deep learning to neuroimaging data acquired 
from individuals with MCI to predict subsequent transition to AD with promising results. For 
example, Suk et al. (2015) successfully predicted conversion from MCI to AD with 83.3% 
accuracy, after combining structural MRI and PET data. However, no studies have yet examined 
transition to illness in other psychiatric disorders with a prodromal phase, such as psychosis, even 
though we know that it is possible to distinguish between converters and non-converters using 
conventional machine learning (Pettersson-Yeo et al., 2013; Valli et al., 2016; Zarogianni et al., 
2013). Overall, the best results were achieved in neurologic disorders. This is a prevalent finding 
across neuroimaging machine learning studies (Orrù et al, 2012) and likely due to the fact that 
psychiatric disorders do not have, as of yet, reliable diagnostic biomarkers (e.g. Prata, Mechelli, 
& Kapur, 2014), and therefore diagnosis rests purely on clinical interviews, leading to diagnostic 
labels with poor reliability (Regier et al., 2013) and biological validity (Insel et al., 2010; Jablensky, 
2016; Kapur, Phillips, & Insel, 2012). To our knowledge only one study has used deep learning to 
predict treatment outcome. Munsell et al. (2015) achieved an accuracy of 57% when classifying 
TLE patients who did and did not suffer from seizures after surgical intervention. As discussed 
earlier, however, this modest result could potentially be explained by the absence of formal 





Deep learning is a very flexible approach, meaning that is it possible to combine different 
architectures and manipulate a range of hyperparameters within the same model. In addition, the 
vast majority of existing studies have been published in the last 2 years, and therefore the field of 
deep learning applied to neuroimaging of brain-disorders should be considered still at a very early 
stage. Possibly as a result of this combination of flexibility and novelty, the methodology of the 
studies reviewed in this article varied considerably. For example, some studies employed a whole-
brain approach whereas others focussed on a subset of regions of interest; some studies used 
the raw data without any form of feature selection or dimensionality reduction whereas others 
performed a number of transformations on the data to extract relevant features; and different 
studies used different deep learning architectures. Such methodological variability means that, at 
present, the reliability and replicability of the existing results remain unclear.  
 
4.4.2. The promise of convolutional neural networks  
CNNs are a particular type of feedforward neural network inspired by how the human visual cortex 
process information. Over the past decade, CNNs have been breaking records in computer vision 
across several competitions, making this approach a very promising one (Krizhevsky et al., 2012). 
Consistent with this, our review has shown that CNNs have generated the most encouraging 
results in the context of neuroimaging. In its raw form, neuroimaging data comprises millions of 
voxels. Considering the current computational resources available, putting all voxel intensities 
through a fully connected network would lead to an unfeasible number of weights to be estimated. 
Two intrinsic properties of CNNs - weight sharing and local connectivity - result in a significantly 
reduced number of weights, making it computationally possible to run the network at the voxel-
level. Although in neuroimaging CNNs have only been used to examine MCI and AD patients, the 
accuracies of the studies published so far have been consistently high (i.e. ≥95% for AD and 
≥86% for MCI versus controls). High accuracies have been observed with different modalities 
including structural MRI (A. Gupta et al., 2013; Hosseini-Asl et al., 2016; Payan & Montana, 2015), 
resting-state fMRI (Sarraf & Tofighi, 2016) and CT imaging (X. W. Gao & Hui, 2016), as well as 
with small (X. W. Gao & Hui, 2016; Sarraf & Tofighi, 2016) and large (A. Gupta et al., 2013; 




an alternative and interesting approach which involved pre-training a CNN in one Alzheimer’s 
dataset (CADDementia) and then fine-tuning and testing it in another dataset from the same 
diagnostic group (ADNI). The results were very promising for both 2-way and 3-way classifications 
(HC vs. AD; HC vs. MCI; AD vs. MCI; and HC vs. AD vs. MCI), although it should be noted that 
the ADNI sample was of modest size. Taken together, these results are in line with the successful 
performances of CNN-based models reported in other scientific areas, and highlight CNNs as a 
promising tool in neuroimaging.  
 
4.4.3. From binary to multiclass classifications  
In the context of neuroimaging, the vast majority of conventional machine learning studies have 
relied on binary classifications involving the comparison between a group of patients and a group 
of healthy controls (Orrù et al., 2012; Wolfers et al., 2015). This can be explained by the fact that 
these studies have typically employed SVM, which was originally designed for binary 
classification problems (Hsu & Lin, 2002). However, the real challenge for clinicians is not to 
differentiate between patients and controls but to develop biomarkers which could be used to 
choose amongst alternative diagnoses or different stages of illness progression. Looking forward, 
therefore, machine learning models will need to be able to discriminate amongst several possible 
alternatives in order to inform real-world clinical decision making. Many approaches have been 
proposed to enable SVM to handle multiclass classification problems (Fei & Liu, 2006; Hsu & Lin, 
2002). However, this is still an active research area (Kumar & Gopal, 2011) and none of the 
proposed approaches have been tested in the context of neuroimaging. Most neuroimaging 
studies using SVM addressed the multiclass problem by performing several binary classifications 
(for example, AD vs. HC, MCI vs. HC and AD vs. MCI) or one-against-all classifications (for 
example, AD vs. MCI & HC and MCI vs. AD & HC). However, similar to other approaches such k-
nearest neighbours and gaussian process for example, deep learning requires less technical 
effort to perform multiclass comparisons, and therefore could contribute for a solution to this issue. 
This is mainly due to the use of the so-called softmax function in the output layer, which can be 
considered an extension of the binary logistic regression to several classes. Here the output 
reflects the probability of belonging to each class, which is a more intuitive index of class 




solutions (Fei & Liu, 2006). In light of its suitability for multiclass classification, a number of studies 
have used deep learning to carry out 3 or 4-way classifications between different disorder 
subtypes or different stages of illness. For example, three of these studies were able to classify 
children into healthy controls and three ADHD subtypes (inattentive, hyperactive and combined) 
(Hao et al., 2015; Kuang, Guo, An, Zhao, & He, 2014; Kuang & He, 2014). Notably, there is also 
preliminary evidence for the use of deep learning to distinguish between individuals at no 
imminent risk of dementia, those identified at risk who will and will not develop dementia, and 
those with established Alzheimer’s disease (Liu, Liu, Cai, Che, et al., 2015; Liu et al., 2014; H.-I. 
Suk, Lee, et al., 2016). These are encouraging findings, as they highlight how deep learning could 
help bridge the existing gap between neuroimaging findings and real-world clinical practice.  
 
4.4.4. Is deep learning superior to conventional machine learning? 
Despite the success of deep learning in several scientific areas, the superiority of this analytical 
approach in neuroimaging is yet to be demonstrated. On the one hand, deep learning has been 
described as a potentially more powerful approach than conventional shallow machine learning, 
as it is capable of learning highly intricate and abstract patterns from the data, which can 
particularly useful in the case of brain-based disorders (Plis et al., 2014). On the other hand, given 
that neuroimaging data is very high-dimensional, the nonlinear approach of deep learning might 
not be advantageous as there are not enough data points to extract meaningful nonlinear patterns 
from the data, whereas the linear approach employed in conventional shallow machine learning 
might be more appropriate. Here we tried to clarify this issue by systematically examining the 
difference in performance between deep learning and conventional shallow machine learning in 
studies which used both approaches. A total of twenty-five studies reported classification accuracy 
for both deep learning and conventional shallow machine learning, with the latter being a kernel-
based method, either SVM or MKL. For the majority of these studies deep learning performed 
better than conventional shallow machine learning as shown in Figure 4.5, and in some cases the 
difference was by a reasonable margin (Xiaobing Han et al., 2015; Plis et al., 2014; H. Il Suk & 
Shen, 2013).  
 




specific circumstances, for example depending on the modality type or the sample size. However, 
our systematic review provides anecdotal evidence that studies combining imaging and non-
imaging data tend to have a larger margin in favour of deep learning (Figure 4.6). This is 
consistent with the notion that the association between brain abnormalities and cognitive 
symptoms, for example, is likely to exist at a deep and abstract level, and as such can be captured 
more effectively by deep learning methods than traditional shallow machine learning methods 
(Plis et al., 2014). 
 
Overall, machine learning techniques thrive with larger samples. One would expect this to be 
especially true for deep learning: since a deep model is inherently more complex than 
conventional shallow machine learning models, larger sample sizes should be needed to 
compensate for the greater number of parameters to be estimated and to take full advantage of 
deep learning’s ability to detect highly intricate and abstract patterns in the data. We were 
therefore expecting to see an increase in the margin by which deep learning outperforms kernel-
based methods as sample sizes increase. Such increase however was not observed, as the 
pattern of difference in performance did not seem to vary systematically with sample size; one 
possibility is that larger sample sizes than those used in the existing literature would be required 
to detect increases in the margin by which deep learning outperforms kernel-based methods.  
 
In conclusion, our review suggests that, overall, deep learning performs better than conventional 
shallow machine learning. In light of the increasing interest in deep learning, however, we cannot 
exclude a publication bias which favoured studies showing the superiority of this new analytical 
approach relative to conventional shallow machine learning methods (Boulesteix, Lauer, & 
Eugster, 2013). As the number of studies applying deep learning to neuroimaging data increases, 
a thorough assessment of publication bias would be useful to establish the reliability of this initial 
trend in favour of deep learning. 
 
4.4.5. Interpretability of deep learning in neuroimaging 
Despite having demonstrated state-of-the-art performances across several fields, deep learning 




(Alain & Bengio, 2016; Yosinski, Clune, Nguyen, Fuchs, & Lipson, 2015). For example, deep 
neural networks have been referred to as a “black box” in contrast with other techniques, such as 
logistic regression, which are less complex and more intuitive. Such lack of transparency has 
important implications for the interpretability of the results when deep learning is applied to 
neuroimaging data. Due to the multiple nonlinearities, it can be challenging to trace the 
consecutive layers of weights back to the original brain image in order to identify which features 
(e.g. regions) are providing the greatest contribution to classification (H.-I. Suk et al., 2015). This 
information however would be useful in the context of clinical neuroimaging where the aim is not 
only to detect but also localise abnormalities. A first potential issue is that a model with an 
excellent performance may be using irrelevant features (e.g. orientation of the images, imaging 
artefacts), as oppose to clinically meaningful information (e.g. regional grey matter, connectivity 
between different brain regions), to classify participants. A second potential issue is that an 
accurate model which provides no information about the underlying neuroanatomical or 
neurofunctional alterations would be of limited clinical utility, for example with respect to treatment 
development and optimization.  
 
Despite its complex inner workings which make the visualization and interpretation of the weights 
challenging, deep learning can be used in a way which enables transparency. This is illustrated 
by several neuroimaging studies included in this review that did report the most important features 
(Deshpande et al., 2015; J. Kim et al., 2016; Liu et al., 2014; H.-I. Suk, Wee, et al., 2016). 
However, these studies used a variety of approaches to isolate the most informative features, and 
at present there is no standard and intuitive method for visualizing weights or interpreting latent 
feature representations (H.-I. Suk et al., 2015). This has motivated several attempts to develop 
new and intuitive ways of enhancing the interpretability of deep learning within the recent literature 
(Dahne et al., 2015; Grün, Rupprecht, Navab, & Tombari, 2016; Simonyan, Vedaldi, & Zisserman, 
2013; Yosinski et al., 2015; Zeiler & Fergus, 2014). There are two main methodological 
approaches to address this issue, including input modification methods and deconvolution 
methods. Input modification methods are visualization techniques that involve the systematic 
modification of the input and the measurement of any resulting changes in the output as well as 




these methods is the so-called occlusion method (Zeiler & Fergus, 2014) which involves covering 
portions of the input image up to find the areas of the input data that influence the probability of 
the output classes. In contrast, deconvolution methods aim to determine the contribution of one 
or more features of the input data to the output. This involves selecting an activation of interest in 
an output neuron and then computing the contribution of each neuron in the next lower layers to 
this activation. Here a number of strategies are available to model the nonlinearities present 
across the layers, for example, deconvnet (Zeiler & Fergus, 2014) and guided backpropagation 
(Springenberg, Dosovitskiy, Brox, & Riedmiller, 2014). 
 
4.4.6. The challenge of overfitting  
Overfitting is arguably one of the main challenges in machine learning. Given their inherent 
complexity, deep learning networks are particularly prone to overfitting, i.e., learning irrelevant 
fluctuations in the data that limit generalizability. Not surprisingly, different approaches to address 
this issue, known as regularization strategies, have been developed and are now present in most 
deep learning algorithms. In section 4.2.1.4 we described some of the most commonly used 
regularization strategies applied to modern deep learning, namely weight decays and dropout. As 
expected, several studies reviewed here have used some form of regularization. The majority 
(Hosseini-Asl et al., 2016; J. Kim et al., 2016; Liu, Liu, Cai, Che, et al., 2015) have employed the 
L1 or L2 norms, which prevent overfitting by penalizing very low or very high weight values. At 
least one study (Li et al., 2014) employed dropout, where a random number of nodes and 
respective connections are temporarily removed to extract different sets of features that can 
independently produce a useful output. The importance of regularization strategies in deep 
learning could potentially account for the fact that Munsell and colleagues, who trained 4- and 5-
hidden layer models (for inferring diagnostic and treatment outcome, respectively) without using 
any form of regularization, reported such low performance for deep learning (Munsell et al., 2015).  
 
An additional approach for minimising the risk of overfitting involves reducing the dimensionality 
of the data before inputting them into the model. A possible way of achieving this is by extracting 
region- or patch-level features (as opposed to using voxel-level data). Using different types of 




inputted into the model is (for example, voxel-level features are very detailed, and also very noisy; 
region-level features on the other hand, ignore more localized patterns and are less sensitivity to 
noise). Another option to reduce dimensionality is feature selection. Feature selection is common 
in conventional machine learning, where linear methods such as principal component analysis, 
independent component analysis or elastic net, are used to select the most discriminating features 
that are then fed to a classifier. However, the use of conventional feature selection methods prior 
to a deep learning model seems counterintuitive, since one of the main advantages of deep 
learning is the ability to learn, through a purely data-driven method, the most useful features for 
classification. Several studies reported in this review have attempted to reduce the dimensionality 
of the data by extracting region- or patch-level features, using feature selection, or combining the 
two approaches. We note, however, that all CNN-based models were applied to voxel-level data 
without being preceded by any form of feature selection and yet reported consistently high 
performances on unseen data. This suggests that deep learning, and CNN-models and particular, 
can perform well with neuroimaging data without the requirement to downsize or even preprocess 
the data. For example, Hosseini-Asl et al. (2016) achieved high levels of accuracy when 
classifying AD and healthy controls, after applying a CNN to voxel-level data without any 
preprocessing or even skull stripping of the images. This finding has potential implications for the 
development of clinical tools, as it suggests that it might be possible to apply deep learning to raw 
neuroimaging data, thereby saving time as well as technical resources.  
 
In addition to overfitting due to the complex nature of deep learning, overfitting may have also 
occurred in several of the studies presented here due to the inappropriate use of feature selection 
and dimensionally reduction (e.g. PCA) approaches. From most articles, it was not clear whether 
these strategies were implemented within a cross-validation framework. Failure to do so means 
that the train and test data are no longer independent, and therefore, when the model is tested 
the data is not completely new to the model as it should be, resulting in inflated performances. 
This issue has also been highlighted in other review articles in psychiatric neuroimaging 






4.4.7. Technical expertise and computational requirements  
The studies reviewed in this article employed a wide range of deep learning architectures and 
hyperparameters. Such flexibility is what makes deep learning a very powerful tool but comes at 
a potentially high cost. The number of layers, the number of nodes within each layer and the 
activation function of each node are only a few examples of a long list of variables one has to 
consider when designing and optimizing a deep learning model. Automated optimization 
strategies are not yet widely available, making optimisation a manual process that requires a great 
deal of technical expertise and is potentially prone to subjective bias. Since the number of 
parameters to be estimated is very large, the computational requirements of deep learning are 
also more demanding than those of conventional machine learning methods. For example, Kim 
et al. (2016) reported that the estimation of a deep learning model with three hidden layers took 
100 times longer than the estimation of a standard SVM model (~3.3 days vs. 0.8h).  However, 
with the fast-growing availability of graphical processing units (GPUs), the application of deep 
learning to neuroimaging data is likely to become less and less time-consuming in the future.   
 
4.4.8. Limitations of deep learning 
Despite the promising initial findings, there are some important limitations that need to be 
considered. Perhaps the most obvious (and perhaps most controversial) limitation is the need for 
very large sample sizes to train deep learning models. This is due to their highly level of 
complexity, i.e. a large number of observations is needed in order to make up for the substantial 
number of parameters to be estimated. However, large sample sizes have been one the biggest 
challenges in psychiatric neuroimaging research, where a sample with a few hundred participants 
is considered exceptionally large. This is in sharp contrast with disciplines where deep learning is 
considered state-of-the-art and where data is abundant. For example, areas in which deep 
learning has excelled, such as image recognition, typically use datasets with one million examples 
(Krizhevsky, Sutskever, & Hinton, 2012). Significant larger samples, with dozens of thousands of 
participants, are now emerging in neuroimaging research (Kaufmann et al., 2019) which may 
allow explore deep learning closer to its full potential. Another important and related limitation of 
deep learning models is the higher risk of overfitting compared to traditional machine learning 




nature, more prone to learning noise or fluctuations in the training data that are not necessarily 
related to the task and therefore hinder generalizability. The actual training of deep learning 
models is also challenging. The optimization of the weights is typically formulated as a highly non-
convex optimization problem, with multiple local minima that make it very difficult to find a global 
minima (Goodfellow, Bengio, & Courville, 2016), although many suggest this may not be a serious 
problem (LeCun, Bengio, & Hinton, 2015). Training also requires extensive expertise to 
understand how the vast number of hyperparameters effect the learning process (e.g. learning 
rate, number of neurons, number of layers) and how best to tune them. Finally, also rather 
controversial is the lack of interpretability of deep learning models. At the moment, the strength 
of deep learning lies mostly on its pure data-driven mechanistic prediction and therefore traditional 
models may be more appropriate for gaining insight into neurobiological mechanisms of 
psychiatric and neurological disorders. 
 
4.5. Conclusions and Future Directions  
While still in its initial stages, the application of deep learning in neuroimaging has shown 
promising results and has the potential of leading to fundamental advances in the search for 
imaging-based biomarkers of psychiatric and neurologic disorders. Nevertheless, several 
improvements will be required before the full potential of deep learning in neuroimaging can be 
achieved. Firstly, given the complexity of deep learning models, we need to move away from 
studies with small to modest sample sizes in favour of much larger cohorts. A possible way of 
achieving this is through multi-centre collaborations, in which data is collected using the same 
recruitment criteria and scanning protocols across sites. A further way of increasing the sample 
size is through multi-site data sharing initiatives, such as ADNI for Alzheimer's disease and ADHD-
200 for ADHD. Secondly, the integration of CNN and recurrent neural networks (i.e. networks that 
allow the processing of data with sequential inputs such as videos or speech) is likely to lead to 
significant advances in deep learning in the next few years (Donahue et al., 2017). In 
neuroimaging, this integration could be particularly useful for analysing fMRI data, as it would 
allow the detection of intricate spatial patterns while simultaneously modelling the temporal 
component of the BOLD signal. Thirdly, we anticipate that an increasing number of neuroimaging 




a large sample of similar enough images. This could help tackle the curse of dimensionality – a 
common problem in neuroimaging studies of brain disorders (A. Gupta et al., 2013; Hosseini-Asl 
et al., 2016). Evidence from vision science, where deeper models such as VGG net (Simonyan & 
Zisserman, 2014), residuals networks (He, Zhang, Ren, & Sun, 2016) and Inception-v4 (Szegedy, 
Ioffe, Vanhoucke, & Alemi, 2016) are achieving the highest performances, suggests that transfer 
learning could be particularly useful when deeper models are employed. Fourthly, we suggest 
that the so-called augmentation technique - which it is commonly used in computer vision – could 
be useful in the context of neuroimaging. This technique involves increasing the sample size by 
applying transformations to the data (e.g., rotation, shear, scaling), and then train a model that is 
invariant to such transformations. The use of augmentation could also address the issue of 
modest sample sizes and lead to a decrease in prepossessing time (because steps such as 
rotation may become redundant). Finally, the use of deep learning to predict continuous scores is 
another interesting area for further research with potential clinical applicability, following the 
encouraging results obtained using conventional machine learning methods (Gong et al., 2014; 
Stonnington et al., 2010; Tognin et al., 2013). So far, only one study has used deep learning to 
predict clinical scores from structural MRI scans in patients with Alzheimer’s disease (Brosch & 
Tam, 2013).  
 
In conclusion, the capacity of deep learning models to learn complex and abstract representations 
through nonlinear transformations, makes this a promising approach to single subject prediction 
in neuroimaging. While there are still important challenges to overcome, the findings reviewed 
here provide preliminary evidence supporting the potential role of deep learning in the future 
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Han et al. (2015) PCA + SVM Voxel-level intensities extracted from resting-state 
fmri images 
Liu et al. (2015a) 
(sMRI only) 
Elastic net + SVM 
(LIBSVM) 
83 ROIs of grey matter volume extracted from T1- 
weighted. 
Liu et al. (2015a) 
(sMRI + PET) 
Elastic net + 
MKSVM (rbf 
kernel) (LIBSVM) 
83 ROIs with grey matter volume and regional 
average of cerebral metabolic rate of glucose 
extracted from T1- weighted and PET images, 
respectively. 
Liu et al. (2015b) Elastic net + 
MKSVM (rbf 
kernel) (LIBSVM) 
83 ROIs with grey matter volume and regional 
average of cerebral metabolic rate of glucose 
extracted from T1- weighted and PET images, 
respectively.  
Liu et al. (2014) Elastic net + 
MKSVM (rbf 
kernel) (LIBSVM) 
83 ROIs with grey matter volume and regional 
average of cerebral metabolic rate of glucose 
extracted from T1- weighted and PET images, 
respectively.  
Li et al. (2014a) PCA + LASSO + 
SVM (linear 
kernel) 
189 total features containing the grey matter volume 
of 93 ROIS extracted from T1-weighted images, 
regional average of cerebral metabolic rate of glucose 
extracted from PET images, and three CSF 
biomarkers (Aβ42,t−tau, and p-tau ) 




93 ROIs with grey matter volume and regional 
average of cerebral metabolic rate of glucose 
extracted from T1- weighted and PET images, 
respectively, and three CSF biomarkers (Aβ42,t−tau, 
and p-tau ) 
Suk et al. (2015a) MKSVM (linear 
kernel) 
93 ROIs with grey matter volume and regional 
average of cerebral metabolic rate of glucose 
extracted from T1- weighted and PET images, 
respectively, and three CSF biomarkers (Aβ42,t−tau, 
and p-tau ) 
Hu et al. (2016) SVM 90×90 functional connectivity matrix 
Kim et al. (2016) SVM (linear 
kernel) (LIBSVM) 
Whole-brain functional connectivity matrix containing 
6670 pairs of regions from the AAL atlas. 
Plis et al. (2014) SVM (rbf kernel) 60465 voxel-level grey matter volumes extracted from 
T1-weighted images 
Munsell et al. 
(2015) 
Elastic net + SVM 
(linear kernel) 
(LIBSVM) 
82×82 density connectivity matrix  






Using machine learning and 
structural neuroimaging to detect 
first episode psychosis: 
reconsidering the evidence 
 
This chapter is based on the paper entitled Using machine learning and structural neuroimaging 
to detect first episode psychosis: reconsidering the evidence published in Schizophrenia Bulletin. 
 
Vieira, S., Gong, Q., Pinaya, W. H. L., Scarpazza, C., Tognin, S., Crespo-Facorro, B., Tordesillas-
Gutierrez, D., Ortiz-Garcia, V., Setién-Suero, E., Scheepers, F., van Haren, N. E. M., Kahn, R. S., 
Reis Marques, T., Murray, R., David, A., Dazzan, P., McGuire, P. & Mechelli, A. (2019). Using 
Machine Learning and Structural Neuroimaging to Detect First Episode Psychosis: Reconsidering 







Over the last three decades, traditional mass-univariate neuroimaging approaches have revealed 
neuroanatomical abnormalities in individuals with psychosis (Chan et al., 2011; Fusar-Poli et al., 
2011; Smieskova et al., 2010; Torres et al., 2016; A Vita et al., 2012). Because these abnormalities 
were detected using group-level inferences, it has not been possible to use this information to 
make diagnostic and treatment decisions about individual patients. Machine learning is an area 
of artificial intelligence that promises to overcome this issue by learning meaningful patterns from 
the imaging data and using this information to make predictions about unseen individuals 
(Davatzikos et al., 2005). Several machine learning studies have attempted to use 
neuroanatomical data to distinguish patients with established schizophrenia from healthy 
individuals, with promising results (Kambeitz et al., 2015; Orrù et al., 2012; Wolfers et al., 2015; 
Zarogianni et al., 2013). At present, however, there are two important limitations in the existing 
literature that limit the translational applicability of the findings in real-world clinical practice. First, 
given the well-established effects of illness chronicity and anti-psychotic medication on brain 
structure (Bora et al., 2011; Navari & Dazzan, 2009; van Erp et al., 2016, 2018; Antonio Vita et 
al., 2015), it is unclear to what extent classification was based on neuroanatomical changes 
associated with these factors rather than the onset of the illness per se. Consistent with this, both 
disease-stage and anti-psychotic medication were identified as significant moderators in a recent 
meta-analysis of diagnostic biomarkers in schizophrenia (Kambeitz et al., 2015). Also in line with 
this, Pinaya et al (2016) reported that the same machine learning model that was able to 
distinguish between patients with established schizophrenia and healthy controls with an 
accuracy of 74%, showed poor generalizability (56%) when applied to a cohort of individuals with 
first episode psychosis (FEP). Taken collectively, these findings suggest that representations 
learned from patients with established schizophrenia may not be applicable to individuals with a 
first episode of the illness. Second, the clinical utility of any machine learning-based diagnostic 
tool for detecting patients with an established illness is likely to be very limited; in contrast, 
detecting the initial stages of an illness, when diagnosis may be uncertain and treatment is yet to 
be decided, is likely to have much greater clinical utility.  
 




in the initial stages of the illness when the effects of illness chronicity and anti-psychotic 
medication are minimal. These studies have produced inconsistent results, including poor (e.g. 
51% in Winterburn et al (2017)), modest (e.g. 63% in Pettersson-Yeo et al (2013)) and good (e.g. 
86% in Borgwardt et al (2013) or 85% in Xiao et al (2017)) accuracies. There are a number of 
possible reasons for such inconsistency. First, most of the studies used small samples (N≤50) 
(see Kambeitz et al (2015) for a meta-analysis), which have been shown to yield unstable results 
(Nieuwenhuis et al., 2012; Schnack & Kahn, 2016). Second, the vast majority of studies used 
data from a single site, and as such may have generated results that were specific to the 
characteristic of the local sample rather than the illness per se. Third, a series of recent articles 
have highlighted potential methodological issues that may have caused inflated results in some 
of the published studies (Arbabshirani et al., 2017; Janssen, Mourão-Miranda, & Schnack, 2018; 
Schnack & Kahn, 2016; Winterburn et al., 2017; Wolfers et al., 2015; Woo et al., 2017). These 
issues include, for example, (i) failure to use a nested cross-validation (CV) framework to avoid 
knowledge-leakage between training and test sets; (ii) failure to perform feature transformation 
and/or selection within a rigorous CV framework resulting in so-called “double dipping”; (iii) 
publication bias leading to an over-representation of positive findings, especially in studies with 
small samples and (iv) failure to test performance on additional independent samples. Also, we 
note that all studies have employed traditional ‘shallow’ machine learning techniques, such as 
support vector machine and logistic regression. The intuitiveness of such techniques has made 
them very popular in neuroimaging studies of psychiatric and neurological disease. Deep learning 
is an alternative type of machine learning which has been gaining considerable attention in clinical 
neuroimaging (Arbabshirani et al., 2017; Pinaya et al., 2016; Vieira, Pinaya, & Mechelli, 2017; 
Wolfers et al., 2015). Contrary to traditional machine learning, where the immediate input data is 
used to extract patterns (hence the term ‘shallow’), deep learning learns complex latent features 
of brain structure through consecutive nonlinear transformations (hence the term ‘deep’) which 
are then used for classification. Given its ability to learn more intricate and abstract patterns, deep 
learning might be particularly suitable to detect the subtle and heterogenous neuroanatomical 
abnormalities characteristic of the early stages of psychosis (Chan et al., 2011; Plis et al., 2014; 





This study aims to elucidate the extent to which the application of machine learning to 
neuroanatomical data allows distinction between patients with first episode psychosis and healthy 
controls at the individual level. To overcome the limitations of previous studies, we used a total of 
five datasets from different sites, each with a sample size above the recommended threshold for 
a stable performance (Nieuwenhuis et al., 2012), and employed both shallow and deep machine 
learning techniques. In addition, following a series of recent articles highlighting potential 
methodological issues in the existing literature (Arbabshirani et al., 2017; Janssen et al., 2018; 
Schnack & Kahn, 2016; Winterburn et al., 2017; Wolfers et al., 2015; Woo et al., 2017), we put in 
place a series of precautions to minimise the risk of overfitting. Based on previous studies, we 
hypothesize that: 1) FEP and HC will be classified with statistically significant performances 
ranging between 70% and 80% (Kambeitz et al., 2015) and 2) deep learning will perform better 




Participants were recruited as part as five independent studies carried out in multiple sites, all of 
which have been previously published:  
- Site 1: Chengdu, China (Gong et al., 2015) 
- Site 2: London, England (GAP study) (Di Forti et al., 2009) 
- Sites 3 and 4: Santander A and B, Spain (PAFIP study) (Pelayo-Terán et al., 2008) 
- Site 5: Utrecht, The Netherlands (GROUP study) (Korver et al., 2012) 
 
All patients were experiencing their first psychotic episode, defined as the first manifestation of 
psychotic symptoms meeting criteria for a psychotic disorder, as specified by the DSM-IV (APA, 
2000) or ICD-10 (Organization World Health, 1992). Recruitment details are reported in Chapter 
2, sections 2.1. 
 
5.2.2. MRI data acquisition and preprocessing 
At all 5 sites, volumetric MRIs were acquired using a T1-weighted protocol. At four sites, the 




sequence are reported in Chapter 2, section 2.2.2. From each image, three types of data features 
were extracted (see Chapter 5 supplementary material): 
 
- Voxel-wise grey matter volume (VWGMV): whole-brain voxel-wise estimate of the local density 
of GM in a given voxel region (Ashburner, 2007).  
- Voxel-wise cortical thickness (VWCT): cortical thickness maps in which each voxel in the grey 
matter is assigned a thickness value (Hutton et al., 2008, 2009). 
- Surfaced-based regional volumes and cortical thickness (SB-ROIs): volume and thickness of 
predefined cortical and subcortical regions extracted with FreeSurfer (Fischl, 2012). 
 
5.2.3. Statistical analysis 
5.2.3.1. Demographic and clinical variables 
Differences in age, sex and total intracranial volume (TIV) between FEP and healthy controls (HC) 
were examined using an independent-samples t-test and chi-square test, as implemented in the 
Statistical Package for the Social Sciences 24.0 (SPSS 24.0). 
 
5.2.3.2. Group-level comparisons 
For completeness, a standard group-level analysis was also carried out for each site and type of 
feature set separately. See Chapter 5 supplementary material sections 1.4.1. and 2.1 for methods 
and results, respectively. 
 
5.2.3.3. Multivariate pattern recognition analysis 
5.2.3.3.1. Dimensionality reduction: principal component analysis 
Principal component analysis (PCA) was used to reduce the number of voxels of the VWGMV 
and VWCT maps (see Chapter 5 supplementary material). 
 
5.2.3.3.2. Classifiers 
Four methods were used for classification: k-nearest neighbours (KNN), logistic regression (LR), 
support vector machine (SVM) and deep neural networks (DNN). These methods were chosen 




learning can be more powerful at the expense of transparency; popularity: SVM and LR and 
among the most machine learning techniques used in previous studies; and novelty: deep 
learning has yielded promising results in psychiatric neuroimaging but is yet to be applied to FEP. 
KNN, LR and SVM were implemented using the Scikit-Learn library (Pedregosa et al., 2011) 
(sklearn) for python 3.5. Deep neural network (DNN) was implemented using Tensorflow v.1.4 
(Abadi, Chu, et al., 2016) and Keras v.2.1 (Chollet & others, 2015) libraries. The random seed 
was kept the same for all models to ensure the reproducibility of the results. This approach 
guaranteed that the starting weights and train/test split at each fold of the CV would remain the 
same within and between algorithms for the same site. 
 
5.2.3.3.2.1 K-nearest neighbours 
K-nearest neighbours (KNN) is a non-parametric method based on multivariate pairwise distance 
measures between data points. Once presented with unseen data, it calculates the Euclidean 
distance between this new data point and each of the surrounding neighbours. Classification is 
done by assigning the unseen data to the same class as the majority of its neighbours (Altman, 
1992). The optimal number of neighbours was tuned via grid search by testing 10 possible odd 
values ranging from 3 to 21 in increments of 2. 
 
5.2.3.3.2.2. Logistic regression 
Logistic regression (LR) was implemented via elastic net, a regularized regression that combines 
the regularizations L1 and L2 penalties of LASSO (Least Absolute Shrinkage and Selection 
Operator) and ridge regression, respectively. While the ridge penalty retains all variables and 
minimizes the impact of irrelevant features, the LASSO penalty discards unimportant variables 
(H. Zou & Hastie, 2005). Grid search was used to find the optimal relative contribution of each 
penalty via tuning of the hyperparameter l1_ratio as defined by sklearn from eleven possible 
values between 0 and 1 with increments of 0.1. 
 
5.2.3.3.2.3. Support vector machine 
Support vector machine (SVM) is a supervised machine learning technique that maps the input 




the model finds the optimal separating hyperplane by finding the largest margin of separation 
between the two classes within the training set. Once the hyperplane is determined, it can be 
used to predict the class of new unseen observations (Pereira & Mitchell, 2008; Vapnik, 1995). In 
this study, a linear kernel was chosen to contrast with the characteristic nonlinear approach of 
deep learning. The soft margin (C) parameter, that controls the trade-off between having zero 
training errors and allowing misclassifications, was tuned from a possible range of values (2-5, 2-
3, ..., 213, 215) using grid search, i.e. all possible values in a given range were tested.  
 
5.2.3.3.2.4. Deep neural network 
Given its flexible architecture, deep learning can be used to build a variety of different neural 
networks (LeCun et al., 2015). Here we employed a deep neural network, with the components 
resulting from the PCA (for the VWGMV and VWCT data) or the SB-ROIs as inputs; the general-
purpose deep neural network (DNN) was chosen as it allowed for automated and non-biased 
optimization of the hyperparameters, which in turn helps prevent overfitting. Deep neural networks 
are multi-layered fully-connected networks where higher-level features are learned as a nonlinear 
combination of lower-level features, thus allowing the extraction of complex and abstract patterns 
from the data. Once the model learns these higher-level features, it can determine a separation 
surface to classify the different classes (LeCun et al., 2015; Vieira et al., 2017).  The performance 
of DNN models relies on the specification of several architectural and learning hyperparameters. 
To prevent bias, the number of layers, number of units, optimizer, learning rate, decay, activation 
function and epoch and were optimized using random search as implemented by sklearn. To 
decrease the chances of overfitting, two additional parameters were also included at each layer: 
i) L2 regularizer, which penalizes high weights (Krogh & Hertz, 1992) and ii) dropout, where 
randomly selected neurons are ignored during training (Srivastava et al., 2014). Each layer was 
initialized via Glorot (also known as Xavier) initialization (normal distribution) (Glorot & Bengio, 
2010). In the output layer, the classification was performed by a softmax function. Training was 
carried out using a mini-batch with 8 training samples for VWGMV and VWCT data, and 128 for 
the SB-ROIs. DNN models were optimized via random search due to the high number of 
parameters to test: at each fold, 500 different combinations of randomly selected values for each 
















Figure 5.1. Analysis pipeline. Three features were extracted from each image: VWGMV, VWCT and 
FreeSurfer SB-ROIs. The dimensionality of VWGMV and VWCT was reduced through PCA. The resulting 





Number of layers 2, 3, 4, 5 
Number of units 10, 20, 50, 75, 100, 150 
Activation function ReLU, Leaky ReLU 
Learning rate 0.001, 0.005, 0.01, 0.1, 0.2 
Learning rate decay 10-6, 10-5, 10-4, 10-3 
Epochs 50, 100, 150 
Optimizer Stochastic gradient descent (SGD), Adam 
Momentum 0.99, 0.9, 0.95 
L2 coefficient  10-5, 10-4, 10-3, 10-2 











5.2.3.3.3 Model training and testing 
Within-site classification. All models were assessed through a nested 10-fold stratified CV 
framework (Figure 5.2) to ensure that the data for hyperparameter tuning and the data to test the 
algorithm were strictly independent. A 10-fold CV was chosen as a trade-off between bias, 
variance and the demanding computational resources required to run the DNNs. 
 
Figure 5.2. Schematic representation of nested CV. Nested CV involves a secondary inner CV loop using 
the training data from the primary outer CV split, where different sets of hyperparameters are tested (e.g. 
different values for the C parameter for SVM). The best performing hyperparameters amongst the 10 inner 
folds are then used to train a model in the whole training set defined by the outer loop. This model is then 
tested using the test set of the outer loop. The final performance is estimated by averaging accuracies in the 
test set across all 10 outer folds. 
 
Cross-site classification. The best site-level model was further tested in each one of the remaining 
independent samples. This was done by running the 10 instances of the trained model (one 
trained model for each one of the 10 CV folds) on the independent sample. This resulted in ten 
sets of class membership probabilities, one for each of the 10 instances. The final predicted label 
was estimated using the soft voting method, i.e. by averaging the ten predicted probabilities 
(participants with a probability equal or higher than 0.5 were assigned to the patients’ group, 




5.2.3.3.4. Performance measures 
Balanced accuracy, sensitivity and specificity as defined in section 2.3.2.5.1. in Chapter 2 were 
used to measure the performance of each classifier. Statistical significance of the balanced 
accuracy was determined by permutation testing with 1000 permutations (see Chapter 5 
supplementary material).  
 
5.2.3.3.5. Effect of anti-psychotic medication and psychotic symptoms 
To examine whether anti-psychotic medication and psychotic symptoms contributed to the 
classifiers’ performance, chlorpromazine equivalents and positive and negative psychotic 
symptoms were regressed against the predicted labels using a logistic regression as implemented 
by the Logit function from the statsmodel python library. Because all patients from site 1 were 
anti-psychotic naïve, the investigation of the effects of medication was limited to sites 2, 3, 4 and 
5. The size of the effects of medication and psychotic symptoms was measured in terms of odds 
ratio (OR) and respective 95% confidence interval (CI). The statistical significance threshold was 
set to 0.05. 
 
5.3. Results 
5.3.1. Socio-demographic and clinical parameters 
No statistically significant differences were identified between patients and controls for age, sex 
or total GM volume at each site (Table 5.2). 
 
5.3.2. Single-subject classification 
Can we detect FEP at the individual level? 
Balanced accuracy, sensitivity, specificity and statistical significance for each feature set of 
interest and site are presented in Table 5.3 (for a visual display of the accuracies and standard 
deviations see sFigure 5.3 in the supplementary materials). Overall, results were poor to modest 
across all types of feature sets and sites; although the site with the smallest sample size (site 2) 
showed the lowest performance consistently across all feature sets. Overall, regression analyses 
examining the effect of anti-psychotic medication and psychotic symptoms on the performance of 




What is the most effective type of feature set? 
There was no clear effect of type of feature set across sites. However, it can be seen that SM-
ROIs data tended to yield higher accuracies, especially when analysed with DNN.  
 
Can we generalise the results from one site to the others? 
The best performances were achieved by two DNN models at sites 1 and 3 using SB-ROIs, with 
70.5% and 70.2%, respectively. However, both models generalized poorly when tested on the 
remaining sites: specifically, the DNN model from site 1 achieved accuracies 
(sensitivity/specificity) of 52.1% (56.3%/47.9%), 61.1% (70.0%/52.7%), 52.1% (65.7%/38.6%) 
and 50.0% (48.3%/51.7%) when applied to sites 2 through 5, respectively; whilst the DNN model 
from site 3 achieved accuracies of 52.2% (96.5%/8.4%), 49.2% (83.5%/33.4%), 55.1% 
(70.1%/40.0%)  and 51.0% (67.5%/34.6%)  when applied to sites 1, 2, 4 and 5, respectively. To 
examine the possibility that poor generalizability was due to site differences, the same DNN model 
was applied to the total data with the five sites added as additional features. Features weights 
were then investigated to determine the importance of site. Results showed that out of the 174 
features, the weights for site 1, 2, 3, 4 and 5 ranked 110, 150, 108, 71 and 112, respectively. 
 
5.4. Discussion 
In the last few years, there has been increasing interest in the translational potential of machine 
learning approaches in psychosis. As the field matures, there is emerging scepticism about 
replicability and generalizability, which has led to recent calls for greater caution in the 
interpretation of the findings (Arbabshirani et al., 2017; Schnack & Kahn, 2016; Winterburn et al., 
2017; Wolfers et al., 2015; Woo et al., 2017). This study aimed to elucidate the extent to which 
the application of machine learning to neuroanatomical data allows detection of individuals at the 
early stages of psychosis when the effects of illness chronicity and anti-psychotic medication are 
minimal. To overcome the limitations of the existing literature, we used five independent datasets 
and put in place a series of methodological precautions to avoid overoptimistic results. Contrary 
to expectation, the performances of all methodological approaches tested were poor to modest 
across all sites. Below we discuss some of the main aspects that emerge from our investigation, 
including sample size, full independence of training and test data, cross-site generalizability and 




Table 5.2. Demographic and clinical characteristics for FEP and HC for each site. 
TIV: total intra-cranial volume; L: liters; M: male; F: female; FEP: first episode psychosis; HC: healthy controls; PANSS: Positive and Negative Symptoms Scale; bSAPS: 
Scale for the Assessment of Negative Symptoms; cSANS: Scale for the Assessment of Negative Symptoms; ns: p>.0
  Chengdu, China (N=224)   
London, England 
(N=142)   
Santander A, Spain 
(N=220)   
Santander B, Spain 





  HC FEP HC FEP HC FEP HC FEP HC FEP 
N 112 112 71 71 110 110 70 140 81 81 
Sex (%) 
M  51 (46) 51 (46) 36 (51) 36 (51) 68 (62) 68 (62) 45 (64) 90 (64) 64 (79) 64 (79) 
F 61 (54) 61 (54) 35 (49) 35 (49) 42 (38) 42 (38) 25 (46) 50 (46) 17 (21) 17 (21) 
 χ2=ns χ2=ns χ2=ns χ2=ns χ2=ns 
Age M(SD) 
27.2 (7.3) 25.7 (8.1) 26.8 (7.1) 26.4 (6.2) 29.7 (7.8) 28.5 (8.6) 27.3 (7.5) 28.3 (7.6) 26.9 (8.0) 25.2 (5.9) 
t=ns t=ns t=ns t=ns t=ns 
TIV (L) M(SD) 
1.5 (0.1) 1.5 (0.2) 1.5 (0.2) 1.5 (0.2) 1.5 (0.1) 1.4 (0.2) 1.5 (0.1) 1.5 (0.1) 1.6 (0.1) 1.5 (0.2) 
t=ns t=ns t=ns t=ns t=ns 
Positive 
symptoms M(SD) - 24.6 (6.6)
a - 13.9 (5.5)a - 14.7 (4.6)b - 14.4 (4.1)b - 15.9 (6.3)a 
Negative 
symptoms M(SD) - 18.2 (7.7)
a - 16.0 (6.0)a - 6.3 (4.6)c - 6.1 (5.0)d - 16.2 (6.9)a 
Duration of illness 
(years) Med 
(IQR) 




Table 5.3. Accuracies (sensitivity/specificity) for each feature set and algorithm across all sites 
using nested 10-fold stratified cross-validation. The classifier yielding the best balanced accuracy 
is highlighted in bold for each site. 
**p<.01, *p<.05; SVM: support vector machine; LR: logistic regression; KNN: k-nearest neighbours; DNN: 
deep neural network; SM-ROIs: surfaced-based regional volumes and cortical thickness; VWGMV: voxel-
based morphometry; VWCT: voxel-based cortical thickness 
 
5.4.1. Sample size, homogeneity and publication bias 
A possible explanation for why our accuracies are lower than those reported in the existing 
literature is that some of the previous studies may have reported overoptimistic results due to the 




KNN 60.7** (74.3/47.1) 60.7** (49.5/71.9) 62.1** (72.1/52.1) 
LR 61.9** (64.9/58.9) 60.1** (62.9/58.6) 67.2** (65.8/68.5) 
SVM 61.3** (66.4/56.2) 60.7** (63.0/58.5) 52.7* (24.6/97.3) 




KNN 56.7 (50.9/62.5) 43.9 (33.6/54.3) 53.5 (38.4/68.6) 
LR 51.6 (45.0/58.2) 51.9 (53.8/50.0)  61.6** (63.2/60.0) 
SVM 45.9 (49.3/42.5) 53.9 (53.4/54.3) 51.0 (96.3/5.7) 




KNN 59.6** (45.5/73.6) 50.5 (31.8/69.1) 58.0* (50.0/66.4) 
LR 58.6* (58.2/59.1) 63.2** (63.6/62.7) 59.1* (58.2/60.0) 
SVM 60.5** (61.8/59.1) 65.9** (68.2/63.6) 51.8* (90.9/12.7) 




KNN 56.6* (91.8/21.4) 58.9** (70.7/47.1) 59.5* (67.7/51.1) 
LR 54.8 (73.9/35.7) 59.6** (57.8/61.4) 62.6** (56.8/62.4) 
SVM 56.0 (65.0/47.1) 57.4* (71.9/42.9) 58.4* (71.9/52.9) 




KNN 52.7 (53.6/51.8) 54.5 (33.8/75.3) 52.2 (36.5/67.9) 
LR 58.5* (61.7/55.4) 61.3** (56.8/65.7) 60.5** (60.6/60.4) 
SVM 60.7** (59.7/61.7) 62.4** (63.1/61.8) 56.3 (51.2/61.4) 




use of fairly small sample sizes. To illustrate this possibility, we tested for an association between 
sample size and classification accuracy across studies using machine learning and structural MRI 
(sMRI) in the existing literature (see Chapter 5 supplementary material). Unsurprisingly, we found 
a moderate negative association for studies that examined established schizophrenia (r=-.41) and 
FEP (r=-.59; after excluding Xiao et al (2017) which was a clear outlier; Figure 5.3A). This is 
consistent with the notion that some of the previous studies may have reported overoptimistic 
accuracies due to the use of inadequate sample size. 
 
There are at least two possible ways in which inadequate sample size can lead to an inflated 
estimation of the accuracy of an algorithm, including sample homogeneity and publication bias 
(Schnack & Kahn, 2016; Woo et al., 2017). Firstly, smaller samples tend to be more 
homogeneous, making it easier for an algorithm to learn shared abnormalities in patients relative 
to controls and resulting in higher accuracies. In contrast, larger samples tend to be more 
heterogeneous due to the loosening of inclusion criteria; in this case, it may be more challenging 
to find a shared pattern of abnormalities resulting in lower performances. This inverse relationship 
between sample size and accuracy was not observed in our investigation; however, this might be 
explained by the fact that there was not sufficient variability in sample size across our five 
datasets. Secondly, smaller samples tend to be unstable and thus yield underestimated as well 
as overestimated accuracies (Nieuwenhuis et al., 2012; Varoquaux, 2017). This may, in turn, lead 
to publication bias, with overestimated accuracies being more likely to be published. In their meta-
analysis of machine learning studies of schizophrenia, Kambeitz et al (2015) reported that no 
publication bias was evident when all studies - including sMRI, fMRI and DTI - were examined 
together. To test for publication bias in sMRI studies, we repeated the same statistical analysis 
focusing on this modality (see supplementary material). This revealed a statistically significant 
asymmetry in the funnel plot of published studies, indicating the presence of publication bias 
(Figure 5.3B). This is in line with emerging concerns about possible over-representation of inflated 
performances in the literature (Arbabshirani et al., 2017; Schnack & Kahn, 2016; Winterburn et 





5.4.2. Full independence of training and testing set data 
Following recent recommendations on how to overcome methodological issues that may have led 
to initial inflated results (Arbabshirani et al., 2017; Wolfers et al., 2015; Woo et al., 2017), we 
adopted two important methodological precautions. First, the use of simple CV, in which the same 
test data is used to both tune model hyperparameters and evaluate its performance, has been 
criticized as it almost certainly leads to inflated performances (Arlot & Celisse, 2010; Varma & 
Simon, 2006). In the present investigation, algorithms were trained and tested via nested CV. This 
ensured that the test set remained fully independent from the training set, with only the latter 
being used to optimise model parameters. Second, implementing feature selection in a two-step 
approach, where for example univariate tests (e.g. t-test) are applied in the whole sample and 
only the statistically significant features are used for classification, is likely to result in 
overoptimistic performances as features are chosen based their performance on data that should 
be completely independent for testing the classifier. In the present investigation, therefore, 
transformations to the data such feature selection were implemented embedded within the CV 
framework, i.e. parameters were derived from the training data only and subsequently applied to 
the test set. The adoption of these methodological precautions, aimed at ensuring full 
independence between training and test data, might explain the fact that accuracies in the present 
investigation were lower than expected. Nevertheless, despite the precautions used to ensure the 
independence of the train and test, the voxel-level features used in this study were computed 
using a study-specific template (i.e. DARTEL) based on the total data available for each site. This 
is the most common approach in machine learning studies that use voxel-level psychiatric 
neuroimaging data (Kambeitz-Ilankovic et al., 2019; Pettersson-Yeo, 2013; Valli et al., 2016). 
However, it should be acknowledged that this is not the optimal approach for a machine learning 
study, since both the training and test data are transformed together using information present on 
both sets, and therefore compromising the independence between training and test sets. The 
decision to use this approach outside the CV framework was based on limited computational 
resources and time. A more rigorous solution would be to build a template using the training data 





5.4.3. Cross-site generalizability 
The use of independent samples to develop and validate an algorithm is a critical requirement if 
the ultimate aim is to develop flexible machine learning-based tools that could be used in a clinical 
setting (Arbabshirani et al., 2017; Woo et al., 2017). However, only a minority of studies have 
attempted to do this (Dluhoš et al., 2017; Schnack & Kahn, 2016; Schnack et al., 2014), and most 
of them have reported considerably lower performances in the independent sample. In the present 
investigation, the highest accuracies – obtained using specific combinations of dataset, type of 
feature set and algorithm – were 70% (in sites 1 and 3 with surface-based regional features and 
DNN); this performance would appear to be in line with previous similar studies. However, 
selectively reporting these accuracies from our wider set of results would have portrayed a 
distorted picture of the potential of machine learning to detect the initial stages of psychosis at the 
individual level (Janssen et al., 2018). This is especially true since, after testing these two models 
in independent datasets, their performance did not hold up indicating low cross-site 
generalizability. Such low cross-site generalizability could be due to site-related differences in 
scanning parameters, cultural interpretation of diagnostic criteria and ethnicity; therefore, it might 
be possible to achieve higher cross-site generalizability by combining samples that are 
homogenous with respect to these variables. Nevertheless, our current results indicate that 
algorithms developed using data from a specific centre do not perform well when applied to data 
from other centres, and thus have limited clinical applicability. 
 
5.4.4. Testing multiple pipelines 
Because existing studies tend to differ with respect to several methodological aspects, at present, 
it is difficult to say which pipeline is optimal for detecting FEP (Salvador et al., 2017). Multi-pipeline 
studies have therefore been proposed as a useful way to disentangle what aspects works best 
(Arbabshirani et al., 2017). Importantly, this approach may also help build more generalizable 
models, as the development of a bespoke, and possibility overfitted, pipeline to a local sample is 
less likely to occur. Consistent with this, Salvador et al (2017) tested the performance of a range 
of machine learning approaches in different types anatomical features extracted from patients 
with schizophrenia and controls, and reported lower accuracies (66-68%) compared to previous 




FEP and reported poor to modest accuracies, ranging from 51% to 73%. Taken collectively, 
evidence from these studies, including our own, suggest that when features are not manually 
carved to fit one algorithm applied to one specific small dataset performance tends to drop. This 
can be seen in Figure 5.3A where two generations of studies emerge: initially there were mostly 
small single -site, -feature and -algorithm high-performance studies; more recently the use of 1) 
larger samples, 2) multi-centre studies (Dluhoš et al., 2017; Rozycki et al., 2018), 3) assessment 
of different algorithms and/or features in one/several site(s) (Salvador et al., 2017; Winterburn et 
al., 2017) or 4) independent sample testing (Dluhoš et al., 2017; Rozycki et al., 2018) are 
reshaping the original, and possibly over-inflated, enthusiasm with more realistic performances. 
 
 
Figure 5.3. Summary of sMRI machine learning studies over time and funnel plot. A. Accuracy of diagnostic 
sMRI machine learning studies over time and sample size (circle increases with sample size). From the first 
study until 2015, the vast majority of studies reported accuracies ranging between 70% and 100%; from 
2016, however, performances have dropped overall with accuracies ranging between chance-level and 85%. 
B. Funnel plot for sMRI studies in SZ and FEP showing the distribution of individual studies according to 
their sample size (1/√ESS) and effect size (logDOR). The plot revealed a statistically significant asymmetric 
distribution around the result of the meta-analyses of machine learning-sMRI studies (Kambeitz et al., 2015) 
(p=.013), indicating a bias favouring higher effect sizes. 
 
5.4.5. What next for machine learning-sMRI studies of psychiatric disease? 




statistically significant result (even with a small effect size), in neuroimaging machine learning 
studies it has been observed that larger samples do not necessarily equate to better results; 
instead, these tend to lead to lower accuracies potentially due to increased heterogeneity 
(Schnack, 2017; Schnack & Kahn, 2016). In fact, this observed inversed relationship between 
sample size and performance is also not commonly observed in more classical machine learning 
applications (Banko & Brill, 2001). Despite this challenge, larger samples are likely to be more 
representative of the illness, less likely to overfit and thus carry more translational potential. Future 
machine learning studies will have to address this issue to overcome the increasingly apparent 
bottleneck in the performance that is arising with larger sample sizes (Figure 5.3A). A possible 
way of doing so could be to use normative models, where an individual is mapped against a 
normative model that should encompass the heterogeneity characteristic of the normal 
population. Here, illness is considered an extreme case within a normal range, which is likely to 
be a more ecologically valid approach than the traditional case-control paradigm (Marquand, 
Rezek, Buitelaar, & Beckmann, 2016; Sato, Rondina, & Mourão-Miranda, 2012). 
 
Greater methodological standardization based on ‘good-practice recommendations’ could also 
help disentangle the current conflicting evidence. For example, guidelines for minimum sample 
size such as the threshold (n>130) proposed by Nieuwenhuis et al (2012) are a good start. The 
need for independent sample testing has also been widely acknowledged as an essential step 
towards generalizability (Arbabshirani et al., 2017; Woo et al., 2017) however, even the most 
recent studies do not always perform this. Moving forward, this type of generalizability test is likely 
to become a gold standard for machine learning diagnostic studies. More transparency in the 
implementation of machine learning is also needed. Several studies do not provide enough 
information about how the algorithm was trained and tested (Arbabshirani et al., 2017; Schnack, 
2017; Tandon & Tandon, 2018). This hinders a thorough assessment of the validity of the study 
as well as its replicability. It should also be noted that, even if sMRI was able to distinguish 
between patients with FEP and disease-free individuals with high levels of accuracy, this would 
be of limited clinical utility. This is because, from a clinical translation perspective, the real 
challenge is not to distinguish between patients and disease-free individuals, but to develop 




treatment (Tandon & Tandon, 2018).  
 
5.5. Conclusion 
The present investigation attempted to overcome the limitations of the existing literature using a 
number of strategies. Firstly, we studied FEP patients in which the effects of anti-psychotic 
medication and illness chronicity are likely to be minimal. Secondly, the sample size of each of 
our five datasets was greater than the recommended threshold for achieving a stable performance 
in machine learning-sMRI studies (Nieuwenhuis et al., 2012). Third, critical methodological 
precautions (e.g. nested CV and appropriate use of feature selection) were adopted to ensure an 
unbiased assessment of performance. Fourth, we systematically assessed the performance of a 
range of algorithms and features across several datasets, thereby minimizing the possibility of 
developing a bespoke and likely overfitted model to a single site. Fifth, we assessed the cross-
site generalizability of the best models at the single-site level. Our findings suggest that the use 
of machine learning and sMRI allows detection of FEP at the individual level with relatively modest 
accuracies – lower than what was expected based on previous studies and much lower than what 
would be required for clinical translation. We speculate that some of the previous results may 
have been over-optimistic due to a combination of small sample sizes, less-than-rigorous 
methodologies and possible publication bias and argue that the current evidence for the 
diagnostic value of machine learning and structural neuroimaging should be reconsidered 
towards a more cautious interpretation.  
 
The DNN models showed a small superiority compared to traditional approaches when ROIs were 
used as input features. This small improvement is in line with the growing popularity of deep 
learning in psychiatric neuroimaging (Durstewitz, Koppe, & Meyer-Lindenberg, 2019; Vieira, 
Pinaya, & Mechelli, 2017). However, when the significant additional computational costs and 
expertise required to achieve it are put in context, the superiority of DNNs is not that clear. For 
example, each DNNs used in this study took roughly 3 days to run. On the other hand, an SVM 
model with the same number of features took less than 10 minutes. The same has been observed 
by Kim et al (2016), where their DNN models applied to functional connectivity matrices took 




increasing availability of better computational resources, it likely that this discrepancy will 
decrease significantly in the next few years. 
 
Over the past few years the number of machine learning studies in psychosis has been increasing 
rapidly (Tandon & Tandon, 2018). As larger samples and more powerful computational resources 
become available, this momentum is likely to continue to grow over the coming years (Bzdok & 
Yeo, 2017). Therefore, it is as important for the research community to be aware of the challenges 
and limitations of applying machine learning to psychosis including, for example, several 
potential ”distortion” of the findings along the machine learning pipeline as discussed in a recent 
review (Tandon & Tandon, 2018). In light of these challenges and limitations, the extent to which 
the application of machine learning in psychosis will lead to a more valid construct of the illness 
remains an open question. We encourage researchers to continue pursuing the integration of 
machine learning and neuroimaging, whilst exercising caution to avoid inflated results and 










sTable 5.1. Sample size of each dataset. We report the number of subjects available (top row), 
the number of subjects excluded after matching patients and controls for age and sex (middle 

















Available 330 204 257 223 225 
Excluded 106 62 37 13 63 
Final 224 142 220 210 162 
 
5.1.2. MRI preprocessing 
After checking all T1-weighted images for scanner artefacts and gross anatomical abnormalities, 
images were preprocessed to extract three types of anatomical features: voxel-wise GM volume 
(VWGMV), voxel-wise cortical thickness (VWCT) and surface-based volumes and cortical 
thickness (SB-ROIs). 
 
5.1.2.1. Voxel-wise maps 
Two different voxel-wise features were extracted: grey matter volume and cortical thickness. 
Common to both features, images were first reoriented along the anterior-posterior commissure 
line and set the anterior commissure as the origin of the spatial coordinates to assist the 
normalization algorithm. Reoriented images were then segmented into GM, WM and CSF 
partitions as implemented in SPM12 (Ashburner & Friston, 2005) 
(http://www.fil.ion.ucl.ac.uk/spm).  
 
5.1.2.1.1. Grey matter volume  




toolbox (Ashburner, 2007). This procedure warps the grey matter and white matter partitions into 
a new study-specific reference space representing an average of all the subjects included in the 
analysis, thus maximizing accuracy and sensitivity (Scarpazza, Tognin, Frisciata, Sartori, & 
Mechelli, 2015; Yassa & Stark, 2009). The warped grey matter partitions were then affine-
transformed into MNI space. An additional modulation step was used to scale the grey matter 
probability values by the Jacobian determinants of the deformations, thereby ensuring that the 
total amount of grey matter in each voxel was conserved after registration (Mechelli et al., 2005). 
Finally, the GM probability maps were smoothed using a standard 8mm FWHM Gaussian kernel. 
 
5.1.2.1.2. Cortical thickness 
A voxel-based Laplacian method (Jones et al., 2000), implemented as an SPM toolbox (Hutton 
et al., 2008, 2009), was used to create a voxel-based cortical thickness (VBCT) map for each 
subject using the GM, WM and CSF partitions generated in the segmentation step. Briefly, the 
resulting VBCT maps contained cortical thickness values within voxels identified as grey matter 
and zeros outside the cortex. Each VBCT map was warped into the corresponding site-specific 
DARTEL reference space. The warped images were then normalized to MNI space and smoothed 
with a 6 mm Gaussian kernel. The same warps, modulation and smoothing were also applied to 
a binary mask created from each original VBCT map. Subsequently the warped, scaled and 
smoothed VBCT maps were divided by the corresponding warped, scaled, and smoothed mask.   
 
5.1.2.2. Surface-based volume and cortical thickness 
FreeSurfer 5.3 (http://surfer.nmr.mgh.harvard.edu) (Fischl, 2012) was used to parcellate each 
participant’s raw brain image into subcortical and cortical regions according to the Desikan-
Killiany atlas (Desikan et al., 2006) using the ‘recon-all’ command. FreeSurfer is a well-
established automated procedure for imaging preprocessing and analysis which details have 
been extensively described elsewhere (Dale, Fischl, & Sereno, 1999a; Fischl et al., 2002, 2004). 
A total of 169 features were used, including 33 volumes of subcortical structures plus volume and 
thickness of 34 cortical regions per hemisphere (after removing white matter hypo-intensities, 5th 





5.1.3. sStatistical analysis 
5.1.3.1. Group-level analysis 
5.1.3.1.1. Grey matter volume and cortical thickness 
Voxel-based morphometry (VBM) was used to calculate group-level differences in VWGMV and 
VWCT between FEP and HC groups at each site. An independent-sample t-test was used with 
statistical inferences made at p<0.05 after family-wise error (FWE) correction for multiple 
comparisons and a minimum extent threshold of 5 voxels.  
 
5.1.3.1.2 Surface-based regional volumes and cortical thickness 
Mean difference between the FEP and HC groups for each SB-ROI was analysed with an 
independent-sample t-test as implemented in SPSS 24.0 using a statistical threshold of p<0.05 
and additional Bonferroni correction for multiple comparisons.  
 
All reported results (sResults, section 5.2) were obtained without covariates of no interest to 
ensure consistency between group- and individual-level statistical analyses. However, statistical 
analyses with age and sex as covariates were also carried out for completeness; this yielded 
identical results except for surface-based regional volumes and cortical thickness data (sTable 
5.7-5.9). 
 
5.1.3.2. Multivariate pattern recognition analysis 
5.1.3.2.1. Dimensionality reduction: principal component analysis 
Principal component analysis (PCA) is a well-established unsupervised method for feature 
reduction in neuroimaging. PCA reduces dimensionality by geometrically projecting the data into 
lower dimensions called principal components (PCs), with the aim of finding the best summary of 
the data using a limited number of PCs. PCA uses an orthogonal transformation to convert a set 
of observations of possibly correlated features into a set of values of uncorrelated features (PC). 
PCs are then ranked according to explained variance in descending order. A detailed description 
of PCA is given elsewhere (Jolliffe, 2002; Lever et al., 2017). In the present investigation, PCA 
was mainly used to allow the processing of VWGMV and VWCT data with the general purpose 




to compute without first reducing the dimensionality of the data. As regularized methods, LR and 
SVM would not require this step. However, PCA was also used in combination with these methods 
to facilitate comparison between all approaches as well as to alleviate computational 
requirements. PCA was implemented within the CV framework; at each fold, dimensionality was 
reduced by 1) extracting the minimum number of principal components whilst retaining cumulative 
90% of the variance from the data in the training set only, 2) projecting all grey matter/cortical 
thickness maps onto the resulting principal components and 3) using the resulting values for 
classification and 4) projecting the test data into the same components derived from the training 
set, and using the former for testing. PCA was implemented using the default parameters of the 
class PCA from the decomposition module of the sklearn library (v0.20) (Pedregosa et al., 2011). 
 
5.1.3.2.2. Feature scaling: Standardization 
Standardization was performed by removing the mean and scaling to unit variance using 
StandardScaler from the preprocessing module of the sklearn library (v0.20) (Pedregosa et al., 
2011). This procedure was applied to each feature independently. Standardization is a common 
requirement for many machine learning methods, since algorithms might behave poorly if the 
individual features do not resemble normally distributed data. In addition, features with bigger 
scales might dominate the loss function of the training algorithms. To avoid “double dipping”, the 
statistics (mean and variance) were obtained using only the training set, and these same values 
were used in the standardization of test set.  
 
5.1.3.2.3. Most contributing brain regions of the DNN models 
The most contributing were identified with the function SmoothGrad (Smilkov, Thorat, Kim, 
Viégas, & Wattenberg, 2017) as implemented by the iNNvestigate library (Alber et al., 2018). 
Briefly, SmoothGrad works by first adding Gaussian noise to several copies of the input data. 
Each copy is then put through the trained model and a saliency map is generated from the 
network’s gradients. This results in several saliency maps that are then average to estimate a 
final smoothed saliency map. Smoothgrad takes two parameters: noise level or standard 
deviation of the Gaussian perturbations, and n, the number of samples to average over. Here we 




5.1.3.2.4. Significance testing 
The balanced accuracy of each classifier was tested for significance using permutation testing, 
whereby subjects were randomly assigned to one of the classes (patients/control), so that the 
labels no longer match the data in any meaningful way, and the 10-fold CV cycle repeated 1000 
times. This resulted in a distribution of accuracies reflecting the null hypothesis that the classifier 
did not exceed chance. The number of times the classifier’s performance was greater than or 
equal to the true accuracy was divided by 1000 to determine a p-value. A p-value lower than 0.05 
was considered statically significant.  
 
5.2. sResults 
No significant VWGMV decreases in FEP relative HC were found at any site. In contrast, VWGMV 
increases were detected in the bilateral thalamus at site 3; in the left putamen and the right 
pallidum at site 4; and in the right putamen at site 5. No significant increased or decreased VWCT 
was observed in FEP compared to HC at any site, except for site 1 in which FEP showed 
increased thickness in the left fusiform gyrus and left superior frontal gyrus. Significant differences 
in SB-ROIs between FEP and HC were found for sites 3 and 4. At site 3, patients showed smaller 
right hippocampus volume as well as a reduced thickness of the inferior parietal lobe; whereas at 
site 4 patients showed a significant cortical thinning in the left inferior temporal gyrus, pars 
opercularis and rostral middle frontal gyrus, as well as a larger 3rd ventricle. These results are 














sTable 5.2. Group-level analysis: GWGMV.  
Region 
Peak MNI Coordinates 
(x,y,z) 
Cluster size 
(No. of Voxels) 
z p 
FEP > HC     
Site 3     
      Left thalamus -16,-28,12 37 5.5 .006 
      Right thalamus 16,-24,14 17 4.7 .014 
Site 4     
      Left putamen -30,-12,-4 118 5.3 .001 
      Right pallidum 20,-10,-4 17 4.6 .014 
Site 5     









































sFigure 5.2. Cortical region with increased VWCT in FEP relative to controls in site 1. 
 
 
sTable 5.4. Group-level analysis: SB-ROIs.  
Region t p 
FEP < HC   
Site 3   
      Right hippocampus 4.3 <.001 
      Left inferior parietal (thickness) 3.9 <.001 
Site 4   
      Left inferior temporal gyrus (thickness) 3.6 <.001 
      Left pars opercularis (thickness) 4.0 <.001 
      Left rostral middle frontal gyrus (thickness) 4.8 <.001 
FEP > HC   
Site 4   
      Third ventricle -4.1 <.001 
 
Region 
Peak MNI Coordinates 
(x,y,z) 
Cluster size 
(No. of Voxels) 
z p 
FEP > HC     
Site 1     
      Left fusiform gyrus -30,-10,-36 11 4.7 .012 































Peak MNI Coordinates 
(x,y,z) 
Cluster size 
(No. of Voxels) 
z p 
FEP > HC     
Site 3     
      Left thalamus -16,-28,12 40 5.6 .006 
      Right thalamus 16,-24,14 19 4.8 .014 
Site 4     
      Left putamen -30,-14,-2 110 5.1 .001 
      Right pallidum 28,-10,-4 17 4.6 .014 
Site 5     






(No. of Voxels) 
z p 
FEP > HC     
Site 1     
      Left fusiform gyrus -30,-10,-36 16 5.0 .008 




sTable 5.7. Group-level analysis controlling for age and sex: SB-ROIs. 
Region F p 
FEP < HC   
Site 3   
      Right hippocampus 22.4 <.001 
      Left inferior parietal gyrus (thickness) 20.7 <.001 
      Left precuneos (thickness) 15.3 <.001 
      Left superior frontal gyrus (thickness) 12.8 <.001 
      Left supramarginal gyrus (thickness)  17.2 <.001 
Site 4   
      Left parsopercularis (thickness) 15.6 <.001 
      Left rostral middle frontal gyrus (thickness) 21.9 <.001 
Site 5   
     Left hippocampus 15.7 <.001 
FEP > HC   
Site 3   
      Left lateral ventricle 14.8 <.001 
Site 4   


















sFigure 5.3. Balanced accuracies and standard deviations of the different algorithms and feature sets for 
each site. KNN: k-nearest neighbours; LR: logistic regression; SVM: support vector machines; DNN: deep 
neural network; SB-ROIS: surfaced-based regional volumes and cortical thickness; VBM: voxel-based 








sTable 5.8. Statistical significance for all classifiers. 
KNN: k-nearest neighbours; LR: logistic regression; SVM: support vector machines; DNN: deep neural 
network; SB-ROIS: surfaced-based regional volumes and cortical thickness; VBM: voxel-based 
morphometry; VBCT: voxel-based cortical thickness.




KNN .003 .001 .002 
LR .003 .003 .001 
SVM .003 .004 .013 




KNN .083 .891 .200 
LR .381 .346 .009 
SVM .757 .207 .450 




KNN .004 .444 .011 
LR .021 .002 .013 
SVM .005 .001 .036 




KNN .041 .003 .028 
LR .129 .012 .001 
SVM .081 .032 .030 




KNN .237 .163 .262 
LR .033 .003 .007 
SVM .007 .004 .408 
DNN .108 .010 .008 
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sTable 5.9. Odds ratio, confidence interval and p-value for the effects of anti-psychotic medication and psychotic symptoms 
on predicted labels. 
 
























































































































































































































































































































































































5.3.1. Association between sample size and classification accuracy 
Accuracy and sample sizes from existing studies using machine learning and sMRI were 
extracted as follows:  
- up until and including 2013, this information was taken from the latest meta-analysis Kambeitz 
et al (Kambeitz et al., 2015); 
- from 2014 to 2016 this information was taken from the review Arbabshirani et al (2017); 
- seven further subsequent studies were identified: Pinaya et al (2016); Salvador et al (2017); 
Winterburn et al (2017); Xiao et al (2017); Rozycki et al (2018); Dluhoš et al (2017) and de Moura 
et al (2018). Xiao et al (2017) was excluded as it was a clear outlier (see Figure 5.3A). 
 
Pearson’s correlation was used to test for the association between all sample sizes and 
accuracies. The same studies were used for Figure 5.3A. 
 
5.3.2. Publication bias 
Sample size, true positives, false positives, true negatives and false negative scores from each 
study were extracted from Kambeitz et al (2015). In addition, the main result from the meta-
analyses of machine learning-sMRI studies in psychosis (established schizophrenia and FEP 
combined) was also extracted from the same study. Publication bias was assessed using the 
same procure as in Kambeitz et al (2015) which in turn was based on recommendations for 
diagnostic classification studies described in Deeks et al (2005). Briefly, a measure of sample size 
and effect size were calculated as follows: 
 
- Effective sample size (ESS) was calculated from the patients and control groups sample size 
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The resulting funnel plot was tested for asymmetry through a regression analysis weighted by 









Using deep learning and 









Despite the impressive advances in the understanding of the neurobiological basis of psychiatric 
disorders in the last decades, there are growing concerns about the reliability and reproducibility 
of most findings (Anonymus, 2013). Perhaps the most noteworthy source of concern is the high 
risk of false positives (Button et al., 2013) and heterogeneous findings (IntHout et al., 2015) 
associated with the small studies that dominate most of the neuroscientific literature. The pressing 
need for larger samples has led to exceptional efforts (Landhuis, 2017; Poldrack & Gorgolewski, 
2014; Smith & Nichols, 2018; Van Horn & Toga, 2014) such as large consortia, including the 
Human Connectome Project (HCP) (Van Essen et al., 2013), ENIGMA (Bearden & Thompson, 
2017), ADNI (Mueller et al., 2005b) and UK Biobank (Sudlow et al., 2015), as well as several 
neuroimaging data sharing initiatives (Eickhoff et al., 2016; Ferguson et al., 2014; Woo et al., 
2017). In psychosis for example, the ENIGMA consortium has led to unprecedented sample sizes 
in ChSz research, with two recent studies of neuroanatomical abnormalities in a total sample of 
9572 (van Erp et al., 2018) and 4568 (van Erp et al., 2016) participants. In the first effort to 
combine several publicly available datasets of ChSz, Gupta et al. (C. N. Gupta et al., 2015) 
analysed 784 patients and 936 healthy controls collected from 23 sites. More recently, Rozycki 
(2018) analysed data from 5 sites totalling 448 healthy controls and 387 ChSz patients. 
 
While such movement is paving the way for more reliable and reproducible findings, there is also 
a growing demand for clinically translatable research (Borgwardt & Fusar-Poli, 2012). Machine 
learning is an area of artificial intelligence that promises to meet this demand by being able to 
learn meaningful patterns from the data and using this information to make predictions about 
unseen individuals (Hastie, 2009). The promise of this new approach has led to a surge of studies 
in the last decade across the field of psychiatric neuroimaging, most of which based on 
neuroanatomical data (Arbabshirani et al., 2017; Wolfers et al., 2015; Woo et al., 2017), including 
in psychosis (Kambeitz et al., 2015; Orrù et al., 2012; Zarogianni et al., 2013). Nevertheless, the 
overwhelming majority of studies so far have been conducted in small local samples (Kambeitz 
et al., 2017, 2015), which have been shown to yield unreliable results (Nieuwenhuis et al., 2012; 
Schnack & Kahn, 2016; Varoquaux, 2017). By capitalizing on the growing number of 
neuroimaging consortia and data-sharing initiatives, machine learning mega-studies are now 
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starting to emerge in the hope of finding more robust and generalizable multivariate biomarkers 
that can be used for predictions at the level of the individual (e.g. Nunes et al., 2018; Wegmayr, 
Aitharaju, & Buhmann, 2018; Zhang-James et al., 2019). In most studies, machine learning 
models are trained and tested by either i) pooling all data together and using a standard CV (e.g. 
10-fold CV) – pooled validation; or ii) training the model in all sites but one which is used for 
testing, until all sites have been used for testing (i.e. leave-one-site-out CV) – cross-site validation. 
In psychosis, Rozycki et al. (2018) used neuroanatomical data collected from 440 patients 
diagnosed with ChSz and 501 controls to successfully distinguish the two groups with a promising 
accuracy of 76% for the pooled data and 75% for the cross-site validation. More recently, Schwarz 
et al. (2019), was able to discriminate ChSz and controls with an AUC-ROC (area under the 
receiver operating characteristic curve) of 74% and 71% for the pooled and cross-site validation, 
respectively, using structural data of 375 patients and 1729 controls. However, given the well-
established effects of illness chronicity and antipsychotic medication on brain structure (Bora et 
al., 2011; Antonio Vita et al., 2015) it is unclear to what extent classification was based on 
neuroanatomical changes associated with these factors rather than the onset of the illness per 
se. De Pierrefeu (2018) addressed the issue of chronicity by classifying a smaller sample of 276 
ChSz and 330 controls with an accuracy of 72% for the cross-site validation. The same models 
were subsequently validated in an independent sample of 43 FEP and 90 controls with accuracies 
of 73%, suggesting some overlap between the features that distinguish ChSz and FEP from 
controls. To date however, there have been no large-scale machine learning studies trained in a 
large sample of FEP individuals, which would be more likely to unveil more specific patterns 
characteristic of the early stages of psychosis. 
 
Although traditional machine learning approaches, such as support vector machine and logistic 
regression-based models used the studies above, remain popular techniques, an alternative 
family of methods known as deep learning is gaining considerable attention in the wider research 
community (Gulshan et al., 2016). Deep learning is a family of representation-learning methods 
capable of detecting multiple levels of latent representations from the data (LeCun et al., 2015). 
This is achieved by combining consecutive layers of simple nonlinear transformations that allow 
the extraction of increasingly abstract features, which may be particularly suitable to model the 
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subtle, widespread and heterogenous neuroanatomical abnormalities characteristic of the early 
stages of psychosis (Plis et al., 2014; Schnack, 2017). Preliminary evidence across several 
psychiatric and neurologic disorders has shown promising results (Durstewitz et al., 2019; Vieira 
et al., 2017). The aim of this study was to apply a deep learning model to neuroanatomical data 
to identify individuals at the early stages of psychosis, where the effect to confounding variables 
is minimal, from controls in a large sample of 958 participants. It is hypothesised that: i) the deep 
learning model will outperform traditional classifiers and ii) classification will be mostly driven by 




In this study, all data described in Chapter 2 was combined to create a large multi-centre dataset. 
The recruitment criteria for each site are reported in section 2.1.2 in Chapter 2. Briefly, patients 
experiencing their first psychotic episode as defined by either the DSM (APA, 2000) or ICD-10 
(Organization World Health, 1992) and controls from the same geographical area were recruited 
as part of five independent studies carried out in four sites: China (Gong et al., 2015), England 
(Di Forti et al., 2009), Spain (Pelayo-Terán et al., 2008) and The Netherlands (Korver et al., 2012). 
At each site, data was match between FEP and HC with respect to sex and age (+/- 5years) to 
mitigate unwanted effects from these demographic variables (for more details see section 5.1.1.2 
in the supplementary materials in Chapter 5). The final demographic and clinical characteristics 
for each site and combined data are reported in Table 6.2.  
 
6.2.2. Magnetic resonance imaging 
6.2.2.1. Acquisition 
At all five sites, structural magnetic resonance imaging (sMRI) data was acquired using a T1- 
weighted protocol with a SPGR sequence. The details of the image acquisition sequence varied 
between scanners, as reported in Chapter 2, section 2.3.2. 
 
6.2.2.2. MRI preprocessing 
The T1-weighted images were preprocessed using the FreeSurfer image analysis package 
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(version 5.3.0, http://surfer.nmr.mgh.harvard.edu/) (Fischl, 2012). FreeSurfer is a widely used fully 
automated suite of tools capable of estimating a wide range of surface-base morphometric 
measures including the volume of subcortical structures as well as several cortical metrics such 
as cortical thickness and volume. In this study, the volume of 33 subcortical brain regions as well 
as the volume and thickness of 68 cortical regions, as defined by the Desikan-Killiany atlas 
(Desikan et al., 2006), were extracted using the ‘recon-all’ command. For a complete list of the 
brain regions included, please refer to Table 2.1 in Chapter 2. The details of the subcortical and 
cortical preprocessing stages are described in section 2.2.3.2 in Chapter 2. Briefly, each image 
was corrected for intensity normalization, followed by the removal of non-brain tissue, 
segmentation of the subcortical WM and deep GM volumetric structures, tessellation of GM and 
WM boundaries, automated topology correction, surface deformation, registration to a spherical 
atlas and parcellation based on a spherical in-built atlas to extract morphometric measurements 
for specific cortical regions (Dale et al., 1999; Fischl et al., 1999).  
 
6.2.3. Deep neural network 
6.2.3.1. Model specification 
Deep neural networks (DNNs) are a deep learning general-purpose network characterized by its 
distinctive multi-layered and fully-connected architecture. Its layer-wise structure allows for 
successive nonlinear transformations of the input data, such that the network learns increasingly 
abstract features. These are then used to perform a task, for example distinguish between two 
groups (Bengio et al., 2015). For a detailed description of the structure and training procedure 
involved in DNNs see section 2.3.2.4.2 in Chapter 2. 
 
In this study, the volumes of 33 subcortical brain regions as well as the thicknesses and volumes 
of 34 cortical regions form each hemisphere were concatenated to form a 1-dimensional (1D) 











Figure 6.1. DNN structure. The volumes and thicknesses of subcortical and cortical brain regions were 
concatenated into a 1D vector and used as input features for a DNN.  
 
The weights of the DNN were initialized via Glorot (also known as Xavier) initialization (normal 
distribution) (Glorot & Bengio, 2010) and subsequently adjusted using backpropagation and a 
gradient descent-based optimizer with a mini-batch size of 128 training examples. ReLu was 
chosen as the activation function at each neuron and in the output layer, a softmax function was 
used to perform the binary classification (FEP or HC). As in Chapter 5, the optimal number of 
layers, number of neurons in each layer, optimizer, learning rate, learning rate decay, epoch, as 
well as L2 regularizer (Krogh & Hertz, 1992) and dropout (Srivastava et al., 2014) were 
determined using nested cross-validation (CV) (see section 2.4.2 in this Chapter).  
 
The motivation for the use of SB-ROIs in combination with DNNs was two-fold. First, the 
dimensionality of this type of data is considerably lower compared to the standard whole-brain 
voxel-level data, for example. In the context of deep learning, this has important implications in 
terms of overfitting and computational resources. As a nonlinear complex approach, i.e. with many 
parameters to estimate, deep learning is particularly prone to overfitting compared to traditional 
machine learning methods. Therefore, a reduced number of input features will decrease the 
likelihood of overfitting by reducing model complexity as well as alleviate computational 
requirements. Although the dimensionality of voxel-level data could have been addressed with 
the use of more sophisticated models such as autoencoders, CNNs or a combination of the two, 
this would become prohibitively expensive for amount of data to be analysed and the 




33 subcortical volumes 
68 cortical volumes 





allowed for the automatic, as opposed to manual, tuning of hyperparameters, therefore reducing 
the risk of overfitting. Second, the results from the site-level analysis in Chapter 5 showed a 
superior, albeit modest, performance of SB-ROIs over the other types of features included in this 
work, namely VWGMB and VWCT. 
 
6.2.3.2. Model training 
The DNN was trained using two validation schemes: stratified 10-fold CV (pooled validation) and 
leave-one-site-out (LOSO) CV (cross-site validation). Both validation types included a stratified 
nested CV for hyperparameter tuning to minimize bias during model selection, consistent with 
recommended practice (Varma & Simon, 2006). For the pooled validation, this first involved 
partitioning the total data into 10 parts with the same proportion of HC and FEP. Nine parts were 
combined to create a training set and the remaining was used as the test set; this split training/test 
defines the first iteration of the outer CV. For the cross-site validation, four sites are used for 
training, and one site is used for testing. For the remaining process, the procedure is the same 
for both validation types. The training set is further divided into 10 parts, with the same proportion 
of HC and FEP. Nine parts are combined to create a new training set, and the part left-out was 
used as the validation set. With these sets defined, a random selection of hypermeters from an a 
priori defined search space (Table 6.1) is chosen to build a DNN with, for example, number of 
layers=3, number of neurons in each layer=50,  learning rate=0.01, learning rate decay=10-4, 
epochs=100, optimizer=SGD, momentum=0.9, L2 norm=10-3 and dropout rate=0.5. This DNN is 
then trained on the new training set and its balanced accuracy is estimated in the validation set. 
This process was repeated 10 times using the same combination of hyperparameters, each time 
with one of the 10 possible validation sets. The cross-validated mean balanced accuracy for that 
particular combination of hyperparameters was then estimated. This entire process was repeated 
500 times, each time with a different random combination of parameters (different number of 
layers, number of neurons, different activation function, etc). This resulted in a total of 500 cross-
validated mean balanced accuracies. The combination of hyperparameters that yielded the best 
performance was then used to train a DNN again in the whole training data set as defined by the 
outer CV and test it in the test set. This process is done iteratively 10 and 5 times for the pooled 
and cross-site validations, respectively, each time with a different training and test sets as defined 
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by the outer CV. The final balanced accuracies are averaged to estimate the model’s final 
performance. 









6.2.4. Traditional machine learning algorithms 
Logistic regression and support vector machine, two popular and well-established machine 
learning techniques in psychiatric neuroimaging, were also used for comparison.  
 
6.2.4.1. Logistic regression 
A logistic regression (LR) is a simple yet powerful supervised algorithm that aims to find the 
optimal linear combination of the input features and outputs the probability of the input data 
belonging to a default class (e.g. HC), which can then be converted to a binary prediction. In this 
study, LR was implemented via elastic net, a regularized regression that combines the 
regularizations L1 norm and L2 norm. The former retains all variables and minimizes the impact 
of irrelevant features, therefore reducing the model’s dependency on a specific group of features 
from the training set. The latter on the other hand, discards unimportant variables reducing the 
overall model complexity (H. Zou & Hastie, 2005). The optimal relative contribution of each 
penalty was determined by tuning the ratio between the two via grid search. The value for this 
ratio was chosen from eleven possible values between 0 and 1 with increments of 0.1 via nested 
stratified 10-fold CV, where lower values indicate a larger contribution from L2 relative to L1 while 
values closer to 1 indicate the opposite. 
 
Parameter Values 
Number of layers 2, 3, 4, 5 
Number of units 10, 20, 50, 75, 100, 150 
Learning rate 0.001, 0.005, 0.01, 0.1, 0.2 
Learning rate decay 10-6, 10-5, 10-4, 10-3 
Epochs 50, 100, 150 
Optimizer Stochastic gradient descent (SGD), Adam 
Momentum 0.99, 0.9, 0.95 
L2 norm  10-5, 10-4, 10-3, 10-2 
Dropout rate 0.2, 0.5, 0.7 
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6.2.4.2. Support vector machine 
Support vector machine (SVM) is a popular supervised machine learning technique that aims to 
classify data points by maximising the margin between classes in a high-dimensional space 
(Pereira et al., 2009; Vapnik, 1995). This is achieved by projecting the data into a feature space 
using a similarity function, known as a kernel. Here, the algorithm is trained to find the optimal 
separating hyperplane by maximising the margin between the examples lying closest to the 
separating plane (and hence the most difficult to classify), known as the support vectors. This 
particular hyperplane is learned from the training data and subsequently used as a decision 
boundary where observations in the test set falling on either side of the hyperplane are assigned 
to either class (Noble, 2006). In this study, a linear kernel was chosen to contrast with the 
characteristic nonlinear approach of deep learning. The soft margin (C) parameter, that controls 
the trade-off between having zero training errors and allowing misclassifications, was tuned from 
a possible range of values (2-5, 2-3, ..., 213, 215) using grid search via nested stratified 10-fold CV. 
 
6.2.5. Model performance 
The final performance for each classifier was assessed by estimating the average balanced 
accuracy, sensitivity and specificity across the 10 and 5 iterations of the pooled and cross-site 
CVs, respectively. The balanced accuracy of each classifier was tested for significance using 
permutation testing. This consisted of randomly assigning participants to one of the classes 
(FEP/HC) and run the same pooled/cross-site CV model. This procedure was repeated 1000 
times. This resulted in a distribution of accuracies reflecting the null hypothesis that the classifier 
did not exceed chance. The number of times the classifier’s performance was greater than or 
equal to the true accuracy was divided by 1000 to determine a p-value. A p-value lower than 0.05 
was considered statically significant. 
 
6.2.6. Effect of scanner 
The effect of scanner on each individual feature was mitigated using a linear regression model as 
implemented by the OLS function from the statsmodels library (version 0.10.1) for Python 
(Seabold & Perktold, 2010). Five hot-one-encoded variables, one coding each site, were entered 
as the independent variables in a series of linear regression models, each one predicting one of 
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the input features. The resulting residuals for each feature were standardized by removing the 
mean and scaling to unit variance using the StandardScaler from the preprocessing module of 
the sklearn library (v0.20) (Pedregosa et al., 2011). The standardized residuals subsequently 
used as input features for each one of the classifiers. Importantly, this procedure was 
implemented within the CV framework to avoid knowledge-leakage between training and test sets. 
In practice, this involved fitting each linear regression to the training data and use the resulting 
regression parameters to estimate the residuals in the training and test sets. Likewise, 
standardization consisted in estimating the mean and standard-deviation for each feature in the 
training set and used to standardize the training and test sets. 
 
6.2.7. Most contributing brain regions 
The most contributing features to discriminate between FEP and HC for the two DNN models – 
pooled and cross-site validation – were identified with the function SmoothGrad (Smilkov, Thorat, 
Kim, Viégas, & Wattenberg, 2017) as implemented by the iNNvestigate library (Alber et al., 2018). 
Briefly, SmoothGrad works by first adding Gaussian noise to several copies of the input data. 
Each copy is then put through the trained model and a saliency map is generated from the 
network’s gradients. This results in several saliency maps that are then average to estimate a 
final smoothed saliency map. Smoothgrad takes two parameters: noise level or standard deviation 
of the Gaussian perturbations, and n, the number of samples to average over. Here we use the 
default parameters, standard deviation of 0.1, and 64 copies of in the input. The ranked lists of 
features from each CV modality were compared using Kendall’s Tau-b, a rank correlation 
coefficient that measures the degree of similarity between two rankings.  
 
6.2.8. Experiments 
All experiments were done in Python (version 3.6). DNNs were implemented with Tensorflow v.1.4 
(Abadi, Agarwal, et al., 2016) and Keras v.2.1 (https://keras.io/) libraries. Both LR and SVM were 
implemented using the Scikit‐learn library (version 0.19.2; Pedregosa et al., 2011). The same 
random seed was used across all classifiers to ensure the starting weights and the split of 




6.3.1. Demographic and clinical characteristics 
No statistically significant differences were identified between patients and controls for age, sex 
at each site and in the combined dataset (Table 6.2).  
 
6.3.2. Pooled validation 
In the pooled validation analysis, the DNN model was able to classify patients and controls with 
65.4% balanced accuracy, 63.3% sensitivity and 67.5% specificity. Although a modest 
performance, it was able to distinguish the two groups with a higher performance compared to 
LR and SVM with a balanced accuracy of 58.1% and 61.6%, respectively (Table 6.3). 
 




   
            LR: logistic regression; SVM: support vector machine; DNN: deep neural network; ***p<.001 
 
6.3.3. Cross-site validation 
The classification accuracy when all but one of the sites were used for training yielded a balanced 
accuracy of 59.3% for the DNN and 56.8% and 58.0% for the LR and SVM models, respectively. 
 
         Table 6.4. Balanced accuracy, sensitivity and specificity for LOSO CV. 




LR:logistic regression; SVM: support vector machine; DNN: deep neural network; ***p<.001 
The optimized hyperparameters for all models is shown in sTables 6.1 and sTable 6.2 in the 
supplementary materials. 
 Balanced Accuracy Sensitivity Specificity 
LR 61.0±5.2*** 65.2±13.7 56.8±7.9 
SVM 61.6±4.1***  64.6±6.8 58.6±4.7 
DNN 65.4±3.9*** 63.3±7.1 67.5±5.3 
 Balanced Accuracy Sensitivity Specificity 
LR 56.8±2.4*** 60.4±18.5 53.3±18.8 
SVM 58.0±3.9*** 72.4±11.7 43.5±17.0 
DNN 59.3±3.1*** 63.5±8.6 55.1±6.1 
 
 173 
Table 6.2. Demographic and clinical characteristics for FEP and HC for each site and combined data. 
TIV: total intra-cranial volume; L: litres; M: male; F: female; FEP: first episode psychosis; HC: healthy controls. aPANSS: Positive and Negative Symptoms Scale; bSAPS: 








Santander A, Spain 
(N=220) 
  









  HC FEP HC FEP HC FEP HC FEP HC FEP HC FEP 
N 112 112 71 71 110 110 70 140 81 81 444 514 
Sex (%) 
M  51 (46) 51 (46) 36 (51) 36 (51) 68 (62) 68 (62) 45 (64) 90 (64) 64 (79) 64 (79) 264 (59) 309 (60) 
F 61 (54) 61 (54) 35 (49) 35 (49) 42 (38) 42 (38) 25 (46) 50 (46) 17 (21) 17 (21) 180 (41) 205 (40) 
 χ2=ns χ2=ns χ2=ns χ2=ns χ2=ns χ2=ns 
Age M(SD) 
27.2 (7.3) 25.7 (8.1) 26.8 (7.1) 26.4 (6.2) 29.7 (7.8) 28.5 (8.6) 27.3 (7.5) 28.3 (7.6) 26.9 (8.0) 25.2 (5.9) 27.6 (7.5) 26.8 (7.3) 
t=ns t=ns t=ns t=ns t=ns t=ns 
TIV (L) M(SD) 
1.5 (0.1) 1.5 (0.2) 1.5 (0.2) 1.5 (0.2) 1.5 (0.1) 1.4 (0.2) 1.5 (0.1) 1.5 (0.1) 1.6 (0.1) 1.5 (0.2) 
- 
- 
t=ns t=ns t=ns t=ns t=ns  
Positive symptoms 
M(SD) 
- 24.6 (6.6)a - 13.9 (5.5)a - 14.7 (4.6)b - 14.4 (4.1)b - 15.9 (6.3)a - - 
Negative 
symptoms M(SD) 
- 18.2 (7.7)a - 16.0 (6.0)a - 6.3 (4.6)c - 6.1 (5.0)d - 16.2 (6.9)a - - 
Duration of illness 
(years) Med (IQR) 
- 0.3 (1.1) - 1.1 (0.3) - 0.3 (0.7) - 0.3 (0.9) - 0.6 (1.0) - - 
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6.3.4. Most contributing features 
The top features driving the predictions of the DNN in the pooled and cross-site validation are 
displayed in Figure 6.2. For a complete list of regions and their respective weights and rankings, 









Figure 6.2. Top 15 regions with the highest weights. L: left, R: right. 
 
It can be seen that the right inferior lateral ventricle, third ventricle, right hippocampus and left 
pallidum were the four brain regions with the largest weights in both validation schemes. Other 
common regions, albeit some in different hemispheres, included the putamen, insula and 
entorhinal cortex as well as the lingual, inferior parietal, lateral and medial orbitofrontal gyri. The 
correlation between the rankings of the regions from each validation schemes was moderate 
when all regions were considered (rt=.31, p<.001) and high for top five brain regions (rt=.73, 
p<.05). The coefficients for the LR and SVM as well as their respective overall weight-based 




The increasing efforts to overcome the limitations of small samples combined with the demands 







L rostralanterior cingulate thickness
R putamen
R lingual thickness






















R inferior lateral ventricle
A. Cross-site validation B. Pooled validation 
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findings towards large-scale machine learning studies in order to find reliable multivariate markers 
that can be used in clinical practice. The aim of this study was to use a promising machine learning 
method, known as deep learning, to discriminate individuals with a recent first psychotic episode 
from controls at the individual level, based on a large sample of neuroanatomical data. 
 
Overall, the accuracies obtained from the pooled data were much lower than the ones reported 
by most single-site studies (Kambeitz et al., 2015). At least two reasons may explain this 
discrepancy. First, smaller studies tend to yield unstable performances (Nieuwenhuis et al., 2012; 
Varoquaux, 2017) which, in combination with less-than-rigours methods (Arbabshirani et al., 
2017; Wolfers et al., 2015) and publication bias speculated elsewhere (Schnack & Kahn, 2016) 
and shown in Chapter 5, may have contributed to the over-representation of inflated results from 
small local single-site studies. Second, finding a pattern of shared abnormalities in patients 
relative to controls is likely to be easier in smaller homogeneous samples recruited with stringent 
inclusion criteria compared larger studies with loosen criteria that result in more heterogenous 
samples. In a multi-site study made up of several relatively large single-site samples such as the 
present study, this is further exacerbated by the use of different diagnostic criteria, inclusion 
criteria, assessment protocols, including different scanners and acquisition parameters across the 
different sites (Schnack, 2017). This results in a trade-off between homogeneous small-sample 
and heterogeneous large-sample studies: while the former tends to perform well at the cost of 
lower generalizability, the latter are more likely to yield lower accuracies but with better 
generalizability since it is expected that whatever the pattern identified, it will be more 
representative of the alterations in that diagnostic group (Schnack & Kahn, 2016). Building 
predictive models that yield potentially high accuracies at the expense of generalizability has, of 
course, limited translational potential. Therefore, despite less encouraging, the findings from this 
study are likely to be more reliable than those reported in initial small studies. This inversed 
relationship between performance and sample size was initially observed when single-site 
samples increased from a few dozen to a few hundred (Schnack & Kahn, 2016; Wolfers et al., 
2015). During the last two years, as samples continue to increase even further to several hundred 
or even a few thousand participants, this trend is becoming more apparent, possibly due to the 
added heterogeneity from combining several independent datasets. For example, Nunes et al. 
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(2018) reported a classification accuracy of 65.2% in a sample of 853 individuals diagnosed with 
bipolar disorder and 2167 controls, while some of the single-site accuracies from sites included 
in the same study were as high as 81.1%. Faraone et al. (2019) were able to distinguish 1393 
patients with attention-deficit/hyperactivity disorder from 1320 controls with an  AUC-ROC of 67%, 
although findings at the single-site level tend to be much higher (Wolfers et al., 2015). The same 
trend is observed in ChSz. Rozycki (2018) and Schwarz (Schwarz et al., 2019) reported an 
accuracy and AUC-ROC of 76% and 74% in a sample of 941 and 2014 participants, respectively, 
which, although encouraging for such large samples, are lower than many smaller studies 
(Kambeitz et al., 2015; Wolfers et al., 2015; Zarogianni et al., 2013).    
 
As hypothesised, the DNN was able to discriminate the two groups with better performance than 
the traditional approaches, suggesting that modelling complex nonlinear relationships between 
brain regions may be useful to identify the neuroanatomical abnormalities in the early stages of 
psychosis. This is consistent with the initial evidence shown in Chapter 4, that deep learning tends 
to perform similar or better than traditional machine learning. Nevertheless, when the DNN was 
trained in a group of sites and tested in an independent site (cross-site validation), performance 
dropped to 59.3%; a similar accuracy compared to that of the traditional approaches. The drop in 
performance from the pooled to the cross-site validation is not surprising, as the latter is a more 
demanding test of generalizability (Woo et al., 2017). Similar lower cross-site accuracies were 
also found by Nunes (2018) with 58.7% in bipolar disorder and in FEP with 62.0% in a study with 
480 participants (Dluhoš et al., 2017). Nevertheless, compared to the traditional approaches, the 
DNN suffered a larger decrease in accuracy. Therefore, the possibility that the superior 
performance in the pooled data may have steamed from overfitting cannot be ruled out, despite 
the use of a large sample, relatively low dimensional data and regularization strategies. Based on 
the above and in the absence of other similarly large studies, we speculate that a reliable 
classification accuracy of FEP based on sMRI data may be around 60%. The performance of 
recent large-scale studies in ChSz seem to be converging around 70% (de Pierrefeu et al., 2018; 
Rozycki et al., 2018; Schwarz et al., 2019), as predicted in a ´accuracy-sample size’ model based 
on ChSz and FEP (albeit in much smaller number) sMRI studies published up until 2016 (Schnack 
& Kahn, 2016). However, identifying FEP is more challenging than ChSz due to the more subtle 
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effects (Egerton et al., 2011) combined with the increased heterogeneity characteristic with the 
early stages of psychosis, and it is therefore reasonable to expect that large-scale FEP studies 
will converge at an performance lower than ChSz.  
 
The brain regions driving both the pooled and cross-site validation analysis were highly 
consistent, suggesting a reproducible signature of the main neuroanatomical abnormalities at the 
individual level. The main common regions comprised the third and inferior lateral ventricles, basal 
ganglia (putamen and pallidum), temporal regions such as the hippocampus, entorhinal cortex 
and lingual gyrus, as well as the inferior parietal gyrus, orbitofrontal regions and the insula. These 
regions have been repeatedly implicated at group-level in both established (C. N. Gupta et al., 
2015; van Erp et al., 2016, 2018) and first-episode (X. Gao et al., 2018; Shah et al., 2017) 
psychosis. Critically, similar patterns of anatomical changes have also been reported in large 
multivariate studies in ChSz (de Pierrefeu et al., 2018) and FEP (Dluhoš et al., 2017).  
 
6.5. Conclusion and future directions 
To our knowledge this is the largest machine learning study in the early stages of psychosis to 
date. Although less encouraging, the results presented in this study provide a step towards recent 
calls for a new generation of machine learning applications that favours reliable and generalizable 
findings from large-scale studies (Schnack & Kahn, 2016; Woo et al., 2017). Furthermore, we 
also found a reproducible signature of the main neuroanatomical abnormalities driving the 
distinction between FEP and controls, consistent with the literature. Future studies should include 
other diagnosis to assess the specificity of these models and their neuroanatomical signatures. 
For example, the putamen, identified here as an important region for classification, has been 
identified as a transdiagnostic marker for psychiatric illness (Gong et al., 2018). Importantly, future 
studies could also investigate whether a non-linear SVM would be able to match or outperform 
the DNN model, since it is possible that a simpler model than a DNN could reach the same or 
better result. Critically, results from this study support the premise that neuroanatomical data 
alone will not be able to identify FEP with the necessary performance for clinical translation. There 
is initial evidence showing the superiority of functional MRI over sMRI data in diagnostic 
classification in psychosis (Kambeitz et al., 2015). Future large-scale studies should address the 
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reliability of such findings, or better yet, combine both modalities to maximise performance using 
advance data fusion methods (Calhoun & Sui, 2016). In addition, future studies could also 
leverage on recent sophisticated approaches such as domain adaptation as a potential solution 
to mitigate inter-scanner differences for cross-site models. Put simply, domain adaptation 
techniques address the assumption of most machine learning applications that the training and 
future data must be in the same feature space and have the same distribution, by allowing models 
to ‘transfer knowledge’ from one domain (source domain) to another (target domain) (Pan & Yang, 
2010). This is a promising approach for neuroimaging as it would allow, for example, to train a 
model in one scanner and adapt it to another scanner; thus avoiding having to train a model from 
scratch for each scanner every time. Finally, while developing models to identify the first 
manifestation of a psychotic disorder is an important endeavour, the main challenge in clinical 
decision-making remains predicting conversion to illness, disease progression and treatment 
response. Therefore, similar mega-analytic efforts now emerging for diagnostic classification 




Chapter 6 supplementary materials 
 
sTable 6.1. Optimized hyperparameters for each fold of the two DNN models 
(10-fold CV and LOSO CV). Each cell contains the optimized number of 
layers, number of units, learning rate, learning rate decay, optimizer, 
momentum (if optimizer is SGD), L2 norm and dropout rate. 
 10-fold CV LOSO CV 
Fold 1 4, 150, .001, .01, SGD, .99, 0, .5  3, 50, .01, .01, SGD, .99, 10-5, .5 
Fold 2 4, 75, .005, .001, SGD, .9, 10-5, .5 3, 150, .005, .001, Adam, 10-5, .5 
Fold 3 3, 50, .001, .01, Adam, 0, .5 5, 100, .005, .01, Adam, 10-5, .2 
Fold 4 4, 75, .001, 10-5, SGD, .9, 10-4, 0.5 5, 100, .001, .001, Adam, 10-3, .5 
Fold 5 5, 100, .001, .001. Adam, 0, .5 5, 150, .001, 10-4, Adam, .01, .5 
Fold 6 4, 100, .001, 10-5, SGD, .9, 10-3, .5 - 
Fold 7 3, 75, .005, .01, Adam, 0, .7 - 
Fold 8 5, 100, .001, .001, Adam, 0, .5 - 
Fold 9 5, 150, .01, .01, SGD, .95, 10-3, .5 - 




sTable 6.2. Optimized hyperparameters for each fold of the two 
regularized logistic regression and SVM models (10-fold CV 
and LOSO CV). Each cell contains the optimized value for the 
L1/L2 ratio and C hyperparameters for the regularized logistic 
regression and SVM models, respectively. 
 10-fold CV LOSO CV 
 Regularized LR SVM Regularized LR SVM 
Fold 1 0.4 0.03125 0.1 0.03125 
Fold 2 0.8 0.5 1 0.03125 
Fold 3 0.4 2 0.2 0.5 
Fold 4 0.2 0.03125 0.5 2 
Fold 5 0.7 0.03125 0.1 0.5 
Fold 6 0.6 0.03125 - - 
Fold 7 0.5 0.5 - - 
Fold 8 0.2 0.03125 - - 
Fold 9 0.9 0.03125 - - 





sTable 6.3. Coefficients and ranking for each feature for the pooled and cross-
site validations. 
 
Cross-site validation Pooled validation 
 Coefficients Rank Coefficients Rank 
Right_Inf_Lat_Vent 0.50 1 0.37 1 
3rd_Ventricle 0.49 2 0.35 2 
Left_Pallidum 0.47 4 0.33 3 
Right_Hippocampus 0.48 3 0.31 4 
Right_Putamen 0.38 9 0.29 5 
rh_entorhinal_thickness 0.45 5 0.27 6 
Left_Putamen 0.35 12 0.26 7 
lh_lateraloccipital_thickness 0.10 118 0.25 8 
rh_lateralorbitofrontal_thickness 0.33 15 0.24 9 
Right_Accumbens_area 0.12 108 0.24 10 
lh_inferiorparietal_thickness 0.14 92 0.23 11 
lh_medialorbitofrontal_thickness 0.20 47 0.23 12 
lh_insula_thickness 0.30 20 0.23 13 
rh_inferiorparietal_thickness 0.43 6 0.23 14 
lh_lingual_thickness 0.22 41 0.23 15 
rh_rostralanteriorcingulate_volume 0.25 30 0.23 16 
lh_transversetemporal_thickness 0.27 25 0.22 17 
Right_Amygdala 0.24 31 0.22 18 
lh_temporalpole_volume 0.42 7 0.22 19 
rh_cuneus_thickness 0.18 56 0.22 20 
CC_Mid_Anterior 0.07 161 0.21 21 
rh_medialorbitofrontal_thickness 0.35 11 0.21 22 
Left_Inf_Lat_Vent 0.17 69 0.21 23 
rh_medialorbitofrontal_volume 0.17 70 0.21 24 
rh_transversetemporal_thickness 0.18 55 0.20 25 
Left_Amygdala 0.08 152 0.20 26 
rh_temporalpole_volume 0.10 121 0.20 27 
CC_Central 0.14 88 0.20 28 
rh_middletemporal_thickness 0.17 71 0.19 29 
rh_caudalanteriorcingulate_volume 0.32 16 0.19 30 
lh_paracentral_thickness 0.17 66 0.19 31 
th_Ventricle 0.05 168 0.19 32 
lh_parstriangularis_volume 0.32 17 0.19 33 
rh_pericalcarine_thickness 0.29 22 0.19 34 
lh_transversetemporal_volume 0.22 39 0.18 35 
rh_parahippocampal_thickness 0.26 26 0.18 36 
rh_lingual_thickness 0.39 8 0.18 37 
rh_insula_volume 0.34 13 0.18 38 
lh_parahippocampal_thickness 0.30 21 0.18 39 
lh_pericalcarine_volume 0.11 117 0.18 40 
lh_superiorfrontal_thickness 0.27 24 0.18 41 
lh_cuneus_volume 0.16 80 0.18 42 
rh_temporalpole_thickness 0.17 62 0.18 43 
CC_Posterior 0.08 145 0.17 44 
rh_isthmuscingulate_volume 0.17 61 0.17 45 
lh_precuneus_volume 0.12 106 0.17 46 
Right_Cerebellum_Cortex 0.14 91 0.17 47 
lh_inferiortemporal_thickness 0.22 43 0.17 48 
lh_paracentral_volume 0.09 144 0.16 49 
lh_rostralanteriorcingulate_thickness 0.36 10 0.16 50 
Left_Lateral_Ventricle 0.09 136 0.16 51 
rh_superiortemporal_volume 0.21 45 0.16 52 
rh_precuneus_volume 0.09 131 0.16 53 
lh_rostralanteriorcingulate_volume 0.08 150 0.16 54 
lh_isthmuscingulate_volume 0.13 94 0.16 55 
rh_lateralorbitofrontal_volume 0.17 67 0.16 56 
lh_bankssts_thickness 0.11 116 0.16 57 
rh_rostralanteriorcingulate_thickness 0.13 95 0.16 58 
lh_lateralorbitofrontal_volume 0.16 76 0.16 59 
lh_precuneus_thickness 0.24 32 0.16 60 
rh_superiorfrontal_thickness 0.10 127 0.16 61 
lh_frontalpole_thickness 0.19 52 0.16 62 
CC_Anterior 0.10 128 0.15 63 
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lh_entorhinal_thickness 0.15 83 0.15 64 
lh_entorhinal_volume 0.22 37 0.15 65 
lh_parahippocampal_volume 0.09 134 0.15 66 
rh_postcentral_volume 0.17 64 0.15 67 
rh_postcentral_thickness 0.23 35 0.15 68 
rh_bankssts_volume 0.26 27 0.15 69 
lh_insula_volume 0.20 49 0.15 70 
rh_parstriangularis_volume 0.16 78 0.15 71 
rh_inferiortemporal_volume 0.08 157 0.15 72 
rh_parsopercularis_thickness 0.15 86 0.15 73 
Right_Pallidum 0.10 130 0.15 74 
rh_lateraloccipital_volume 0.15 84 0.15 75 
lh_parsopercularis_volume 0.23 34 0.15 76 
lh_posteriorcingulate_volume 0.10 124 0.15 77 
lh_pericalcarine_thickness 0.08 155 0.14 78 
lh_middletemporal_volume 0.11 115 0.14 79 
Left_Cerebellum_White_Matter 0.23 36 0.14 80 
lh_bankssts_volume 0.06 166 0.14 81 
rh_transversetemporal_volume 0.16 81 0.14 82 
Left_Hippocampus 0.29 23 0.14 83 
CC_Mid_Posterior 0.17 65 0.14 84 
rh_parsorbitalis_thickness 0.10 123 0.14 85 
lh_lateralorbitofrontal_thickness 0.34 14 0.14 86 
rh_middletemporal_volume 0.12 102 0.14 87 
rh_lateraloccipital_thickness 0.18 57 0.14 88 
rh_supramarginal_volume 0.16 77 0.14 89 
rh_precentral_thickness 0.18 58 0.14 90 
rh_parsopercularis_volume 0.11 114 0.14 91 
Brain_Stem 0.13 97 0.14 92 
rh_caudalanteriorcingulate_thickness 0.16 79 0.14 93 
lh_parsorbitalis_thickness 0.09 137 0.14 94 
lh_middletemporal_thickness 0.22 42 0.14 95 
lh_medialorbitofrontal_volume 0.12 110 0.14 96 
rh_cuneus_volume 0.14 90 0.14 97 
Right_Lateral_Ventricle 0.25 28 0.14 98 
lh_fusiform_thickness 0.10 120 0.13 99 
Left_Cerebellum_Cortex 0.21 46 0.13 100 
lh_postcentral_volume 0.15 85 0.13 101 
Left_VentralDC 0.09 142 0.13 102 
lh_inferiorparietal_volume 0.21 44 0.13 103 
lh_frontalpole_volume 0.10 126 0.13 104 
rh_superiortemporal_thickness 0.17 63 0.13 105 
rh_superiorfrontal_volume 0.13 93 0.13 106 
rh_fusiform_volume 0.08 154 0.13 107 
lh_caudalanteriorcingulate_volume 0.09 135 0.13 108 
rh_fusiform_thickness 0.08 148 0.13 109 
lh_supramarginal_thickness 0.12 103 0.13 110 
lh_lateraloccipital_volume 0.09 141 0.13 111 
rh_caudalmiddlefrontal_volume 0.24 33 0.13 112 
lh_cuneus_thickness 0.12 107 0.13 113 
rh_caudalmiddlefrontal_thickness 0.18 54 0.12 114 
rh_precentral_volume 0.16 72 0.12 115 
lh_posteriorcingulate_thickness 0.25 29 0.12 116 
rh_superiorparietal_volume 0.11 113 0.12 117 
lh_superiorparietal_thickness 0.12 109 0.12 118 
Right_Thalamus_Proper 0.07 160 0.12 119 
rh_lingual_volume 0.22 40 0.12 120 
rh_parahippocampal_volume 0.12 101 0.12 121 
lh_superiortemporal_volume 0.09 143 0.12 122 
lh_superiorparietal_volume 0.08 151 0.12 123 
CSF 0.09 140 0.12 124 
Right_VentralDC 0.11 111 0.12 125 
lh_postcentral_thickness 0.07 159 0.12 126 
lh_superiorfrontal_volume 0.09 133 0.12 127 
rh_supramarginal_thickness 0.22 38 0.12 128 
Left_Thalamus_Proper 0.31 19 0.12 129 
lh_fusiform_volume 0.06 164 0.12 130 
rh_parstriangularis_thickness 0.10 122 0.11 131 
lh_isthmuscingulate_thickness 0.12 104 0.11 132 
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rh_superiorparietal_thickness 0.13 99 0.11 133 
Right_Cerebellum_White_Matter 0.20 48 0.11 134 
rh_frontalpole_thickness 0.09 139 0.11 135 
rh_posteriorcingulate_thickness 0.14 89 0.11 136 
rh_inferiortemporal_thickness 0.07 163 0.11 137 
lh_parsopercularis_thickness 0.18 60 0.11 138 
lh_lingual_volume 0.15 87 0.11 139 
rh_paracentral_volume 0.10 125 0.11 140 
rh_isthmuscingulate_thickness 0.11 112 0.11 141 
lh_superiortemporal_thickness 0.19 50 0.11 142 
rh_insula_thickness 0.09 138 0.11 143 
rh_frontalpole_volume 0.06 165 0.11 144 
rh_rostralmiddlefrontal_volume 0.07 158 0.11 145 
Left_Accumbens_area 0.05 167 0.10 146 
rh_posteriorcingulate_volume 0.16 74 0.10 147 
rh_inferiorparietal_volume 0.08 146 0.10 148 
lh_inferiortemporal_volume 0.19 51 0.10 149 
rh_paracentral_thickness 0.10 129 0.10 150 
rh_entorhinal_volume 0.09 132 0.10 151 
rh_bankssts_thickness 0.16 75 0.10 152 
lh_caudalanteriorcingulate_thickness 0.08 147 0.10 153 
Right_Caudate 0.18 59 0.10 154 
lh_supramarginal_volume 0.07 162 0.10 155 
lh_precentral_volume 0.08 156 0.10 156 
lh_temporalpole_thickness 0.04 169 0.10 157 
lh_rostralmiddlefrontal_thickness 0.16 73 0.10 158 
rh_rostralmiddlefrontal_thickness 0.15 82 0.10 159 
rh_precuneus_thickness 0.19 53 0.10 160 
lh_caudalmiddlefrontal_thickness 0.13 98 0.10 161 
lh_parstriangularis_thickness 0.32 18 0.09 162 
rh_parsorbitalis_volume 0.10 119 0.09 163 
rh_pericalcarine_volume 0.13 96 0.09 164 
lh_rostralmiddlefrontal_volume 0.08 149 0.09 165 
lh_parsorbitalis_volume 0.17 68 0.09 166 
lh_caudalmiddlefrontal_volume 0.08 153 0.09 167 
Left_Caudate 0.12 100 0.08 168 





sTable 6.4. Coefficients and ranking for each feature for the pooled and cross-site validations for 
the SVM model (rt	p
 
 Cross-site validation Pooled validation  
  
Coefficients Rank Coefficients Rank 
Rh_inferiorparietal_thickness 0.86 1 0.85 1 
Rh_insula_volume 0.81 3 0.83 2 
Right_Lateral_Ventricle 0.63 6 0.72 3 
Right_Hippocampus 0.82 2 0.72 4 
Right_Inf_Lat_Vent 0.67 4 0.69 5 
3rd_Ventricle 0.63 5 0.67 6 
Lh_transversetemporal_thickness 0.54 10 0.66 7 
Lh_insula_volume 0.53 11 0.66 8 
Right_Putamen 0.62 7 0.61 9 
Lh_parstriangularis_volume 0.52 12 0.60 10 
Lh_parstriangularis_thickness 0.52 14 0.57 11 
Left_Cerebellum_White_Matter 0.61 8 0.56 12 
Rh_precuneus_thickness 0.44 24 0.54 13 
Lh_rostralanteriorcingulate_thickness 0.58 9 0.51 14 
Lh_precuneus_thickness 0.44 23 0.50 15 
Lh_medialorbitofrontal_thickness 0.38 33 0.50 16 
Lh_superiorfrontal_thickness 0.49 18 0.50 17 
Rh_superiorfrontal_volume 0.46 21 0.50 18 
Rh_middletemporal_volume 0.51 17 0.47 19 
Rh_supramarginal_thickness 0.47 19 0.46 20 
Lh_parahippocampal_thickness 0.40 29 0.45 21 
Left_Pallidum 0.38 34 0.45 22 
Lh_middletemporal_thickness 0.46 22 0.45 23 
Rh_rostralanteriorcingulate_volume 0.40 28 0.45 24 
Lh_temporalpole_volume 0.51 15 0.43 25 
CC_Central 0.52 13 0.43 26 
Rh_caudalanteriorcingulate_volume 0.33 44 0.43 27 
Rh_lingual_thickness 0.41 25 0.43 28 
Lh_lateralorbitofrontal_thickness 0.51 16 0.43 29 
Lh_inferiorparietal_thickness 0.32 49 0.42 30 
Rh_medialorbitofrontal_thickness 0.41 27 0.42 31 
Lh_parsopercularis_volume 0.41 26 0.42 32 
Rh_lateralorbitofrontal_thickness 0.33 46 0.38 33 
Lh_inferiortemporal_volume 0.28 58 0.38 34 
Lh_inferiorparietal_volume 0.39 32 0.37 35 
Lh_transversetemporal_volume 0.25 65 0.37 36 
Left_Thalamus_Proper 0.46 20 0.37 37 
Rh_middletemporal_thickness 0.37 35 0.36 38 
Lh_lingual_thickness 0.34 40 0.35 39 
Rh_transversetemporal_volume 0.28 57 0.35 40 
Rh_postcentral_thickness 0.34 41 0.34 41 
Rh_parahippocampal_thickness 0.29 52 0.34 42 
Lh_medialorbitofrontal_volume 0.24 67 0.34 43 
Left_Lateral_Ventricle 0.39 31 0.33 44 
Lh_inferiortemporal_thickness 0.34 42 0.31 45 
Right_Accumbens_area 0.35 38 0.31 46 
Right_Amygdala 0.36 36 0.30 47 
Lh_middletemporal_volume 0.30 51 0.30 48 
Right_Cerebellum_White_Matter 0.19 81 0.29 49 
Lh_paracentral_thickness 0.29 53 0.29 50 
Rh_posteriorcingulate_volume 0.35 39 0.29 51 
Lh_precuneus_volume 0.27 61 0.28 52 
Rh_entorhinal_thickness 0.34 43 0.28 53 
Lh_caudalmiddlefrontal_volume 0.26 62 0.28 54 
Lh_lateraloccipital_thickness 0.11 103 0.27 55 
Rh_pericalcarine_thickness 0.39 30 0.26 56 
CC_Mid_Posterior 0.19 76 0.25 57 
Rh_precentral_thickness 0.32 48 0.24 58 
Rh_isthmuscingulate_volume 0.29 56 0.24 59 
Lh_superiortemporal_thickness 0.33 45 0.23 60 
Right_ventraldc 0.25 64 0.23 61 
Lh_cuneus_thickness 0.26 63 0.23 62 
Rh_caudalmiddlefrontal_volume 0.23 69 0.22 63 
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Rh_parstriangularis_thickness 0.18 84 0.22 64 
Rh_lateraloccipital_volume 0.27 60 0.21 65 
Rh_cuneus_volume 0.21 72 0.21 66 
Rh_transversetemporal_thickness 0.19 80 0.21 67 
Rh_postcentral_volume 0.29 54 0.21 68 
Lh_temporalpole_thickness 0.19 78 0.21 69 
Rh_frontalpole_volume 0.21 73 0.20 70 
Left_Inf_Lat_Vent 0.27 59 0.20 71 
Rh_rostralanteriorcingulate_thickness 0.16 90 0.19 72 
Rh_superiorparietal_thickness 0.17 86 0.19 73 
Rh_parstriangularis_volume 0.11 105 0.19 74 
Lh_postcentral_volume 0.19 79 0.19 75 
Lh_entorhinal_thickness 0.25 66 0.19 76 
Rh_lateraloccipital_thickness 0.30 50 0.19 77 
Lh_parahippocampal_volume 0.16 92 0.18 78 
Right_Thalamus_Proper 0.22 71 0.18 79 
Rh_fusiform_thickness 0.19 77 0.18 80 
Rh_superiortemporal_volume 0.24 68 0.18 81 
Rh_temporalpole_thickness 0.36 37 0.17 82 
Lh_caudalanteriorcingulate_thickness 0.15 93 0.17 83 
Lh_posteriorcingulate_thickness 0.18 83 0.16 84 
Left_Putamen 0.14 97 0.16 85 
Lh_entorhinal_volume 0.32 47 0.16 86 
Left_Cerebellum_Cortex 0.20 75 0.16 87 
Rh_caudalanteriorcingulate_thickness 0.07 127 0.16 88 
Rh_bankssts_volume 0.20 74 0.15 89 
Lh_insula_thickness 0.29 55 0.15 90 
Lh_fusiform_thickness 0.02 159 0.15 91 
Lh_parsorbitalis_volume 0.07 124 0.15 92 
Rh_lateralorbitofrontal_volume 0.22 70 0.14 93 
Lh_cuneus_volume 0.13 99 0.14 94 
Rh_lingual_volume 0.07 126 0.14 95 
Rh_inferiortemporal_thickness 0.08 123 0.14 96 
Rh_parsorbitalis_thickness 0.02 158 0.14 97 
Rh_inferiortemporal_volume 0.03 156 0.14 98 
Lh_rostralmiddlefrontal_thickness 0.15 96 0.14 99 
Lh_precentral_volume 0.17 85 0.13 100 
Rh_inferiorparietal_volume 0.03 152 0.13 101 
Brain_Stem 0.11 104 0.13 102 
Rh_caudalmiddlefrontal_thickness 0.16 91 0.13 103 
Rh_superiorparietal_volume 0.08 119 0.13 104 
Left_Hippocampus 0.11 108 0.13 105 
Lh_rostralmiddlefrontal_volume 0.09 118 0.13 106 
Rh_precentral_volume 0.06 135 0.13 107 
Lh_lateraloccipital_volume 0.10 110 0.12 108 
CC_Mid_Anterior 0.09 113 0.12 109 
Lh_pericalcarine_volume 0.12 100 0.12 110 
Rh_bankssts_thickness 0.16 88 0.12 111 
Lh_bankssts_volume 0.06 133 0.12 112 
Lh_parsorbitalis_thickness 0.16 89 0.12 113 
Lh_postcentral_thickness 0.05 142 0.12 114 
Rh_medialorbitofrontal_volume 0.11 102 0.12 115 
Lh_frontalpole_thickness 0.09 116 0.11 116 
Rh_frontalpole_thickness 0.16 87 0.11 117 
Rh_posteriorcingulate_thickness 0.14 98 0.11 118 
Left_ventraldc 0.08 122 0.10 119 
Left_Accumbens_area 0.04 150 0.10 120 
Rh_rostralmiddlefrontal_thickness 0.02 161 0.09 121 
Lh_frontalpole_volume 0.05 136 0.09 122 
Lh_superiorparietal_thickness 0.02 160 0.09 123 
Lh_precentral_thickness 0.01 166 0.09 124 
Rh_supramarginal_volume 0.19 82 0.09 125 
Rh_paracentral_thickness 0.04 148 0.09 126 
Lh_pericalcarine_thickness 0.09 115 0.09 127 
Rh_parsopercularis_thickness 0.05 137 0.08 128 
Rh_fusiform_volume 0.02 157 0.08 129 
Rh_pericalcarine_volume 0.08 120 0.08 130 
Lh_caudalanteriorcingulate_volume 0.07 125 0.07 131 
Right_Caudate 0.05 141 0.07 132 
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CSF 0.04 147 0.07 133 
Rh_isthmuscingulate_thickness 0.10 109 0.07 134 
Lh_supramarginal_volume 0.08 121 0.07 135 
Rh_superiortemporal_thickness 0.11 107 0.06 136 
Lh_paracentral_volume 0.15 95 0.06 137 
Lh_isthmuscingulate_volume 0.11 106 0.06 138 
Left_Amygdala 0.09 112 0.06 139 
Lh_supramarginal_thickness 0.00 168 0.06 140 
Rh_insula_thickness 0.04 151 0.05 141 
Lh_bankssts_thickness 0.05 138 0.05 142 
Lh_rostralanteriorcingulate_volume 0.04 149 0.04 143 
Lh_lingual_volume 0.01 164 0.04 144 
Lh_fusiform_volume 0.09 114 0.04 145 
Lh_superiortemporal_volume 0.04 144 0.04 146 
Lh_lateralorbitofrontal_volume 0.06 129 0.04 147 
Lh_superiorparietal_volume 0.05 139 0.03 148 
Lh_parsopercularis_thickness 0.09 117 0.03 149 
Rh_rostralmiddlefrontal_volume 0.06 132 0.03 150 
Rh_parsorbitalis_volume 0.01 163 0.03 151 
Lh_isthmuscingulate_thickness 0.04 145 0.03 152 
Rh_precuneus_volume 0.05 143 0.02 153 
CC_Posterior 0.05 140 0.02 154 
Right_Pallidum 0.01 167 0.02 155 
Rh_temporalpole_volume 0.09 111 0.02 156 
Th_Ventricle 0.01 165 0.01 157 
Rh_parsopercularis_volume 0.02 162 0.01 158 
Rh_parahippocampal_volume 0.04 146 0.01 159 
Left_Caudate 0.03 155 0.01 160 
Rh_entorhinal_volume 0.00 169 0.01 161 
Lh_posteriorcingulate_volume 0.03 153 0.01 162 
Rh_paracentral_volume 0.06 134 0.01 163 
Rh_superiorfrontal_thickness 0.06 131 0.00 164 
Lh_caudalmiddlefrontal_thickness 0.12 101 0.00 165 
Rh_cuneus_thickness 0.03 154 0.00 166 
Right_Cerebellum_Cortex 0.07 128 0.00 167 
Lh_superiorfrontal_volume 0.15 94 0.00 168 





sTable 6.5. Coefficients and ranking for each feature for the pooled and cross-






 Coefficients Rank Coefficients Rank 
Rh_inferiorparietal_thickness 0.86 1 0.90 1 
Rh_insula_volume 0.82 2 0.89 2 
Right_Inf_Lat_Vent 0.76 5 0.81 3 
Lh_transversetemporal_thickness 0.54 19 0.76 4 
3rd_Ventricle 0.62 12 0.75 5 
Right_Lateral_Ventricle 0.81 3 0.75 6 
Lh_insula_volume 0.53 21 0.73 7 
Right_Putamen 0.64 11 0.71 8 
Right_Hippocampus 0.80 4 0.68 9 
Lh_superiorfrontal_thickness 0.72 6 0.63 10 
Lh_lateralorbitofrontal_thickness 0.49 25 0.53 11 
Lh_parstriangularis_thickness 0.66 9 0.52 12 
Right_Amygdala 0.35 51 0.51 13 
Lh_precuneus_thickness 0.45 31 0.51 14 
Rh_precuneus_thickness 0.46 30 0.51 15 
Lh_rostralanteriorcingulate_thickness 0.70 7 0.50 16 
Lh_medialorbitofrontal_thickness 0.58 18 0.49 17 
Lh_middletemporal_thickness 0.52 23 0.49 18 
Lh_parstriangularis_volume 0.68 8 0.48 19 
Rh_parahippocampal_thickness 0.39 40 0.48 20 
Rh_caudalanteriorcingulate_volume 0.61 14 0.48 21 
Rh_rostralanteriorcingulate_volume 0.62 13 0.47 22 
Rh_superiorfrontal_volume 0.59 15 0.47 23 
Rh_middletemporal_volume 0.59 16 0.46 24 
Lh_lingual_thickness 0.27 65 0.46 25 
Lh_temporalpole_volume 0.50 24 0.45 26 
CC_Central 0.42 34 0.45 27 
Left_Cerebellum_White_Matter 0.64 10 0.45 28 
Lh_inferiortemporal_volume 0.40 39 0.45 29 
Lh_inferiorparietal_thickness 0.41 37 0.44 30 
Lh_caudalmiddlefrontal_volume 0.31 61 0.43 31 
Rh_supramarginal_thickness 0.54 20 0.42 32 
Rh_lingual_thickness 0.38 45 0.39 33 
Right_Cerebellum_White_Matter 0.17 93 0.38 34 
Left_Thalamus_Proper 0.59 17 0.37 35 
Rh_medialorbitofrontal_thickness 0.41 36 0.37 36 
Left_Pallidum 0.31 60 0.37 37 
Lh_parahippocampal_thickness 0.22 79 0.37 38 
Lh_inferiorparietal_volume 0.39 41 0.37 39 
Left_Hippocampus 0.32 58 0.36 40 
Rh_postcentral_thickness 0.38 44 0.35 41 
Lh_middletemporal_volume 0.53 22 0.34 42 
Rh_pericalcarine_thickness 0.36 47 0.34 43 
Right_Accumbens_area 0.43 33 0.34 44 
Rh_isthmuscingulate_volume 0.36 48 0.32 45 
Lh_medialorbitofrontal_volume 0.34 56 0.32 46 
Lh_parsopercularis_volume 0.41 38 0.32 47 
Lh_cuneus_thickness 0.06 137 0.32 48 
Rh_lateralorbitofrontal_thickness 0.26 67 0.31 49 
Lh_insula_thickness 0.35 52 0.31 50 
Left_Lateral_Ventricle 0.47 29 0.31 51 
Rh_transversetemporal_volume 0.44 32 0.30 52 
Lh_inferiortemporal_thickness 0.34 54 0.30 53 
Lh_posteriorcingulate_thickness 0.32 57 0.29 54 
Lh_transversetemporal_volume 0.34 55 0.28 55 
Rh_precentral_thickness 0.37 46 0.28 56 
Lh_precuneus_volume 0.22 76 0.28 57 
Rh_entorhinal_thickness 0.39 42 0.27 58 
Rh_lateraloccipital_volume 0.32 59 0.27 59 
Rh_bankssts_volume 0.14 104 0.26 60 
Rh_superiorparietal_thickness 0.36 49 0.25 61 
Rh_lateraloccipital_thickness 0.19 89 0.25 62 
Lh_lateraloccipital_thickness 0.05 140 0.25 63 
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Lh_superiortemporal_thickness 0.47 27 0.25 64 
Right_Thalamus_Proper 0.23 74 0.24 65 
Lh_paracentral_thickness 0.36 50 0.24 66 
Rh_rostralanteriorcingulate_thickness 0.35 53 0.24 67 
Lh_temporalpole_thickness 0.22 77 0.24 68 
Lh_rostralmiddlefrontal_volume 0.14 106 0.23 69 
Lh_postcentral_volume 0.21 82 0.23 70 
Rh_posteriorcingulate_volume 0.21 81 0.22 71 
Lh_entorhinal_volume 0.17 94 0.22 72 
Rh_postcentral_volume 0.38 43 0.21 73 
Lh_caudalanteriorcingulate_thickness 0.12 110 0.20 74 
Rh_posteriorcingulate_thickness 0.41 35 0.20 75 
Rh_middletemporal_thickness 0.47 28 0.19 76 
Lh_superiorparietal_thickness 0.09 121 0.19 77 
Lh_fusiform_thickness 0.09 120 0.19 78 
Lh_rostralmiddlefrontal_thickness 0.21 83 0.18 79 
Rh_supramarginal_volume 0.24 70 0.18 80 
Right_ventraldc 0.30 62 0.17 81 
Lh_bankssts_volume 0.01 159 0.17 82 
Rh_transversetemporal_thickness 0.19 90 0.17 83 
Lh_cuneus_volume 0.24 71 0.17 84 
Rh_caudalanteriorcingulate_thickness 0.07 134 0.16 85 
Rh_precentral_volume 0.15 100 0.16 86 
Lh_precentral_volume 0.23 75 0.16 87 
Left_Accumbens_area 0.09 116 0.16 88 
Lh_frontalpole_volume 0.09 117 0.16 89 
Left_Inf_Lat_Vent 0.24 69 0.15 90 
Rh_inferiortemporal_thickness 0.20 86 0.15 91 
Rh_parsorbitalis_thickness 0.00 168 0.14 92 
Rh_parstriangularis_thickness 0.22 78 0.14 93 
Left_Putamen 0.09 115 0.14 94 
Left_Cerebellum_Cortex 0.29 63 0.14 95 
Lh_parsorbitalis_thickness 0.15 101 0.14 96 
Lh_pericalcarine_thickness 0.23 72 0.14 97 
Rh_caudalmiddlefrontal_volume 0.26 66 0.13 98 
Rh_temporalpole_thickness 0.47 26 0.13 99 
Rh_fusiform_thickness 0.18 92 0.13 100 
Rh_lingual_volume 0.21 84 0.13 101 
Rh_cuneus_volume 0.07 131 0.13 102 
Rh_inferiortemporal_volume 0.09 118 0.13 103 
Lh_lingual_volume 0.03 149 0.13 104 
Rh_rostralmiddlefrontal_volume 0.17 95 0.12 105 
Rh_superiortemporal_volume 0.28 64 0.12 106 
Lh_lateraloccipital_volume 0.06 138 0.12 107 
CSF 0.02 153 0.12 108 
Lh_pericalcarine_volume 0.01 161 0.12 109 
Rh_superiortemporal_thickness 0.02 156 0.12 110 
Left_Amygdala 0.03 152 0.12 111 
Rh_superiorparietal_volume 0.13 108 0.11 112 
Rh_bankssts_thickness 0.01 162 0.11 113 
Rh_caudalmiddlefrontal_thickness 0.00 165 0.11 114 
Lh_parsorbitalis_volume 0.17 96 0.11 115 
Rh_medialorbitofrontal_volume 0.23 73 0.11 116 
Rh_frontalpole_thickness 0.06 139 0.10 117 
Rh_precuneus_volume 0.03 147 0.10 118 
Lh_precentral_thickness 0.15 103 0.10 119 
Rh_inferiorparietal_volume 0.09 122 0.10 120 
Rh_frontalpole_volume 0.13 109 0.10 121 
Lh_frontalpole_thickness 0.07 132 0.10 122 
Lh_posteriorcingulate_volume 0.12 111 0.09 123 
Rh_pericalcarine_volume 0.02 158 0.09 124 
Rh_rostralmiddlefrontal_thickness 0.02 155 0.09 125 
Rh_paracentral_thickness 0.04 144 0.09 126 
CC_Mid_Posterior 0.20 87 0.09 127 
Lh_paracentral_volume 0.07 129 0.08 128 
Lh_superiorparietal_volume 0.03 150 0.08 129 
Rh_parsopercularis_volume 0.02 154 0.08 130 
Lh_lateralorbitofrontal_volume 0.08 124 0.08 131 
Lh_caudalanteriorcingulate_volume 0.15 102 0.07 132 
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Lh_entorhinal_thickness 0.17 97 0.07 133 
Right_Caudate 0.11 114 0.07 134 
Brain_Stem 0.08 126 0.07 135 
Rh_temporalpole_volume 0.03 148 0.07 136 
Rh_lateralorbitofrontal_volume 0.19 88 0.06 137 
Lh_isthmuscingulate_volume 0.11 113 0.06 138 
Lh_rostralanteriorcingulate_volume 0.04 146 0.06 139 
Lh_supramarginal_thickness 0.06 136 0.06 140 
CC_Mid_Anterior 0.25 68 0.05 141 
Lh_fusiform_volume 0.07 127 0.05 142 
Rh_entorhinal_volume 0.01 160 0.05 143 
Rh_superiorfrontal_thickness 0.12 112 0.05 144 
Rh_isthmuscingulate_thickness 0.15 98 0.04 145 
Right_Cerebellum_Cortex 0.00 166 0.04 146 
Lh_superiortemporal_volume 0.01 163 0.04 147 
Lh_postcentral_thickness 0.22 80 0.04 148 
Lh_bankssts_thickness 0.07 128 0.03 149 
CC_Posterior 0.04 145 0.03 150 
Rh_parstriangularis_volume 0.05 142 0.03 151 
Lh_supramarginal_volume 0.00 169 0.03 152 
Rh_parahippocampal_volume 0.00 167 0.02 153 
Rh_paracentral_volume 0.05 141 0.02 154 
CC_Anterior 0.07 130 0.02 155 
Lh_parahippocampal_volume 0.18 91 0.02 156 
Lh_parsopercularis_thickness 0.03 151 0.02 157 
Rh_fusiform_volume 0.05 143 0.02 158 
Th_Ventricle 0.13 107 0.02 159 
Lh_caudalmiddlefrontal_thickness 0.14 105 0.02 160 
Rh_cuneus_thickness 0.01 164 0.02 161 
Right_Pallidum 0.08 125 0.02 162 
Left_Caudate 0.09 123 0.01 163 
Rh_parsorbitalis_volume 0.15 99 0.01 164 
Rh_parsopercularis_thickness 0.07 135 0.01 165 
Left_ventraldc 0.02 157 0.01 166 
Lh_isthmuscingulate_thickness 0.07 133 0.00 167 
Rh_insula_thickness 0.09 119 0.00 168 










7.1. Summary of main findings 
Neuroanatomical abnormalities in schizophrenia have been well documented for the past four 
decades (Bora et al., 2011; Glahn et al., 2008). Although evidence suggests qualitatively similar, 
albeit less severe, changes in those who have experienced a recent FEP (Egerton et al., 2011), 
findings have been heterogenous (X. Gao et al., 2018; Shah et al., 2017). This may be partially 
explained by the increased risk of false positives (Button et al., 2013) and heterogeneous findings 
(IntHout et al., 2015) associated with small local studies that dominate the literature. This is in line 
with the ongoing concerns across the wider neuroscientific community regarding the failure of 
replication and reproducibility of findings (Anonymus, 2013) and subsequent calls for greater 
collaboration to build larger and more robust studies (Ferguson et al., 2014; Poldrack & 
Gorgolewski, 2014; Toga et al., 2015). In parallel with this movement, there is also a growing 
demand for clinically translatable research (Borgwardt & Fusar-Poli, 2012). Indeed, while 
neuroimaging has led to significant progress in the understanding of the neural correlates of 
psychosis, it has yet to make substantial impact in clinical practice (Dazzan, 2014; Prata et al., 
2014; Woo et al., 2017). Machine learning promises to meet this demand by allowing inferences 
to be made at the level of the individual (Hastie et al., 2001). Initial attempts at using machine 
learning to distinguish FEP individuals from HC based on neuroanatomical data have yielded 
inconsistent findings (Kambeitz et al., 2015; Schnack & Kahn, 2016). This may be partially due to 
a combination of small sample sizes and less-than-rigorous methods (Nieuwenhuis et al., 2012; 
Schnack & Kahn, 2016; Varoquaux, 2017). In addition, while most evidence comes from well-
established techniques such as SVM, a new approach known as deep learning is emerging as a 
promising development  (LeCun et al., 2015). Contrary to traditional machine learning methods, 
deep learning is capable of finding highly abstract information which may be particularly useful for 
detecting the intricate and widespread pattern of neuroanatomical abnormalities in FEP. 
 
Based on the above, the overarching aim of this doctoral thesis was to investigate 
neuroanatomical abnormalities in FEP at group and individual level in a mega-analytic study. This 
was achieved by collating data from five previous and independent studies carried out at four 
separate research sites. This resulted in the largest sample of FEP individuals to be analysed so 
far. In this context, FEP and HC groups were first compared using a standard mass-univariate 
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approach to test for neuroanatomical alterations common to the five independent sites. This 
allowed to move beyond local sample-dependent findings by testing for the presence of 
abnormalities that are consistent across different sites. Next, a series of studies were conducted 
to investigate the predictive power of machine learning, and deep learning in particular, in 
discriminating FEP from HC using neuroanatomical information. First, a thorough review of the 
literature was carried out to survey the current evidence for deep learning in psychiatric and 
neurologic neuroimaging. Next, a deep learning model, along with three other standard and well-
established methods for comparison, were used to discriminate FEP and HC at the individual 
level. Critically, the same models were applied to the five independent datasets separately to test 
for the reproducibility of findings. Finally, deep learning was used to classify FEP and HC after 
combining all datasets, in a large-scale mega-analysis. The main results from each study are 
summarized below in the context of the hypotheses outlined in Chapter 1. 
 
Study 1: Neuroanatomical abnormalities in first episode psychosis across independent samples: 
a multi-centre mega-analysis 
Consistent with H1, the results obtained through standard univariate analysis revealed a pattern 
of widespread GM volume reductions in fronto-temporal, insular and occipital regions bilaterally 
in FEP relative to HC. Some of the reductions, namely in the left gyrus rectus, medial orbital and 
inferior temporal gyri as well as in the right fusiform and lingual gyri, were negatively correlated 
with positive and negative symptoms, thus partially confirming H2. Similarly some of the 
reductions, namely in the right lingual gyrus and insula, were also negatively correlated with 
duration of illness, therefore partially confirming H3. Furthermore, these reductions were not 
associated with anti-psychotic medication, consistent with H4. An increase in GM volume in the 
right superior temporal gyrus was also found, although this was not associated with severity of 
psychotic symptoms, duration of illness or anti-psychotic medication. 
 
Study 2: Using deep learning to investigate the neuroimaging correlates of psychiatric and 
neurological disorders: methods and applications 
The review of deep learning applications to neuroimaging studies in psychiatric or neurological 
disorders published up until 1st August 2016 yielded a total of 25 studies. As with traditional 
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machine learning methods, the majority of applications have been diagnostic classification 
studies, followed by conversion to illness and prediction of treatment response. Most studies have 
been conducted in patients with MCI and AD mostly via the ADNI dataset. However, other 
disorders have also been analysed, namely ADHD, psychosis, epilepsy and cerebellar ataxia. 
Possibly due to the flexibility inherent to deep learning models and the novelty of this approach, 
the methodology of the studies varied considerably in terms of features used, preprocessing, 
feature engineering and deep learning architectures. With respect to the deep learning model 
used, most studies used some form of autoencoders, CNN or a combination of the two, or even 
DNNs. In the majority of studies comparing their deep learning model to another more well-
established approach, typically a kernel-based method such as SVM, deep learning showed 
improved performance. However, given the novelty and popularity of deep learning, it is not 
possible to exclude the possibility of publication bias in favour of this method. 
 
Study 3: Using machine learning and structural neuroimaging to detect first episode psychosis: 
reconsidering the evidence 
The results from the series of DNN and traditional machine learning models applied to three 
different neuroanatomical features – VWGMV, VWCT and SB-ROIs – to classify FEP and HC at 
each of the five datasets proved partially unexcepted in the context of the results from previous 
studies (Kambeitz et al., 2015; Xiao et al., 2017). Specifically, accuracies ranged from 50% to 
70% for SB ROIs; from 50% to 63% for VWGMV; and from 51% to 68% for VWCT, thus not 
confirming H5 and H6. The best accuracies (70%) were achieved in 2 of the 5 sites, when a DNN 
was applied to the SB-ROIs, therefore partially confirming H7 and H8. However, these models 
generalized poorly when tested on the remaining sites, with accuracies ranging between 50 and 
55%. Upon attempting to interpreting these results, the pool of similar studies was tested for 
publication bias. Results showed a significant bias towards studies with inflated accuracies.  
 
Study 4: Using deep learning and structural data to identify first-episode psychosis: a multi-centre 
mega-analysis 
In the final study of this doctoral work, pooling the five independent datasets into one individual-
level mega-analysis revealed that a DNN was able to discriminate between FEP and HC with an 
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accuracy of 65.4%, sensitivity of 63.3% and specificity of 67.5%, therefore not confirming H9. 
However, as hypothesised in H10, the DNN model outperformed, albeit by a small margin, the 
traditional machine learning approaches. When the model was trained in four sites and tested on 
the remaining site iteratively, accuracy was still statistically significant, albeit with a drop to 59.3%. 
Finally, as hypothesized in H10, there was a moderate level of agreement with respect to the brain 
regions contributing to classification for each model, suggesting a reproducible signature of 
neuroanatomical changes comprising the third and inferior lateral ventricles, basal ganglia 
(putamen and pallidum), temporal regions such as the hippocampus, entorhinal cortex and lingual 
gyrus, as well as the inferior parietal gyrus, orbitofrontal regions and the insula. 
 
7.2. Relationship to previous work 
Based on the above, four overarching themes emerged from this doctoral work: 1) 
neuroanatomical signature of FEP, 2) reliability and reproducibility of machine learning findings in 
psychosis, 3) the promise of deep learning 4) real-world application of machine learning models. 
 
7.2.1. Neuroanatomical signature of first-episode psychosis 
The large-scale group-level univariate analysis reported in Chapter 3 revealed a widespread 
pattern of GM reduction in orbitofrontal regions, several regions across the temporal cortex 
including in the superior, inferior and middle gyri, as well as in the lingual and fusiform gyri and 
the insula. This pattern of GM abnormalities differed, to some extent, to the one identified by the 
large-scale deep learning model in Chapter 6. Here, the main regions driving classification were 
the third and inferior lateral ventricles, basal ganglia including the putamen and pallidum, temporal 
regions such as the hippocampus, entorhinal cortex and lingual gyrus, as well as the inferior 
parietal gyrus, orbitofrontal regions and the insula. At least three reasons may explain this 
difference. First, as described in Chapter 2, VBM and SBM analysis rely on fundamentally different 
methods to extract different anatomical measures. While the former yields a metric (e.g. volume, 
thickness) at the level of the voxel, the latter was used in the present work to extract information 
at region-level according to a built-in atlas. Second, the VBM group-level analysis focused only 
on differences in GM volume, whereas the deep learning analysis used both volume and 
thickness as input features. Finally, and perhaps most importantly, group-level statistics and 
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machine learning address distinct questions. While in the former the goal is to find differences 
between groups as identified by a p-value, in the latter the aim is to classify each subject into 
groups by separating the two groups. From here it follows that, for the same sample and feature 
distribution, a highly significant group difference does not necessarily translate into a high 
classification accuracy, and vice-versa (Arbabshirani et al., 2017). However, it is interesting to 
note that some brain areas, namely orbitofrontal and temporal regions as well as the insula, 
emerged in both traditional VBM group- and machine learning analysis. In principle, a 
simultaneous significant group-level difference and high classification accuracy can arise when 
the mean value for a given feature is so far apart between the groups that the values of most of 
participants of the two groups do not overlap (Arbabshirani et al., 2017). This is an unlikely 
scenario since the overall accuracy, i.e. using all features, was modest. Therefore, it is more likely 
that the distribution of fronto- temporal-insular regions, regardless of how they were measured 
(i.e. with a whole-brain voxel or SM-ROI approach) for each group was just different enough to 
yield a significant difference in the VBM analysis and a larger weight compared to other regions 
in the machine learning analysis. The overlap in regions between the two methods may be 
partially explained by the fact that the group-level analysis was forced to find abnormalities in FEP 
common to several sites, in a more conservative analysis compared to simply analysing all sites 
together, thus allowing to mitigate site-specific differences. The fact that these regions emerged 
from such different analytical approaches and anatomical measurements suggests stability and 
reproducibility of these findings, possibly due to the use of a large sample, and provides further 
evidence for fronto-temporal-insular changes in the early stages of psychosis (X. Gao et al., 2018; 
Shah et al., 2017). 
 
7.2.2. Reliability and reproducibility in machine learning in psychosis: sample size and 
heterogeneity 
The poor to modest accuracies from the single-site analysis in Chapter 5 were initially 
unexpected. However, as discussed in that Chapter, approximately 60% of reported accuracies 
in FEP studies used a sample of 50 participants or less, which, in combination with the instability 
of such small samples (Nieuwenhuis et al., 2012), less-than-rigorous methods (Arbabshirani et 
al., 2017; Woo et al., 2017), higher risk of overfitting (Combrisson & Jerbi, 2015) and publication 
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bias shown in Chapter 5, may have resulted in a previously postulated (Schnack & Kahn, 2016; 
Woo et al., 2017) over-representation of inflated accuracies. The sample sizes for each site 
included in the present work can be considered large in comparison with most other studies of 
FEP on even ChSz (Kambeitz et al., 2015). However, a large variation of within-site performances 
(across algorithms and feature types) was still observed. This is somewhat in line with simulations 
of the effect of sample size on the stability of machine learning models in ChSz (Nieuwenhuis et 
al., 2012), albeit accuracies tend to be lower for FEP than established psychotic disorders. An 
additional symptom of instability in performance were the relatively large standard-deviations for 
each dataset (displayed in sFigure 5.3 in the supplementary materials in Chapter 5). In contrast, 
in the large-scale machine learning analyses combining all five datasets, the standard-deviations 
were, as expected, considerably smaller, indicating a more stable and reliable performance 
(Varoquaux, 2017). However, accuracies were also modest at best. This may seem 
counterintuitive at first, as in traditional statistics larger samples tend to equate to ‘better’ results. 
This is because the final result is defined by a p-value, which in turn depends on the sample size, 
such that even a small effect size can become significant in a large enough sample (Schnack, 
2017). For example, in the mega mass-univariate analysis in Chapter 3, although the analysis 
was somewhat constrained by being forced to find differences between the groups common to all 
sites, such large sample could render small effects statistically significant. This raises important 
challenges regarding the use of the p-value in the era of Big Data in neuroimaging (Smith & 
Nichols, 2018). In supervised machine learning however, results rely on how separable groups 
are based on the degree of overlap between their respective feature distributions, which does not 
depend on sample size (Schnack, 2017). Therefore, as sample size increases, the main obstacle 
becomes finding alterations shared by a large number of individuals in one group in relation to 
the other group with an effect size large enough such that groups can be separated. From here it 
follows that, for single-site studies, sample size can be achieved at the expense of loosened 
inclusion criteria, which will result in a less homogenous sample. Here, finding a common pattern 
of alterations with a sufficient effect size will be more challenging. This is due to an increase in 
‘apparent’ heterogeneity (Schnack, 2017), whereby the degree of heterogeneity is partially 
determined by how strict are the inclusion criteria. This may explain why the average results from 
site 2 (51.9%) and site 1 (61.8%) were the worst and best, respectively. While the former included 
 
 196 
patients with any psychotic disorder, the former only recruited first-episode schizophrenia 
patients. Although such variation could have also been due to sampling, i.e. chance, it is possible 
that the distinct levels of ‘apparent’ heterogeneity may have played a role. Interestingly, the overall 
results on the remaining three sites were between sites 1 and 2, as were their recruitment criteria 
by including patients with non-affective psychosis. We can therefore speculate that lower 
performances were associated with loosened inclusion criteria, i.e. more heterogeneous samples, 
as anticipated by Schnack (2017). 
 
Given the limited number of patients that can be recruited at a single site, the time-constraints 
imposed by funding bodies and the limited resources available, large-scale studies such as the 
one here can only be achieved, for now, by combining data from multiple large studies. This adds 
further heterogeneity, as different studies have different inclusion criteria and use different 
assessment protocols. Therefore, the heterogeneity that resulted from pooling all five studies is 
likely to have contributed to the modest performance in the mega machine learning analysis in 
Chapter 6. Nevertheless, this trade-off is thought to be beneficial in the long-run, since such a 
heterogeneous sample ensures that models do not learn to exploit site-specific nuisance variables 
predictive of, but not relevant to, the distinction between FEP and controls, ultimately leading to 
more generalizable models (Durstewitz et al., 2019). As more Big Data initiatives take place, the 
standardisation of these factors across studies may help mitigate this source of heterogeneity 
which could, in turn, maximise the modelling of the left-over ‘true’ heterogeneity of psychosis 
(Schnack, 2017), that is, the different clinical manifestations and neurobiological substrates 
across individuals (Brugger & Howes, 2017; Tordesillas-Gutierrez et al., 2015; Wolfers et al., 
2018). 
 
7.2.3. The promise of deep learning 
As reported in Chapter 5, the best classification accuracy from the single-site analyses were 
achieved in two sites with DNNs. Specifically, these two DNN models were able to classify FEP 
and HC with 70% accuracy. This result is in line with several other similar studies (Kambeitz et 
al., 2015). However, both models generalized poorly when tested on the remaining four sites, a 
strong indicator of overfitting. While a good performance in independent sites is a common issue 
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in psychiatric imaging studies in general (Schnack & Kahn, 2016), generalization tends to be 
particularly difficult to achieve with deep learning models. Although a powerful approach that can, 
in principle, model any relationship, this comes at the expense of complexity. Therefore, as a n 
nonlinear approach with such a large number of parameters to estimate, deep learning is 
particularly prone to overfitting. As reported in Chapter 6, the DNN was also the best performing 
model when all sites were analysed together in a pooled validation, albeit with a modest accuracy 
overall. The (marginal) superior performance of DNN over traditional linear models suggests that 
the inter-relations between regions may be better captured with nonlinear associations. 
Nevertheless, the drop in performance when the same model was trained in all but one site, a 
more conservative estimate of generalizability, suggests that the initial performance may be partly 
due to overfitting. However, the performance of the deep learning model was still higher, although 
by a slim margin, than that of traditional linear classifiers. Overall, and in keeping with the 
conclusion from Chapter 4, deep learning performed at least the same or better than traditional 
machine learning models. Although the sample used in this study was much larger than previous 
studies of FEP, it may not have been large enough for such a complex approach as deep learning 
to capture the subtle neuroanatomical changes that characterize the early stages of psychosis 
without overfitting. Indeed, the birth of deep learning and the (still) growing popularity that quickly 
followed was propelled by the increasing availability of powerful computers and huge amounts of 
data that are still not available (and may never be) in psychiatric neuroimaging. For example, 
areas in which deep learning has excelled, such as image and speech analysis, typically use 
datasets with 106 examples (He, Zhang, Ren, & Sun, 2015; Krizhevsky et al., 2012). Therefore, 
the results of this doctoral work should be taken as an initial attempt to use this advanced method 
to identify abnormalities at the early stages of psychosis. As the Big Data movement keep gaining 
momentum, larger samples will allow to explore deep learning to its full potential and help 
asserting its superiority in psychiatric neuroimaging in general, and in psychosis in particular. The 
last decade has already witnessed an unprecedented increase in sample sizes psychosis 
research, from a few dozen to several hundred participants such as in this doctoral work. Studies 
with a few thousand participants have now also started to emerge in other major psychiatric 




In addition to being especially ‘data hungry”, interpretability is an additional important caveat of 
deep learning networks (Hinton, 2018). Specifically, the retrieval of the features driving the 
decision-making of an algorithm is of particular importance to mental health and medicine in 
general. Here, a model that is capable of accurately diagnosing an individual or correctly 
predicting a relapse for example, without providing an explanation of how the decision was made, 
is likely to be received with caution or even suspicion. At the moment however, the strength of 
deep learning models lies mostly on its pure data-driven mechanistic predictions rather than an 
insightful view into the neurobiological mechanisms of psychiatric disorders (Durstewitz et al., 
2019). This is because a network’s predictions are based on learned nonlinear features whose 
meaning depends on complex interactions between uninterpreted features from the previous 
layers (Hinton, 2018). The lack of transparency is a well-known property of these models and new 
methods to open the ‘black-box’ are emerging (Chakraborty et al., 2017). In this work, the brain 
regions driving classification in Chapter 6 have been previously implicated in psychosis, which 
provides some reassurance that the model made decision based on relevant information for the 
task. However, it is possible that, had the initial parameters used to initialize the network been 
different, the network could have derived other brain regions as important for classification. 
Similarly, once the model was trained and tested, had the method to extract the best contributing 
regions been different, the group of features identified could have also differed from the ones 
reported.  
 
7.2.4. Real-world application of machine learning in early intervention services 
Although much progress has been made since the initial studies in the early 2000s in ChSz 
patients, the deployment of machine learning based tools to clinical practice in early intervention 
services is yet to become reality. This section briefly discusses four issues and challenges that 
will likely come into focus in the years to come: i)  model development and validation process, ii) 
how good is good enough?, iii) case-control design and reliability of diagnostic labels and iv) 
economic viability and ethical issues. 
 
The model development and validation process 
It has been suggested that for a model to be implemented in the real world, it will have to surpass 
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four increasingly demanding stages of validation, in which model performance is estimated in i) 
one sample using CV (development stage), ii) new independent datasets (prospective validation), 
iii) across multiple laboratories and scanners (generalization), iv) diverse populations. According 
to this framework, only 9% of neuroimaging-based models across the psychiatric spectrum had 
gone beyond the initial development phase up until 2016 (Woo et al., 2017). In ChSz, very few 
studies so far have attempted to validate their single-site models in independent samples (e.g. 
Nieuwenhuis et al., 2017). As expected, this figure is much lower in FEP, with only one study 
(Dluhoš et al., 2017), in addition to the present work, reaching the prospective validation stage. 
Critically, the performance in independent samples across the psychiatric spectrum has been 
remarkedly lower than studies in the model-development stage, suggesting substantial optimistic 
biases (Woo et al., 2017). Therefore, although machine learning has brought a new purpose to 
psychiatric neuroimaging, much work is still needed to achieve clinical translation. Much larger 
samples capable of capturing the ‘true’ heterogeneity of the early stages of psychosis, whilst 
putting in place strategies to mitigate sources of ‘apparent’ heterogeneity across research centres, 
combined with data- and model-sharing initiatives will be needed in order to progress beyond the 
development stage. 
 
How good is good enough? 
The implementation of a machine learning tool into the clinical practice will need to ensure a 
minimum required level of performance. This raises the question of how good is good enough. It 
has been suggested that a machine learning-based tool can be considered useful if it reaches an 
accuracy similar or superior to standard methods (Shortliffe & Sepúlveda, 2018). However, in the 
absence of robust biomarkers for psychosis (Prata et al., 2014), there is currently no benchmark 
from an existing biologically-based diagnostic method. Results from this doctoral work suggest 
that a reliable identification of FEP based on neuroanatomical data may be around 60%. Although 
it may be possible to improve this performance, accuracies in ChSz seem to be converging 
towards 70%, suggesting that the classification of FEP will probably not go beyond 70%. From 
here it follows that a machine learning-based tool to identify the initial stages of psychosis 
exclusively based on anatomical information may not be good enough. It is also important to 
consider the potential cost of misclassification. The selected threshold for a tool to identify FEP 
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should take into account the fact that the cost of erroneously misclassifying someone ill as healthy 
may be higher (e.g. further psychotic episodes, reliance on other carers, unemployment) than the 
cost of misclassifying someone healthy as ill (mainly unnecessary examinations). Thus, an 
algorithm which provides excellent sensitivity but only good specificity may be preferred to one 
with the opposite pattern (Savitz, Rauch, & Drevets, 2013). 
 
The case-control design and reliability of diagnostic labels 
The vast majority of machine learning studies in psychosis (Kambeitz et al., 2015; Zarogianni et 
al., 2013), including the present work, and in psychiatric neuroimaging in general (Arbabshirani 
et al., 2017; Wolfers et al., 2015) have been based on the case-control design, where a supervised 
algorithm attempts to separate participants diagnosed with a particular disorder from controls. 
Although intuitive, this application may only reach the same level of diagnostic accuracy as 
traditional, interview based, methods of clinical assessment. This is due to the fact that the initial 
development of the decision function and subsequent testing, relies on the distinction between 
subjects whose labels are pre-defined by the researcher. Therefore, it would be an expression of 
logical confusion to expect a supervised algorithm to allow better diagnostic classification than 
traditional clinical assessment from which it was developed. This circular logic is further 
compromised by the more fundamental limitation of the current diagnostic system. This system 
defines a series of diagnostic labels according to clusters of symptoms that can only be 
determined by clinical interviews and observation. This has resulted in diagnostic categories with 
low reliability, some even with an inter-rater agreement little better than chance (Freedman et al., 
2013). The diagnosis of schizophrenia has shown an acceptable level of inter-rater agreement, 
which is far from optimal. In addition to low reliability, none of the current psychiatric diagnostic 
categories seem to have a corresponding neurobiological signature, which is indicative of poor 
biological validity (Kapur et al., 2012; Prata et al., 2014). Although these are well-recognized 
issues in psychiatry, its implications for machine learning applications have been less discussed. 
In diagnostic classification studies, such as this thesis, where the aim is to use some 
neurobiological measure to separate individuals with a predefined diagnostic label from disease-
free individuals (defined by the absence of any diagnostic label), the success of classifiers is 
limited, in part, by the reliability and biological validity of the diagnostic labels. Specifically, we 
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assume the diagnostic labels behave as in Figure 7.1A. i.e. they measure what we want (they are 
valid) every time (they are reliable). However, based on the exposed above, some would argue 
that Figure 7.1B better illustrates the current scenario, i.e. psychiatric diagnostic labels may not 







Figure 7.1. Bull’s eye analogy to illustrate the validity and reliability of psychiatric diagnostic labels. The 
different dots represent different clinical assessments and respective diagnostic labels; the closer the dots 
are to each other, the higher the reliability. The centre represents what is meant to be measured, e.g. 
diagnosis of schizophrenia; the closer to the centre, the higher the validity. A represents a scenario where 
diagnostic labels are both reliable and valid. In B, diagnostic labels are unreliable and not valid. 
 
Therefore, if, for example, some of the FEP individuals included in the present work have been 
wrongly labelled (and/or the controls wrongly labelled as not having any mental disorder), then 
finding a pattern that differentiates the two groups will become more difficult. Similarly, if FEP as 
we define it is not a valid neurobiological construct, then there may not be a robust pattern to be 
found. Taken collectively, these issues could also explain the modest results found in this thesis, 
as well as the results found in psychiatry in general. Moving forward, machine learning 
applications to psychiatry will have to circumvent these issues. Sophisticated tools, therefore, 
should be able to make decisions beyond the constraints of diagnostic labels ascertained by 
traditional assessments and criteria. This may be addressed in a number of ways including, using 
the extracted features maps and their specificities and commonalties across different psychiatric 
disorders to redefine current nosological systems, or alternatively omit labels all together and 
focus on the prediction of different functional domains as described in Research Domain Criteria 
(RDoC) (Cuthbert, 2015; Morris & Cuthbert, 2012) or use unsupervised methods to identify new 
demarcations between individuals (Durstewitz et al., 2019). 
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Economic viability and ethical issues 
Before the implementation of any machine learning-based tool in clinical practice, a thorough 
assessment of cost-effectiveness and ethical implications will be necessary. At the moment, due 
to the absence of reliable biomarkers for functional psychosis (e.g. schizophrenia), MRI 
assessments in early intervention services are generally reserved for atypical cases and/or cases 
of suspected organic psychosis (e.g. epilepsy, tumour, encephalitis) (Borgwardt & Schmidt, 2017), 
a rare condition that can led to serious consequences if undetected (Joyce, 2018; Keshavan & 
Kaneko, 2013). Given its limited purpose, the routine use of neuroimaging has been shown to 
have limited economical cost-effectiveness (Albon et al., 2008; Khandanpour, Hoggard, & 
Connolly, 2013). However, the hope is that machine learning will greatly expand the use of 
imaging in early intervention services, not only for diagnostic but mostly for prognostic and 
treatment optimization purposes. Going forward, the economic burden of routine MRI 
assessments will have to be revisited to take into account the potential of machine learning in 
reducing the current elevated economic and societal burden associated with psychotic disorders 
(Olesen et al., 2012). Ethical issues will also have to be considered. Perhaps of special 
importance are the issues of accountability and privacy. As decision-making capacity is 
transferred from the human to the intelligent system, the moral and legal accountability of the 
human will diminish accordingly (Goering, Klein, Dougherty, & Widge, 2017; Kellmeyer et al., 
2016). This will generate important discussions about how to create and implement legal 
guidelines to adjudicate accountability in cases of system failures. Similarly, the current trend of 
digitalization of biomedical data will result in enormous stockpiles of personal information, and 
dedicated efforts will have to be put in place to protect this data from unwarranted access and 
illegitimate use as well as to preserve the privacy of individual patients (Amunts, 2018; Kellmeyer, 
2018; Yuste et al., 2017). 
 
7.3. Strengths 
Overall, the core strengths of the present doctoral work are fivefold. First, the sample size was 
the largest ever FEP sample of structural imaging data to be analysed with either univariate or 
multivariate methods. Indeed, the vast majority of neuroanatomical studies so far have been small 
local studies (X. Gao et al., 2018; Shah et al., 2017) which have been associated with a higher 
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risk of false positives (Button et al., 2013) and heterogeneous findings (IntHout et al., 2015). By 
combining five datasets, I was able to show, for the first time, a pattern of GM volume reductions 
related to symptoms severity that was present consistently across several independent sites in a 
group-level mega-analysis. This allowed to address site-dependent findings by identifying 
structural abnormalities above and beyond site-related differences. Similarly, the multivariate 
mega-analysis with traditional machine learning and deep learning provided a more reliable 
insight into the application of machine learning to neuroanatomical data in psychosis. Although 
accuracies were lower than that of most previous single-site studies (Kambeitz et al., 2015; Xiao 
et al., 2017), this was not unexpected given the increased heterogeneity inherent to larger and 
multi-centre studies (Schnack & Kahn, 2016). In addition, such a large sample is likely to be more 
representative of the FEP population and therefore should lead to results with more translational 
potential. Large samples sizes are also especially important for deep learning. Given their 
complexity and nonlinearity, these models thrive when applied to large amounts of data. While 
sample sizes similar to other areas of research are not yet possible, the work presented in this 
thesis was the largest deep learning investigation of the neuroanatomical basis of psychosis to 
date.  
 
Second, as the application of deep learning keeps gains momentum across clinical neuroimaging, 
the first review of the current evidence in psychiatric and neurologic neuroimaging carried out as 
part of this doctoral work represents a useful resource for the neuroimaging community. The 
review also provides an introduction of deep learning to non-experts including its strengths but 
also its pitfalls such as proneness to overfitting and lack of transparency. Given the notorious 
popularity of deep learning, a thorough evaluation of the literature as well as its merits and 
limitations are essential to avoid misconceptions of its potential. This is especially relevant to non-
experts, such as applied researchers and clinicians who are new to the field.      
 
Third, I was able to show, through a series of carefully implemented multi -site, -feature and -
machine learning algorithm experiments, that the predictive power of machine learning to 
recognise the initial stages of psychosis based on structural imaging may not be as high as initially 
thought. This comes at a time of growing concerns about potentially inflated findings due to the 
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use of small samples and less-than-rigours methods (Arbabshirani et al., 2017; Janssen et al., 
2018; Woo et al., 2017). Indeed, most evidence so far has come from small local samples, where 
the possibility of a bespoke and likely overfitted pipeline cannot be ruled out. Consistent with this, 
I was also able to show evidence of publication bias, further supporting the already suspected 
over-representation of inflated results in the literature. Therefore, the work presented in this thesis 
is a valuable contribution towards recent calls for the next generation of machine learning studies 
with larger samples that allow more reliable estimates and independent sample validation 
(Schnack & Kahn, 2016). 
 
Fourth, the use of deep neural networks represented the first attempt to classify FEP and HC 
based on neuroanatomical information using this novel approach. While, classic and simpler 
machine learning approaches are likely to be more suited for the traditional small neuroimaging 
study, as the Big Data movement gains momentum in the neuroimaging community, the 
combination of deep learning with large-scale samples may help capturing more complex 
interactions between neuroanatomical abnormalities across different brain regions.  
 
Finally, by investigating individuals with a recent FEP, many of the confounding factors associated 
with ChSz are minimised if not removed completely, including the effects of prolonged exposure 
to anti-psychotic medication, effects of institutionalisation and the effects of chronicity. In addition, 
by focusing on those in the earliest stages of psychosis it is hoped that the findings may ultimately 
inform the provision of earlier and more effective treatment intervention, which in turn may delay 
the onset of psychotic relapse, if not prevent it altogether. 
 
7.4. Limitations 
A number of limitations also need to be considered when interpreting the results reported in this 
thesis. First, the structural MRI data was collected using different scanners and acquisition 
sequences. Although this was not an issue for the single-site analysis, it is most likely that this 
might have had an impact on the findings from the independent sample validations and mega-
analyses in Chapters 5 and 6, respectively. For example, in the mega machine learning analysis, 
data from the different sites was harmonised by regressing out the effect of the scanner from each 
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feature. This is a standard method to deal with confounding variables in general (Rao, Monteiro, 
& Mourao-Miranda, 2017). However, perhaps a more sophisticated and tailored approach may 
have helped mitigating the effect of scanner even further. 
 
Second, patients also differed with respect to exposure to anti-psychotic medication. Specifically, 
all patients were anti-psychotic naïve in site 1; patients from sites 3 and 4 were either naïve or 
had minimal exposure; finally, sites 2 and 5 had more relaxed criteria and included patients that 
met the inclusion criteria regardless of their anti-psychotic medication intake, resulting in a more 
heterogenous group. Although no effect was found in the univariate and single-site multivariate 
analyses, the impact of anti-psychotic medication cannot be ruled out. In addition, the possible 
effect of anti-psychotic medication was not tested for in the mega machine learning analysis in 
Chapter 6. 
 
Third, the neuroanatomical abnormalities in FEP have been shown to vary according to several 
factors such as ethnicity (Gong et al., 2015), substance use (Rapp, Bugra, Riecher-Rossler, 
Tamagni, & Borgwardt, 2012) and IQ (Czepielewski, Wang, Gama, & Barch, 2017), for example. 
The studies included in the present work did not take these factors into account. This information 
was either not collected or made available for analyses. Had they been made available however, 
dealing with confounders in machine learning applied to neuroimaging is not trivial (Rao et al., 
2017) and most studies deal with this issue by matching groups with respect to the key 
confounders variables. 
 
7.5. Future work 
Based on the findings presented here, there are a number of promising initiatives that could be 
developed as well as possible avenues to be investigated in years to come. Perhaps most vital is 
the standardization of several measurements that can facilitate the integration of the data from 
different sites. Although a data sharing movement is already underway in the psychiatric 
neuroimaging community, the benefits of having access to large amounts of data will have to be 
balanced against the issue of heterogeneity in assessment protocols, especially with respect to 
imaging acquisition. The uniformization of imaging protocols will allow pooling different datasets 
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into a single investigation with minimal impact of between-centre differences. On this regard, the 
ADNI consortium has developed a structural MRI sequence that generates an image with similar 
properties independently of the scanner model and manufacturer (Jack, Bernstein et al. 2008). 
While there are already a few multi-centre projects in psychosis that have adopted this approach 
(e.g. van Os et al. 2014; Cannon, Cadenhead et al. 2008), these are still a minority.   
 
This doctoral work set out to discriminate FEP from HC using only neuroanatomical data. This 
imaging modality data was chosen based on the amount of data available which was considerably 
larger than that of other modalities. However, while maximizing sample size was a priority, there 
is increasing evidence suggesting that the neural mechanisms underlying psychosis may be 
better described as a complex pattern of ‘dysconnectivity’ in function and structure between brain 
regions (Friston, Brown, Siemerkus, & Stephan, 2016; Friston & Frith, 1995; McGuire & Frith, 
1996; Pettersson-Yeo, Allen, Benetti, McGuire, & Mechelli, 2011). There is also evidence showing 
that this ‘dysconnectivity hypothesis’ is already present at the first psychotic episode (O’Neill et 
al., 2018). Although such evidence comes mostly from classic group-comparisons between 
patients and controls, a recent meta-analysis of machine learning studies in psychosis has also 
demonstrated the superiority of functional relative to neuroanatomical imaging data (Kambeitz et 
al., 2015), suggesting that brain connectivity may be more informative to identify psychosis at the 
individual level. At least one study has applied a DNN to functional connectivity to distinguish 
ChSz from HC, albeit in a relatively small sample of 100 participants (J. Kim et al., 2016) . Similar 
efforts dedicated to the initial stages of the illness in large-scale samples such as the one used in 
the present work could potentially shed light on the usefulness of functional connectivity without 
the typical confounds in ChSz. Additionally, one could also leverage on the different information 
conveyed by separate modalities in a multimodal approach (Calhoun & Sui, 2016). Deep learning 
may be particularly useful here, since we lack strong hypotheses of how different modalities 
interact (Durstewitz et al., 2019; Plis et al., 2018; Srinivasagopalan, Barry, Gurupur, & 
Thankachan, 2019). 
 
The work presented here used the general-purpose and simplest form of deep leaning models. 
This was done due to limited computational resources. Future studies could make use of more 
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sophisticated networks such as autoencoders or convolutional networks for example, that may 
potentially unveil more useful patterns from single and/or multimodal imaging to identify FEP. 
Such approaches may be more computationally demanding and prone to overfitting. However, 
one may increase the effective “n” and alleviate computational burden simultaneously by using 
transfer learning, where knowledge gained with one dataset (or task) is transferring to another 
(Caruana, 1998). The main premise here is that distinct imaging datasets share basic structural 
properties and that leveraging on the hierarchical structure of the learned features with a deep 
learning model it is possible to use one dataset to learn more general properties of the data and 
then fine-tune the model in the dataset of interest. The increasing availability of imaging data will 
certainly be a useful resource in the next few years that may allow building models that capture 
the general essence of neuroimaging data, which are subsequently applied to specific tasks. 
 
As with the vast majority of studies so far, the present work used the traditional case-control 
design to identify FEP individuals from HC. Despite intuitive, this design forces the algorithm to 
find a decision function that separates the two groups, which, given the known heterogeneity 
within both patients and controls (Brugger & Howes, 2017; Meyer-Lindenberg, 2010), may not be 
the most suitable approach to capture individualized patterns of abnormality needed for clinical 
translation (Marquand et al., 2016). Normative approaches, where individuals are mapped against 
a normative model that should encompass the heterogeneity characteristic of the normal 
population, are a promising avenue to address this issue (Marquand et al., 2016; Mourão-Miranda 
et al., 2011). Indeed, by considering illness as an extreme case within a normal range, the 
normative approach lends itself better to the already existing notion amongst clinicians that 
psychopathology is better understood as an extreme of a ‘normal’ phenomenon. The combined 
use of normative models with the increasing availability of data is a promising opportunity for 
further developments in machine learning-based tools for clinical decision making (Pinaya, 
Mechelli, & Sato, 2018). 
 
Finally, future studies could also expand the approach used in this present work to include other 
diagnosis and/or investigate longitudinal outcomes. Distinguishing between alternative 
diagnoses, anticipating relapses or recovery, and choosing the optimal treatment for a particular 
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patient are likely to be of more clinical value than distinguishing between patients with FEP from 
disease-free individuals. As sample sizes increase and new methods, such as the normative 
approach, bring machine learning closer to clinical decision making, the investigation of such 




The present doctoral work aimed to address recent calls for more reliable, reproducible and 
translatable findings in psychiatric neuroimaging. Overall, results showed that FEP individuals 
manifest volumetric changes in fronto-temporal-insular regions that can be detected both at the 
group and individual level. Furthermore, this thesis provided a more realistic picture of the 
potential of machine learning to differentiate the initial stages of psychosis from HC. Based on the 
collection of results presented in this thesis, including both single and multi-study analysis, I 
speculate that the reliable separation of FEP from controls at the individual level based on 
neuroanatomical information is around 60%. This is lower than the accuracies reported by the 
majority of previous small local studies. Finally, deep learning showed a marginal superiority over 
traditional methods, indicating promise for unravelling biomarkers for the early stages of 
psychosis. However, there are still important challenges to overcome. These include the 
expensive computational resources and the amount of data required. However, solutions to both 
these obstacles are evolving rapidly and Big Data in combination with deep learning models will 
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a  b  s  t  r a  c  t
Deep  learning  (DL)  is a family  of machine  learning  methods  that  has  gained  considerable  attention  in
the  scientific  community,  breaking  benchmark  records  in  areas  such  as  speech  and  visual  recognition.  DL
differs  from  conventional  machine  learning  methods  by  virtue  of its  ability  to  learn  the  optimal  represen-
tation  from  the  raw  data  through  consecutive  nonlinear  transformations,  achieving  increasingly  higher
levels  of  abstraction  and  complexity.  Given  its ability  to detect abstract  and  complex  patterns,  DL has
been  applied  in  neuroimaging  studies  of  psychiatric  and neurological  disorders,  which  are characterised
by  subtle  and  diffuse  alterations.  Here  we  introduce  the  underlying  concepts  of  DL and  review  studies
that  have  used  this  approach  to  classify  brain-based  disorders.  The  results  of these  studies  indicate  that
DL  could  be a powerful  tool in  the current  search  for  biomarkers  of  psychiatric  and  neurologic  disease.  We
conclude our review  by  discussing  the  main  promises  and  challenges  of  using  DL  to elucidate  brain-based
disorders,  as  well  as possible  directions  for  future  research.
©  2017  The  Authors.  Published  by  Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
In the last two decades, neuroimaging studies of psychiatric
and neurological patients have relied on mass-univariate ana-
lytical techniques (e.g. statistical parametric mapping). These
studies typically compared patients with a diagnosis of interest
against disease-free individuals and reported neuroanatomical or
neurofunctional differences at group level. The simplicity and inter-
pretability of this approach have led to significant advances in our
understanding of the neurobiology of psychiatric and neurological
disorders. Mass-univariate analytical techniques, however, suffer
from at least two significant limitations. First, statistical inferences
are drawn from multiple independent comparisons (i.e. one for
each voxel) based on the assumption that different brain regions
act independently. This assumption, however, is not in line with our
current understanding of brain function in health and disease (Fox
et al., 2005; Biswal et al., 2010); for example, several psychiatric
and neurological symptoms are best explained by network-level
changes in structure and function rather than focal alternations
(Mulders et al., 2015; Kennedy and Courchesne, 2008; Sheffield
and Barch, 2016). Second, mass-univariate techniques can be used
to detect differences between groups but do not allow statistical
inferences at the level of the individual. In contrast, a clinician has
to make diagnostic and treatment decisions about the person in
front of them. These two limitations may  have contributed to the
limited translational impact of neuroimaging findings in everyday
clinical practice so far.
In an attempt to overcome these limitations, the neuroimaging
community has developed a growing interest in machine learning
(ML), an area of artificial intelligence that aims to develop algo-
rithms that discover trends and patterns in existing data and use
this information to make predictions on new data. This is achieved
through the use of computational statistics and mathematical opti-
mization (Hastie et al., 2001). ML  methods are multivariate and
therefore take the inter-correlation between voxels into account,
thereby overcoming the first limitation of mass-univariate analyti-
cal techniques. In addition, ML  methods allow statistical inferences
at single subject level and therefore could be used to inform diag-
nostic and prognostic decisions of individual patients, thereby
overcoming the second limitation of mass-univariate analytical
techniques (Arbabshirani et al., 2016). ML  methods can be divided
into two broad categories: supervised and unsupervised learning.
In supervised ML,  one seeks to develop a function which maps two
or more sets of observations to predefined categories or values. In
contrast, unsupervised methods seek to determine how the data are
organized without using any a priori information supplied by the
operator; here the main objective is to discover unknown structure
in the data (Hastie et al., 2001).
Over the past decade, several ML  methods have been applied to
neuroimaging data from psychiatric and neurological patients with
varying degrees of success (Arbabshirani et al., 2016; Wolfers et al.,
2015). The most popular amongst these methods is Support Vector
Machine (SVM), a supervised technique that works by estimating
an optimal hyperplane that best separates two classes. When these
classes are not linearly separable, SVM uses external functions (ker-
nels) that map  the original data into a new feature space where
the data become linearly separable (Pereira et al., 2009; Vapnik,
1995). Despite its popularity, SVM has been criticised for not per-
forming well on raw data and requiring the expert use of design
techniques to extract the less redundant and more informative fea-
tures (a step known as “feature selection”) (LeCun et al., 2015; Plis
et al., 2014). These features, rather than the original data, are then
used for classification. While SVM remains a very popular technique
within the neuroimaging community, an alternative family of ML
methods known as deep learning (DL) (Bengio, 2009) is gaining con-
siderable attention in the wider scientific community (Arbabshirani
et al., 2016; Calhoun and Sui, 2016; LeCun et al., 2015). Deep learn-
ing methods are a type of representation-learning methods, which
means that they can automatically identify the optimal represen-
tation from the raw data without requiring prior feature selection.
This is achieved through the use of a hierarchical structure with
different levels of complexity, which involves the application of
consecutive nonlinear transformations to the raw data. These trans-
formations result in increasingly higher levels of abstraction, where
higher-level features are more invariant to the noise present in the
input data than lower level ones (LeCun et al., 2015). Inspired by
how the human brain processes information, the building blocks of
DL neural networks ! known as “artificial neurons” ! are loosely
modelled after biological neurons. Artificial neurons are organized
in layers. A deep neural network consists of an input layer, two or
more hidden layers and an output layer. The input layer comprises
the data inputted into the model (e.g. voxel intensity); the hidden
layers learn and store increasingly more abstract features of the
data; these features are then fed to the output layer that assigns
the observations to classes (e.g. controls vs. patients). Learning is
achieved through an iterative process of adjustment of the inter-
connections between the artificial neurons within the network,
much like in the human brain (Bengio, 2009). An essential aspect
of DL that differentiates it from other ML  methods is that the fea-
tures are not manually engineered; instead, they are learned from
the data, resulting in a more objective and less bias-prone process.
Besides, the ability to achieve higher orders of abstraction and com-
plexity relative to other ML  methods such as SVM makes DL better
suited for detecting complex, scattered and subtle patterns in the
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From a historical perspective, the use of DL in scientific research
can be traced back to the perceptron (i.e. the original version
of the artificial neuron), which many researchers refer to as the
first ML  algorithm (McCulloch and Pitts, 1943). After several set-
backs, the pioneering work of Warren McCulloch and Walter Pitts
resulted in the development of what is now known as artificial
neural networks. However, such networks were able to handle a
limited number of hidden layers. It was only in the 2000s that
researchers developed a new approach for training artificial neu-
ral networks that allowed the inclusion of several hidden layers
resulting in greater levels of complexity (Hinton et al., 2006).
This breakthrough led to the development of a new family of ML
methods ! known as deep learning ! which has been shown to out-
perform previous state-of-the-art classification methods in areas
such as speech recognition, computer vision and natural language
processing (Krizhevsky et al., 2012; Le et al., 2012).
The use of DL could be particularly useful in the investigation
of psychiatric and neurological disorders, which tend to be associ-
ated with subtle and diffuse neuroanatomical and neurofunctional
abnormalities. Since high-level features can be more robust against
noise in the input data, deep architectures may  be more suitable to
identify diagnostic and prognostic biomarkers than conventional
ML methods. DL techniques might also provide an ideal tool to
investigate the multi-faceted nature of psychiatric and neurologi-
cal disorders since cross-modality relationships (e.g. neuroimaging
and genetics) are likely to occur at an even deeper level (Plis et al.,
2014). In addition to these conceptual differences, the use of DL to
investigate psychiatric and neurological disorders has the practical
advantage of not requiring manual feature selection (LeCun et al.,
2015). Therefore, it is unsurprising that an increasing number of
neuroimaging studies are using DL to elucidate the neural corre-
lates of these disorders (e.g. Payan and Montana, 2015; Plis et al.,
2014; Kim et al., 2016).
Given the insurgence of interest in DL within the field of neu-
roimaging, this review aims to give a brief overview of DL and
potential applications to the investigation of brain-based disorders.
In the first part of the review, we outline the underlying concepts
of DL. To achieve this, we will use one of the simplest DL structures,
i.e. the multilayer perceptron, to illustrate the steps of training and
testing. This will be followed by a brief description of the most
common DL architectures used in the field of neuroimaging, includ-
ing stacked autoencoders, deep belief networks and convolutional
neural networks. The second part of this article aims to summarise
the studies that have applied DL to neuroimaging data to inves-
tigate psychiatric and neurological disorders. Finally, in the third
part of the review, we discuss the main themes that have emerged
from our review of the existing literature, and make a number of
suggestions for future research directions.
2. Overview
Deep learning refers to the training and testing of multi-layered
neural networks that are capable of learning complex structures
and achieve high levels of abstraction. There are two  main types
of DL models which differ with respect to how the information
is propagated through the network. In feedforward networks, the
information is propagated through the network in just one direc-
tion, from the input to the output layer. Recurrent networks, in
contrast, contain feedback connections that allow the information
from past inputs to affect the current output. These connections
enable the information to persist within the neural network, akin to
a form of memory, and this allows the models to process sequential
data, such as speech and language, in a natural way.
The implementation of DL in the context of supervised classi-
fication problems involves two main steps. In the first step, the
so-called training phase,  a subset of the available data known as
the training set is used to optimize the network’s parameters to
perform the desired task (classification). In the second step, the so-
called testing phase, the remainder subset which is known as the test
set is used to assess whether the trained model can blind-predict
the class of new observations. When the amount of available data
is limited, it is also possible to run the training and testing phases
several times on different training and test splits of the original
data and then estimate the average performance of the model ! an
approach known as cross-validation. The two phases of training and
testing are not a specific feature of DL but are used in conventional
ML methods.
In this section, we will discuss the use of feedforward DL for
classification problems. We will start with the multilayer percep-
tron (MLP), the simplest deep neural network (DNN) architecture,
to illustrate three important aspects of deep learning ! network
structure, training and testing. We will then describe more com-
plex networks, including stacked autoencoders and deep belief
networks. Finally, we  will describe the increasingly popular con-
volutional neural networks (CNN), an important adaptation of the




MLPs are organized in a layer-wise structure where each layer
stores increasingly more abstract representations of the data
(Fig. 1). The first layer is the input layer where the data is entered
into the model. In neuroimaging, the data can be represented as
a one-dimensional vector with each value corresponding to the
intensity of one voxel. The last layer is the output layer which, in
the context of classification, yields the probability of a given sub-
ject belonging to one group or the other. The layers between the
input and output layers are called hidden layers, with the number
of hidden layers representing the depth of the network. Each layer
comprises a set of artificial neurons or “nodes” (Fig. 1a) in which
each neuron is fully connected to all neurons in the previous layer
(Fig. 1b). Each connection is associated with a weight value, which
reflects the strength and direction (excitatory or inhibitory) of each
neuron input, much like a synapse between two biological neurons.
Unlike SVM, which relies on expert designed transformations
to handle nonlinearly separable classes, the structure of neural
networks itself allows the transformation of the input space. The
consecutive layers perform a cascade of nonlinear transformations
that distort the input space allowing the data to become more easily
separable (Fig. 2). The optimal number of layers and nodes within
each layer are not estimated as part of the learning process itself but
are defined a priori. These a priori parameters, which are not opti-
mized during the training, are called hyperparameters. It should be
noted that the development of algorithms to find optimum values
of these hyperparameters is an active area of research, and that at
present there are no fixed rules (Bergstra et al., 2011; Gelbart et al.,
2014).
2.1.2. Training
Traditionally, neural networks can learn through a gradient
descent-based algorithm. The gradient descent algorithm aims to
find the values of the network weights that best minimise the error
(difference) between the estimated and true outputs. Since MLPs
can have several layers, in order to adjust all the weights along the
hidden layers, it is necessary to propagate this error backward (from
the output to the input layer). This propagation procedure is called
backpropagation, and allows the network to estimate how much
the weights from the lower layers need to be changed by the gradi-









S. Vieira et al. / Neuroscience and Biobehavioral Reviews 74 (2017) 58–75 61
(a)
(b)
Fig. 1. (a) The building block of deep neural networks ! artificial neuron or node.
Each input xi has an associated weight wi . The sum of all weighted inputs, !xiwi ,
is  then passed through a nonlinear activation function f, to transform the pre-
activation level of the neuron to an output yj . For simplicity, the bias terms have
been omitted. The output yj then serves as input to a node in the next layer. Sev-
eral  activation functions are available, which differ with respect to how they map
a  pre-activation level to an output value. The most commonly activation functions
used are the rectifier function (where neurons that use it are called rectified linear
unit (ReLU)), the hyperbolic tangent function, the sigmoid function and the soft-
max  function. The latter is commonly used in the output layer as it can compute
the  probability of multiclass labels. (b) Example of a feedforward multilayer neural
network (also referred to as multilayer perceptron) with two  classes, in which the
nodes in one layer are connected to all neurons in the next layer (fully connected
network). For each neuron j in the first hidden layer, a nonlinear function is applied
to the weighted sum of the inputs. The result of this transformation (yj) serves as
input for the second hidden layer. The information is propagated through the net-
work up to the output layer, where the softmax function yields the probability of a
given observation belonging to each class.
the weights are set at random. When the training set is presented to
the network, this forward propagates the data through the nonlin-
ear transformation along the layers. The estimated output is then
compared to the true output, and the error is propagated from the
output towards the input, allowing the gradient descent algorithm
to adjust the weights as required. The process continues iteratively
until the error has reached its minimum value. The backpropaga-
tion algorithm does not work well with the original models of DNNs
that were based on sigmoid and hyperbolic tangent nonlinearities.
In these models, the information of the error becomes increasingly
smaller as it propagates backward from the output to the input
layer, to a point where initial layers do not get useful feedback on
how to adjust their weights ! an issue known as the vanishing
gradient problem. Therefore, initially, the use of backpropagation
yielded poor solutions for networks with three or more hidden lay-
ers (Schmidhuber, 2015). In 2006, however, Hinton and colleagues
put forward the idea of “greedy layerwise training”, which consists
of two  steps: 1) an unsupervised step, where each layer is trained
individually and 2) a supervised step, where the previously trained
layers are stacked, one additional layer is added to perform the
classification (the output layer), and the whole network parame-
ters are fine-tuned (Hinton et al., 2006). This breakthrough led to
the fast-growing interest in deep learning and enabled the devel-
opment of at least two types of pre-trained networks that have
shown promising results: stacked autoencoders and deep belief
networks. It should be noted that these methods are not actual clas-
sifiers themselves; instead, they are networks that are pre-trained
to learn useful patterns in the data and then fed to a real classifier
at the final layer. These two  types of networks and their unique
characteristics are described in Section 2.2 and 2.3.
2.1.3. Testing
The performance of a deep neural network can be evaluated
by several performance measures, such as sensitivity, specificity,
accuracy and F-score. Sensitivity refers to the proportion of true
positives correctly identified (e.g. the proportion of subjects that
were predicted as patient and are true patients), and specificity
refers to true negatives correctly identified (e.g. the proportion
of subjects that were predicted as healthy controls and are true
healthy controls). The accuracy of a classifier represents the over-
all proportion of correct classifications. The statistical significance
of this overall accuracy can be tested using parametric tests such
as permutation testing, which measures how likely the observed
accuracy would be obtained by chance. Metrics such as F-score and
balanced accuracy, which take into account each group’s sample
size, are particularly useful in cases where classes are unbalanced.
The F-score is a measure that combines precision or positive pre-
dictive value (proportion of individuals classified as cases were
actually cases) and sensitivity (proportion of true cases correctly
classified as such). Balanced accuracy, on the other hand, corre-
sponds to the average accuracy obtained on either class (Brodersen
et al., 2010).
2.1.4. Risk of overfitting and possible strategies
Due to the use of multiple nonlinear transformations, deep net-
works are highly complex models that involve the estimation of a
very large number of parameters. This can lead to the model learn-
ing particular fluctuations in the training data that are irrelevant
Fig. 2. Effect of the depth of the model. Each dot corresponds to a neuroimage-based data visualized in a two-dimensional map. With more hidden layers, the data becomes









62 S. Vieira et al. / Neuroscience and Biobehavioral Reviews 74 (2017) 58–75
Fig. 3. (a) Shallow or simple autoencoder. In its shallow structure, an autoencoder is comprised of an input layer, that represents the original data (e.g., pixels in an image),
one  hidden layer that represents the transformed data, and an output layer that reconstructs the original input data. (b) Stacked autoencoder. Two simple autoencoders are
stacked  with a 2-class softmax classifier as the final layer. From each simple autoencoder, the output layer is discarded, and the hidden layer is used as the input layer for
next  autoencoder.
Fig. 4. Generic structure of a CNN. For illustrative purpose, this example only has one layer of each type; a real-world CNN, however, would have several convolutional and
pooling  layers (usually interpolated) and one fully-connected layer. (a) Input layer. In its simplest way, the data is inputted into the network in such a way  that each pixel
corresponds to one node in the input layer. (b) Convolutional layer. A 3 ! 3 filter or kernel (in green) is used to multiply the spatially corresponding 3 ! 3 nodes in the image.
The  resulting weighted sum is then passed through a nonlinear function to derive the output value of one node in the feature map. The repetition of this same operation
across all possible receptive fields results in one complete feature map. The same procedure with different kernels (in orange and blue) will result in separate complete
feature  maps. (c) Pooling layer. The size of each feature map  can be reduced by taking the maximum value (or average) from a receptive field in the previous layer. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
for the purpose of classification " an issue known as “overfitting”.
When this happens, the model will perform very well on the train-
ing data but will not be able to replicate its performance on unseen
data (Srivastava et al., 2014). The risk of overfitting is particu-
larly high in the context of neuroimaging, where the number of
data points (e.g. number of voxels) for a subject is much larger
than the total number of subjects, resulting in high-dimensional
data (Arbabshirani et al., 2016). However, there are a number of
strategies that can be used to minimise the risk of overfitting, col-
lectively known as “regularization”. A first strategy involves the
use of weight decays (e.g., L1 and L2 norms) to penalise models
with very high weights. It has been observed that extreme (very
low or very high) weight values in a ML  model are symptomatic
of the model trying to learn the regularities of the data perfectly
(Moody et al., 1995). By forcing weights to remain low, the net-
work becomes less dependent on the training data and is able to
better generalise to unseen data (Nowlan and Hinton, 1992). A sec-
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a random number of nodes and their respective incoming and out-
going connections from the network during training. This means
that the contribution of dropped-out neurons to the activation of
downstream neurons is temporally removed on the forward pass
and that any weight updates are not applied to these neurons on
the backward pass. The aim of dropout is to extract different sets of
features that can independently produce a useful output, thereby
allowing higher levels of generalizability (Srivastava et al., 2014).
2.2. Autoencoders
Autoencoders are a special case of feedforward networks which
comprise of two main components. The first component, i.e. the
“encoder”, learns to generate a latent representation of the input
data, whereas the second component, i.e. the “decoder”, learns to
use these learned latent representations to reconstruct the input
data as close as possible to the original (Fig. 3a) (Vincent et al.,
2010).
Since an autoencoder does not make use of labels, its train-
ing is an unsupervised learning process. In its shallow structure,
an autoencoder is comprised of three layers: an input layer, one
hidden layer and an output layer. The training to perform the
input-copying task can be useful to extract meaningful features
of the input data. This automatic feature extraction can be per-
formed using an error function (or loss function) that encourages
the model encoder to have specific characteristics, such as sparsity
of the representation (sparse autoencoders) and robustness to noise
(denoising autoencoders). Since autoencoders are automatic fea-
tures extractors, they can also be stacked to create a deep structure
to increase the level of abstraction of learned features. In this case,
the network is pre-trained, i.e. each layer is treated as a shallow
autoencoder, generating latent representations of the input data.
These latent representations are then used as input for the subse-
quent layers before the full network is fine-tuned using standard
supervised learning (Fig. 3b) (Larochelle et al., 2007).
2.3. Deep belief networks
Deep belief networks (DBNs), proposed by Hinton et al. (2006),
are technically the first DL models. Similar to stacked autoencoders,
DBNs are comprised of stacked shallow feature extractors, known
as restricted Boltzmann machines (RBMs). An RBM is composed by
only two layers: a visible layer and a hidden layer. Just like autoen-
coders, RBMs also aim to learn and extract useful features from
the data. However, RBMs differ from autoencoders with regards
to their training processes. RBMs can be interpreted as a stochastic
neural network. Therefore, instead of using deterministic functions
and the reconstruction error (like the autoencoders), the RBM uses
the maximum-likelihood estimation to find a stochastic represen-
tation of the input in its hidden layer (latent features). To do this,
RBMs are usually trained using a gradient descent algorithm, with
the likelihood gradient being performed by an approximation algo-
rithm known as contrastive divergence (Hinton et al., 2006). Here
the input data, stored in the visible layer, are propagated to the
hidden layer as in a feedforward network, and the resulting sum
of the weighted inputs provides a measure of the neuron activa-
tion probability. The activation of hidden neurons can be thought
of as the network’s internal representation of the data, which is
then propagated back to the visible layer in an attempt to recon-
struct the input data from the network’s internal representation.
The network, therefore, learns by adjusting the weights based on
the discrepancy between the true and reconstructed data. Similarly
to autoencoders, RBMs can be stacked to create a deep network,
where the hidden layer representation of one RBM serves as input
layer for the following RBM, and the network can learn higher-level
features from lower-level ones to arrive at an abstract representa-
tion of the data. Furthermore, the neural network corresponding to
a trained DBN can be augmented by adding an output layer, where
units represent the labels corresponding to the input sample. This
results in a standard neural network for classification that can be
further trained using supervised learning algorithms.
2.4. Convolutional neural networks
Convolutional neural networks (CNNs) are a special type of feed-
forward neural networks that were initially designed to process
images, and as such are biologically-inspired by the visual cortex
(LeCun et al., 1998). In addition to the input and output layers,
CNN can comprise of three types of layers: a convolutional layer, a
pooling layer, and a fully-connected layer (Fig. 4).
The convolutional layer is organized in several feature maps.
Every neuron in a feature map  is connected to a fixed set of neurons
in a local region of the previous layer – the receptive field – in such a
way that the whole image is covered (“local connectivity”). Within
the same feature map, the connections between each neuron and
the corresponding receptive field share the same weights, whereas
different feature maps use different sets of weights (“weight shar-
ing”). As a result of this architecture, a feature map  can be thought
of as a “feature detector” that scans the whole image for the same
pattern. This pattern is usually known as the kernel. Kernels in a
CNN are learned during the training process, as opposed to in SVM,
where they are defined a priori. In a network with several con-
volutional layers, each layer codes for increasingly more abstract
features (e.g. lines ! edges ! eyes ! face). The pooling layer sim-
ply reduces the number of neurons of the previous convolutional
layer. The fully-connected layers are similar to the hidden lay-
ers from the conventional MLP  where the neurons are connected
to all neurons from the previous layer. All combined, the proper-
ties of CNN (local connectivity, weight sharing and pooling) result
in a significant reduction in the number of parameters, which in
turn decreases the likelihood of overfitting, and alleviates compu-
tational processing.
3. Review of DL studies of psychiatric or neurological
disorders
In order to identify previous applications of DL in neuroimag-
ing studies of psychiatric or neurological disorders, a search was
conducted on 1st August 2016 across several databases (PubMed,
IEEE Xplore, Scopus and ArXiv) using the following search terms:
(“deep learning” OR “deep architecture” OR “artificial neural net-
work” OR “autoencoder” OR “convolutional neural network” OR
“deep belief network”) AND (neurology OR neurological OR psy-
chiatry OR psychiatric OR diagnosis OR prediction OR prognosis
OR outcome) AND (neuroimaging OR MRI  OR “Magnetic Resonance
Imaging” OR “fMRI” OR “functional Magnetic Resonance Imaging”
OR PET OR “Positron emission tomography”). This review did not
include EEG studies, although there is some evidence that DL can
also be used with this type of data, particularly in epilepsy (Page
et al., 2014). The initial search yielded a total of 172 articles. As the
next step, we  screened and cross-referenced these articles for stud-
ies that had applied a deep learning model to neuroimaging data
to investigate a psychiatric or neurologic condition; this identified
a total of 25 articles which were relevant to our review. We  orga-
nized these articles as follows: i) diagnostic studies,  which aimed
to classify patients from healthy controls, ii) studies on conversion
to illness,  which used baseline scans from individuals identified as
being at high risk of developing a psychiatric or neurologic disorder
to predict subsequent transition to the illness, and finally iii) stud-
ies predicting treatment response, which used baseline scans from
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Table 1
Diagnostic studies.
Authors, year Sample size Technique Features Previous
feature
selection
DL architecture Comparison Accuracy (%)
Gupta et al. (2013)a AD = 200 sMRI WB voxel-level No Sparse AE & CNN HC vs. AD 94.7
MCI  = 411 HC vs. MCI  86.4
HC  = 232 AD vs. MCI  88.1
HC vs. AD vs. MCI  85.0
Payan and Montana
(2015)a
HC = 755 sMRI WB voxel-level No Sparse AE & CNN HC vs. AD 95.4
AD  = 755 HC vs. MCI 92.1
MCI = 755 AD vs. MCI  86.8
HC vs. AD vs. MCI  89.5
Hosseini-Asl et al.
(2016) a,b
HC = 70* sMRI WB voxel-level No AE & CNN HC vs. AD 97.6
AD  = 70* HC vs. MCI  90.8
MCI  = 70* AD vs. MCI  95.0
HC vs. AD vs. MCI  89.1
Chen et al. (2015)a HC = 123 sMRI WB voxel-level Yes SAE HC vs. AD 89.0
AD  = 94 HC vs. MCI 81.7
MCI = 121
Liu et al. (2015a)a HC = 204 sMRI WB region-level Yes SAE HC vs. AD 82.6
AD  = 180 HC vs. MCI  72.0
MCI  = 374
Gao and Hui (2016) HC = 117 CT WB voxel-level No CNN HC vs. AD vs. Lesion 87.7




HC = 15 rsfMRI WB voxel-level No CNN HC vs. AD 96.9
AD  = 28
Suk et al. (2016)a HC = 31 rsfMRI WB region-level Yes DAE HC vs. MCI  72.6
MCI  = 31
HC = 25 rsfMRI WB region-level Yes DAE HC vs. MCI  81.1
MCI  = 12
Hu et al. (2016)a HC = 52 rsfMRI WB region-level No SAE HC vs. MCI  87.5
MCI  = 48
Han et al. (2015)a HC = nr rsfMRI WB voxel-level No AE & CNN HC vs. AD 80.0
AD  = nr
Liu et al. (2015a)a HC = 77 sMRI & PET WB region-level Yes SAE HC vs. AD 91.4
AD  = 85 HC vs. MCI  82.1
MCI  = 169
Suk et al. (2014)a HC = 101 sMRI & PET WB region-level Yes DBM HC vs. AD 94.9
AD  = 93 HC vs. MCI  80.6
MCI  = 204
Liu et al. (2014)a HC = 77 sMRI & PET WB region-level Yes SAE HC vs. AD 87.8
AD  = 65 HC vs. MCI 76.9
MCI = 169
Suk et al. (2015b)a HC = 52 sMRI & PET & CSF WB region-level Yes DW-S2 MTL  HC vs. AD 95.1
AD  = 51 HC vs. MCI  80.1
MCI  = 99 HC vs. AD vs. MCI  62.9
HC  = 229 sMRI & PET & CSF WB region-level Yes DW-S2 MTL  HC vs. AD 90.3
AD  = 198 HC vs. MCI  70.9
MCI  = 403 HC vs. AD vs. MCI  57.7
Liu et al. (2015b)a HC = 77 sMRI & PET & MMSE  WB region-level Yes SAE HC vs. AD 90.1
AD  = 85 HC vs. AD vs. MCI  59.2
MCI  = 169
Suk et al. (2015a)a HC = 52 sMRI & PET & CSF &
MMSE  & ADASCog
WB region-level Yes SAE HC vs. AD 98.8
AD  = 51 HC vs. MCI  90.7
MCI  = 99 AD vs. MCI  83.7
Li et al. (2014)a HC = 52 sMRI & PET & CSF &
MMSE  & ADASCog
WB region-level Yes MLP  HC vs. AD 91.4
AD  = 51 HC vs. MCI  77.4
MCI  = 99
Suk and Shen (2013)a HC = 52 sMRI & PET & CSF &
MMSE  & ADASCog
WB region-level No SAE HC vs. AD 95.9
AD  = 51 HC vs. MCI  85.0
MCI  = 99




HC = 744 rsfMRI WB region-level Yes FCC HC vs. ADHD-C !90.0
ADHD-C = 260 HC vs. ADHD-I !90.0
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Table  1 (Continued)
Authors, year Sample size Technique Features Previous
feature
selection
DL architecture Comparison Accuracy (%)
Kuang et al. (2014)c HC = 69 to 110 rsfMRI ROI (PFC)
ROI (VC)
ROI (CC)
Yes DBN HC vs. ADHD-C vs.
ADHD-I vs. ADHD-H
37.4 to 71.8***
ADHD-C = 16 to
95
HC vs. ADHD-C vs.
ADHD-I vs. ADHD-H
34.4 to 68.8***
ADHD-I = 2 to 5 HC vs. ADHD-C vs.
ADHD-I vs. ADHD-H
37.1 to 72.7***
ADHD-H = 1 to
50
Kuang and He (2014)c HC = 42 to 95 rsfMRI ROI (PFC) Yes DBN HC vs. ADHD-C vs.
ADHD-I vs. ADHD-H
44.4 to 80.9***
ADHD-C = 0 to
77
ADHD-I = 0 to
44
ADHD-H = 0 to
6
Hao et al. (2015)c HC = 69 to 110 rsfMRI ROI (PFC, VC, SSC and
CC combined)
Yes DBaN HC vs. ADHD-C vs.
ADHD-I vs. ADHD-H
48.9 to 72.7***
ADHD-C = 16 to
95
ADHD-I = 2 to 5
ADHD-H = 1 to
50
Plis et al. (2014) HC = 191 sMRI WB  voxel-level No DBN HC vs. SZ 91**
SZ and
FEP = 198
Kim et al. (2016)d HC = 50 rsfMRI WB  region-level Yes SAE HC vs. SZ 85.8
SZ  = 50
Munsell et al. (2015) HC = 48 DTI WB  region-level No SAE HC vs. TLE 69.0
TLE  = 70










* Sample sizes for the fine-tuning stage only (pre-training included an additional 386 samples).
** F-score.
*** Range of accuracies obtain from the different datasets used; HC, healthy controls; SZ, schizophrenia, FEP, first episode psychosis; ADHD, attention deficit/hyperactive
disorder; ADHD-C, attention-deficit/hyperactive disorder combine subtype; ADHD-I, attention-deficit/hyperactive disorder inattentive subtype; ADHD-H, attention-
deficit/hyperactive disorder hyperactive subtype; SCA2, spinocerebellar ataxia type 2; SCA6, spinocerebellar ataxia type 6; AT, ataxia-telangiectasia; TLE, temporal lobe
epilepsy; AD, Alzheimer’s disease; MCI, mild cognitive impairment; CC, cingulate cortex; VC, visual cortex, PFC, pre-frontal cortex; SSC, somatosensory cortex; sMRI, struc-
tural  MRI; rsfMRI, resting-state functional MRI; CT, computed tomography; PET, Positron emission tomography; DTI, diffusion tensor imaging; CSF, cerebrospinal fluid; MMSE,
mini  mental state examination; ADASCog, Alzheimer’s Disease Assessment Scale’s cognitive subscale; AE, autoencoder, SAE, stacked autoencoder; FCC, fully-connected cas-
cade;  DBN, deep belief network, DBaN, deep Bayesian network; CNN, convolutional neural network; DAE, deep autoencoder; DBM, deep Boltzman machine; DW-S2 MTL,
deep  weighted subclass-based sparse multi-task learning; MLP, multilayer perceptron; nr, not reported.
subsequent treatment response. These studies are summarised in
Tables 1, 2 and 3 which provide the following information: sample
size; type of data used as input; whether a whole brain (WB) or
region of interest (ROI) approach was used; whether the informa-
tion inputted into the model comprised of voxel or region-level
features; whether feature selection was or was  not used before
inputting the data into the model; general type of DL architecture;
diagnostic groups being investigated; and accuracy. Whenever
performed, we also report the accuracies obtained for multiclass
classifications, which involve discriminating between more than
two classes (e.g. healthy controls vs. mild cognitive impairment vs.
Alzheimer’s disease).
3.1. Diagnostic studies
Studies using DL to classify psychiatric or neurological patients
from healthy individuals have used a range of neuroimaging modal-
ities including structural MRI  (sMRI), resting-state fMRI (rsfMRI),
positron emission tomography (PET) and a combination of differ-
ent modalities (multimodal studies) (see Table 1). From Table 1 it
can be seen that the vast majority of these studies were carried out
in Alzheimer’s disease (AD) and its prodromal stage, mild cognitive
impairment (MCI). In addition, a smaller number of studies exam-
ined psychosis, attention deficit/hyperactivity disorder (ADHD),
cerebellar ataxia and temporal lobe epilepsy (TLE). Within each
diagnostic category, we first give an overview of the studies that
have used a single neuroimaging modality, followed by studies that
employed a multimodal approach and, finally, studies that have
combined neuroimaging and clinical data within a single classifier.
3.1.1. Mild Cognitive Impairment and Alzheimer Dementia
In one of the first studies using DL in AD and MCI, Gupta et al.
(2013) argued that, since (i) natural images and brain imaging have
similar, and therefore interchangeable, low-level features (e.g. lines
and corners) and (ii) natural images, contrary to neuroimaging, are
abundant, then natural images could be used to learn low level
features which could then be used to identify lesions along the sur-
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Table 2
Conversion to illness.




DL architecture Comparison Accuracy
(%)
Liu et al. (2015a)a HC = 204 sMRI WB region-level Yes SAE AD vs MCI-C vs
MCI-NC vs HC
46.3
AD  = 180
MCI-C = 160
MCI-NC = 214




Liu et al. (2015a)a HC = 77 sMRI & PET WB region-level Yes SAE AD vs MCI-C vs
MCI-NC vs HC
53.8
AD  = 85
MCI-C = 67
MCI-NC = 102
Liu et al. (2014)a HC = 77 sMRI & PET WB region-level Yes SAE AD vs MCI-C vs
MCI-NC vs HC
47.4
AD  = 65
MCI-C = 67
MCI-NC = 102
Suk et al. (2015b)a MCI-C = 43 sMRI & PET & CSF WB region-level Yes DW-S2 MTL  MCI-NC vs
MCI-C
74.2
MCI-NC = 56 AD vs MCI-C vs
MCI-NC vs HC
53.7
AD  = 51
HC = 52
MCI-C = 167 sMRI & PET & CSF WB region-level Yes DW-S2 MTL  MCI-NC vs
MCI-C
73.9
MCI-NC = 236 AD vs MCI-C vs
MCI-NC vs HC
47.8
HC  = 52
AD = 198
Li et al. (2014)a MCI-C = 43 sMRI & PET & CSF &
MMSE  & ADASCog




Suk and Shen (2013)a MCI-C = 43 sMRI & PET & CSF &
MMSE  & ADASCog




Suk et al. (2015a)a MCI-C = 43 sMRI & PET & CSF &
MMSE  & ADASCog




a ADNI dataset; HC, healthy controls; AD, Alzheimer’s disease; MCI-NC, mild cognitive impairment non-converters; MCI-C, mild cognitive impairment converters; sMRI,
structural MRI; PET, Positron Emission Tomography; CSF, cerebrospinal fluid; MMSE, mini mental state examination; ADASCog, Alzheimer’s Disease Assessment Scale’s








DL architecture Comparison Accuracy (%)
Munsell et al. (2015) TLEns = 41 DTI WB region-level No SAE TLEns vs TLEs 57.0
TLEs  = 29
HC, healthy controls; TLE-ns, temporal lobe epilepsy without seizures; TLE-ns, temporal lobe epilepsy with seizures; DTI, diffusion tensor imaging.
learned in one set of data are used to solve a problem in another
set of data, is known as “transfer learning”. Based on this premise,
the authors pre-trained a sparse autoencoder to learn features from
natural images, which were then applied to structural MRI  data via
a CNN, achieving a classification accuracy of 94.7% for AD versus
controls, 86.4% for MCI  versus controls and 88.1% for AD versus
MCI. Consistent with the authors’ hypothesis, this method outper-
formed the one where the learned features were extracted from the
neuroimaging data (93.8%, 83.3% and 86.3% for the same compar-
isons, respectively). However, a few years later and using a similar
approach, Payan and Montana (2015) found comparable classifica-
tion accuracies using features that were learned from the structural
MRI  data itself. This could potentially be explained by the fact that
Payan and Montana (2015) used a much larger sample, as well as by
the fact that authors used 3D brain images, as opposed to 2D, which
possibly contain more useful patterns for classification. Indeed,
Payan and Montana (2015) reported that, in general, the models
based on 3D outperformed those based on 2D brain images (AD vs.
HC (2D/3D) = 95.4%/95.4%; AD vs. MCI  (2D/3D) = 82.2%/86.8%; MCI
vs. HC (2D/3D) = 90.1%/92.1%). The best accuracy (97.6%) from sin-
gle modality studies came from Hosseini-Asl et al. (2016), who also
used transfer learning. Instead of extracting features from natural
images and then fine-tuning the model on Alzheimer’s patients and
controls, as seen in Gupta et al. (2013); Hosseini-Asl et al. (2016)
used one Alzheimer’s dataset for pre-training and another inde-
pendent Alzheimer’s dataset to fine-tune the model. By performing
the pre-training on an Alzheimer’s dataset, this approach allowed
for the network to extract generic features related to AD biomark-
ers, such as the ventricular size, hippocampus shape, and cortical
thickness as opposed to more generic low-level features as in Gupta
et al. (2013). By using two independent samples during the com-
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are much less dataset-specific, and should therefore be more gen-
eralizable. The final model’s architecture was also deeper than in
previous studies, which probably also contributed to the high accu-
racy. Taken collectively, these studies suggest that the application
of DL to structural MRI  data allows the classification of individu-
als with AD and MCI  with high levels of accuracy. Consistent with
the increasing popularity of CNN models, studies that have applied
either CNN or a combination of AE and CNN have shown better
performances compared to those using only AE, although it should
be noted that the former group of studies tended to have larger
samples than the latter group. In addition, and similar to the trend
reported in computer vision competitions and research, the best
performances were obtained by the deepest CNN models.
Studies of AD and MCI  using resting-state imaging have also
achieved promising results. For example, Han et al. (2015) designed
a hierarchical convolutional sparse autoencoder (HCSAE), which
essentially extracts the most discriminating features from the
resting-state data and encodes them in a convolutional manner.
This particular arrangement allows for the extraction of the most
useful information while conserving abundant detail. The final
model classified AD and controls with an 80.0% accuracy and sig-
nificantly outperformed SVM, which only yielded an accuracy of
50% (Fig. 4). While this is a promising result, the model assumed
that functional networks were statistic over time ! an assumption
which underlies the vast majority of ML  applications to resting-
state neuroimaging data. However, recent studies have shown that
the network-level functional organization of the brain is dynamic
rather than static (Hutchison et al., 2013). Suk et al. (2016) have
addressed this issue by developing an approach which classifies
people with MCI  and healthy controls using a deep autoencoder to
extract hierarchical nonlinear relations among brain regions, whilst
modelling the inherent functional dynamics of resting-state data.
This was also one of the few studies in which the same DL model
was tested against and surpassed other competing models in two
independent datasets (72.6% for dataset 1 and 80.0% for dataset 2),
thus providing evidence of replicability, a crucial feature for diag-
nostic tools. In line with the studies using structural imaging, the
best performance for the classification of AD patients with resting-
state data was  also obtained by a CNN model with an accuracy of
96.9% (Sarraf and Tofighi, 2016). These studies provide initial evi-
dence that brain activity at resting state can be useful in identifying
MCI  and AD patients. We  note that, compared to the performances
obtained from structural data, DL models applied to functional data
seem to perform worse. This discrepancy could be explained by the
substantial difference in sample size between the two  types of stud-
ies ! while the smallest study using structural data included 140
subjects (Hosseini-Asl et al., 2016) the largest study using functional
data included 62 subjects (Suk et al., 2016).
With regards to multimodal studies, Liu et al. (2014) applied
a stacked autoencoder (SAE) to structural and PET data and suc-
cessfully distinguished AD and MCI  from controls with an accuracy
of 87.8% and 76.9%, respectively. Using a very similar dataset, the
same team (Liu et al., 2015a) achieved a better performance by
designing a model where the hidden layers were able to infer the
correlations between sMRI and PET, thus better capturing the syn-
ergy between the two modalities. This model classified AD and MCI
against controls with an accuracy of 91.4% and 82.1%, respectively.
Interestingly, the application of the same model to a structural data
alone resulted in less impressive accuracies of 82.6% and 72% for AD
and MCI, respectively. This discrepancy suggests that the integra-
tion of structural and functional data may  improve classification
accuracy. However, this conclusion should be drawn with great
caution since that the authors did not report classification accuracy
for PET data alone.
Finally, four studies have tried combining neuroimaging data
with clinical information to build a more robust classification
model. For example, Suk and Shen (2013) used a SAE to extract
latent features from neuroimaging data (sMRI, PET and CSF), which
were then used to predict clinical data (measured using the Mini-
Mental State Examination – MMSE  – and Alzheimer’s Disease
Assessment Scale’s cognitive subscale – ADAS-cog) and class labels.
As the final step, the resulting learned features were used to classify
AD and MCI  from healthy individuals with an accuracy of 95.9% and
85.0%, respectively. Notably, two more studies (Li et al., 2014; Suk
et al., 2015a) that have used the same exact sample (taken from the
publicly available dataset ADNI; Alzheimer’s Disease Neuroimag-
ing Initiative) and the same types of data (sMRI, PET, CSF, MMSE
and ADAS-cog) have also reported high accuracies for both AD
and MCI  despite using different implementations of DL.  In general,
studies combining clinical with neuroimaging data have, in gen-
eral, reported higher accuracies than studies using single modality
or multiple neuroimaging modalities. This is in line with previous
studies using conventional ML  methods (e.g. Willette et al., 2014;
Moradi et al., 2015; Zhang and Shen, 2012) and highlights the use-
fulness of adding clinical information in the classification of AD and
its prodromal phase.
3.1.2. Attention-deficit/hyperactive disorder
With regards to attention-deficit/hyperactivity disorder
(ADHD), all five studies included here have used resting-state
neuroimaging data. For example, Deshpande et al. (2015) applied
a fully connected cascade artificial neural network – a variation
of the multilayer perceptron – to functional connectivity from
ADHD and healthy controls. The model successfully distinguished
between the inattentive and combined subtypes from healthy
controls with an accuracy of 90% for both comparisons, while
the two subtypes were discriminated with an accuracy of 95%.
Connections between frontal areas and the cerebellum were
identified as the most discriminating features. There is also evi-
dence that healthy children and children diagnosed with three
different ADHD subtypes (inattentive, hyperactive and combined)
can be distinguished in one single model using a multiclass
approach, without the need to perform binary classifications
between healthy controls and each ADHD subtypes. This evidence
comes from three studies that have used data from different sites
taken from the ADHD-200 consortium, a data-sharing platform
aimed at understanding the neural basis of ADHD (Milham et al.,
2012). Kuang et al. (2014) attempted to discriminate between
healthy controls and ADHD subtypes (inattentive, hyperactive and
combined) using data acquired from three different sites. Rather
than looking at the whole brain, the authors first parcellated the
brain and trained different DBNs for each brain area to examine
which part of the brain best discriminated ADHD (regardless of
subtypes) from healthy controls. A 4-way DBN was  then performed
for the each best discriminating area – prefrontal (PFC), cingulate
(CC) and visual (VC) cortex – in each one of the three datasets
separately (dataset 1: PFC = 37.4%, CC = 37.1%, VC = 34.4%; dataset
2: PFC = 54.0%, CC = 54.0%, VC = 51.2%; dataset 3: PFC = 71.8%,
CC = 72.7%, VC = 68.8%). Kuang and He (2014) partially replicated
these findings by applying the same DL approach to functional
measures of the prefrontal cortex; this allowed a 4-way classifi-
cation accuracy of 44.4%, 55.6% and 80.9% in three independent
samples from the ADHD-200 consortium. Finally, Hao et al. (2015)
identified the most discriminating areas – prefrontal, cingulate,
somatosensory and visual cortex – and then combined them
within a single model. The resulting input data were put through a
deep Bayesian network (DBaN), where a DBN was used to reduce
the dimensionality of the data and a Bayesian network was  used
to extract the relationships between the data. The resulting model
achieved a 4-way classification accuracy of 48.8%, 54.0% and 72.7%
for three independent samples also taken from the ADHD-200
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solve multiclass classifications problems, as all performances were
well above chance level (25% for a classification with 4 classes).
In addition, these studies suggest that DL can extract meaningful
information from patterns of brain functioning to classify ADHD
from controls and, more notably, to differentiate between ADHD
subtypes. Nevertheless, we note that all four studies conducted in
ADHD had unbalanced sample sizes between classes. For example,
in Kuang et al. (2014), there were just between 2 and 5 children
in the Inattentive subtype within each site, while the number of
healthy children ranged from 69 to 110 per site. Similarly, each
site in Kuang and He (2014) did not include any participants on at
least one ADHD subtype which may  have introduced a bias in the
4-way classification performed across all sites. With the exception
of Hao et al. (2015) which reported sensitivity and specificity, all
studies assessed model performance by estimating the overall
accuracy. This metric is simply the proportion of participants
correctly identified, and therefore does not take the unbalance
between classes into account; this means that it is possible to
have a good overall accuracy even if several participants from a
class are misclassified (or even if all participants from a class are
misclassified if the sample size for that class is very small compared
to the total sample size). Therefore, given the highly imbalanced
sample sizes, the possibility that the performances reported in
these studies are inflated cannot be ruled out. This possibility is
supported by the observation of much lower sensitivities (43.9%,
22.9% and 55.6% for each site) than specificities (68.8%, 87.7% and
83.0%), in Hao et al. (2015).
3.1.3. Psychosis
With respect to psychosis, two studies have been performed
with promising results. Using structural MRI  data from four
independent studies, Plis et al. (2014) applied a DBN to the
original pre-processed images obtaining an impressive F-score
of 91%. While this was a highly promising result, the patients
group included both first episode and chronic schizophrenia
patients, which could have diluted the models’ performance. More
recently, Kim et al. (2016) extracted functional connectivity pat-
terns obtained from resting-state functional MRI  of individuals
diagnosed with schizophrenia and healthy controls and performed
a series of experiments with an SAE-based model, in which differ-
ent hyperparameters were tested. The proposed model consisted of
an SAE with weight sparsity control, i.e. only a random selection of
neurons in a given layer was activated, that classified schizophre-
nia patients and controls with an accuracy of 85.5%, outperforming
SVM by a margin of 8.1%. Consistent with the literature on brain
functional abnormalities in schizophrenia (Kühn and Jürgen, 2013;
van der Meer et al., 2010), the most relevant features for the clas-
sification were the functional connectivity between the thalamus
and the cerebellum, the frontal and temporal areas and between the
precuneus/posterior cingulate cortex and the striatum. Despite this
encouraging result, the sample sizes for each class were modest (50
for each group) and, therefore, it is not clear how well these find-
ings will generalise to a different sample. Nevertheless, both studies
suggest that DL can effectively classify psychosis patients on the
basis of neuroanatomical and neurofunctional information. Despite
the evidence that structural and functional data provide comple-
mentary information on the neural basis of psychosis (Cabral et al.,
2016; Radua et al., 2012; Schultz et al., 2012), to date there have
been no DL studies using a multimodal approach in psychosis. In
addition, despite the evidence that psychosis, similar to AD, is pre-
ceded by a prodromal stage (Yung et al., 2005), there have been
no studies applying DL to neuroimaging data to classify individu-
als at high risk of developing psychosis from healthy controls or
distinguishing between high risk individuals who will and will not
develop the illness.
3.1.4. Temporal lobe epilepsy
One study examined the potential of DL to classify healthy indi-
viduals and patients diagnosed with temporal lobe epilepsy (TLE)
from diffusion-weighted images (DWI) (Munsell et al., 2015). A
stacked autoencoder was  used to extract meaningful features from
patients’ connectome while SVM was  chosen as the classifier. Deep
learning was  suggested as an attractive ML  alternative because
it is capable of encoding latent, nonlinear relationships in high
dimension data. This combination yielded a relatively modest accu-
racy of 69%. In addition, this model was  outperformed by another
approach where features were extracted using a well-known linear
automated method (ElasticNet) instead, which achieved an accu-
racy of 80%. This discrepancy in favour of the second model could
potentially be explained by the absence of any form of regulariz-
ers in the first model. Given the high complexity resulting from the
numerous parameters to be estimated, DL models are more prone
to overfitting (high performance on the training data while per-
forming poorly on unseen data) than conventional ML  approaches.
One standard solution, that the authors did not use, is to address
this issue is by tuning the level of model complexity and penalizing
highly intricate ones in order to have better generalizing models.
3.1.5. Cerebellar ataxia
One study was conducted in cerebellar ataxia (CA), a neu-
rodegenerative disorder that affects mainly the cerebellum, with
multiple genetics variations each with its characteristic pattern of
anatomical degeneration. Yang et al. (2014) applied a stacked AE to
T1-weighted images of the cerebellum taken from healthy controls
and individuals suffering from three CA subtypes: spinocerebellar
ataxia type 2 (SCA2), spinocerebellar ataxia type 6 (SCA6) or ataxia-
telangiectasia (AT). The proposed method classified the four groups
with an accuracy of 86.3%, an impressive result for a 4-way classi-
fication. However, the confusion matrix reported by the authors
indicates that no case with the SCA2 subtype was correctly classi-
fied. Because the sample size of this group (only four participants)
contributed very little for the total sample size (80), it is still pos-
sible to misclassify all its cases and achieve a low error rate. In
such cases, a high accuracy can be misleading, as it may  reflect an
overestimation of the algorithm’s performance (Arbabshirani et al.,
2016). Balanced accuracy, for example, is a potentially useful alter-
native as it calculates the average of correct predictions of each
class individually (Alberg et al., 2004).
In short, since the first study published in 2013, there is already
preliminary evidence that DL allows the accurate classification of
a range of neurologic and psychiatric disorders, by extracting dis-
criminating features from either single or multimodal imaging as
well as other types of data such as clinical and cognitive informa-
tion.
3.2. Conversion to illness
3.2.1. From Mild Cognitive Impairment to Alzheimer Dementia
A total of 8 studies have attempted to predict transition to ill-
ness using neuroimaging data, and all of them have focussed on
the transition from MCI  to AD (Table 2). With one exception (Liu
et al., 2015a), all studies used a multimodality approach, with three
of them also including clinical measures in the prognostic model.
The highest accuracy (83.3%), was  achieved by a model which
included sMRI, PET, CSF and two clinical measures: the MMSE  and
the ADAS-cog (Suk et al., 2015a). Interestingly, the lowest perfor-
mance (57.4%) resulted from a model which used the same input
data (sMRI, PET, CSF, MMSE  and ADASCog) and a similar sample
size (Li et al., 2014). However, the two studies differed on the DL
approach, with the former employing a semi-supervised approach
with a multilayer perceptron pretrained using a stacked sparse
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These findings highlight the potential impact of the DL architecture
on performance, although we cannot exclude the contribution of
other sample-specific factors to the results (e.g. recruitment crite-
ria). Overall, this initial sample of studies suggests that individuals
diagnosed with MCI  who later convert to dementia can be identified
using cutting-edge DL methods. Although, in general, accuracies are
not as high as when classifying AD or MCI  from healthy controls,
this is not surprising since brain differences as well as clinical and
cognitive symptoms between those identified as being at risk who
do and do not develop a disorder are likely to be subtle. In addition
to these encouraging results, the suitability of DL to multiclass clas-
sification means this analytical approach can easily be employed
to examine the biomarkers of different stages of the illness. Four
studies have taken advantage of this by conducting 4-way classi-
fications to discriminate between no eminent risk of AD (healthy
controls), individuals in the prodromal stage who did not (MCI-
C) and did develop dementia (MCI-C) and established Alzheimer’s
(AD). Accuracies ranged from 46.3% to 53.8%. By using a deep Boltz-
mann machine to extract features from structural MRI  and PET
images, Liu et al. (2015a) classified the four groups with an over-
all accuracy of 53.8%. Suk et al. (2015b) examined the replicability
of a DL approach known as deep weighted subclass-based sparse
multi-task learning (DW-S2 MTL) in two different datasets, con-
sidering both binary and multi-way comparisons. The proposed
model, specifically designed to mitigate the effect of less useful fea-
tures for classification, showed a comparable performance for both
binary (74.2% vs. 73.9%) and 4-way (53.7% vs. 47.8%) classifications,
thus suggesting good replicability. Taken collectively, these studies
provide initial evidence that DL methods could be used to discrim-
inate amongst different stages of illness ! a common challenge in
standard clinical settings.
3.3. Treatment outcome
Prediction of response to treatment is a research area of high
clinical interest. In several psychiatric and neurological disorders,
a better understanding of why some patients benefit from a cer-
tain treatment whereas others do not, could help clinicians make
more-effective treatment decisions and improve long-term clinical
outcomes (Mechelli et al., 2015). However, so far, only one study
has used DL to predict clinical response to treatment (Table 3).
Munsell et al. (2015) attempted to develop an algorithm that dis-
tinguished between patients with TLE who did and did not benefit
from surgical treatment. This was implemented using a stacked
autoencoder to extract meaningful features from the connectome
of patients who were then classified using SVM. This model, how-
ever, yielded a low accuracy of 57%. For comparison, the author
investigated another option where features were extracted with an
alternative linear approach instead of an autoencoder. This second
model resulted in a higher accuracy of 70%. Again, this discrepancy
in favour of the second model could potentially be explained by the
absence of any form of regularizers in the first model. This model
comprised 4 layers, resulting in a high number of weights to be
estimated which, together with a modest sample size (41 patients
without seizures and 29 with seizures after treatment), might have
resulted in overfiting.
3.4. How does DL compare to a traditional machine learning
approach?
A total of twenty-five studies included in this review com-
pared a DL model against a kernel-based model (SVM or MKL) in
order to elucidate how DL compares to a more conventional ML
approach. The results of these comparisons are shown in Fig. 5. It
can be seen that, for the majority of studies, DL showed improved
performance compared to SVM. Given the small sample of stud-
ies, it is difficult to identify specific characteristics of the studies
associated with greater or smaller improvement in performance
following the implementation of DL. However, a margin favour-
ing DL studies appears to be more evident in studies that have
integrated different modalities with cognitive and/or clinical data
(Fig. 6). This anecdotal observation is consistent with the notion
that DL is a powerful tool for detecting abstract relations within
the data, especially between different types of data that are likely
to be associated in complex ways, such as neuroimaging and clini-
cal/cognitive information (Plis et al., 2014).
Since DL requires a large number of observations to learn
increasingly complex patterns compared to conventional ML  meth-
ods, one would expect to find a greater difference between the two
methods as sample size increases. However, the effect of sample
size on the difference in performance is unclear, possibly due to
the small number of studies currently available. There is a minor-
ity of studies where SVM/MKL matched or even outperformed the
proposed DL model. Amongst these, Munsell et al. (2015) reported
the largest margin favouring SVM. However, this article had one of
the smallest sample sizes (118 for the diagnostic comparison and 70
for the treatment outcome comparison) while employing one of the
deepest networks with 5 layers. Notably, out of all the studies com-
paring the two approaches, Munsell et al. (2015) was the only one
that did not make any formal attempt to prevent overfitting of the
DL model, for example through the use of regularization. We  note
that susceptibility to overfitting becomes more pronounced when
deeper and thus more complex networks are used, as in the study
by Munsell et al. (2015), due to the higher number of weights to be
estimated (Srivastava et al., 2014). Therefore, we  speculate that the
use of small sample sizes, coupled with the high-dimensionality
of the data (i.e. when the number of variables highly exceeds the
number of participants), may  have increased the risk of overfitting
in this study.
4. Discussion
ML  has been gaining considerable attention in the neuroimaging
community due to its advantages over traditional analytical meth-
ods based on mass-univariate statistics. In particular, ML  methods
take the inter-correlation between regions into account, while
mass-univariate methods operate under the assumption that dif-
ferent regions act independently. In addition, ML  methods can be
used to make inferences at the single-subject level ! a critical
difference with mass-univariate analytical methods that are only
sensitive to differences at group-level. DL is a type of ML  which is
increasingly used in neuroimaging after leading to major scientific
advances in the areas of speech recognition, computer vision and
natural language processing by significantly outperforming other
state-of-the-art classification methods (Krizhevsky et al., 2012; Le
et al., 2012). There are two  main characteristics that distinguish DL
from conventional ML  methods: first, DL is capable of learning fea-
tures from the raw data without the requirement for a priori feature
selection, resulting in a more objective or less bias-prone process;
second, DL uses a hierarchy of nonlinear transformations, which
make this approach ideally suited for detecting complex, scattered
and subtle patterns in the data. Given its ability to detect abstract
patterns from the data, DL can be considered a promising tool in
neuroimaging, as most brain-based disorders are characterised by
a scattered and diffused pattern of neuroanatomical and neuro-
functional alterations (Plis et al., 2014). In previous sections of this
review, we have described the most common DL architectures and
have provided an overview of the studies that have applied DL to
neuroimaging data to investigate psychiatric and neurological dis-
orders. In this final section, we  discuss the main themes that have
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Fig. 5. Results of studies comparing DL and kernel-based models. The graph shows the accuracies (F-score for Plis et al., 2014) for DL models (blue), kernel-based models
(red)  and the difference between the two (green). HC, healthy controls; ADHD, attention deficit and hyperactive disorder; AD, Alzheimer’s disease; MCI, mild cognitive
impairment; MCI-NC, mild cognitive impairment non-converters; MCI-C, mild cognitive impairment converters; SZ, schizophrenia; TLE, temporal lobe epilepsy; TLEs,
temporal lobe epilepsy with seizures after treatment; TLEns, temporal lobe epilepsy without seizures after treatment. (For interpretation of the references to colour in this
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Fig. 6. Difference in performance of DL against kernel-based methods for single
modality, multimodal as well as for multimodal with cognitive/clinical data studies,
according to sample size.
consistencies and inconsistencies in the existing literature (ii) the
promise of CNNs, (iii) the issue of multiclass classification, (iv) how
DL performs compared with conventional ML  methods, (v) inter-
pretability of DL in neuroimaging, (vi) the challenge of overfitting
and (vii) technical expertise and computational requirements. We
conclude by discussing possible directions for future research.
4.1. Main conclusions from the existing literature
The majority of published studies have been conducted in
patients with MCI  and/or AD; this may  be explained by the
availability of ADNI, a very large open-source dataset including
thousands of patients, to the neuroimaging community (Mueller
et al., 2005a, 2005b). However, studies have also been conducted
in other disorders including ADHD, psychosis, TLE and cerebellar
ataxia. Taken collectively, the findings published so far suggest
that DL can be applied to neuroimaging data, including both struc-
tural and functional modalities, to classify diagnostic groups from
healthy individuals. Indeed, the performance of the classifiers has
been consistently high, with several studies reporting accuracies
above 95% for binary classifications between patients and con-
trols (Deshpande et al., 2015; Hosseini-Asl et al., 2016; Payan and
Montana, 2015; Sarraf and Tofighi, 2016; Suk and Shen, 2013; Suk
et al., 2015a; Suk et al., 2015b). Nevertheless, the application of
a supervised model for diagnostic classification is arguably cir-
cular: since diagnostic labels in the training and testing datasets
are predetermined through clinical examination, logic dictates that
a perfect performance from an ML  algorithm will simply mimic
clinical assessment. Being able to predict a future diagnosis, or
anticipate who  will and will not benefit from a certain treatment,
are questions of greater translational value in clinical practice. A
total of 8 studies have applied DL to neuroimaging data acquired
from individuals with MCI  to predict subsequent transition to AD
with promising results. For example, Suk et al. (2015a) success-
fully predicted conversion from MCI  to AD with 83.3% accuracy,
after combining structural MRI  and PET data. However, no studies
have yet examined transition to illness in other psychiatric dis-
orders with a prodromal phase, such as psychosis, even though
we know that it is possible to distinguish between converters and
non-converters using conventional ML  (Zarogianni et al., 2013;
Pettersson-Yeo et al., 2013; Valli et al., 2016). To our knowledge
only one study has used DL to predict treatment outcome. Munsell
et al. (2015) achieved an accuracy of 57% when classifying TLE
patients who  did and did not suffer from seizures after surgi-
cal intervention. As discussed earlier, however, this modest result
could potentially be explained by the absence of formal strategies
to avoid overfitting of the DL model.
DL is a very flexible approach, meaning that is it possible to
combine different architectures and manipulate a range of hyper-









S. Vieira et al. / Neuroscience and Biobehavioral Reviews 74 (2017) 58–75 71
of existing studies have been published in the last 2 years, and
therefore the field of DL applied to neuroimaging of brain-disorders
should be considered still at a very early stage. Possibly as a result of
this combination of flexibility and novelty, the methodology of the
studies reviewed in this article varied considerably. For example,
some studies employed a whole-brain approach whereas others
focussed on a subset of regions of interest; some studies used the
raw data without any form of feature selection whereas others per-
formed a number of transformations on the data to select relevant
features; and different studies used different DL architectures. Such
methodological variability means that, at present, the reliability
and replicability of the existing results remain unclear.
4.2. The promise of convolutional neural networks
CNNs are a particular type of feedforward neural network
inspired by how the human visual cortex process information.
Over the past decade, CNNs have been breaking records in com-
puter vision across several competitions, making this approach
a very promising one (Krizhevsky et al., 2012). Consistent with
this, our review has shown that CNNs have generated the most
encouraging results in the context of neuroimaging. In its raw
form, neuroimaging data comprises millions of voxels. Consid-
ering the current computational resources available, putting all
voxel intensities through a fully connected network would lead
to an unfeasible number of weights to be estimated. Two intrin-
sic properties of CNNs – weight sharing and local connectivity
– result in a significantly reduced number of weights, making it
computationally possible to run the network at the voxel-level.
Although in neuroimaging CNNs have only been used to exam-
ine MCI  and AD patients, the accuracies of the studies published
so far have been consistently high (i.e. !95% for AD and !86% for
MCI  versus controls). High accuracies have been observed with
different modalities including structural MRI  (Gupta et al., 2013;
Hosseini-Asl et al., 2016; Payan and Montana, 2015), resting-state
fMRI (Sarraf and Tofighi, 2016) and CT imaging (Gao and Hui, 2016),
as well as with small (Gao and Hui, 2016; Sarraf and Tofighi, 2016)
and large (Gupta et al., 2013; Hosseini-Asl et al., 2016; Payan and
Montana, 2015) sample sizes. Hosseini-Asl et al. (2016) used an
alternative and interesting approach which involved pre-training
a CNN in one Alzheimer’s dataset (CADDementia) and then fine-
tuning and testing it in another dataset from the same diagnostic
group (ADNI). The results were very promising for both 2-way and
3-way classifications (HC vs. AD; HC vs. MCI; AD vs. MCI; and HC
vs. AD vs. MCI), although it should be noted that the ADNI sam-
ple was of modest size. Taken together, these results are in line
with the successful performances of CNN-based models reported
in other scientific areas, and highlight CNNs as a promising tool in
neuroimaging.
4.3. From binary to multiclass classifications
In the context of neuroimaging, the vast majority of conven-
tional ML  studies have relied on binary classifications involving the
comparison between a group of patients and a group of healthy con-
trols (Orrù et al., 2012; Wolfers et al., 2015). This can be explained
by the fact that these studies have typically employed SVM, which
was originally designed for binary classification problems (Hsu and
Lin, 2002). However, the real challenge for clinicians is not to differ-
entiate between patients and controls but to develop biomarkers
which could be used to choose amongst alternative diagnoses or
different stages of illness progression. Looking forward, therefore,
ML  models will need to be able to discriminate amongst several
possible alternatives in order to inform real-world clinical decision
making. Many approaches have been proposed to enable SVM to
handle multiclass classification problems (Fei and Liu, 2006; Hsu
and Lin, 2002). However, this is still an active research area (Kumar
and Gopal, 2011) and none of the proposed approaches have been
tested in the context of neuroimaging. Most neuroimaging studies
using SVM addressed the multiclass problem by performing sev-
eral binary classifications (for example, AD vs. HC, MCI vs. HC and
AD vs. MCI) or one-against-all classifications (for example, AD vs.
MCI  & HC and MCI  vs. AD & HC). DL however, requires less techni-
cal effort to perform multiclass comparisons, and therefore could
provide a solution to this issue. This is mainly due to the use of
the so-called softmax function in the output layer, which can be
considered an extension of the binary logistic regression to sev-
eral classes. Here the output reflects the probability of belonging
to each class, which is a more intuitive index of class membership
than some of the most sophisticated indices being developed for
SVM multiclass solutions (Fei and Liu, 2006). In light of its suit-
ability for multiclass classification, a number of studies have used
DL to carry out 3 or 4-way classifications between different dis-
order subtypes or different stages of illness. For example, three of
these studies were able to classify children into healthy controls
and three ADHD subtypes (inattentive, hyperactive and combined)
(Hao et al., 2015; Kuang and He, 2014; Kuang et al., 2014). Notably,
there is also preliminary evidence for the use of DL to distinguish
between individuals at no imminent risk of dementia, those identi-
fied at risk who  will and will not develop dementia, and those with
established Alzheimer’s disease (Liu et al., 2015a; Liu et al., 2014;
Suk et al., 2015b). These are encouraging findings, as they highlight
how DL could help bridge the existing gap between neuroimaging
findings and real-world clinical practice.
4.4. Is deep learning superior to conventional machine learning?
Despite the success of DL in several scientific areas, the supe-
riority of this analytical approach in neuroimaging is yet to be
demonstrated. On the one hand, DL has been described as a poten-
tially more powerful approach than conventional shallow ML, as it
is capable of learning highly intricate and abstract patterns from the
data, which can particularly useful in the case of brain-based disor-
ders (Plis et al., 2014). On the other hand, given that neuroimaging
data is very high-dimensional, the nonlinear approach of DL  might
not be advantageous as there are not enough data points to extract
meaningful nonlinear patterns from the data, whereas the linear
approach employed in conventional shallow ML  might be more
appropriate. Here we tried to clarify this issue by systematically
examining the difference in performance between DL and conven-
tional shallow ML in studies which used both approaches. A total
of twenty-five studies reported classification accuracy for both DL
and conventional shallow ML,  with the latter being a kernel-based
method, either SVM or MKL. For the majority of these studies DL
performed better than conventional shallow ML  as shown in Fig. 5,
and in some cases the difference was  by a reasonable margin (e.g.
Han et al., 2015; Plis et al., 2014; Suk and Chen, 2013).
From the available evidence, it is not clear whether DL tends to
perform better under specific circumstances, for example depend-
ing on the modality type or the sample size. However, our
systematic review provides anecdotal evidence that studies com-
bining imaging and non-imaging data tend to have a larger margin
in favour of DL (see Fig. 6). This is consistent with the notion that
the association between brain abnormalities and cognitive symp-
toms, for example, is likely to exist at a deep and abstract level,
and as such can be captured more effectively by DL methods than
traditional shallow ML methods (Plis et al., 2014).
We know that the application of traditional shallow ML  methods
to neuroimaging data leads to higher and more stable accuracies
as the sample size increases (Nieuwenhuis et al., 2012). One  would
expect this to be especially true for DL: since a deep model is inher-
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sample sizes should be needed to compensate for the greater num-
ber of parameters to be estimated and to take full advantage of
DL’s ability to detect highly intricate and abstract patterns in the
data. We  were therefore expecting to see an increase in the mar-
gin by which DL outperforms kernel-based methods as sample sizes
increase. Such increase however was not observed, as the pattern of
difference in performance did not seem to vary systematically with
sample size; one possibility is that larger sample sizes than those
used in the existing literature would be required to detect increases
in the margin by which DL outperforms kernel-based methods.
In conclusion, our review suggests that, overall, DL performs
better than conventional shallow ML.  In light of the increasing
interest in DL, however, we cannot exclude a publication bias which
favoured studies showing the superiority of this new analytical
approach relative to conventional shallow ML  methods (Boulesteix
et al., 2013). As the number of studies applying DL to neuroimaging
data increases, a thorough assessment of publication bias would be
useful to establish the reliability of this initial trend in favour of DL.
4.5. Interpretability of DL in neuroimaging
Despite having demonstrated state-of-the-art performances
across several fields, DL has been under scrutiny for its lack of
transparency during the learning and testing processes (Alain and
Bengio, 2016; Lou et al., 2012; Yosinski et al., 2015). For example,
deep neural networks have been referred to as a “black box” in
contrast with other techniques, such as logistic regression, which
are less complex and more intuitive. Such lack of transparency has
important implications for the interpretability of the results when
DL is applied to neuroimaging data. Due to the multiple nonlineari-
ties, it can be challenging to trace the consecutive layers of weights
back to the original brain image in order to identify which features
(e.g. regions) are providing the greatest contribution to classifica-
tion (Suk et al., 2015a). This information however would be useful
in the context of clinical neuroimaging where the aim is not only to
detect but also localise abnormalities. A first potential issue is that a
model with an excellent performance may  be using irrelevant fea-
tures (e.g. orientation of the images, imaging artefacts), as oppose
to clinically meaningful information (e.g. regional grey matter, con-
nectivity between different brain regions), to classify participants. A
second potential issue is that an accurate model which provides no
information about the underlying neuroanatomical or neurofunc-
tional alterations would be of limited clinical utility, for example
with respect to treatment development and optimization.
Despite its complex inner workings which make the visualiza-
tion and interpretation of the weights challenging, DL can be used
in a way which enables transparency. This is illustrated by several
neuroimaging studies included in this review that did report the
most important features (e.g., Deshpande et al., 2015; Kim et al.,
2016; Liu et al., 2014; Suk et al., 2016). However, these studies
used a variety of approaches to isolate the most informative fea-
tures, and at present there is no standard and intuitive method
for visualizing weights or interpreting latent feature representa-
tions (Suk et al., 2015a). This has motivated several attempts to
develop new and intuitive ways of enhancing the interpretability
of DL within the recent literature (e.g., Grün et al., 2016; Samek
et al., 2015; Simonyan et al., 2013; Yosinski et al., 2015; Zeiler
and Fergus, 2014). There are two main methodological approaches
to address this issue, including input modification methods and
deconvolution methods. Input modification methods are visual-
ization techniques that involve the systematic modification of the
input and the measurement of any resulting changes in the output
as well as in the activation of the artificial neurons in the inter-
mediate layers of the network. An example of these methods is
the so-called occlusion method (Zeiler and Fergus, 2013) which
involves covering portions of the input image up to find the areas of
the input data that influence the probability of the output classes.
In contrast, deconvolution methods aim to determine the contri-
bution of one or more features of the input data to the output. This
involves selecting an activation of interest in an output neuron and
then computing the contribution of each neuron in the next lower
layers to this activation. Here a number of strategies are available
to model the nonlinearities present across the layers, for example,
deconvnet (Zeiler and Fergus, 2013) and guided backpropagation
(Springenberg et al., 2014).
4.6. The challenge of overfitting
Overfitting is arguably one of the main challenges in ML.  Given
their inherent complexity, DL networks are particularly prone to
overfitting, i.e., learning irrelevant fluctuations in the data that limit
generalizability. Not surprisingly, different approaches to address
this issue, known as regularization strategies, have been developed
and are now present in most DL algorithms. In section 2.1.4 we
described some of the most commonly used regularization strate-
gies applied to modern DL, namely weight decays and dropout. As
expected, several studies reviewed here have used some form of
regularization. The majority (e.g., Hosseini-Asl et al., 2016; Kim
et al., 2016; Liu et al., 2015a) have employed the L1 or L2 norms,
which prevent overfitting by penalizing very low or very high
weight values. At least one study (Li et al., 2014) employed dropout,
where a random number of nodes and respective connections are
temporarily removed to extract different sets of features that can
independently produce a useful output. The importance of regu-
larization strategies in DL could potentially account for the fact
that Munsell and colleagues, who trained 4- and 5-hidden layer
models (for inferring diagnostic and treatment outcome, respec-
tively) without using any form of regularization, reported such low
performance for DL (Munsell et al., 2015).
An additional approach for minimising the risk of overfitting
involves reducing the dimensionality of the data before inputting
them into the model. A possible way  of achieving this is by extract-
ing region- or patch-level features (as opposed to using voxel-level
data). Using different types of features (whether voxel, patch or
region) can have implications for how detailed the information
inputted into the model is (for example, voxel-level features are
very detailed, and also very noisy; region-level features on the
other hand, ignore more localized patterns and are less sensitiv-
ity to noise). Another option to reduce dimensionality is feature
selection. Feature selection is common in conventional ML, where
linear methods such as principal component analysis, independent
component analysis or elastic net, are used to select the most dis-
criminating features that are then fed to a classifier. However, the
use of conventional feature selection methods prior to a DL model
seems counterintuitive, since one of the main advantages of DL is
the ability to learn, through a purely data-driven method, the most
useful features for classification. Several studies reported in this
review have attempted to reduce the dimensionality of the data
by extracting region- or patch-level features, using feature selec-
tion, or combining the two approaches. We  note, however, that all
CNN-based models were applied to voxel-level data without being
preceded by any form of feature selection and yet reported consis-
tently high performances on unseen data. This suggests that DL, and
CNN-models and particular, can perform well with neuroimaging
data without the requirement to downsize or even preprocess the
data. For example, Hosseini-Asl et al. (2016) achieved high levels of
accuracy after applying a CNN to voxel-level data without any pre-
processing or even skull stripping of the images. This finding has
potential implications for the development of clinical tools, as it
suggests that it might be possible to apply DL to raw neuroimaging
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4.7. Technical expertise and computational requirements
The studies reviewed in this article employed a wide range of DL
architectures and hyperparameters. Such flexibility is what makes
DL a very powerful tool but comes at a potentially high cost. The
number of layers, the number of nodes within each layer and the
activation function of each node are only a few examples of a long
list of variables one has to consider when designing and optimizing
a DL model. Automated optimization strategies are not yet widely
available, making optimisation a manual process that requires a
great deal of technical expertise and is potentially prone to subjec-
tive bias. Since the number of parameters to be estimated is very
large, the computational requirements of DL are also more demand-
ing than those of conventional ML  methods. For example, Kim et al.
(2016) reported that the estimation of a DL model with three hidden
layers took 100 times longer than the estimation of a standard SVM
model (!3.3 days vs. 0.8 h). However, with the fast-growing avail-
ability of graphical processing units (GPUs), the application of DL to
neuroimaging data is likely to become less and less time-consuming
in the future.
5. Conclusions and future directions
While still in its initial stages, the application of DL in neu-
roimaging has shown promising results and has the potential of
leading to fundamental advances in the search for imaging-based
biomarkers of psychiatric and neurologic disorders. Nevertheless,
several improvements will be required before the full potential of
DL in neuroimaging can be achieved. Firstly, given the complex-
ity of DL models, we need to move away from studies with small
to modest sample sizes in favour of much larger cohorts. A pos-
sible way of achieving this is through multi-centre collaborations,
in which data is collected using the same recruitment criteria and
scanning protocols across sites. A further way of increasing the sam-
ple size is through multi-site data sharing initiatives, such as ADNI
for Alzheimer’s disease and ADHD-200 for ADHD. Secondly, the
integration of CNN and recurrent neural networks (i.e. networks
that allow the processing of data with sequential inputs such as
videos or speech) is likely to lead to significant advances in DL in
the next few years (Donahue et al., 2015). In neuroimaging, this
integration could be particularly useful for analysing fMRI data, as it
would allow the detection of intricate spatial patterns while simul-
taneously modelling the temporal component of the BOLD signal.
Thirdly, we anticipate that an increasing number of neuroimag-
ing studies will make use of transfer learning, which involves
using previously learned features from a large sample of similar
enough images. This could help tackle the curse of dimensionality
" a common problem in neuroimaging studies of brain disor-
ders (Gupta et al., 2013; Hosseini-Asl et al., 2016). Evidence from
vision science, where deeper models such as VGG net (Simonyan
and Zisserman, 2014), residuals networks (He et al., 2015) and
Inception-v4 (Szegedy et al., 2016) are achieving the highest perfor-
mances, suggests that transfer learning could be particularly useful
when deeper models are employed. Fourthly, we  suggest that the
so-called augmentation technique – which it is commonly used in
computer vision – could be useful in the context of neuroimag-
ing. This technique involves increasing the sample size by applying
transformations to the data (e.g., rotation, shear, scaling), and then
train a model that is invariant to such transformations. The use
of augmentation could also address the issue of modest sample
sizes and lead to a decrease in prepossessing time (because steps
such as rotation may  become redundant). Finally, the use of DL to
predict continuous scores is another interesting area for further
research with potential clinical applicability, following the encour-
aging results obtained using conventional ML  methods (e.g. Gong
et al., 2014; Stonnington et al., 2010; Tognin et al., 2014). So far,
only one study has used DL to predict clinical scores from struc-
tural MRI  scans in patients with Alzheimer’s disease (Brosch and
Tam, 2013).
In conclusion, the capacity of DL models to learn complex
and abstract representations through nonlinear transformations,
makes this a promising approach to single subject prediction in
neuroimaging. While there are still important challenges to over-
come, the findings reviewed here provide preliminary evidence
supporting the potential role of DL in the future development of
diagnostic and prognostic biomarkers of psychiatric and neurologic
disorders.
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Despite the high level of interest in the use of machine learning 
(ML) and neuroimaging to detect psychosis at the individual 
level, the reliability of the "ndings is unclear due to potential 
methodological issues that may have in#ated the existing lit-
erature. This study aimed to elucidate the extent to which the 
application of ML to neuroanatomical data allows detec-
tion of "rst episode psychosis (FEP), while putting in place 
methodological precautions to avoid overoptimistic results. 
We tested both traditional ML and an emerging approach 
known as deep learning (DL) using 3 feature sets of interest: 
(1) surface-based regional volumes and cortical thickness, 
(2) voxel-based gray matter volume (GMV) and (3) voxel-
based cortical thickness (VBCT). To assess the reliability of 
the "ndings, we repeated all analyses in 5 independent data-
sets, totaling 956 participants (514 FEP and 444 within-site 
matched controls). The performance was assessed via nested 
cross-validation (CV) and cross-site CV. Accuracies ranged 
from 50% to 70% for surfaced-based features; from 50% 
to 63% for GMV; and from 51% to 68% for VBCT. The 
best accuracies (70%) were achieved when DL was applied 
to surface-based features; however, these models generalized 
poorly to other sites. Findings from this study suggest that, 
when methodological precautions are adopted to avoid over-
optimistic results, detection of individuals in the early stages 
of psychosis is more challenging than originally thought. In 
light of this, we argue that the current evidence for the diag-
nostic value of ML and structural neuroimaging should be 
reconsidered toward a more cautious interpretation.
Key words:  multivariate pattern recognition/classi"cation/ 
psychosis/neuroimaging/multi-site
Introduction
Over the last 3 decades, traditional mass-univariate neu-
roimaging approaches have revealed neuroanatomical 
abnormalities in individuals with psychosis.1–5 Because 
these abnormalities were detected using group-level 
inferences, it has not been possible to use this informa-
tion to make diagnostic and treatment decisions about 
individual patients. Machine learning (ML) is an area of 
arti"cial intelligence that promises to overcome this issue 
by learning meaningful patterns from the imaging data 
and using this information to make predictions about 
unseen individuals.6 Several ML studies have attempted 
to use neuroanatomical data to distinguish patients with 
established schizophrenia from healthy individuals, with 
promising results.7–10 At present, however, there are two 
important limitations in the existing literature that limit 
the translational applicability of the "ndings in real-
world clinical practice. First, given the well-established 
effects of illness chronicity and antipsychotic medica-
tion on brain structure,11–15 it is unclear to what extent 
classi"cation was based on neuroanatomical changes 
associated with these factors rather than the onset of the 
illness per se. Consistent with this, both disease-stage and 
antipsychotic medication were identi"ed as signi"cant 
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moderators in a recent meta-analysis of diagnostic bio-
markers in schizophrenia.7 Also in line with this, Pinaya 
et!al16 reported that the same ML model that was able to 
distinguish between patients with established schizophre-
nia and healthy controls (HCs) with an accuracy of 74% 
showed poor generalizability (56%) when applied to a 
cohort of individuals with "rst episode psychosis (FEP). 
Taken collectively, these "ndings suggest that represen-
tations learned from patients with established schizo-
phrenia may not be applicable to individuals with a "rst 
episode of the illness. Second, the clinical utility of any 
ML-based diagnostic tool for detecting patients with an 
established illness is likely to be very limited; in contrast, 
detecting the initial stages of an illness, when diagnosis 
may be uncertain and treatment is yet to be decided, is 
likely to have much greater clinical utility.
So far only a limited number of  studies have applied 
ML to neuroanatomical data in the initial stages of  the 
illness when the effects of  illness chronicity and anti-
psychotic medication are minimal. These studies have 
produced inconsistent results, including poor (eg, 51% 
in Winterburn et! al17), modest (eg, 63% in Pettersson-
Yeo et!al18), and good (eg, 86% in Borgwardt et!al19 or 
85% in Xiao et!al20) accuracies. There are a number of 
possible reasons for such inconsistency. First, most of 
the studies used small samples (N #50) (see Kambeitz 
et! al7 for a meta-analysis), which have been shown to 
yield unstable results.21,22 Second, the vast majority of 
studies used data from a single site, and as such may 
have generated results that were speci"c to the charac-
teristic of  the local sample rather than the illness per 
se. Third, a series of  recent articles have highlighted 
potential methodological issues that may have caused 
in$ated results in some of  the published studies.9,17,22–25 
These issues include, eg, (1) failure to use a nested cross-
validation (CV) framework to avoid knowledge-leakage 
between training and test sets; (2) failure to perform fea-
ture transformation and/or selection within a rigorous 
CV framework resulting in so-called “double dipping”; 
(3) publication bias leading to an overrepresentation of 
positive "ndings, especially in studies with small sam-
ples and (4) failure to test performance on additional 
independent samples. Also, we note that all studies have 
employed traditional “shallow” ML techniques, such 
as support vector machine and logistic regression. The 
intuitiveness of  such techniques has made them very 
popular in neuroimaging studies of  psychiatric and neu-
rological disease. Deep learning (DL) is an alternative 
type of  ML, which has been gaining considerable atten-
tion in clinical neuroimaging.9,16,23,26 Contrary to tradi-
tional ML, where the immediate input data are used to 
extract patterns (hence the term “shallow”), DL learns 
complex latent features of  brain structure through con-
secutive nonlinear transformations (hence the term 
“deep”), which are then used for classi"cation. Given its 
ability to learn more intricate and abstract patterns, DL 
might be particularly suitable to detect the subtle and 
heterogeneous neuroanatomical abnormalities charac-
teristic of  the early stages of  psychosis.1,27,28
This study aims to elucidate the extent to which the 
application of  ML to neuroanatomical data allows 
distinction between patients with FEP and HCs at the 
individual level. To overcome the limitations of  previ-
ous studies, we used a total of  5 datasets from different 
sites, each with a sample size above the recommended 
threshold for a stable performance,21 and employed both 
shallow and deep ML techniques. In addition, following 
a series of  recent articles highlighting potential method-
ological issues in the existing literature,9,17,22–25 we put in 
place a series of  precautions to minimize the risk of  over-
"tting. On the basis of  previous studies, we hypothesize 
that (1) FEP and HC will be classi"ed with statistically 
signi"cant performances ranging between 70% and 80%7 




Participants were recruited as part as 5 independent stud-
ies carried out in multiple sites, all of which have been 
previously published:
- Site 1: Chengdu, China29
- Site 2: London, England (Genetic and Psychosis 
study30)
- Sites 3 and 4: Santander A! and B, Spain (Programa 
Asistencial Fases Iniciales de Psicosis (First Episode 
Psychosis Clinical Program) study31)
- Site 5: Utrecht, The Netherlands (Genetic Risk and 
Outcome of Psychosis study32)
All patients were experiencing their "rst psychotic epi-
sode, de"ned as the "rst manifestation of psychotic 
symptoms meeting criteria for a psychotic disorder, as 
speci"ed by the DSM-IV33 or ICD-1034. The demographic 
and clinical characteristics, including duration of illness, 
are reported in table!1. For information on recruitment 
criteria, see supplementary material.
MRI Data Acquisition and Preprocessing
High-resolution three-dimensional T1-weighted images 
were acquired independently at each site (supplementary 
table!2). From each image, 3 types of data features were 
extracted (see supplementary material):
- Voxel-based gray matter volume (GMV): whole-brain 
voxel-wise estimate of the local density of gray matter 
(GM) in a given voxel region35
- Voxel-based cortical thickness (VBCT): cortical thick-
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- Surfaced-based regional volumes and cortical thick-
ness: volume and thickness of prede!ned cortical and 
subcortical regions extracted with FreeSurfer38
Statistical Analysis
Demographic and Clinical Variables. Differences in age, 
gender, and total intracranial volume between FEP and 
HCs were examined using an independent-samples t-test 
and chi-square test, as implemented in the Statistical 
Package for the Social Sciences 24.0 (SPSS 24.0).
Group-Level Comparisons. For completeness, a standard 
group-level analysis was also carried out for each site 
and type of feature set separately. See supplementary 
material sections 1.4.1. and 2.1 for methods and results, 
respectively.
Multivariate Pattern Recognition Analysis. Dimensionality 
Reduction: Principal Component Analysis Principal 
component analysis (PCA) was used to reduce the num-
ber of voxels of the GMV and VBCT maps (see supple-
mentary material).
Classi!ers Four methods were used for classi!cation: 
k-nearest neighbors (KNN), logistic regression (LR), 
support vector machine (SVM) and deep neural networks 
(DNN) (see supplementary material). These methods 
were chosen based on their increasing order of complex-
ity (KNN is a straightforward algorithm, whereas DL 
can be more powerful at the expense of transparency), 
popularity (SVM and LR are among the most ML tech-
niques used in previous studies), and novelty (DL has 
yielded promising results in psychiatric neuroimaging but 
is yet to be applied to"FEP) (!gure 1).
KNN: non-parametric method that uses the distance 
between data points to make new predictions by assign-
ing unseen data to the same class to which the closest 
data points belong to39.
LR: regression model applied to one dependent cat-
egorical variable implemented via elastic net, a regular-
ized regression that combines the regularizations L1 and 
L2 penalties of Least Absolute Shrinkage and Selection 
Operator (LASSO)"and ridge regression, respectively, to 
avoid over!tting.40
SVM: method that estimates a hyperplane with an 
optimum margin that best separates two classes, deter-
mined by the maximum distance from any data point. 
Once de!ned, this hyperplane is used to classify unseen 
data.41,42
DNN: multi-layered fully connected networks in which 
higher-level features are learned as a nonlinear combina-
tion of lower-level features, allowing the extraction of 
complex and abstract patterns.43
Model Training and Testing
Within-site classi!cation. All models were assessed through 
a nested 10-fold strati!ed CV framework  (!gure" 2) to 
ensure that the data for hyperparameter tuning and 
Fig. 1. Three features were extracted from each image: GMV, VBCT, and FreeSurfer surface-based regional volumes and cortical 
thickness. The dimensionality of GMV and VBCT was reduced through PCA. The resulting features were analyzed with four classi!ers: 
(a) SVM, (b) LR, (c) KNN and (d) DNN. GMV, gray matter volume; VBCT, voxel-based cortical thickness; PCA, principal component 
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Fig. 2. Schematic representation of nested CV. Nested CV involves a secondary inner CV loop using the training data from the 
primary outer CV split, where different sets of hyperparameters are tested (eg, different values for the C parameter for SVM). The best-
performing hyperparameters among the 10 inner folds are then used to train a model in the whole training set de!ned by the outer loop. 
This model is then tested using the test set of the outer loop. The !nal performance is estimated by averaging accuracies in the test set 
across all 10 outer folds. CV, cross-validation; SVM, support vector machine.
the data to test the algorithm were strictly independent. 
A" 10-fold CV was chosen as a trade-off between bias, 
variance, and the demanding computational resources 
required to run"DNN.
Cross-site classi!cation. The best site-level model was 
further tested in each one of the remaining independent 
samples. All 10 instances trained during the CV were 
used to classify the participants from all the remaining 
sites separately. The resulting ensemble of models pre-
dicted the class of each participant using the soft voting 
method, where the class label was de!ned by the average 
of the 10 predicted probabilities.
Performance Measures Balanced accuracy, sensitivity, 
and speci!city were chosen as the performance metrics. 
Statistical signi!cance of the balanced accuracy was 
determined by permutation testing with 1000 permuta-
tions (see supplementary material).
Effect of  Antipsychotic Medication and Psychotic 
Symptoms To examine whether antipsychotic medica-
tion or psychotic symptoms contributed to the classi!ers’ 
performance, chlorpromazine equivalents and positive 
and negative psychotic symptoms were regressed against 
the predicted labels using an logistic regression (see sup-
plementary material for details).
Results
Sociodemographic and Clinical Parameters
No statistically signi!cant differences were identi!ed 
between patients and controls for age, gender, or total 
GMV at each site (table"1).
Single-Subject Classi!cation
Can We Detect FEP at the Individual Level? Balanced 
accuracy, sensitivity, speci!city, and statistical signi!-
cance for each feature set of  interest and site are pre-
sented in table"2 (for a visual display of  the accuracies 
and standard deviations see supplementary !gure" 3 
in the supplementary material). Overall, results were 
poor to modest across all types of  feature sets and sites, 
although the site with the smallest sample size (site 
2)" showed the lowest performance consistently across 
all feature sets. Overall, regression analyses examining 
the effect of  antipsychotic medication and psychotic 
symptoms on the performance of  each classi!er did not 
show a signi!cant effect (see supplementary material).
What Are the Most Effective Type of Feature Set? There 
was no clear effect of type of feature set across sites. 
However, it can be seen that surface-based regional data 
tended to yield higher accuracies, especially when ana-
lyzed with DNN.
Can We Generalize the Results From One Site to the Others? 
The best performances were achieved by two DNN models 
at sites 1 and 3 using regional volumes and cortical thick-
ness, with 70.5% and 70.2%, respectively. However, both 
models generalized poorly when tested on the remaining 
sites: speci!cally, the DNN model from site 1 achieved 
accuracies (sensitivity/speci!city) of 52.1% (56.3%/47.9%), 
61.1% (70.0%/52.7%), 52.1% (65.7%/38.6%), and 50.0% 
(48.3%/51.7%) when applied to sites 2 through 5, respec-
tively; whereas the DNN model from site 3 achieved accu-
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(70.1%/40.0%), and 51.0% (67.5%/34.6%) when applied to 
sites 1, 2, 4 and 5, respectively. To examine the possibility 
that poor generalizability was due to site differences, the 
same DNN model was applied to the total data with the 5 
sites added as additional features. Features weights were then 
investigated to determine the importance of site. Results 
showed that out of the 174 features, the weights for site 1, 
2, 3, 4, and 5 ranked 110, 150, 108, 71, and 112, respectively.
Discussion
In the last few years, there has been increasing inter-
est in the translational potential of  ML approaches in 
psychosis. As the !eld matures, there is emerging skep-
ticism about replicability and generalizability, which 
has led to recent calls for greater caution in the inter-
pretation of  the !ndings.9,17,22,23,25 This study aimed to 
elucidate the extent to which the application of  ML 
to neuroanatomical data allows detection of  individ-
uals at the early stages of  psychosis when the effects 
of  illness chronicity and antipsychotic medication are 
minimal. To overcome the limitations of  the existing 
literature, we used 5 independent datasets and put in 
place a series of  methodological precautions to avoid 
overoptimistic results. Contrary to expectation, the 
performances of  all methodological approaches tested 
were poor to modest across all sites. Later we discuss 
some of  the main aspects that emerge from our inves-
tigation, including sample size, full independence of 
training and test data, cross-site generalizability, and 
testing multiple pipelines. We conclude the discussion 
by considering possible future directions.
Sample Size, Homogeneity, and Publication!Bias
A possible explanation for why our accuracies are lower 
than those reported in the existing literature is that some 
of the previous studies may have reported overoptimistic 
results due to the use of fairly small sample sizes. To illus-
trate this possibility, we tested for an association between 
sample size and classi!cation accuracy across studies 
using ML and structural MRI (sMRI) in the existing lit-
erature (see supplementary material). Unsurprisingly, we 
found a moderate negative association for studies that 
examined established schizophrenia (r"="#.41) and FEP 
(r"="#.59; after excluding Xiao et"al,20 which was a clear 
outlier; !gure"3A). This is consistent with the notion that 
some of the previous studies may have reported overopti-
mistic accuracies due to the use of inadequate sample"size.
There are at least two possible ways in which inade-
quate sample size can lead to an in$ated estimation of the 
accuracy of an algorithm, including sample homogene-
ity and publication bias.22,25 First, smaller samples tend to 
be more homogeneous, making it easier for an algorithm 
to learn shared abnormalities in patients relative to con-
trols and resulting in higher accuracies. In contrast, larger 
samples tend to be more heterogeneous due to the loosen-
ing of inclusion criteria; in this case, it may be more chal-
lenging to !nd a shared pattern of abnormalities resulting 
in lower performances. This inverse relationship between 
Table 2. Accuracies (Sensitivity/Speci!city) for Each Feature Set and Algorithm Across All Sites Using Nested 10-fold Strati!ed Cross-
Validation. The Classi!er Yielding the Best Balanced Accuracy Is Highlighted in Bold for Each Site
  Regional volumes and cortical thickness GMV VBCT
Site 1
Chengdu, China
KNN 60.7** (74.3/47.1) 60.7** (49.5/71.9) 62.1** (72.1/52.1)
LR 61.9** (64.9/58.9) 60.1** (62.9/58.6) 67.2** (65.8/68.5)
SVM 61.3** (66.4/56.2) 60.7** (63.0/58.5) 52.7* (24.6/97.3)
DNN 70.5** (72.2/68.8) 57.7** (59.5/56.0) 66.4** (63.9/68.3)
Site 2
London, England
KNN 56.7 (50.9/62.5) 43.9 (33.6/54.3) 53.5 (38.4/68.6)
LR 51.6 (45.0/58.2) 51.9 (53.8/50.0) 61.6** (63.2/60.0)
SVM 45.9 (49.3/42.5) 53.9 (53.4/54.3) 51.0 (96.3/5.7)
DNN 58.8* (49.5/68.0) 40.8 (47.4/34.3) 53.4 (52.4/55.3)
Site 3
Santander A, Spain
KNN 59.6** (45.5/73.6) 50.5 (31.8/69.1) 58.0* (50.0/66.4)
LR 58.6* (58.2/59.1) 63.2** (63.6/62.7) 59.1* (58.2/60.0)
SVM 60.5** (61.8/59.1) 65.9** (68.2/63.6) 51.8* (90.9/12.7)
DNN 70.2** (70.0/70.4) 50.2 (52.7/63.6) 59.6 (60.0/59.1)
Site 4
Santander B, Spain
KNN 56.6* (91.8/21.4) 58.9** (70.7/47.1) 59.5* (67.7/51.1)
LR 54.8 (73.9/35.7) 59.6** (57.8/61.4) 62.6** (56.8/62.4)
SVM 56.0 (65.0/47.1) 57.4* (71.9/42.9) 58.4* (71.9/52.9)
DNN 62.0** (76.8/47.1) 59.3* (81.4/37.1) 58.8** (62.4/53.1)
Site 5
Utrecht, The Netherlands
KNN 52.7 (53.6/51.8) 54.5 (33.8/75.3) 52.2 (36.5/67.9)
LR 58.5* (61.7/55.4) 61.3** (56.8/65.7) 60.5** (60.6/60.4)
SVM 60.7** (59.7/61.7) 62.4** (63.1/61.8) 56.3 (51.2/61.4)
DNN 54.9 (59.2/51.8) 58.0** (58.1/57.9) 60.1** (56.1/64.2)
Note: SVM, support vector machine; LR, logistic regression, KNN, k-nearest neighbors; DNN, deep neural network; GMV,"voxel-based 
gray matter volume; VBCT, voxel-based cortical thickness.

















Page 7 of 10
Using ML and Structural Neuroimaging to Detect FEP
sample size and accuracy was not observed in our inves-
tigation; however, this might be explained by the fact that 
there was not suf!cient variability in sample size across 
our !ve datasets. Second, smaller samples tend to be 
unstable and thus yield underestimated as well as overes-
timated accuracies.21,44 This may, in turn, lead to publica-
tion bias, with overestimated accuracies being more likely 
to be published. In their meta-analysis of ML studies of 
schizophrenia, Kambeitz et"al7 reported that no publica-
tion bias was evident when all studies—including sMRI, 
functional magnetic resonance imaging, and DTI—were 
examined together. To test for publication bias in sMRI 
studies, we repeated the same statistical analysis focus-
ing on this modality (see supplementary material). This 
revealed a statistically signi!cant asymmetry in the fun-
nel plot of published studies, indicating the presence of 
publication bias (!gure"3B). This is in line with emerging 
concerns about possible overrepresentation of in#ated 
performances in the literature.17,22,23,25
Full Independence of Training and Testing Set!Data
Following recent recommendations on how to overcome 
methodological issues that may have led to initial in#ated 
results,9,23,25 we adopted two important methodological 
precautions. First, the use of simple CV, in which the same 
test data are used to both tune model hyperparameters and 
evaluate its performance, has been criticized as it almost 
certainly leads to in#ated performances.45,46 In the pres-
ent investigation, algorithms were trained and tested via 
nested CV. This ensured that the test set remained fully 
independent from the training set, with only the latter being 
used to optimize model parameters. Second, implementing 
feature selection in a 2-step approach, where, eg, univariate 
tests (eg, t-test) are applied in the whole sample and only 
the statistically signi!cant features are used for classi!ca-
tion, is likely to result in overoptimistic performances as 
features are chosen based their performance on data that 
should be completely independent for testing the classi!er. 
In the present investigation, therefore, transformations 
to the data, such as feature selection, were implemented 
within the CV framework, ie, parameters were derived 
from the training data only and subsequently applied to 
the test set. The adoption of these methodological precau-
tions, aimed at ensuring full independence between train-
ing and test data, might explain the fact that accuracies in 
the present investigation were lower than expected.
Cross-Site Generalizability
The use of independent samples to develop and validate 
an algorithm is a critical requirement if  the ultimate 
aim is to develop #exible ML-based tools that could be 
used in a clinical setting.23,25 However, only a minority of 
studies have attempted to do this, eg,22,47,48, and most of 
them have reported considerably lower performances in 
the independent sample. In the present investigation, the 
highest accuracies—obtained using speci!c combinations 
of dataset, type of feature set and algorithm—were 70% 
(in sites 1 and 3 with surface-based regional features and 
DNN); this performance would appear to be in line with 
previous similar studies. However, selectively reporting 
Fig. 3. (A) Accuracy of diagnostic sMRI ML studies over time and sample size (circle increases with sample size). From the !rst study 
until 2015, the vast majority of studies reported accuracies ranging between 70% and 100%; from 2016, however, performances have 
dropped overall with accuracies ranging between chance-level and 85%. (B) Funnel plot for sMRI studies in schizophrenia and FEP 
showing the distribution of individual studies according to their sample size (1/$ESS) and effect size (log"diagnostic odds ratio). The plot 
revealed statistically signi!cant asymmetric distribution around the main effect of sMRI studies (P"=".013), indicating a bias favoring 
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these accuracies from our wider set of results would have 
portrayed a distorted picture of the potential of ML to 
detect the initial stages of psychosis at the individual 
level.24 This is especially true since after testing these 
two models in independent datasets, their performance 
did not hold up, indicating low cross-site generalizabil-
ity. Such low cross-site generalizability could be due to 
site-related differences in scanning parameters, cultural 
interpretation of diagnostic criteria, and ethnicity; there-
fore, it might be possible to achieve higher cross-site gen-
eralizability by combining samples that are homogenous 
with respect to these variables. Nevertheless, our current 
results indicate that algorithms developed using data 
from a speci!c centre do not perform well when applied 
to data from other centers, and thus have limited clinical 
applicability.
Testing Multiple Pipelines
Because existing studies tend to differ with respect to 
several methodological aspects, at present, it is dif!cult 
to say which pipeline is optimal for detecting FEP.47 
Multi-pipeline studies have therefore been proposed as 
a useful way to disentangle what aspects works best.23 
Importantly, this approach may also help build more 
generalizable models, as the development of a bespoke, 
and possibility over!tted, pipeline to a local sample is 
less likely to occur. Consistent with this, Salvador et"al47 
tested the performance of a range of ML approaches 
in different types anatomical features extracted from 
patients with schizophrenia and controls, and reported 
lower accuracies (66%–68%) compared to previous simi-
lar studies using a single pipeline. Winterburn et" al17 
also used multiple pipelines in FEP and reported poor 
to modest accuracies, ranging from 51% to 73%. Taken 
collectively, evidence from these studies, including our 
own, suggest that when features are not manually carved 
to !t one algorithm applied to one speci!c small dataset, 
performance tends to drop. This can be seen in !gure"3A 
where two generations of studies emerge: initially, there 
were mostly small single-site, single-feature, and single-
algorithm high-performance studies; more recently the 
use of (1) larger samples,16,47,20,54 (2) multicentre stud-
ies,48,49 (3) assessment of different algorithms and/or fea-
tures in one/several site(s),17,47 or (4) independent sample 
testing48,49 are reshaping the original, and possibly overin-
#ated, enthusiasm with more realistic performances.
What Next for ML-sMRI Studies of Psychiatric 
Disease?
Unlike group-level analysis, where larger samples lead to 
increased chance of  detecting a statistically signi!cant 
result (even with a small effect size), in ML larger sam-
ples do not necessarily equate to better results; instead, 
these tend to lead to lower accuracies due to increased 
heterogeneity.22,28 Despite this challenge, larger samples 
are likely to be more representative of  the illness, less 
likely to over!t and thus carry more translational poten-
tial. Future ML studies will have to address this issue 
to overcome the increasingly apparent bottleneck in the 
performance that is arising with larger sample sizes (!g-
ure"3A). A"possible way of  doing so could be to use nor-
mative models, where an individual is mapped against a 
normative model that should encompass the heterogene-
ity characteristic of  the normal population. Here, illness 
is considered an extreme case within a normal range, 
which is likely to be a more ecologically valid approach 
than the traditional case–control paradigm.50,51
Greater methodological standardization based on 
“good-practice recommendations” could also help dis-
entangle the current con#icting evidence. For example, 
guidelines for minimum sample size such as the thresh-
old (n > 130)"proposed by Nieuwenhuis et"al21 are a good 
start. The need for independent sample testing has also 
been widely acknowledged as an essential step toward 
generalizability23,25; however, even the most recent stud-
ies do not always perform this. Moving forward, this 
type of  generalizability test is likely to become a gold 
standard for ML diagnostic studies. More transparency 
in the implementation of  ML is also needed. Several 
studies do not provide enough information about how 
the algorithm was trained and tested.23,28,52 This hinders 
a thorough assessment of  the validity of  the study as well 
as its replicability. Finally, it should be noted that, even if  
sMRI was able to distinguish between patients with FEP 
and disease-free individuals with high levels of  accuracy, 
this would be of  limited clinical utility. This is because, 
from a clinical translation perspective, the real challenge 
is not to distinguish between patients and disease-free 
individuals, but to develop biological tests that could be 
used to choose between alternative diagnoses and opti-
mize treatment.52
Conclusion
The present investigation attempted to overcome the 
limitations of the existing literature using a number of 
strategies. First, we studied patients with FEP in which 
the effects of antipsychotic medication and illness chro-
nicity are likely to be minimal. Second, the sample size 
of each of our 5 datasets was greater than the recom-
mended threshold for achieving a stable performance in 
ML–sMRI studies.21 Third, critical methodological pre-
cautions (eg, nested CV and appropriate use of feature 
selection) were adopted to ensure an unbiased assess-
ment of performance. Fourth, we systematically assessed 
the performance of a range of algorithms and features 
across several datasets, thereby minimizing the possibil-
ity of developing a bespoke and likely over!tted model 
to a single site. Fifth, we assessed the cross-site general-
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!ndings suggest that the use of ML and sMRI allows 
detection of FEP at the individual level with relatively 
modest accuracies—lower than what was expected based 
on previous studies and much lower than what would be 
required for clinical translation. We speculate that some 
of the previous results may have been over-optimistic due 
to a combination of small sample sizes, less-than-rigor-
ous methodologies, and possible publication bias and 
argue that the current evidence for the diagnostic value of 
ML and structural neuroimaging should be reconsidered 
toward a more cautious interpretation.
Over the past few years, the number of ML studies in 
psychosis has been increasing rapidly.52 As larger samples 
and more powerful computational resources become 
available, this momentum is likely to continue to grow 
over the coming years.53 Therefore, it is important for the 
research community to be aware of the challenges and 
limitations of applying ML to psychosis " such as the 
several potential “distortion” of the !ndings along the 
ML pipeline, as discussed in a recent review.52 In light 
of these challenges and limitations, the extent to which 
the application of ML in psychosis will lead to a more 
valid construct of the illness remains an open question. 
We encourage researchers to continue pursuing the inte-
gration of ML and neuroimaging, while exercising cau-
tion to avoid in#ated results and ultimately a distorted 
view of the potential of this approach in psychiatric 
neuroimaging.
Supplementary Material
Supplementary data are available at Schizophrenia 
Bulletin online.
Funding
This work was supported by the European Commission 
(PSYSCAN—Translating neuroimaging !ndings 
from research into clinical practice; 603196 to P.M.); 
International Cooperation and Exchange of the National 
Natural Science Foundation of China (81220108013 to 
Q.G." and A.M.); Wellcome Trust’s Innovator Award 
(208519/Z/17/Z to A.M.); Foundation for Science and 
Technology (SFRH/BD/103907/2014 to S.V.), and 
São Paulo Research Foundation (FAPESP) (Brazil; 
2013/05168-7 to W.H.L.P.). The authors have declared 
that there are no con#icts of interest in relation to the 
subject of this study.
References
 1. Chan" RC, Di" X, McAlonan" GM, Gong" QY. Brain ana-
tomical abnormalities in high-risk individuals, !rst-episode, 
and chronic schizophrenia: an activation likelihood estima-
tion meta-analysis of illness progression. Schizophr Bull. 
2011;37(1):177–188.
 2. Fusar-Poli"P, Borgwardt"S, Crescini"A, et"al. Neuroanatomy 
of vulnerability to psychosis: a voxel-based meta-analysis. 
Neurosci Biobehav Rev. 2011;35(5):1175–1185.
 3. Torres"US, Duran"FL, Schaufelberger"MS, et"al. Patterns of 
regional gray matter loss at different stages of schizophrenia: 
a multisite, cross-sectional VBM study in !rst-episode and 
chronic illness. Neuroimage Clin. 2016;12:1–15.
 4. Smieskova"R, Fusar-Poli"P, Allen"P, et"al. Neuroimaging pre-
dictors of transition to psychosis–a systematic review and 
meta-analysis. Neurosci Biobehav Rev. 2010;34(8):1207–1222.
 5. Vita" A, De" Peri" L, Deste" G, Sacchetti" E. Progressive loss 
of cortical gray matter in schizophrenia: a meta-analysis 
and meta-regression of longitudinal MRI studies. Transl 
Psychiatry. 2012;2(11):e190.
 6. Davatzikos" C, Shen" D, Gur" RC, et" al. Whole-brain mor-
phometric study of schizophrenia revealing a spatially 
complex set of focal abnormalities. Arch Gen Psychiatry. 
2005;62(11):1218–1227.
 7. Kambeitz" J, Kambeitz-Ilankovic" L, Leucht" S, et" al. 
Detecting neuroimaging biomarkers for schizophrenia: a 
meta-analysis of multivariate pattern recognition studies. 
Neuropsychopharmacology. 2015;40(7):1742–1751.
 8. Zarogianni"E, Moorhead"TW, Lawrie"SM. Towards the iden-
ti!cation of imaging biomarkers in schizophrenia, using 
multivariate pattern classi!cation at a single-subject level. 
Neuroimage Clin. 2013;3:279–289.
 9. Wolfers" T, Buitelaar" JK, Beckmann" CF, Franke" B, 
Marquand" AF. From estimating activation locality to pre-
dicting disorder: a review of pattern recognition for neuroim-
aging-based psychiatric diagnostics. Neurosci Biobehav Rev. 
2015;57:328–349.
 10. Orrù" G, Pettersson-Yeo" W, Marquand" AF, Sartori" G, 
Mechelli" A. Using support vector machine to iden-
tify imaging biomarkers of  neurological and psychi-
atric disease: a critical review. Neurosci Biobehav Rev. 
2012;36(4):1140–1152.
 11. Navari" S, Dazzan" P. Do antipsychotic drugs affect brain 
structure? A"systematic and critical review of MRI !ndings. 
Psychol Med. 2009;39(11):1763–1777.
 12. Vita"A, De"Peri"L, Deste"G, Barlati"S, Sacchetti"E. The effect 
of antipsychotic treatment on cortical gray matter changes 
in schizophrenia: does the class matter? a meta-analysis and 
meta-regression of longitudinal magnetic resonance imaging 
studies. Biol Psychiatry. 2015;78(6):403–412.
 13. Bora"E, Fornito"A, Radua"J, et"al. Neuroanatomical abnor-
malities in schizophrenia: a multimodal voxelwise meta-
analysis and meta-regression analysis. Schizophr Res. 
2011;127(1-3):46–57.
 14. van"Erp"TGM, Hibar"DP, Rasmussen"JM, et"al. Subcortical 
brain volume abnormalities in 2028 individuals with schizo-
phrenia and 2540 healthy controls via the ENIGMA consor-
tium. Mol Psychiatry. 2016;21(4):547–553.
 15. van" Erp" TGM, Walton" E, Hibar" DP, et" al.; Karolinska 
Schizophrenia Project. Cortical brain abnormalities in 
4474 individuals with schizophrenia and 5098 control sub-
jects via the Enhancing Neuro Imaging Genetics Through 
Meta Analysis (ENIGMA) Consortium. Biol Psychiatry. 
2018;84(9):644–654.
 16. Pinaya" WH, Gadelha" A, Doyle" OM, et" al. Using deep 
belief  network modelling to characterize differences 
in brain morphometry in schizophrenia. Sci Rep. 
2016;6(1):38897.
 17. Winterburn" JL, Voineskos" AN, Devenyi" GA, et" al. Can 

















Page 10 of 10
S. Vieira et!al
controls using magnetic resonance imaging and machine 
learning? A!multi-method and multi-dataset study. Schizophr 
Res. 2017 Dec 20. pii: S0920-9964(17)30736-3. doi:10.1016/j.
schres.2017.11.038. [Epub ahead of print]
 18. Pettersson-Yeo! W, Benetti! S, Marquand! AF, et! al. Using 
genetic, cognitive and multi-modal neuroimaging data to 
identify ultra-high-risk and "rst-episode psychosis at the indi-
vidual level. Psychol Med. 2013;43(12):2547–2562.
 19. Borgwardt!S, Koutsouleris!N, Aston!J, et!al. Distinguishing 
prodromal from "rst-episode psychosis using neuroana-
tomical single-subject pattern recognition. Schizophr Bull. 
2013;39(5):1105–1114.
 20. Xiao! Y, Yan! Z, Zhao! Y, et! al. Support vector machine-
based classi"cation of "rst episode drug-naïve schizophrenia 
patients and healthy controls using structural MRI. Schizophr 
Res. 2017 Dec 2. pii: S0920-9964(17)30735-1. doi: 10.1016/j.
schres.2017.11.037. [Epub ahead of print]
 21. Nieuwenhuis!M, van!Haren!NE, Hulshoff!Pol!HE, Cahn!W, 
Kahn! RS, Schnack! HG. Classi"cation of  schizophre-
nia patients and healthy controls from structural MRI 
scans in two large independent samples. Neuroimage. 
2012;61(3):606–612.
 22. Schnack! HG, Kahn! RS. Detecting neuroimaging biomark-
ers for psychiatric disorders: sample size matters. Front 
Psychiatry. 2016;7:50.
 23. Arbabshirani!MR, Plis!S, Sui!J, Calhoun!VD. Single subject 
prediction of brain disorders in neuroimaging: promises and 
pitfalls. Neuroimage. 2017;145:137–165.
 24. Janssen! RJ, Mourão-Miranda! J, Schnack! HG. Making 
individual prognoses in psychiatry using neuroimag-
ing and machine learning. Biol Psychiatry Cogn Neurosci 
Neuroimaging. 2018;3(9):798–808.
 25. Woo!CW, Chang!LJ, Lindquist!MA, Wager!TD. Building bet-
ter biomarkers: brain models in translational neuroimaging. 
Nat Neurosci. 2017;20(3):365–377.
 26. Vieira! S, Pinaya! WH, Mechelli! A. Using deep learning to 
investigate the neuroimaging correlates of psychiatric and 
neurological disorders: methods and applications. Neurosci 
Biobehav Rev. 2017;74:58–75.
 27. Plis! SM, Hjelm! DR, Salakhutdinov! R, et! al. Deep learn-
ing for neuroimaging: a validation study. Front Neurosci. 
2014;8:229.
 28. Schnack! HG. Improving individual predictions: machine 
learning approaches for detecting and attacking heterogeneity 
in schizophrenia (and other psychiatric diseases). Schizophr 
Res. 2017 Oct 24. pii: S0920-9964(17)30649-7. doi:10.1016/j.
schres.2017.10.023. [Epub ahead of print]
 29. Gong!Q, Dazzan!P, Scarpazza!C, et!al. A neuroanatomical 
signature for schizophrenia across different ethnic groups. 
Schizophr Bull. 2015;41(6):1266–1275.
 30. Di! Forti! M, Morgan! C, Dazzan! P, et! al. High-potency 
cannabis and the risk of psychosis. Br J Psychiatry. 
2009;195(06):488–491.
 31. Pelayo-Terán!JM, Pérez-Iglesias!R, Ramírez-Bonilla!M, et!al. 
Epidemiological factors associated with treated incidence of 
"rst-episode non-affective psychosis in Cantabria: insights 
from the Clinical Programme on Early Phases of Psychosis. 
Early Interv Psychiatry. 2008;2(3):178–187.
 32. Korver! N, Quee! PJ, Boos! HB, Simons! CJ, de! Haan! L; 
GROUP investigators. Genetic Risk and Outcome of 
Psychosis (GROUP), a multi-site longitudinal cohort 
study focused on gene-environment interaction:  objectives, 
 sample characteristics, recruitment and assessment 
 methods. Int J Methods Psychiatr Res. 2012;21(3):205–221.
 33. APA. Diagnostic and Statistical Manual of Mental Disorders 
4th Edition (DSM!IV!TR). Washington, DC: American 
Psychiatric Association; 2000.
 34. Organization World Health. International Classi!cation of 
Diseases, Tenth Revision. Geneva, Switzerland: World Health 
Organization; 1992.
 35. Ashburner! J. A fast diffeomorphic image registration algo-
rithm. Neuroimage. 2007;38(1):95–113.
 36. Hutton!C, De!Vita!E, Ashburner!J, Deichmann!R, Turner!R. 
Voxel-based cortical thickness measurements in MRI. 
Neuroimage. 2008;40(4):1701–1710.
 37. Hutton! C, Draganski! B, Ashburner! J, Weiskopf! N. A 
comparison between voxel-based cortical thickness and 
voxel-based morphometry in normal aging. Neuroimage. 
2009;48(2):371–380.
 38. Fischl!B. FreeSurfer. Neuroimage. 2012;62(2):774–781.
 39. Altman!NS. An introduction to kernel and nearest-neighbor 
nonparametric regression. Am Stat. 1992;46(3):175–185.
 40. Zou! H, Hastie! T. Regularization and variable selection via 
the elastic net. J R Stat Soc Ser B (Statistical Methodol). 
2005;67(2):301–320.
 41. Pereira! F, Mitchell! T, Botvinick! M. Machine learning 
classi"ers and fMRI: a tutorial overview. Neuroimage. 
2009;45(1):S199–S209.
 42. Vapnik! V. The Nature of Statistical Learning Theory. New 
York: Springer; 1995.
 43. LeCun! Y, Bengio! Y, Hinton! G. Deep learning. Nature. 
2015;521(7553):436–444.
 44. Varoquaux! G. Cross-validation failure: small sample sizes 
lead to large error bars. Neuroimage. 2018;180:68–77.
 45. Arlot!S, Celisse!A. A survey of cross-validation procedures 
for model selection. Stat Surv. 2010;4:40–79.
 46. Varma!S, Simon!R. Bias in error estimation when using cross-val-
idation for model selection. BMC Bioinformatics. 2006;7(1):91.
 47. Salvador!R, Radua!J, Canales-Rodríguez!EJ, et!al. Evaluation 
of machine learning algorithms and structural features for 
optimal MRI-based diagnostic prediction in psychosis. PLoS 
One. 2017;12(4):e0175683.
 48. Dluho#!P, Schwarz!D, Cahn!W, et!al. Multi-center machine 
learning in imaging psychiatry: a meta-model approach. 
Neuroimage. 2017;155:10–24.
 49. Rozycki!M, Satterthwaite!TD, Koutsouleris!N, et!al. Multisite 
machine learning analysis provides a robust structural imag-
ing signature of schizophrenia detectable across diverse 
patient populations and within individuals. Schizophr Bull. 
2018;44(5):1035–1044.
 50. Marquand! AF, Rezek! I, Buitelaar! J, Beckmann! CF. 
Understanding heterogeneity in clinical cohorts using nor-
mative models: beyond case-control studies. Biol Psychiatry. 
2016;80(7):552–561.
 51. Sato!JR, Rondina!JM, Mourão-Miranda!J. Measuring abnor-
mal brains: building normative rules in neuroimaging using 
one-class support vector machines. Front Neurosci. 2012;6:178.
 52. Tandon! N, Tandon! R. Will machine learning enable us to 
"nally cut the gordian knot of schizophrenia. Schizophr Bull. 
2018;44(5):939–941.
 53. Bzdok! D, Yeo! BTT. Inference in the age of  big data: 
future perspectives on neuroscience. Neuroimage. 
2017;155:549–564.
 54. de!Moura!AM, Pinaya!WHL, Gadelha!A, et!al. Investigating 
brain structural patterns in "rst episode psychosis and 
schizophrenia using MRI and a machine learning approach. 
















                   Supplementary material 
 
Contents 
1. eMethods ........................................................................................................................................... 2 
1.1. Participants ..................................................................................................................................... 2 
1.1.1. Recruitment procedure and criteria .............................................................................................. 2 
1.1.2. Matching ...................................................................................................................................... 4 
1.2. MRI data acquisition ....................................................................................................................... 5 
1.3. MRI preprocessing .......................................................................................................................... 5 
1.3.1. Voxel-based maps ....................................................................................................................... 5 
1.3.2. Surface-based volume and cortical thickness .............................................................................. 6 
1.4. eStatistical analysis ......................................................................................................................... 7 
1.4.1. Group-level analysis .................................................................................................................... 7 
1.4.2. Multivariate pattern recognition analysis ...................................................................................... 7 
1.4.2.1. Dimensionality reduction: principal component analysis ........................................................... 7 
1.4.2.2. Feature scaling: Standardization .............................................................................................. 8 
1.4.2.3. Classifiers ................................................................................................................................. 8 
1.4.2.4. Performance measures ............................................................................................................ 11 
1.4.2.5. Significance testing…………………………………………………………………………………...11 
1.4.2.6. Effect of medication and psychotic symptoms…………………………………………................12 
2. eResults ........................................................................................................................................... 12 
2.1. Group-level analyses .................................................................................................................... 12 
3. eDiscussion ...................................................................................................................................... 21 
3.1. Association between sample size and classification accuracy ..................................................... 21 




eTable 1. Sample size of each dataset. ................................................................................................. 4 
eTable 2. Image acquisition parameters for each site. ........................................................................... 5 
eTable 3. Parameters for tuning for DNN. ............................................................................................. 11 
eTable 4. Group-level analysis: GMV. .................................................................................................. 13 
eTable 5. Group-level analysis: VBCT. ................................................................................................. 14 
eTable 6. Group-level analysis: surface-based regional volumes and cortical thickness. ................... 15 
eTable 7. Group-level analysis controlling for age and gender: GMV. ................................................. 16 
eTable 8. Group-level analysis controlling for age and gender: VBCT. ................................................ 16 
eTable 9. Group-level analysis controlling for age and gender: surface-based regional volumes and 
cortical thickness. ................................................................................................................................. 16 
eTable 10. Statistical significance for all classifiers. ............................................................................. 18 
eTable 11. Odds ratio, confidence interval and p-value for the effects of anti-psychotic medication and 












1.1.1. Recruitment procedure and criteria 
Site1: Chengdu, China 
First episode patients were recruited from the West China Hospital of Sichuan University in 
Chengdu (China), as part of a wider study of psychiatric disorders in China. Diagnosis and 
duration of illness were determined by the consensus of two clinical psychiatrists using the 
Structured Interview for the DSM-IV Axis I Disorder (SCID)1. At the time of scanning, all 
patients were medication-naïve. Healthy controls were recruited by poster advertisement and 
screened using the SCID-I to confirm the lifetime absence of psychiatric disorders, as well as 
interviewed and subsequently excluded if they had any known history of psychiatric illness in 
first-degree relatives. Participants were excluded if they met any of the following criteria: (i) 
history of drug or alcohol abuse, (ii) pregnancy, and (iii) any physical illness such as hepatitis, 
cardiovascular disease, or neurological disorder, as assessed by interview and review of 
medical records.   
 
Site 2: London, England 
Participants were recruited from the South London and Maudsley Foundation Trust and 
scanned at the Institute of Psychiatry, Psychology and Neuroscience in London (England). 
Diagnosis of schizophrenia was formulated by an experienced psychiatrist using the ICD-10 
criteria. Healthy controls were recruited through local advertisement from the same 
geographical areas as patients. A screening tool (Psychosis Screening Questionnaire2) was 
used to exclude the presence of psychotic symptomatology or a history of psychotic illness. 
Additional exclusion criteria for all participants included learning disabilities (based as an IQ < 
70), current or past neurological illness, brain injury with loss of consciousness for more than 










Sites 3 and 4: Santander A and B, Spain 
Data from Santander A and Santander B were acquired as part of the same large prospective 
longitudinal study on first episode psychosis in the region of Cantabria, although with two 
different scanners (eTable 2). Individuals with FEP were recruited from both inpatient units and 
community services throughout the entire region. Patients were included if they met the 
following criteria: 1) age 15–60 years; 2) DSM-IV criteria for a principal diagnosis of 
schizophrenia, schizophreniform disorder, schizoaffective disorder, brief reactive psychosis, 
or not otherwise specified psychosis; and 3) no prior treatment with antipsychotic medication 
or, if previously treated, a total lifetime of adequate antipsychotic treatment of less than 6 
weeks. Patients with DSM-IV based diagnoses of mental retardation or substance 
dependence (except nicotine dependence) were excluded. Age and gender matched healthy 
controls were recruited from the community through advertisements and were screened for 
current or past history of psychiatric, mental retardation, neurological or general medical 
illness, including substance dependence and significant loss of consciousness, as determined 
by using an abbreviated version of the Comprehensive Assessment of Symptoms and History 
(CASH)3. Clinical records and family interview also confirmed the absence of psychosis in 
first-degree relatives. 
 
Site 5: Utrecht, The Netherlands 
Inpatients and outpatients were identified by clinicians working in regional psychosis 
departments or academic centres and were included if they met the following criteria: 1) age 
range of 16 to 50 years; 2) a diagnosis of nonaffective psychotic disorder according to the 
DSMIV; 3) good command of the Dutch language; and 4) able and willing to give written 
informed consent. Controls were selected through a system of random mailings to addresses 
in the catchment areas of the cases and were included if the following criteria were met: 1) 
age range of 16 and 50 years, 2) no lifetime psychotic disorder, 3) no first-degree family 
member with a lifetime psychotic disorder, 4) good command of the Dutch language, and 5) 











To maximize the use of the data made available, matching was carried out by taking the group 
with smallest sample size (first episode psychosis (FEP) or healthy controls (HC)) and 
randomly selecting participants from the other group according to age (+/- 5 years) and gender. 
For all sites, the FEP:HC matching ratio was 1:1, except for site 4 where the ratio was 2:1.  
 
eTable 1. Sample size of each dataset. We report the number of subjects available (top row), 
the number of subjects excluded after matching patients and controls for age and gender 




















Available 330 204 257 223 225 
Excluded 108 62 37 13 63 










1.2. MRI data acquisition  
eTable 2. Image acquisition parameters for each site. 
 
1.3. MRI preprocessing 
After checking all T1-weighted images for scanner artefacts and gross anatomical 
abnormalities, images were preprocessed to extract three types of anatomical features: voxel-
based grey matter volume, voxel-based cortical thickness and surface-based volumes and 
cortical thickness. 
 
1.3.1. Voxel-based maps 
Two different voxel-based features were extracted: grey matter volume and cortical thickness. 
Common to both features, images were first reoriented along the anterior-posterior 
commissure line and set the anterior commissure as the origin of the spatial coordinates to 
assist the normalization algorithm. Reoriented images were then segmented into grey matter 
(GM), white matter (WM) and cerebrospinal fluid (CSF) partitions as implemented in SPM124 
(http://www.fil.ion.ucl.ac.uk/spm).  
 
1.3.1.1. Grey matter volume  
The segmentation tissue maps for each site were pre-processed separately using the 
Diffeomorphic Anatomical Registration using the Exponentiated Lie algebra (DARTEL) 
 Site 1 Site 2 Site 3 Site 4 Site 5 
Field strength 
(T) 3 3 3 1.5 1.5 
TR/TE (ms) 8.5/3.4 6.9/2.8 8.2/3.7 24/5 30/4.6 
Slice thickness 
(mm) 1 1.2 1 1.5 1.2 
Data matrix 512x512x156 256x256x166 256x256x160 256x256x124 256x256x170 









toolbox5. This procedure warps the grey matter and white matter partitions into a new study-
specific reference space representing an average of all the subjects included in the analysis, 
thus maximizing accuracy and sensitivity6,7. The warped grey matter partitions were then 
affine-transformed into MNI space. An additional modulation step was used to scale the grey 
matter probability values by the Jacobian determinants of the deformations, thereby ensuring 
that the total amount of grey matter in each voxel was conserved after registration8. Finally, the 
GM probability maps were smoothed using a standard 8mm FWHM Gaussian kernel. 
 
1.3.1.2. Cortical thickness 
A voxel-based Laplacian method9, implemented as an SPM toolbox10,11, was used to create a 
voxel-based cortical thickness (VBCT) map for each subject using the GM, WM and CSF 
partitions generated in the segmentation step. Briefly, the resulting VBCT maps contained 
cortical thickness (CT) values within voxels identified as grey matter and zeros outside the 
cortex. Each VBCT map was warped into the corresponding site-specific DARTEL reference 
space. The warped images were then normalized to MNI space and smoothed with a 6 mm 
Gaussian kernel. The same warps, modulation and smoothing were also applied to a binary 
mask created from each original VBCT map. Subsequently the warped, scaled and smoothed 
VBCT maps were divided by the corresponding warped, scaled, and smoothed mask.   
 
1.3.2. Surface-based volume and cortical thickness 
FreeSurfer 5.3 (http://surfer.nmr.mgh.harvard.edu)12 was used to parcellate each participant’s 
raw brain image into subcortical and cortical regions according to the Desikan-Killiany atlas13 
using the ‘recon-all’ command. FreeSurfer is a well-established automated procedure for 
imaging preprocessing and analysis which details have been extensively described 
elsewhere14–16. A total of 169 features were used, including 33 volumes of subcortical 
structures plus volume and thickness of 34 cortical regions per hemisphere (after removing 











1.4. eStatistical analysis 
1.4.1. Group-level analysis 
1.4.1.1. Grey matter volume and cortical thickness 
Voxel-based morphometry (VBM) was used to calculate group-level differences in voxel-
based grey matter volume and voxel-based cortical thickness between FEP and HC groups 
at each site. An independent-sample t-test was used with statistical inferences made at p<0.05 
after family-wise error (FWE) correction for multiple comparisons and a minimum extent 
threshold of 5 voxels.  
 
1.4.1.2. Surface-based regional volumes and cortical thickness 
Surface-based regional volumes and cortical thickness were analysed with an independent-
sample t-test as implemented in SPSS 24.0 using a statistical threshold of p<0.05 and 
additional Bonferroni correction for multiple comparisons.  
 
All reported results (eResults, section 2.1) were obtained without covariates of no interest to 
ensure consistency between group- and individual-level statistical analyses. However, 
statistical analyses with age and gender as covariates were also carried out for completeness; 
this yielded identical results except for surface-based regional volumes and cortical thickness 
data (eTable 7-9). 
 
1.4.2. Multivariate pattern recognition analysis 
1.4.2.1. Dimensionality reduction: principal component analysis 
Principal component analysis (PCA) is a well-established unsupervised method for feature 
reduction in neuroimaging. PCA reduces dimensionality by geometrically projecting the data 
into lower dimensions called principal components (PCs), with the aim of finding the best 
summary of the data using a limited number of PCs. PCA uses an orthogonal transformation 









uncorrelated features (PC). PCs are then ranked according to explained variance in 
descending order. A detailed description of PCA is given elsewhere17,18. In the present 
investigation, PCA was implemented within the CV framework; at each fold, dimensionality 
was reduced by 1) extracting the minimum number of principal components whilst retaining 
cumulative 90% of the variance from the data in the training set only, 2) projecting all grey 
matter/cortical thickness maps onto the resulting principal components and 3) using the 
resulting values for classification and 4) projecting the test data into the same components 
derived from the training set, and using the former for testing. 
 
1.4.2.2. Feature scaling: Standardization 
Standardization was performed by removing the mean and scaling to unit variance. This 
procedure was applied to each feature independently. Standardization is a common 
requirement for many ML methods, since algorithms might behave poorly if the individual 
features do not resemble normally distributed data. In addition, features with bigger scales 
might dominate the loss function of the training algorithms. To avoid “double dipping”, the 
statistics (mean and variance) were obtained using only the training set, and these same 
values were used in the standardization of test set. 
 
1.4.2.3. Classifiers 
K-nearest neighbour (KNN), logistic regression (LR) and support vector machine (SVM) were 
implemented using the Scikit-Learn library19 (sklearn) for python 3.5. Deep neural network 
(DNN) was implemented using Tensorflow v.1.420 and Keras v.2.121 libraries. The random seed 
was kept the same for all models to ensure the reproducibility of the results. This approach 
guaranteed that the starting weights and train/test split at each fold of the CV would remain 










1.4.2.3.1.  K-nearest neighbours 
K-nearest neighbours (KNN) is a non-parametric method based on multivariate pairwise 
distance measures between data points. Once presented with unseen data, it calculates the 
Euclidean distance between this new data point and each of the surrounding neighbours. 
Classification is done by assigning the unseen data to the same class as the majority of its 
neighbours22. The optimal number of neighbours was tuned via grid search by testing 10 
possible odd values ranging from 3 to 21 in increments of 2. 
 
1.4.2.3.2. Logistic regression 
Logistic regression (LR) was implemented via elastic net, a regularized regression that 
combines the regularizations L1 and L2 penalties of LASSO (Least Absolute Shrinkage and 
Selection Operator) and ridge regression, respectively. While the ridge penalty retains all 
variables and minimizes the impact of irrelevant features, the LASSO penalty discards 
unimportant variables23. Grid search was used to find the optimal relative contribution of each 
penalty via tuning of the hyperparameter l1_ratio as defined by sklearn from eleven possible 
values between 0 and 1 with increments of 0.1. 
 
1.4.2.3.3. Support vector machine 
Support vector machine (SVM) is a supervised machine learning technique that maps the 
input data into a feature space using a set of similarity functions known as kernels. In this 
feature space, the model finds the optimal separating hyperplane by finding the largest margin 
of separation between the two classes within the training set. Once the hyperplane is 
determined, it can be used to predict the class of new unseen observations24,25. In this study, 
a linear kernel was chosen to contrast with the characteristic non-linear approach of DL. The 
soft margin (C) parameter, that controls the trade-off between having zero training errors and 
allowing misclassifications, was tuned from a possible range of values (2-5, 2-3, ..., 213, 215) 










1.4.2.3.4. Deep neural network 
Given its flexible architecture, deep learning can be used to build a variety of different neural 
networks26. Here we employed a deep neural network, with the components resulting from the 
PCA (for the VBM and VBCT data) or the regional volumes and cortical thickness as inputs; 
this architecture was chosen as it allowed for automated and non-biased optimization of the 
hyperparameters, which in turn helps prevent overfitting. Deep neural networks are multi-
layered fully-connected networks where higher-level features are learned as a non-linear 
combination of lower-level features, thus allowing the extraction of complex and abstract 
patterns from the data. Once the model learns these higher-level features, it can determine a 
separation surface to classify the different classes26,27.  The performance of DNN models relies 
on the specification of several architectural and learning hyperparameters. To prevent bias, 
the number of layers, number of units, optimizer, learning rate, decay, activation function and 
epoch and were optimized using random search as implemented by sklearn. To decrease the 
chances of overfitting, two additional parameters were also included at each layer: i) L2 
regularizer, which penalizes high weights28 and ii) dropout, where randomly selected neurons 
are ignored during training29. Each layer was initialized via Glorot (also known as Xavier) 
initialization (normal distribution)30. In the output layer, the classification was performed by a 
softmax function. Training was carried out using a mini-batch with 8 training samples for VBM 
and VBCT, and 128 for surface-based volumes and cortical thickness. DNN models were 
optimized via random search due to the high number of parameters to test: at each fold, 500 
different combinations of randomly selected values for each parameter were tested. eTable 3, 
shows all the possible values for each parameter.  


























1.4.2.4. Performance measures 
Performance metrics were calculated according to the below formulas: 
Sensitivity = TP/(TP+FN) 
Specificity = TN/(TN+FP) 
Balanced accuracy = (Sensitivity + Specificity)/2 
 
1.4.2.5. Significance testing 
The balanced accuracy of each classifier was tested for significance using permutation testing, 
whereby subjects were randomly assigned to one of the classes (patients/control), so that the 
labels no longer match the data in any meaningful way, and the 10-fold CV cycle repeated 
1000 times. This resulted in a distribution of accuracies reflecting the null hypothesis that the 
classifier did not exceed chance. The number of times the classifier’s performance was greater 
Parameter Values 
Number of layers 2, 3, 4, 5 
Number of units 10, 20, 50, 75, 100, 150 
Activation function ReLU, Leaky ReLU 
Learning rate 0.001, 0.005, 0.01, 0.1, 0.2 
Learning rate decay 10-6, 10-5, 10-4, 10-3 
Epochs 50, 100, 150 
Optimizer Stochastic gradient descent (SGD), Adam 
Momentum 0.99, 0.9, 0.95 
L2 coefficient  10-5, 10-4, 10-3, 10-2 









than or equal to the true accuracy was divided by 1000 to determine a p-value. A p-value lower 
than 0.05 was considered statically significant.  
 
1.4.2.6. Effect of medication and psychotic symptoms 
To examine whether anti-psychotic medication and psychotic symptoms contributed to the 
classifiers’ performance, chlorpromazine equivalents and positive and negative psychotic 
symptoms were regressed against the predicted labels using a logistic regression as 
implemented by the Logit function from the statsmodel python library. Because all patients 
from site 1 were anti-psychotic naïve, the investigation of the effects of medication was limited 
to sites 2, 3, 4 and 5. The size of the effects of medication and psychotic symptoms was 
measured in terms of odds ratio (OR) and respective 95% confidence interval (CI). The 
statistical significance threshold was set to 0.05. 
 
2. eResults 
2.1. Group-level analyses 
No significant GMV decreases in FEP relative HC were found at any site. In contrast, GMV 
increases were detected in the bilateral thalamus at site 3; in the left putamen and the right 
pallidum at site 4; and in the right putamen at site 5. No significant increased or decreased 
VBCT was observed in FEP compared to HC at any site, except for site 1 in which FEP showed 
increased thickness in the left fusiform gyrus and left superior frontal gyrus. Significant 
differences in surface-based regional volumes and cortical thickness between FEP and HC 
were found for sites 3 and 4. At site 3, patients showed smaller right hippocampus volume as 
well as a reduced thickness of the inferior parietal lobe; whereas at site 4 patients showed a 
significant cortical thinning in the left inferior temporal gyrus, pars opercularis and rostral 



















(No. of Voxels) 
z p 
FEP > HC     
Site 3     
      Left thalamus -16,-28,12 37 5.5 .006 
      Right thalamus 16,-24,14 17 4.7 .014 
Site 4     
      Left putamen -30,-12,-4 118 5.3 .001 
      Right pallidum 20,-10,-4 17 4.6 .014 
Site 5     










































FEP > HC     
Site 1     
      Left fusiform gyrus -30,-10,-36 11 4.7 .012 


















eTable 6. Group-level analysis: surface-based regional volumes and cortical thickness.  
Region t p 
FEP < HC   
Site 3   
      Right hippocampus 4.3 <.001 
      Left inferior parietal (thickness) 3.9 <.001 
Site 4   
      Left inferior temporal gyrus (thickness) 3.6 <.001 
      Left pars opercularis (thickness) 4.0 <.001 
      Left rostral middle frontal gyrus (thickness) 4.8 <.001 
FEP > HC   
Site 4   





















(No. of Voxels) 
z p 
FEP > HC     
Site 3     
      Left thalamus -16,-28,12 40 5.6 .006 
      Right thalamus 16,-24,14 19 4.8 .014 
Site 4     
      Left putamen -30,-14,-2 110 5.1 .001 
      Right pallidum 28,-10,-4 17 4.6 .014 
Site 5     






(No. of Voxels) 
z p 
FEP > HC     
Site 1     
      Left fusiform gyrus -30,-10,-36 16 5.0 .008 









eTable 9. Group-level analysis controlling for age and gender: surface-based regional 
volumes and cortical thickness. 
Region F p 
FEP < HC   
Site 3   
      Right hippocampus 22.4 <.001 
      Left inferior parietal gyrus (thickness) 20.7 <.001 
      Left precuneos (thickness) 15.3 <.001 
      Left superior frontal gyrus (thickness) 12.8 <.001 
      Left supramarginal gyrus (thickness)  17.2 <.001 
Site 4   
      Left parsopercularis (thickness) 15.6 <.001 
      Left rostral middle frontal gyrus (thickness) 21.9 <.001 
Site 5   
     Left hippocampus 15.7 <.001 
FEP > HC   
Site 3   
      Left lateral ventricle 14.8 <.001 
Site 4   











 eFigure 3. Balanced accuracies and standard deviations of the different algorithms and feature sets for 
each site.  
 
KNN: k-nearest neighbours; LR: logistic regression; SVM: support vector machines; DNN: deep neural 































KNN .003 .001 .002 
LR .003 .003 .001 
SVM .003 .004 .013 




KNN .083 .891 .200 
LR .381 .346 .009 
SVM .757 .207 .450 




KNN .004 .444 .011 
LR .021 .002 .013 
SVM .005 .001 .036 




KNN .041 .003 .028 
LR .129 .012 .001 
SVM .081 .032 .030 





KNN .237 .163 .262 
LR .033 .003 .007 
SVM .007 .004 .408 









eTable 11. Odds ratio, confidence interval and p-value for the effects of anti-psychotic medication and psychotic symptoms 
on predicted labels. 
 







































































































































































































































































































































































































3.1. Association between sample size and classification accuracy 
Accuracy and sample sizes from existing studies using ML and sMRI were extracted 
as follows:  
• - up until and including 2013, this information was taken from the latest meta-
analysis Kambeitz et al31; 
• - from 2014 to 2016 this information was taken from the review Arbabshirani et 
al32; 
• - seven further subsequent studies were identified: Pinaya et al33; Salvador et 
al34; Winterburn et al35; Xiao et al36; Rozycki et al37; Dluhoš et al38 and de Moura 
et al39. Xiao et al36 was excluded as it was a clear outlier (see Figure 3a). 
•  
Pearson’s correlation was used to test for the association between all sample sizes 
and accuracies. The same studies were used for Figure 1a. 
 
3.2. Publication bias 
Sample size, true positives, false positives, true negatives and false negative scores 
from each study as well as the overall main effect of ML-sMRI studies in psychosis 
(established schizophrenia and FEP combined) were extracted from Kambeitz et al31. 
Publication bias was assessed using the same procure as in Kambeitz et al31 which in 
turn was based on recommendations for diagnostic classification studies described in 
Deeks et al40. Briefly, a measure of sample size and effect size were calculated as 
follows: 
• Effective sample size (ESS) was calculated from the patients and control 
















The resulting funnel plot was tested for asymmetry through a regression analysis 
weighted by ESS as implemented in R statistical programming language version 
1.1.453 (R Core Team, 2016). 
 
References 
1.  First MB, Gibbon M, Spitzer RL WJ. Structured Clinical Interview for DSM-IV 
Axis II Personality Disorders. American Psychiatric Press: Washington; 1997. 
2.  Bebbington P, Nayani T. The psychosis screening questionnaire. Int J Methods 
Psychiatr Res. 1995;5:11-19. 
3.  Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of 
Symptoms and History (CASH). Arch Gen Psychiatry. 1992;49(8):615. 
doi:10.1001/archpsyc.1992.01820080023004 
4.  Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26(3):839-
851. doi:10.1016/j.neuroimage.2005.02.018 
5.  Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 
2007;38(1):95-113. doi:10.1016/j.neuroimage.2007.07.007 
6.  Yassa M, Stark C. A quantitative evaluation of cross-participant registration 
techniques for MRI studies of the medial temporal lobe. Neuroimage. 
2009;44(2):319-327. doi:10.1016/j.neuroimage.2008.09.016 
7.  Scarpazza C, Tognin S, Frisciata S, Sartori G, Mechelli A. False positive rates 
in Voxel-based Morphometry studies of the human brain: Should we be worried? 
Neurosci Biobehav Rev. 2015;52:49-55. doi:10.1016/j.neubiorev.2015.02.008 
8.  Mechelli A, Price C, Friston K, Ashburner J. Voxel-Based Morphometry of the 










9.  Jones SE, Buchbinder BR, Aharon I. Three-dimensional mapping of cortical 
thickness using Laplace’s equation. Hum Brain Mapp. 2000;11(1):12-32.  
10.  Hutton C, De Vita E, Ashburner J, Deichmann R, Turner R. Voxel-based cortical 
thickness measurements in MRI. Neuroimage. 2008;40(4):1701-1710. 
doi:10.1016/j.neuroimage.2008.01.027 
11.  Hutton C, Draganski B, Ashburner J, Weiskopf N. A comparison between voxel-
based cortical thickness and voxel-based morphometry in normal aging. 
Neuroimage. 2009;48(2):371-380. doi:10.1016/j.neuroimage.2009.06.043 
12.  Fischl B. FreeSurfer. Neuroimage. 2012;62(2):774-781. 
doi:10.1016/j.neuroimage.2012.01.021 
13.  Desikan RS, Ségonne F, Fischl B, et al. An automated labeling system for 
subdividing the human cerebral cortex on MRI scans into gyral based regions 
of interest. Neuroimage. 2006;31(3):968-980. 
doi:10.1016/j.neuroimage.2006.01.021 
14.  Dale AM, Fischl B, Sereno MI. Cortical Surface-Based Analysis. Neuroimage. 
1999;9(2):179-194. doi:10.1006/nimg.1998.0395 
15.  Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling 
of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341-355. 
doi:10.1016/S0896-6273(02)00569-X 
16.  Fischl B, Salat DH, van der Kouwe AJW, et al. Sequence-independent 
segmentation of magnetic resonance images. Neuroimage. 2004;23:S69-S84. 
doi:10.1016/j.neuroimage.2004.07.016 
17.  Jolliffe I. Principal Component Analysis. Springer, Berlin; 2002. 
18.  Lever J, Krzywinski M, Altman N. Points of Significance: Principal component 
analysis. Nat Methods. 2017;14(7):641-642. doi:10.1038/nmeth.4346 
19.  Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: Machine Learning in 
Python. J Mach Learn Res. 2011;12(Oct):2825-2830.  









Proceedings of the 2016 ACM SIGSAC Conference on Computer and 
Communications Security. 2016:308-318. doi:10.1145/2976749.2978318 
21.  Chollet F, others. Keras. 2015. 
22.  Altman NS. An Introduction to Kernel and Nearest-Neighbor Nonparametric 
Regression. Am Stat. 1992;46(3):175-185. 
doi:10.1080/00031305.1992.10475879 
23.  Zou H, Hastie T. Regularization and variable selection via the elastic net. J R 
Stat Soc Ser B (Statistical Methodol). 2005;67(2):301-320. 
24.  Pereira F, Mitchell T. Machine learning classifiers and fMRI : a tutorial overview. 
2008:1-21. doi: 10.1016/j.neuroimage.2008.11.007 
25.  Vapnik V. The Nature of Statistical Learning Theory. Springer; 1995. 
26.  LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521(7553):436-444. 
doi:10.1038/nature14539 
27.  Vieira S, Pinaya WHL, Mechelli A. Using deep learning to investigate the 
neuroimaging correlates of psychiatric and neurological disorders: Methods and 
applications. Neurosci Biobehav Rev. 2017;74:58-75. 
doi:10.1016/j.neubiorev.2017.01.002 
28.  Krogh A, Hertz JA. A Simple Weight Decay Can Improve Generalization. In: 
Lippman DS, Moody JE, Touretzky DS, eds. Advances in Neural Information 
Processing Systems, Vol. 4. Morgan Kaufmann; 1992:950-957. 
29.  Srivastava N, Hinton G, Krizhevsky A, Sutskever I, Salakhutdinov R. Dropout: A 
Simple Way to Prevent Neural Networks from Overfitting. J Mach Learn Res. 
2014;15:1929-1958. 
30.  Glorot X, Bengio Y. Understanding the difficulty of training deep feedforward 
neural networks. In: Proceedings of the Thirteenth International Conference on 
Artificial Intelligence and Statistics. 2010:249-256. 
31.  Kambeitz J, Kambeitz-Ilankovic L, Leucht S, et al. Detecting neuroimaging 









recognition studies. Neuropsychopharmacology. 2015;40(7):1742-1751. 
doi:10.1038/npp.2015.22 
32.  Arbabshirani MR, Plis S, Sui J, Calhoun VD. Single subject prediction of brain 
disorders in neuroimaging: Promises and pitfalls. Neuroimage. 2017;145:137-
165. doi:10.1016/j.neuroimage.2016.02.079 
33.  Pinaya WHL, Gadelha A, Doyle OM, et al. Using deep belief network modelling 
to characterize differences in brain morphometry in schizophrenia. Sci Rep. 
2016;6(38897). doi:10.1038/srep38897 
34.  Salvador R, Radua J, Canales-Rodríguez EJ, et al. Evaluation of machine 
learning algorithms and structural features for optimal MRI-based diagnostic 
prediction in psychosis. PLoS One. 2017;12(4):e0175683. 
doi:10.1371/journal.pone.0175683 
35.  Winterburn JL, Voineskos AN, Devenyi GA, et al. Can we accurately classify 
schizophrenia patients from healthy controls using magnetic resonance imaging 
and machine learning? A multi-method and multi-dataset study. Schizophr Res. 
December 2017. doi:10.1016/ j.schres.2017.11.038 
36.  Xiao Y, Yan Z, Zhao Y, et al. Support vector machine-based classification of first 
episode drug-naïve schizophrenia patients and healthy controls using structural 
MRI. Schizophr Res. December 2017. doi:10.1016/j.schres.2017.11.037 
37.  Rozycki M, Satterthwaite TD, Koutsouleris N, et al. Multisite Machine Learning 
Analysis Provides a Robust Structural Imaging Signature of Schizophrenia 
Detectable Across Diverse Patient Populations and Within Individuals. 
Schizophr Bull. 2018;44(5):1035-1044. doi:10.1093/schbul/sbx137 
38.  Dluhoš P, Schwarz D, Cahn W, et al. Multi-center Machine Learning in Imaging 
Psychiatry: A Meta-Model Approach. Neuroimage. 2017;155:10-24. 
doi:10.1016/j.neuroimage.2017.03.027 
39.  de Moura AM, Pinaya WHL, Gadelha A, et al. Investigating brain structural 






learning approach. Psychiatry Res Neuroimaging. 2018;275:14-20. 
doi:10.1016/j.pscychresns.2018.03.003 
40.  Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and 
other sample size effects in systematic reviews of diagnostic test accuracy was 
assessed. J Clin Epidemiol. 2005;58(9):882-893. 
doi:10.1016/j.jclinepi.2005.01.016 
 
 
 
 
 
 
 
 
 
 
 
